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Zusammenfassung III  
Zusammenfassung 
Umami ist neben süß, bitter, sauer und salzig eine der fünf Grundqualitäten des Geschmackssinnes. 
Dieser Geschmack ist charakteristisch für viele fermentierte Lebensmittel, wie Sojasauce. Umami-
Geschmack wird durch die Aminosäureionen L-Glutamat sowie durch die Nukleinsäureionen 
Inosinat und Guanosinat ausgelöst. Da die Akzeptanz der Konsumenten für Natriumglutamat 
jedoch stetig sinkt, steigt das Interesse der Lebensmittelindustrie an natürlichen umami aktiven 
Zusatzstoffen kontinuierlich. Diese Arbeit erforschte den Umami-Geschmack von unterschiedlich 
produzierten Weizengluten-Hydrolysaten. Am Anfang dieses Projektes wurde der Umami-
Geschmack der Hydrolysate untersucht und deren Peptid-Zusammensetzung bestimmt. Es wurden 
197 verschiedene Komponenten identifiziert, unter ihnen verschiedene bekannte umami aktive 
Substanzen wie Ile-Glu, Val-Glu, Val-Asp, Ser-Glu, Glu-Gln-Glu, Val-Val, pGlu-Pro, pGlu-Gln, 
und pGlu-Gly. Eine derartig detaillierte Analyse der Peptid-Zusammensetzung von Weizengluten-
Hydrolysaten, wurde bisher nicht beschrieben. Die Hydrolysate wurden fraktioniert mit dem Ziel, 
Fraktionen zu erzeugen, die weniger Substanzen enthalten, aber dennoch intensiven Umami 
Geschmack aufweisen. Eine Fraktionierung mittels Größenausschlusschromatographie (SEC) 
führte zu drei geschmacksaktiven Fraktionen. 93 % der Tester beschrieben eine fünffache 
Steigerung des Umami-Geschmacks. Die Peptide in diesen Fraktionen wurden genauer analysiert. 
Unter der Vielzahl der identifizierten Substanzen befanden sich einige, die ausschließlich in der 
einen oder anderen Fraktion detektiert wurden. Außerdem wurden die Umami aktiven Substanzen 
aus dem Ausgangshydrolysat erneut detektiert. Die große Anzahl der identifizierten Substanzen 
machte es zunächst unmöglich, eine einzelne umami aktive Substanz zu entdecken. Eine 
Subfraktionierung mittels präparativer HPLC führte nicht zu Subfraktionen mit intensiven Umami 
Geschmack, obwohl diese umami aktive Substanzen enthielten (Glu-Leu, Val-Glu, Val-Gly,  
Val-Asp, Pro-Glu, Pro-Gly, Pro-Thr, und diketo-Glu-Gln). Eine optimierte SEC wurde zur 
weiteren Subfraktionierung eingesetzt und geschmacksaktive Fraktionen generiert. Hier wurden 
17 Substanzen identifiziert, von denen 2 bekannte Umami-Aktivität aufwiesen (Glu-Leu,  
diketo-Glu-Pro). Die 15 verbleibenden müssen einzeln sensorisch analysiert werden, um 
Substanzen zu identifizieren, die Umami Geschmack aufweisen, bisher aber noch nicht 
beschrieben wurden. 
 
Schlagwörter: Umami, geschmacksaktive glutamyl-Peptide, Weizengluten- Hydrolysat, 
Fraktionierung, Größenausschluss-Chromatografie, präparative HPLC, sensorische Analyse, 
Massenspektrometrie 
IV  Abstract 
  
Abstract 
Umami is one of the five basic tastes beside sweet, bitter, sour, and salty. It is well known in 
various fermented food preparations like soy sauce. Umami represents the taste of L-glutamate and 
5’-ribonucleotides, such as guanosine and inosine monophosphate. Since the acceptance of the 
consumers for monosodium glutamate (MSG) is steadily declining, the interest of the food industry 
for umami active substitutes increased continuously. This study was based on the umami taste of 
wheat gluten hydrolysates. Differently produced hydrolysates were examined. At the beginning of 
this project, the overall umami taste of the samples and the peptide composition were determined. 
Up to 197 small biomolecules were identified, among them several umami active compounds like 
Ile-Glu, Val-Glu, Val-Asp, Ser-Glu, Glu-Gln-Glu, Val-Val, pGlu-Pro, pGlu-Gln, and pGlu-Gly. 
The composition of wheat gluten hydrolysate has not previously been described in such detail. A 
fractionation approach was performed to generate samples containing a lower number of 
substances while still imparting the umami taste.  
Fractionation via Size Exclusion Chromatography (SEC) led to three fractions eliciting intense 
umami taste. A fivefold increase of the umami taste was described by 93 % of the panellists. As 
before, their peptide composition was determined by UPLC-HR-QTOF-MS/MS. Several peptides 
were identified, which made the sub-fractions unique, and the known umami active compounds of 
the starting material were found again. However, the multitude of identified substances made it 
impossible to discover a single substance that imparted the umami taste. Another fractionation was 
performed. Sub-fractionation via prepHPLC did not lead to samples showing a significant umami 
taste in the sensory analysis, even though known umami active substances were identified  
(Glu-Leu, Val-Glu, Val-Gly, Val-Asp, Pro-Glu, Pro-Gly, Pro-Thr, and diketo-Glu-Gln). A refined 
SEC sub-fractionation approach led to taste active sub-fractions. Only 17 substances were 
identified in the sub-fractions, whereas two (Glu-Leu, diketo-Glu-Pro) of them had known umami 
activities. Sensory analysis of the remaining 15 single compounds needs to be performed to 
discover a compound with umami activity, which was not described yet.  
 
Keywords: Umami, taste active glutamyl peptides, wheat gluten hydrolysate, fractionation, Size 
Exclusion Chromatography, preparative HPLC, sensory analysis, mass spectrometry 
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1 Introduction 
1.1 Fermentation, a thousands of years old food processing step 
“La fermentation […] C’est la vie sans l’air, c’est la vie sans gaz oxygène libre” (Pasteur 1876) 
means, fermentation is life without air, it is life without free oxygen. That is how Louis Pasteur 
coined the term fermentation. Millennia ago, humans had begun using this technique by chance. 
At the present time, in biotechnology, all enzymatic and microbial processes leading to the 
conversion of organic substances, with or without oxygen, are summarised under the term 
fermentation (Spektrum Akademischer Verlag Heidelberg 2001).  
When our earliest ancestors milked dairy cattle, they used to drink the milk within hours. 
Otherwise, an unknown reaction was leading to a curdled and sour product in those days. Almost 
accidentally, this process took place in raw material that was unpreserved. One could say that 
fermented food was very likely among the first processed foods consumed by humans. Like Prof. 
Keith H. Steinkraus from the Cornell University mentioned in 1993: “The processes required for 
fermented foods were present on earth when man appeared on the scene… When we study these 
foods, we are in fact studying the most intimate relationship between man, microbes, and foods” 
(Steinkraus 1993). Soured milk and cheese are not the only products created by fermentation. For 
instance, sweet fruit juices of grapes are known to remain sweet for some days before they become 
a pleasant wine-like drink which is mostly liked for its organoleptic characteristics (Hutkins 2006).  
Asian people have been using this technique for centuries in a broad range of food preparations. 
These range from fermented vegetables, fish, and meat to fruits. Especially among the Chinese, 
Indians, Thais, Japanese, Korean, Vietnamese, and Taiwanese people, this is an integral part of 
their cuisine. These cultures are preparing fermented foods according to traditional methods to 
retain the taste impression they are used to (Sivamaruthi, Kesika et al. 2018). Well-known 
examples are the fermented fish sauces from Thailand, so-called nampla, nuoc mam (Vietnam) 
and shottsuru from Japan and the widely consumed fermented soybeans products soy sauce and 
miso (Nakano, Sato et al. 2018). In China, 5 million metric tons of soy sauce are produced 
annually, which equates to 50 % of the global production (Hoang, Ferng et al. 2016).  
Fermentation also has a long tradition in the far north of Sweden. One of their national dishes is 
canned fermented herring called Surströmming. The fermentation lasts several month, for this the 
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fish is placed in brine and stored in barrels before it is bottled in cans without sterilization. 
Although the cans are sealed airtight, the fermentation progresses. This becomes visible through 
the bulging of the cans. The finished dish is known for its intense taste as well as for its intense 
smell (Kobayashi, Kimura et al. 2000). However, fermentation is popular all over the world and 
found in every culture.  
1.2 Basics of fermentation  
Any kind of fermentation is based on the use of microorganisms. Not only their major role in the 
production of alcoholic beverages and food, but also the application of several microbial 
fermentation products as additives in food raised the interest of the food industry. Nowadays, solid-
state fermentation is the method of choice for industrial applications, because economic analyses 
indicated much higher enzyme titres or better product characteristics compared to submerged 
fermentation. Process conditions of fermentation like pH and temperature are limiting the number 
of usable microorganisms. Some bacteria, yeasts and fungi are suitable for this application. The 
most-well known representatives of the bacteria are Lactobacillus sp. (yoghurt production).  
Ethanol production, however, is carried out by yeast (Saccharomyces cerevisiae). Fungi like 
Penicilium roquefortii are used for the production of cheese and miso, and soy sauce is produced 
by Aspergillus oryzae, for example. Soy sauce is very popular due to its intense umami taste.  
Another commonality and at the same time an advantage over chemically synthesised products is 
the desire of consumers for natural foods (Couto and Sanromán 2006). 
1.3 Umami: from “flavour enhancer” to the fifth basic taste 
For centuries, humans believed that there were only four basic tastes: salty, sweet, bitter, and sour. 
Each of these tastes had its own function in humans. Foods rich in carbohydrates often taste sweet 
which helps to identify them as source of energy. Body functions, such as blood circulation or 
water balance are influenced by the absorption of sodium and other salts. Many individuals do not 
like the bitter taste of food. This is explained by the bitter taste of a variety of substances that are 
toxic or harmful for the human organism. To stabilize the acid-base balance of the body and to be 
safe from consuming spoiled food, the excessive intake of sour tasting foods is avoided.  
In the course of time, mankind has learned that there are substances that, although they cause a 
“warning taste” (bitter or sour), can still be consumed almost without hesitation  
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(Chaudhari and Roper 2010). One of the best known examples might be the world’s most popular 
beverage, coffee, which tastes bitter due to its caffeine content.  
Professor Kikunae Ikeda is the discoverer of umami (/uˈmɑːmi/, from Japanese: うま味), which 
means savory and delicious. At the beginning of the 20th century, Prof. Ikeda conducted research 
at the Department of Chemistry of Tokyo Imperial University. He focused on seaweed broth and 
started analysing the composition of this broth after boiling tofu (yudofu) in it. Finally he 
succeeded in extracting monosodium L-glutamate and identified it as the real umami, since this 
compound is responsible for the umami flavour. In 1908, Ikeda applied for a patent  
“a manufacturing method for seasoning with glutamic acid as the key component”, which was 
accepted the same year. Moreover, he proposed umami to be the fifth basic taste. Thus, he sparked 
a decade-long discussion among scientists (Ohkoshi 2018). Glutamate has a taste that is unlike 
any of the other four basic tastes. Many substances like 5’-inositate from dried bonito and  
5’-guanylate from dried Shiitake mushrooms were also found, in the following years, to elicit 
umami taste. Ongoing research shows that umami substances are present in a variety of foods. 
Nevertheless, due to the weak umami taste caused by most of the umami substances, the umami 
taste was debated for a long time. On the contrary, the umami substances were classified as flavour 
enhancers. It took nearly 80 years until the first international umami symposium was held in 
Hawaii in 1985 to discuss the number of problems with umami. Until then, no systematic 
psychophysical data existed for umami. Electrophysiological studies performed with monosodium 
glutamate revealed that no single taste fibres which respond exclusively to monosodium glutamate 
(MSG) were determined. All taste fibres that responded to MSG also responded to sodium 
chloride. There was no indication for the presence of taste fibres that are exclusively stimulated 
by umami substances. However, more advanced recent psychophysical and electrophysiological 
studies showed that umami is, without a doubt, an independent basic taste (Kurihara 2015).  
These data and the discovery of the umami taste receptors mGluR1, mGluR4, and T1R1 + T1R3 
led to the international recognition of umami as the fifth basic taste (Kurihara 2015). One could 
say that the taste of L-glutamate and other amino acids indicates the protein content of food. All 
functions correlating with taste can be viewed as nutritional quality control mechanisms. Scientists 
even hypothesise that fat could be a sixth taste impression (Calvo and Egan 2015). 
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1.4 Human taste perception 
1.4.1 Molecular pathway of tasting 
The perception of man is composed of his five traditional senses hearing, sight, touch, smell, and 
taste. Food intake is significantly influenced by each one of these senses. Salivation is stimulated, 
hormone levels rise, temperature is evaluated, and consistency of the food determines the physical 
safety. All this information, gained during food intake, is transmitted to the central nervous system 
via cranial nerves. In the central nervous system, past experience and olfactory input are combined 
to generate a physiological, emotional, and sensory response. The latter is mainly evoked by the 
human taste organ, the tongue. Taste sensation is caused by taste papillae, which are spread over 
the tongue. They can be divided into three different types:  
The circumvallate papillae are located in the middle and the back of the tongue. On the sides the 
foliate papillae are placed and the fungiform papillae, which settle two-third of the front surface 
(Figure 1.4-1) (Gravina, L Yep et al. 2013). 
 
Figure 1.4-1: Schematic illustration of the human tongue and the localisation of the three different types of 
taste papillae. Fungiform are located in the middle and the front of the tongue, foliates at the sides of the tongue 
and the circumvallate in the back of the tongue (Calvo and Egan 2015). 
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On the soft palate, the upper reaches of the oesophagus, the larynx, and the nasopharynx the 
papillae are found as well. Each individual human papilla consists of three to five taste buds, which 
in turn contain the different taste receptor cells (Smith and Boughter 2007). Five types of tightly 
packed cylindrical cells of epithelial origin form a single taste bud. The data on the number of cells 
found in literature is diffuse; it varies between 50 and 150 (Cygankiewicz, Maslowska et al. 2014) 
and 150 and 300 (Gravina, L Yep et al. 2013). However, it is uniformly reported that the cells have 
some characteristics of neurons, such as the creation of synaptic connections and the ability to 
depolarise (Clapp, Medler et al. 2006) (Mombaerts 2004). Taste buds are composed of three 
different kind of cells: the glial-like cells (type I), the receptor cells (type II), which contain the  
G protein-coupled taste receptors (GPCR), and the presynaptic cells (type III) (Figure 1.4-2). 
Incoming chemicals get in contact with these cells and trigger the taste sensation.  
 
Figure 1.4-2: Schematic illustration of a human taste bud. Taste buds consist of four different cell types, the 
glia-like cells (type I), receptor cells containing G protein-coupled receptors (type II), presynaptic cells  
(type III), and the taste cell precursors. Afferent nerve fibres recognizable synapses with type III cells  
(Calvo and Egan 2015). 
 
Type I cells are thought to transduce the salty taste; type II cells probably impart the bitter, sweet, 
and umami taste. Type III cells most likely mediate the sour taste and initiate cell communication 
and signalling via serotonin release to the afferent neurons (Gravina, L Yep et al. 2013).  
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1.4.2 Structure and activation of G protein-coupled receptors 
Type II cells, which are responsible for the umami taste, contain GPCR. These receptors make up 
the largest family of membrane proteins found in the human genome. Due to the broad spectrum 
of structurally diverse ligands, receptors can be activated and modulate several specific signalling 
pathways. Over 800 different GPCR are known, and they all have seven hydrophobic 
transmembrane segments. The intracellular carboxyl- and the extracellular amino-terminus are 
characteristics of this structural element (Figure 1.4-3) (Kobilka 2007). 
 
Figure 1.4-3: Schematic illustration of a G protein-coupled receptor. The receptor consists of seven 
transmembrane domains (TMD), which are embedded in the membrane. The amino-terminus is located in the 
extracellular and the carboxyl terminus in the intracellular space (Cygankiewicz, Maslowska et al. 2014).  
 
Even though all GPCR have the 7 transmembrane domains (TMD), they can be divided into five 
subfamilies according to differences in the sequences of the TMDs. The frizzled/taste family 
involves 24 members, the glutamate family 15 members, the secretin family 15 members, the 
adhesion family 24 members, and the rhodopsin family is the largest one with 701 members 
(Fredriksson, Lagerström et al. 2003). GPCR are able to bind a variety of structurally diverse 
ligands. The largest molecules, which are bound by the GPCR are peptides and proteins. Small 
organic molecules, ions like H+ and Ca2+, and photons (subatomic particles) can also be 
recognised. Glutamate binds to large amino-terminal domains and thus leads to the activation of 
the receptor (Kobilka 2007). Most of the ligands do not enter the cell, but bind to the N-terminal 
extracellular part of the receptor. The interaction of ligand and receptor leads to a conformational 
change of the receptor. This in turn leads to the binding of a guanyl nucleotide to the cytoplasmic 
receptor domain and the activation of the G protein. The G protein is present as a heterotrimer, 
consisting of the three subunits α, β and γ when it is in its inactive state. Generally, the α- and  
γ-subunits are covalently bound to the membrane via fatty acids. The receptor/ligand complex 
catalyses the exchange of bound guanosine diphosphate (GDP) for guanosine-5`-triphosphate 
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(GTP). This reaction is triggered by interaction of the complex with the G protein. The nucleotide 
itself is bound to the α-subunit. Simultaneously with the GTP binding to the α-subunit, it 
dissociates from the βγ-dimer and transmits the signal of ligand binding to the receptor. One 
receptor/ligand complex is enough to cause the exchange of GDP to GTP on hundreds of  
α-subunits at the same time. This leads to a signal amplification (Stryer 2012). The activated 
G protein stimulates the enzyme adenylate-cyclase, which catalyses the conversion of adenosine 
monophosphate (AMP) to cyclic adenosine monophosphate (cAMP). Furthermore, the 
phospholipase C (PLC) is activated. Signal transduction triggered by PLC is described in section 
1.4.4 (umami taste). The generated cAMP spreads out through the cell, whereas the G protein and 
the adenylate-cyclase remain membrane bound. 
 
Figure 1.4-4: Signal transduction triggered by an activated G protein coupled receptor (GPCR). Ligand 
binding to the extracellular domains of the GPCR leads to a conformational change of the intracellular domain 
of the receptor and the binding of a guanylnucleotide to the α-subunit of the G protein. The G protein trimer 
dissociates and the α-subunit binds to the adenylate-cyclase and activates it (Stryer 2012).  
 
In the next step, the intracellular concentration of second messenger increases, which results in the 
signal transduction in the cell. The most important second messengers are cAMP, cGMP, 
calcium ions, diacylglycerol and inositol-1,4,5-triphosphate. Protein kinase A is activated when 
the cyclic AMP binds to it. The main function of the protein kinase A is the specific 
phosphorylation of serine and tyrosine residues of target proteins which leads to a change of their 
activity. This leads to several different processes in the cell like gene expression or glycogen 
synthesis.  
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Each signal cascade has to be stopped after a while. G proteins are able to stop the signal 
transduction by themselves. The α-subunit has a GTPase activity, which allows the hydrolysis of 
GTP to GDP. After hydrolysis, the α-subunit/GDP complex binds again to the βγ-dimer and 
rebuilds the heterotrimer protein. Subsequently, the receptor also has to be inactivated to avoid the 
permanent activation of other G proteins.  
Two inactivation routes are known. The first one is the dissociation of the ligand from the receptor, 
which returns the receptor to its initial inactive state. Secondly, a kinase is activated by the 
triggered signalling pathway. The kinase phosphorylates serine- and tyrosine-residues at the 
carboxyl term of the receptor. The receptor is thereby inactivated.  
1.4.3 Salty taste mediated by type I cells 
Type I cells are responsible for the maintenance of the taste bud structure. They represent around 
50 % of the total number of taste bud cells Due to the expression of amiloride-sensitive sodium 
channel subunit α and the small voltage-gated inward Na2+ and outward K+ influx and outflux, 
respectively, they trigger the taste of salt. Until now, the downstream signalling mechanism caused 
by salt intake remains unknown. Nevertheless, type I cells play a role in cell signalling or cell 
communication. This function is based on the expression of a membrane bound ATPase, which 
degrades ATP in its surroundings. Furthermore, they probably have an influence on the control of 
the dissipation of cell signalling molecules throughout the taste bud and the isolation of ion 
fluctuations to specific areas (Calvo and Egan 2015) 
1.4.4 Sweet, bitter, and umami taste mediated by type II cells 
In 2010, only 3.8 % of German citizens were aware of the umami taste (Han, Mohebbi et al. 2018). 
However, all receptors that mediate one of this taste sensations belong to the same family, namely 
the taste receptor family (T1R). In 1999, two of the three family members (T1R1 and T1R2) were 
identified (Hoon, Adler et al. 1999). Three years later, in 2001, the third family member, T1R3, 
was identified in the human genome (Li 2009). The receptors are classified as class C GPCR based 
on the N-terminal Venus flytrap (VFT) domain. Other members of the T1R family are the 
metabotropic glutamate receptors (mGluRs), the γ-aminobutyric acid receptors B (GABABR), and 
the calcium sensing receptors (CaSR). The VFT consists of two subdomains, the lower lobe, and 
the upper lobe which are connected and represent the glutamate binding domain. Due to its  
bi-lobed architecture, the domain can be present in an open or closed conformation. Binding of 
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glutamate on one hand stabilises the dimer conformation of the receptor and on the other hand the 
closed conformation of the VFT (Zhang, Klebansky et al. 2008). As described in section 1.4.2, 
ligand binding, in this case glutamate, leads to the activation of the G protein-coupled receptor and 
the subsequent intracellular processes. First intracellular step of the umami taste sensing is the 
activation of a phospholipase β2 (PLCβ2). Synthesis of inositol triphosphate (IP3) is triggered by 
activated phospholipase. It hydrolyses the phospholipid phosphatidylinositol 4,5-bisphosphate 
(PIP2) into IP3 and diacylglycerol (DAG). IP3 stimulates the opening of the ion channel IP3R3. 
Open IP3R3 channels enable Ca
2+ release from the endoplasmic reticulum directly into the cytosol 
of the receptor cell. As a result, the intracellular concentration of Ca2+ increases and assumes two 
different functions there.  
First, it ensures the opening of the taste-selective ion channel TRPM5, which is located in the 
membrane. Secondly, it influences a gap junction hemichannel consisting of pannexin (Panx1). In 
2003, Liu and his colleagues found that Ca2+- depended opening of TRPM5 leads to Na+ influx in 
receptor cells, which in turn results in depolarisation of the cell (Liu and Liman 2003). 
 
 
Figure 1.4-5: Taste transduction mechanism. Ligand binding to the receptor results in conformational change 
and the dissociation of the trimeric G protein. Activation of phospholipase β2 (PLCβ2). The phospholipid PIP2 
is hydrolysed by PLCβ2 to inositol triphosphate (IP3) and diacylglycerol (DAG). Ca2+ release is provoked by 
activated IP3 receptor (IP3R) through IP3. The increased intracellular Ca2+ concentration is responsible for the 
opening of the ion channel TRPM5, which allows a Na+-influx that results in depolarization of the cell 
membrane (Chaudhari and Roper 2010).  
 
The outcome of the opened Panx1 hemichannel is the secretion of ATP (Figure 1.4-5), the taste 
bud transmitter, into the extracellular space surrounding the activated receptor cell  
(Chaudhari and Roper 2010). 
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1.4.5 Cell-to-cell communication initiated by ATP secretion  
After a receptor cell is stimulated by an appropriate ligand, ATP is released. To the present date, 
the neurotransmitter ATP is the only one known to be secreted by receptor cells. This chemical 
stimulus is transduced into signals by the taste buds, which represent specialised sensory organs. 
Finally, the signals are transmitted via primary gustatory afferent fibres into the central nervous 
system (CNS). Furthermore, Huang et al. (2009) hypothesised that ATP also affects adjacent cells 
in the taste bud. In detail, the ATP released by the taste receptor cells (type II) as response to a 
taste stimuli excites the presynaptic cells (type III). In turn, stimulation of these cells results in the 
secretion of the neurotransmitter 5-hydroxytryptamine (5-HT), better known as serotonin, and 
norepinephrine (NE). It is known that NE does not influence adjacent taste bud cells. However, its 
exact function has not been decrypted yet. In contrast, the mechanisms of action of ATP and 5-HT 
are known. Released 5-HT activates 5-HT1A receptors which leads to the inhibition of the 
mobilization of intracellular Ca2+ in the receptor cells. That results in a reduced secretion of ATP. 
This process represents a negative paracrine feedback onto receptor cells. In contrast, released 
ATP has a positive autocrine feedback onto receptor cells (type II). It activates the P2Y1 receptor 
(purinoceptor) and enhances the secretion of ATP (Huang, Dando et al. 2009).  
1.5 Biotechnological generation of bioactive peptides 
Enzymes play the major role in biotechnological processes. Classification of enzymes is based on 
the chemical reaction they catalyse. This results in seven different enzyme classes, which can be 
distinguished by means of the enzyme commission number (EC number). EC 1 are the 
oxidoreductases, EC 2 transferases, EC 3 hydrolases, EC 4 lyases, EC 5 isomerases,  
EC 6 ligases, and EC 7 the translocases. Each of these classes is divided into subclasses. EC 3, the 
hydrolases, have 13 subclasses, of which subclass 4, the proteases or peptidases, encompasses the 
most important enzymes for protein hydrolysis in the food industry. They are able to hydrolyse 
peptide bonds. Depending on their cleavage site, they are further subdivided into endopeptidases 
that act internally and exopeptidases that act near the N- or C-terminus of the polypeptide chain. 
Further classifications into sub-subclasses (serine-, cysteine-, aspartic-, metallo-, and threonine-
endopeptidases) are based on the catalytic mechanism. Due to their specificity proteases have a 
large number of applications. Proteins hydrolysed by specific proteases can have effects on the 
food product, like modification of the sensory quality, reduction of allergic compounds, 
improvement of antioxidative capability, or improved digestibility (Tavano 2013).  
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In addition to these effects, enzymatic hydrolysis has other obvious advantages over conventional 
acidic or alkaline hydrolysis. Peptidolysis of wheat gluten with peptidase mixture Flavourzyme 
(Novozymes, Copenhagen, Denmark) from Aspergillus oryzae, an ascomycete, can be carried out 
at 45 °C at pH 6 (Giesler, Linke et al. 2013). Enzymatic hydrolysis can increase the production of 
bioactive substances. Not all of them are desirable, as bitter tasting-peptides can be formed. 
Compared to acidic hydrolysis these are mild conditions e.g., while chemical processes are carried 
out under harsh conditions, e. g. using 6 M HCl at 110 °C for 24 h (Tsugita and Scheffler 1982), 
which can destroy tryptophan. Furthermore, this kind of treatment will affect nearly all other 
compounds of a food matrix and can end with in the production of harmful substances.  
Nevertheless, soy sauce, which is widespread in Asia, is produced using the precursors of today´s 
biotechnological processes. Traditionally, a mixture of cooked soy beans and roasted wheat is 
fermented for 2 – 3 days below 40 °C. The so called koji fermentation is a two-step process and 
begins with the addition of a starter culture of Aspergillus sojae, Aspergillus oryzae, or, in some 
cases, Aspergillus tamarii. Varying the fermentation conditions leads to soy sauces with different 
characteristics like colour and taste intensity. During the first step (koji) the starter culture secretes 
peptidases and carbohydrase complexes. The different enzymes break down the proteins and 
carbohydrates of the substrates. In the first fermentation step, glutaminases are released, which 
convert glutamine into glutamic acid and thus increase its concentration (Soldo, Blank et al. 2003). 
Among other substances, glutamine and glutamic acid are released with glutamic acid as the most 
abundant amino acid in soybean protein (Van Etten, Hubbard et al. 1959) and wheat  
(Mossé, Huet et al. 1985). Since glutamic acid is known to taste like umami, it is not surprising 
that soy sauce has such an intense taste. A concentration of 1.5 mmol/L monosodium glutamate is 
claimed to be the sensory threshold concentration because it is sufficient to perceive the 
characteristic umami taste in sensory analysis (Soldo, Blank et al. 2003).  
In addition to MSG, there are numerous other substances that contribute to the umami taste like 
the purine-5´-nucleotides adenosine-5´-monophosphate (AMP), guanosine-5´-monophosphate 
(GMP) and inosine-5´-monophosphate (IMP) (Maga 1983). Furthermore, several other substances 
are responsible for the umami taste of Lentinus edodus (Shiitake mushroom). The umami taste is 
significantly caused by ibotenic acid and trichlomic acid, derivatives of oxyglutamic acid  
(Solms 1969).  
The second step is called moromi fermentation. Low molecular mass peptides, amino acids, and 
sugars, formed in the first koji step, are crucial for the subsequent brine fermentation step. For this, 
the brine solution is mixed with koji, from the first step, in equal amounts. The generated mixture 
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has a salt content of about 18 %, which is believed to prevent the growth of unwanted 
microorganisms. Various desirable microorganism are part of the second fermentation step. The 
lactic acid bacterium, Pediococcus halophilus, which leads to a pH drop of the moromi, a salt-
tolerant yeast, Saccharomyces rouxii, for alcoholic fermentation in the middle stage, and a salt-
resistant yeast, Candida sp., which produces phenolic compounds and contributes to the aroma of 
soy sauce (Lioe, Selamat et al. 2010). The moromi fermentation can last from three months to 
three years (Yokotsuka 1961). 
Peptidolysis, which takes place during the fermentation, also releases peptides that confer umami 
taste. The intensity is usually much lower than that produced by MSG. Several di- or tripeptides 
with a molecular mass lower than 500 Da that are produced by the hydrolysis of fish protein and 
isolated from chromatographically generated  fractions are responsible for the umami taste, among 
them Glu-Ser, Glu-Glu, Glu-Asp, Glu-Gln-Glu, Glu-Asp-Glu and Asp-Glu-Ser  
(Noguchi, Arai et al. 1975). The structure of umami active substances is very diverse. In addition 
to the di- and tripeptides mentioned before, tetrapeptides to octapeptides  
(Nakata, Takahashi et al. 1995) and cyclic peptides (2,5-diketopiperazines)  
(Chen, Dewis et al. 2009) have been described to contribute to this flavour. One can only 
hypothesise how many umami active substances have yet to be discovered.  
1.6 Bioactivity of peptides and their condensation products 
Countless natural sources contain high molecular mass proteins. One could name them parent 
proteins that can release various peptides by enzymatic hydrolysis. The peptide activity depends 
on its amino acid sequence. Known bioactive peptides are versatile. They can exercise regulatory 
functions and be used in functional food to prevent food degradation by microorganisms or food 
oxidation. In addition, bioactive peptides also can positively affect human health with regard to 
the nervous, immune, cardiovascular, endocrine, and digestive systems. Further applications are 
the treatment of various disorders and diseases (Sánchez and Vázquez 2017). 
All these facts clarify why the scientific community has such an interest in bioactive peptides. 
Several working groups defined the influence of bioactive peptides on health and discovered a 
positive impact on body functions (Kitts and Weiler 2003). In 2014, more than 1500 different 
bioactive peptides were listed in a database called “Biopep” (University of Warmia and Mazury 
in Olsztyn 2003). Crucial to this activity is the amino acid composition and sequence by which 
they can be classified based on their mode of action. Thus, the hormone and drug-like peptides can 
confer antioxidative, antimicrobial, antihypertensive, antithrombotic, opioid, and 
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immunomodulatory effects. Studies showed that most of the bioactive peptides consist of 3-20 
amino acids (Möller, Scholz-Ahrens et al. 2008). Although little is known about how the structure 
is related to the bioactivity, some structural similarities have been discovered, such as the presence 
of arginine, proline and lysine groups, as well as the general presence of hydrophobic amino acids 
(Kitts and Weiler 2003).  
Bioactive peptides are one way to regulate derailed blood pressure, since hypertension negatively 
affects one quarter of the world´s population, bioactive peptides can be a feasible part of the 
treatment. Physiologically, the blood pressure is regulated by angiotensin I-converting enzyme 
(ACE). It catalyses the conversion of angiotensin I, a decapeptide, to angiotensin II. The former is 
converted to an octapeptide with vasoconstricting effects, which also has an influence on the fluid 
and salt balance in mammals. Several natural sources for the isolation of ACE inhibitory peptides 
are known. Lactobacillus helveticus is able to release the immunomodulatory and hypotensive 
peptides Ile-Pro-Pro and Val-Pro-Pro from β- and κ-casein. The peptides with hypotensive activity 
often carry polar amino acid residues, such as proline and are short chained  
(Hartmann and Meisel 2007).  
In contrast, the structural diversity of antimicrobial peptides is much greater, especially those 
generated from animals or plants. Many peptides that have antimicrobial activity contain 
hydrophobic α-helices. The majority of these peptides is amphiphilic and cationic. The number of 
amino acids that make up antimicrobial peptides ranges from 12 to 45 with a high number of 
hydrophobic residues, but a positive net charge. An advantage of these peptides over more potent 
antimicrobials is that they often have a broader spectrum and are able to rapidly kill the target 
cells. As the bacteria multiply slower than they are killed by the peptides, the risk of resistance 
formation decreases. Since they are able to kill clinically relevant pathogens, they are qualified for 
the potential use as drugs. Their activity is directed against both gram positive and gram negative 
bacteria like Escherichia coli, Enterococcus faecium, Salmonella spp., and Staphylococcus aureus. 
The bacterial cytoplasmic membrane represents the main point of attack of hydrophobic and 
amphiphilic antimicrobial peptides. They can accumulate and form channels in the membrane 
(Minervini, Algaron et al. 2003). This affects the transmembrane electrochemical gradients and 
leads to cell swelling by increased water flow, osmolysis, and cell death (Bechinger 1997). 
Condensation of dipeptides leads to the formation of cyclic dipeptides, 2,5-diketopiperazines 
(Figure 2.8-1), and their stereoisomers. They were discovered in 1924 and are found in a variety 
of organisms, such as animals, plants, bacteria, and fungi and are the smallest cyclic peptides. 
Fungi are the most important source for bioactive cyclic dipeptides (Wang, Li et al. 2017). Six 
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hundred thirty-five bioactive fungal cyclic dipeptides have been discovered, mainly from the 
genera of Aspergillus and Penicillium. The peptides encompass a variety of activities, for example 
cytotoxicity, phytotoxicity, insecticidal, vasodilatory, antituberculosis, antimicrobial, and 
antiviral. For decades, scientists suggested that these dipeptidyl cyclic ring closures can function 
as potent inhibitors of microbial growth, signal molecules, and that they reduce virulence-factor 
production. Their function can be attributed to vary side chains and their structural chirality, which 
make them an interesting basis for drug design. In 2017, scientists demonstrated that proline-based 
cyclic dipeptides (cis-cyclo(L-Leu-L-Pro); cis-cyclo(L-Phe-L-Pro); and cis-cyclo(L-Val-L-Pro)) 
have an inhibitory effect on the proliferation of influenza A virus as well as on plant and human 
pathogenic fungi (Liu, Kim et al. 2017). Beside these activities some cyclic dipeptides are sensory 
active and have been successfully isolated from different food. The popular stewed beef and dried 
aged beef are rich in volatile and semi volatile compounds, from which ten cyclic dipeptides have 
been identified. A study from 2008 found that their organoleptic properties are closely related with 
the concentration used for the sensory analysis. Authors showed that cis-cyclo(L-Pro-L-Val) has 
no taste at 10 and 200 ppm, but tasted bitter from 500 ppm on. In contrast, 10 ppm  
cis-cyclo(L-Leu-L-Pro) tastes like pineapple, glue, or ethyl acrylate and 100 ppm like rare beef, or 
green beans. However, the majority of the ten identified peptides tastes bitter at any of the tested 
concentrations. This elucidates that the taste of cyclic dipeptides is not only based on their 
sequence but also depended on the used concentration (Chen, Dewis et al. 2009). This variety of 
combinations of amino acids, concentrations and synergistic effects can lead to a multitude of 
effects that have yet to be fully discovered. 
1.7 Sensory analysis  
Sensory analyses are widely used in the field of food analysis. They represent a meaningful tool 
for the food industry, research, marketing, and quality assurance. There is a suitable approach for 
almost every imaginable question like determination of product accuracy, or the recognition of 
any deficiencies. Accordingly, numerous factors have to be considered to produce significant 
results. This chapter summarises different factors as well as the different methods and their fields 
of application. Most of the information in this chapter (1.7 to 1.7.3) relates to the worksheets of 
the DLG e.V. (Deutsche Landwirtschafts-Gesellschaft). This is the oldest institution of its kind in 
Germany and has been conducting quality inspections of food and beverages since 1885. 
Nowadays, official tests are carried out by accredited institutions according to  
DIN (Deutsches Institut für Normung) standards (Hildebrandt and Schneider 2009).  
15 Introduction 
 
1.7.1 General information about sensory analysis 
Since the human sense of taste is influenced by numerous factors, just as many have to be 
considered. These are important prerequisites for a successful and meaningful test. Probably the 
most important requirements are sample selection, sample preparation, sample neutralization, 
sample coding, and sample presentation.  
Sample selection: The differences between the samples given to the examiners should be as small 
as possible. They should all be the same size and shape, if not samples have to be homogenised. 
This minimises the possibility that examiners make a biased assessment based on the nature of the 
sample. If homogenisation cannot be carried out, the whole food can be served. If the food is small, 
for example peanuts, a sufficient amount has to be provided to allow the examiner to re-taste and, 
if necessary, exclude outliers (Manthey-Karl and Oehlenschläger 2010).  
Sample preparation: Sample preparation begins with the removal of the sample from the storage 
location. If the food to be examined has to be refrigerated, it must be brought to a sufficient 
temperature before the test in order to improve the mouthfeel. In contrast, if the samples have to 
be tested warm, they have to be warmed immediately before the test  
(Manthey-Karl and Oehlenschläger 2010).  
Sample neutralisation and anonymisation: To avoid wrong conclusions it is necessary to make 
the samples unrecognisable. Since both the shape and the colour allow conclusions to be drawn, 
the samples should e.g., be crushed before the test. Furthermore, the dishes have to be served in 
neutral containers. If this is not possible, names of manufacturers must be pasted or painted over 
or the original container has to be covered (Manthey-Karl and Oehlenschläger 2010).  
Sample coding: To ensure that the examiners will not be influenced by the sample name or 
description, each sample has to be coded with a four or five digit code consisting of numbers, 
letters, or a combination thereof. The code must be placed in such a way that it cannot be removed 
from the sample to prevent manipulation. Only the test leader may be aware of the decryption of 
the code (Manthey-Karl and Oehlenschläger 2010).  
Sample presentation: Each container used for presentation of the samples has to be neutral. 
Moreover, they have to have the same colour, shape, and material. All containers that come in to 
contact with the food must be inert in terms of smell, taste, and dye ability. The order in which the 
samples are tested must be random and should vary from test to test  
(Manthey-Karl and Oehlenschläger 2010).  
All these factors have to be taken into account while planning a reliable sensory analysis.  
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1.7.2 Discrimination of difference tests 
The most common discrimination tests are the triangle test, duo-trio, “A”-“not A”, and  
two-out-of-five-test. These are used when two or more products have to be compared. The 
products have to be very similar, without obvious deviations. Discrimination tests do not give 
information about product quality. Every examiner has to take a decision during the tests even if 
no sensory difference has been recognised. Therefore, it is a so called “forced-choice” method. 
Individual uncertainties in the finding of results should be evenly distributed and not significantly 
influence the result.  
Triangle test: In this test, the samples are submitted as groups of three samples, two of which are 
identical. It is a feasible method for the determination of marginal differences between two 
samples. In §64 of the LFGB (Lebensmittel- und Futtermittelgesetzbuch), examination regulations 
are published that contain significance tables from which the test can be evaluated. The result 
refers to the total number of correct answers relative to the number of examiners. Triangle tests 
must be carried out under constant experimental conditions and require a minimum number of 
examiners between five and seven. Based on this examination method, the following statements 
can be made: 1. There is a significant difference between the samples. Whether it is based on the 
odour, taste, or mouthfeel cannot be determined. 2. The examiners could not determine a 
significant difference between the samples. However, it cannot be ruled out that there is absolutely 
no difference (Oehlenschläger and Manthey-Karl 2010).  
Duo-trio-test: This test is easier than the triangle test, because the examiners know the control 
sample. In this case, a sample pair always consists of one sample and the known control sample. 
Therefore, the likelihood of guessing the correct result is 50 %. Significance tables are published 
in DIN standards for this evaluation. As result, the test leader receives the statement whether a 
difference was detected (Oehlenschläger and Manthey-Karl 2010). 
“A”- not ”A” test: This test should be applied, if neither the triangle nor the duo-trio-test are 
feasible. This is the case, if the samples have slight visual differences or contain strong taste and/or 
odour components. Therefore, the panellists receive a standard sample (A), which is used for 
training purpose. The samples are handed to the examiners and afterwards, based on the internal 
standard (A) a decision has to be made: “A” – not “A”, meaning a difference or no difference was 
determined compared with the standard. Since this is a demanding test, it is done with trained 
tasters that are able to memorise sensory impressions (Oehlenschläger and Manthey-Karl 2010).  
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Two-out-of-five-test: As the name suggests, sample pairs consisting of five samples are given, of 
which two and three are identical. Due to the possibility of placing the samples into the group, the 
likelihood of correct guesses is only 10 %. This leads to an efficient and powerful test. Since the 
workload is high in this case, however, it can lead to fatigue and memory effect of the panellists 
during the course of the test, which can affect the test result. For this reason, the test is only suitable 
for samples that have no intense, sharp, and lasting taste or odour. It is often used to study optical 
and tactile features. The work should only be carried out by trained tasters, who will recognise the 
two identical samples, from which the three identical ones automatically result  
(Oehlenschläger and Manthey-Karl 2010).  
Alternative forced choice: In addition to the tests described, there are feature-related tests like 
the alternative forced choice (AFC) and the ranking test. Their field of application is the evaluation 
of only one attribute, for example, does sample A taste more salty than sample B. The AFC test is 
very specific and widely used for the determination of extremely small differences of the chosen 
attribute. No further information will be received. There are two variants of this test, the one-sided 
and the two-sided test.  
In the one-sided test, the head of the examination group knows the difference between the samples 
and the correct answer (one-sided). Mostly, the questions are formulated in such a way that one 
can only answer yes or no. In the two-sided, test the head of the examination group knows the 
difference as well but he or she has no idea which effect it has and what the examiner has to decide 
correctly (two-sided) (Manthey-Karl and Oehlenschläger 2010).  
Ranking test: The mentioned ranking test is an expansion of the described discrimination tests. It 
enables the comparison of several products and how they are related to each other in terms of 
additives, such as sugar. Thus, there is a quick classification according to the type and intensity of 
characteristics or a classification of popularity. Participants should arrange the samples in a row 
according to the severity of the asked attribute. This methodology is suitable for determining the 
influence of different raw materials or the evaluation of different treatment methods  
(Manthey-Karl and Oehlenschläger 2010).  
1.7.3 Descriptive-, hedonic- and affective sensory tests 
The goal of descriptive-, hedonic- and affective sensory tests is to capture and measure human 
perception and sensation in food consumption. Products are qualitatively and quantitatively 
described to create individual product profiles. Combined with data of hedonic tests, these profiles 
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are used to derive the product acceptance or rejection by consumers. On the basis of this data, 
products are further developed to e.g., increase their sales. The descriptive analyses are thus a link 
between product development, marketing, and market research. In addition, they serve to monitor 
the product profiles during storage and the minimum shelf life. Often, untrained consumers are 
used because they are less biased then experts. However, the consumers must be trained 
compulsorily. Recruiting consumers and training them is the first of three phases in descriptive 
tests. Phase two consists of finding and formulating terms for the odour, taste, and texture of the 
products by the trained consumers for the qualitative description of the samples. The third phase 
includes the quantitative description of the terms formulated in phase two.  
Descriptive analyses are a wide field. The most well-known methods include the consensus 
profiling, conventional profiling, descriptive profiling, quantitative descriptive analysis, and the 
free choice profiling or flash profiling, which are not discussed in detail. For a thorough description 
refer to (Freies Auswahlprofil DIN 10967-3-2001). Last, but not least, affective and hedonic tests 
can be performed. The Latin word affectus means sensation and passion and the Greek word 
hēdoné stands for joy, pleasure, or hēdonikós pleasurable. The names indicate that the human 
emotions like joy and pleasure and their opposing disgust and displeasure are the main focus in 
these tests. As a result, these tests are largely based on unconscious and emotional assessment 
mechanisms. They are often used for new developments and modifications of products, but also 
in product optimization and quality assurance processes (Dürrschmid 2010).  
1.8 Mass Spectrometry, a powerful tool for peptide and protein 
identification 
Over the years, mass spectrometry has become one of the most important analytical approaches 
for peptide and protein identification. Due to the constant advancement of the devices and the thus 
increasing application possibilities, mass spectrometry has become an indispensable part of the 
laboratories of today. Probably the most important areas of application include the determination 
of the amino acid sequence of peptides, the characterization of post-translational modifications as 
well as the determination of the relative and absolute protein quantities. The identification and 
quantification of proteins from highly complex matrices is also possible. By contrast, Edman 
sequencing is unable to generate sequence information from complex peptide mixtures.  
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In routine applications, accuracies of measured molecular masses can be achieved that are  
500 to 1000 times higher compared to estimated molecular masses obtained by SDS-PAGE. This 
high accuracy enables accurate identification of peptides, proteins, and other biomolecules.  
In simple terms, the basic principle consists of the formation of gas-phase ions from intact and 
neutral molecules. These ions allow the determination of the molecular masses. For the realisation 
of this measurement, three components are essential, which are installed in all mass spectrometers: 
an ion source, a mass analyser, and a detector (Figure 1.8-1). The last two components usually are 
inside a high-vacuum chamber. Thus, the number of collisions of the formed ions with gas 
molecules is reduced during analysis.  
 
Figure 1.8-1: Schematic construction of a mass spectrometer. On the left side, the ion source is shown with its 
possible ionisation modes (MALDI; ESI), the middle shows the mass analyser and its variations (IT; Q; TOF; 
FTICR and Orbitrap). On the right side, possible detectors (electron multiplier and array detector) are shown.  
 
All kinds of ion sources are responsible for the production of both positive and negative ions. 
Separation of the formed ions takes place in the mass analyser, based on their mass-to-charge (m/z) 
ratios. Finally, the ions are detected by a multichannel plate or an electron multiplier  
(Zhang, Annan et al. 2014). 
1.9 Tandem Mass Spectrometry (MS/MS) 
Tandem mass spectrometry, also called MS/MS, is typically used to generate sequence information 
from peptides. To achieve this, two mass analysers must be connected in series, each with a 
different task. First, precursor ions of a defined mass to charge ratio (m/z) are isolated. 
Subsequently, isolated precursor ions are fragmented and their product ions are mass-analysed. In 
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case of peptide analysis, the fragments are mainly formed by cleavage of the peptide bonds  
(Zhang, Annan et al. 2014). 
 
Figure 1.9-1: Ion fragmentation pattern of peptides and its nomenclature. Variable amino acid side chains are 
represented by R. Only ions carrying a charge can be detected. The fragment ions are named based on the 
position of the charge at the N- or C-terminus. If the ion carries the charge at the N-terminus, it is called a, b, 
or c. If the charge is at the C-terminus, the fragment ions are called x, y, or z. In addition, the number of 
residues of a fragment ion can be read of the subscripted letters. Depending on the position of the bond break, 
internal ions or immonium ions are formed (Biemann 1990). 
 
The assignment of the most abundant and characteristic low-mass ions of the amino acids is based 
on Biemanns (Biemann 1990) nomenclature (Figure 1.9-1). Identified ions can be used to 
determine the amino acids in a sample.  
1.10 Suitable “mild” ionisation techniques for peptide and protein analysis 
In 2002, the Nobel Prize in chemistry was awarded to John B. Fenn and Koichi Tanaka for the 
revolutionary electrospray ionisation (ESI) and matrix-assisted laser desorption/ionisation 
(MALDI) techniques invented in the 1980s (The Noble Prize 2002). The invention of these 
techniques simplifies the analysis of biomolecules many times over.  
MALDI: The sample to be measured is mixed with a large molar excess of matrix. Of the mixture, 
up to 2 µL are applied onto the surface of a target plate and air dried. However, some requirements 
are placed on the matrix with respect to its behaviour under bombardment with photons of certain 
wavelength. Every commonly used matrix strongly absorbs the UV light it is exposed to. 
Intramolecular interactions are reduced by the separation of the analyte molecules by a large excess 
of the matrix. Furthermore, the matrix must be able to rapidly absorb a large proportion of the 
energy introduced by incoming photons, which ends up in an explosive collapse of the matrix-
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analyte lattice. Thus, both analyte molecules and matrix molecules enter the gas phase. During 
laser irradiation, a dense cloud is formed above the target, in which gas-phase reactions are 
hypothesised to occur. In this reaction, protons are transferred from the matrix to the analyte 
molecules and lead to the analyte’s ionisation. MALDI is most frequently applied with a time of 
flight (TOF) detector for the analysis of small proteins and peptides, which predominantly form 
single charged molecular ions. This combination is suitable for the analysis of unfractionated 
protein hydrolysate (Zhang, Annan et al. 2014). 
ESI: An analyte solution is sprayed through the tip of a fine capillary at atmospheric pressure for 
ion formation. A fine droplet mist is created using a nebuliser gas. In addition, the droplet can only 
be formed and highly charged if a high voltage is applied between the spray tip and the  
counter-electrode. At this point, the peptide or protein molecules are still in the droplet. As the 
solvent evaporates, the molecules pick up protons from the solvent. This results in single to 
multiply charged ions, depending on how many possible points of attack are available for the 
protons. A rough derivation of the maximum charge state is thus possible. Furthermore, it was 
discovered that one proton can be deposited per approximately 1000 Da molecular mass. The 
release of the ions occurs after the drops, in which they are located, continue to shrink. The 
increasing charge density at the drop surface exceeds a critical point and the drops can no longer 
be held together. This phenomenon is called columbic repulsion. After ion release, they enter the 
high-vacuum part of the mass spectrometer to be analysed and detected (Figure 1.10-1).  
 
 
Figure 1.10-1: Schematic illustration of the electrospray ionisation process. Analyte solution is sprayed from 
the tip of the spraying nozzle through the Taylor cone. A positively charged parent droplet containing the 
analyte molecules is formed. Along with solvent evaporation, the droplet shrinks and the charge density on the 
surface of the droplet increases until it reaches a critical point. At this point, the force holding the droplet 
together is exceeded. Coulomb repulsion or coulomb fission ends up in naked charged analyte ions. 
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Usually a mixture of water and acetonitrile containing around 0.1 % formic acid is used for peptide 
analysis. The volatile acid promotes the ionisation of the molecules. However, only a little or none 
fragmentation of peptides is observed in normal ESI mode. In this work, an Ultra Performance 
Liquid Chromatography-Mass Spectrometry (UPLC-MS) combination was used. The complex 
protein mixture has been chromatographically separated before it entered the mass spectrometer. 
Combination of liquid chromatography and mass spectrometry has many advantages. The first 
one, is the mentioned separation of complex mixtures before they enter the mass analyser. 
Secondly, it safes precious and expensive instrument time and prevents sample losses during 
preparation. How frequently mass spectra are recorded can normally be chosen by the analyst.  
One possibility is the operation in scan mode by time. Depending on the complexity of the sample 
it might be suitable to do a scan every second. For peptide analysis, a real-time decision operation 
mode is commonly used. An algorithm enables the system to select the fragments that require 
MS/MS analysis. Today´s technology opens up further possibilities for the analyst to switch 
between MS and MS/MS during a single run. The selection can be made based on the charge states 
of the precursor ions or a defined number of MS/MS can be set per cycle. From the data recorded 
during a run, different displays can be generated. Total Ion current (TIC) is a plot of the total 
number of ions detected during each mass spectrum scan versus time. Depending on the sample 
composition, this representation is often difficult to interpret. To simplify this, the so-called 
extracted ion current (EIC) can be created. It shows the ion current trace of a specific mass. The 
signal intensity-critical quantity produced by ESI is the concentration of the analyte rather than the 
total amount of it (Zhang, Annan et al. 2014). 
1.11 Common Mass Analyzers in Mass Spectrometry 
There are two main categories of mass analyser, the ion-beam and scanning types namely 
quadrupole (Q) and time of flight detector (TOF) and the trapping types ion trap (IT),  
fourier transform ion cyclotron resonance (FTICR), and orbitrap. Since these differ in their 
functional principles, they differ in resolution, MS/MS capability, mass accuracy, and sensitivity 
(Zhang, Annan et al. 2014). Although they are all suitable for peptide analysis, it is essential to 
choose the most efficient analyser for the given problem. This section deals with the quadrupole 
and time of flight detector, since these were exclusively used in this project. 
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Quadrupole: The main task of a quadrupole is the selection of defined mass to charge ratios. Mass 
selection is realised via the four electrodes arranged parallel to each other. These can be set under 
radiofrequency voltage and direct-current voltage.  
 
Figure 1.11-1: Schematic representation of a mass spectrometer including two quadrupoles. Electrospray 
ionisation (ESI) followed by source split and the first quadrupole for mass selection. The dotted line presents 
ions with unstable trajectory (not detectable) and the solid line shows ions selected by quadrupole 1, which are 
fragmented in the second quadrupole and detected in the time of flight detector (TOF).  
 
Ions of a given m/z ratio can pass through the quadrupole unhindered. Unwanted ions are deflected 
from their trajectory, collide with the electrodes and are thus excluded from detection. If a scan 
mode is performed, the applied voltages change continuously and a variety of ions can be detected. 
Most applications combine the quadrupole with a second mass analyser like a second quadrupole 
or the time of flight detector (Figure 1.11-1). In this work, a combination of two quadrupoles and 
a TOF was mainly used. The second quadrupole serves as a collision cell, in which the ions are 
fragmented. Fragmented and charged ions enter the time of flight detector, where the mass to 
charge ratios are recorded. The settings on the quadrupoles can be adapted to almost any 
application.  
Time of flight: Today´s time of flight detector, which is used by many laboratories, goes back to 
a design introduced by Wiley-McLaren in 1955. The first devices were characterised by low 
sensitivity and low resolution, which is why this technique did not prevail initially.  
The method of ion production and the geometric construction of the ion source were the main 
limiting factors of the low resolution, which depends on the length of the produced ion packets. 
The second limitation factor was the acceleration method and the energy spread of an ion packet, 
which is due to the initial energy distribution. With the development of new ionisation techniques 
in the 1980`s, interest in TOF grew steadily. The operation principle of a linear time of flight mass 
spectrometer is quite simple. Ions with equal kinetic energy, but different mass to charge ratios are 
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separated according to their m/z ratios when entering an electric-field-free region. Mathematically, 
the separation is represented as a function of mass. Time of flight is calculated by: 
𝑡 = 𝑙√
𝑚
2𝑧𝑒𝑉
 
Whereby (l) is the fixed distance the ions travel, (z) is the ion charge, (e) is the electronic charge, 
and (V) the accelerating voltage. If the ion energy is constant, the flight time (t) is proportional to 
the square root of the ion mass. Heavy ions reach the detector after the light ions. The ion mass is 
determined by the measured flight time that is needed for the ions to move from the ion source to 
the detector (Li Gangqiang 1997). Beside the linear TOF-MS, a so-called reflectron TOF exists. It 
is equipped with a mirror and acts as an energy-focusing device by correcting the energy 
distribution. Reflectron voltage is set slightly higher than source-accelerating voltage. Thereby, 
ions are slowed down until they stop. Subsequently, ions turn around and get accelerated again 
until they reach a second detector. According to their kinetic energy and velocity, the time of flight 
differs. Thereby, resolution is improved as ions focused into packets have flight times that are 
close together. The TOF is very versatile and can be easily combined with different mass analysers 
and thus offers a versatile field of application (Zhang, Annan et al. 2014).  
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1.12 Aim of this thesis 
As widely known a variety of edible hydrolysates of animal or vegetable origin are showing a 
highly intense umami taste. Precisely for this reason enzymatically generated hydrolysates of 
vegetable proteins from Nestlé were to be screened. A major goal was to identify biomolecules 
like small peptides and their cyclic compounds which were supposed to impart umami taste, or to 
be able to enhance the umami taste. Therefore concerted analytical approaches involving variants 
of FPLC and HPLC combined with extended mass spectrometry had to be developed and 
performed. Furthermore different processing steps had to be analytically characterised to describe 
precursors of the umami taste active substances and to track their reaction pathway caused by the 
processing conditions. Nevertheless the most taste active compounds should be identified by 
means of sensory analyses using a trained panel.  
Finally, the sensory results should be correlated with the analytical results to clearly describe the 
compounds that are responsible for the intense umami taste appreciated by the consumers.  
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2 Material and methods 
2.1 Chemicals 
All chemicals and solvents of HPLC grade used were purchased from Carl Roth  
(Karlsruhe, Germany), Fluka (Neu-Ulm, Germany), Sigma-Aldrich (Steinheim, Germany) and 
VWR International (Darmstadt, Germany), respectively. The used peptides were delivered by 
Bachem (Weil am Rhein, Germany). Ultrapure water used for chromatography and 
spectroscopy was generated by a TKA GenPure system (Niederelbert, Germany).  
 
Table 2.1-1: List of frequently used chemicals and substances.  
Chemical Quality Supplier 
Acetic acid  Pure, 100 % Carl Roth 
Acetonitrile  LC-MS grade Carl Roth 
Amino acid standard Analytical standard Sigma-Aldrich 
Boric acid Puriss. Fluka 
Ethanol  HPLC gradient grade, 
≥ 99.9 % 
Carl Roth 
Formic acid ≥ 98 %, p.a. Carl Roth  
Methanol HPLC grade Carl Roth 
3-Mercaptopropanic acid ≥ 99.9 % Carl Roth 
Monosodium glutamate ≥ 99 % Ajinomoto 
o-Phthaldialdehyde ≥ 99% for synthesis Carl Roth 
Sodium acetate ≥ 99 %, p.a. Carl Roth 
Triethylamine ≥ 99.5 % for synthesis Carl Roth 
Water with 0.1 % formic acid LC-MS grade Carl Roth 
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2.2 Frequently used Devices 
Table 2.2-1: List of used devices 
Device Specification  Manufacturer 
Magnetic stirrer MR 3001 Heidolph (Kelheim) 
pH-meter FiveEasy METTLER TOLEDO (Gießen) 
Piston-stroke pipette Transferpette® Brand (Wertheim) 
Ultra-Filtration system Vivaspin 20, 3 kDa 
(polyethersulfone membrane) 
Sartorius (Göttingen) 
Ultrasonic cleaner / VWR International (Darmstadt) 
Balance SI-234 Denver Instrument (Göttingen) 
Water conditioner GenPure UV-TOC/UF TKA (Niederelbert) 
Centrifuge Rotina 380R Hettich (Lauenau) 
Rotary evaporator LABOROTA 4002- digital  Heidolph (Schwabach) 
Freeze-dryer  VaCo 2 ZIRBUS technology  
(Bad Grund) 
2.3 Ultra-Filtration  
Stock solutions containing 100 mg mL-1 of all Nestlé samples were prepared and separated by 
the means of ultra-filtration. A Vivaspin 20 filtration system (Sartorius, Göttingen, Germany) 
with a cut-off membrane of 3 kDa was used. Centrifugation was carried out with a Rotina 380R 
centrifuge (Hettich, Lauenau, Germany) at 4 °C and 3500 rpm. For further analyses the flow 
through was used.  
2.4 Solvent removal and freeze drying of sub-fractions 
The ethanol fraction of each prepHPLC sub-fraction was distilled off under reduced pressure 
(80 hPa) and 50 °C bath temperature using a rotary evaporator. The remaining aqueous samples 
were transferred into large surface vacuum beakers and freeze dried  
(VaCo 2; ZIBRUS technology, Bad Grund, Germany). Spindle temperature was set to – 40 °C 
and plate temperature to – 11 °C.  
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2.5 Chromatographic Procedures 
2.5.1 Fractionation of Hydrolysed Vegetable Proteins (HVP) using  
Size Exclusion Chromatography (SEC) 
The ultra-filtered sample stock solutions were fractionated according to their molecular mass 
using a SEC “NGC Chromatography System” from Bio RAD (Hercules, California, USA). An 
isocratic separation at a flow rate of 0.5 mL min-1 was performed on a “Superdex Peptide 
10/300 Gl” (GE Healthcare, Little Chalfont, United Kingdom) column. This column is usable 
in the separation in a range of 100 – 7000 Da. Peaks were detected by a UV detector at a 
wavelength of λ = 280 nm. Sodium acetate (25 mM) adjusted to pH 6.0 with acetic acid (1 M) 
was used as eluent. Injection volume was set to 250 µL. For every sample seven fractions of 
5 mL were collected. A three point calibration was carried out with the tripeptide Val-Tyr-Val 
(379 Da), the dipeptide Tyr-Ala (252 Da) and the amino acid tyrosine (181 Da). 
2.5.2 Sub-fractionation using High Performance Liquid Chromatography (prepHPLC) 
The prepHPLC system (AZURA, Knauer, Germany) was equipped with a preparative column 
(NUCLEODUR C18 Pyramid, 5 µm; 16 * 250 mm; MACHEREY-NAGEL, Düren, Germany) 
without temperature control. Chromatographic runs were monitored at 210 nm and gradient 
elution was performed (Table 2.5-1). The injection volume was set to 200 µL.  
Fine- or sub-fractions were cut every ten minutes right from the start. With a total run time of 
60 min this led to six sub-fractions of 80 mL per run at a flow rate of 8 mL min-1. Separation 
was performed using a gradient with ddH2O containing 0.1 % acetic acid (eluent A) and pure 
ethanol (eluent B). 
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Table 2.5-1: Gradient profile of the prepHPLC method for sample fractionation. Flow rate: 8 mL min-1, 
preparative column (NUCLEODUR C18 Pyramid, 5 µm; 16 * 250 mm; MACHEREY-NAGEL, Düren, 
Germany), ddH2O containing 0.1 % acetic acid (eluent A) and pure ethanol (eluent B). 
Runtime [min] Solvent A [%] Solvent B [%] 
0.0 90.0 10.0 
15.0 90.0 10.0 
40.0 40.0 60.0 
45.0 0.0 100.0 
50.0 0.0 100.0 
55.0 90.0 10.0 
60.0 90.0 10.0 
 
2.5.3 Determination of oPA-derivatised free amino acid concentration by HPLC 
The HPLC system consisted of an autosampler, Optimas Spark (TECHLAB, Braunschweig, 
Germany), a fluorescence detector RF-10AXL (Shimadzu, Kyoto, Japan), and a column 
thermostat Jetstream2Plus (Sigma-Aldrich, Steinheim Germany). Pump system PU-980, 
degaser DG-980-50 and a ternary gradient unit LG-980-02 from Jasco  
(Groß-Umstadt, Germany) were used. Amino acid standard solution containing 18 amino acids 
plus β-alanine as internal standard as well as all sample solutions were derivatised using the 
oPA-reagent. Before the derivatisation reaction, 10 µL of the respective sample filtrate was 
mixed with 110 µL potassium borate buffer (0.5 mM; pH 10). Derivatisation was automatically 
performed by the autosampler. Therefore, 20 µL of the oPA-reagent was added to the mixture 
which was allowed to react for 120 seconds and stopped by adding 50 µL of acetic acid (1 M). 
Calibration of the system was carried out with eight standard solutions  
(10, 20, 30, 40, 50, 62.5, 75 and 100 µM) containing the proteinogenic amino acids with the 
exception of proline and cysteine. Separation was performed on an analytical NUCLEODUR 
C18 Pyramid column (250 mm * 4 mm, 5 µm) with a pre-column (EC 4/3, NUCLEODUR C18 
Pyramid, 5 µm) (Macherey- Nagel, Düren, Germany). Excitation wavelength was set to 
λ = 330 nm and the emission was detected at λ = 460 nm. A binary elution gradient at a flow 
rate of 1.0 mL min-1 at 40 °C was applied (Table 2.5-2). Solvent A was a 0.1 M sodium acetate 
solution containing 0.044 % triethylamine at pH 6.5 adjusted with acetic acid (1 M). Solvent B 
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was methanol. Both eluents were membrane filtered (0.45 µm) and degassed with ultrasound 
for 15 min. Run time was set to 60 min.  
 
Table 2.5-2: Gradient profile of the HPLC method for the determination of oPA-derivatised free amino 
acids. Flow rate: 1.0 mL min-1, excitation wavelength λ = 330 nm, emission wavelength λ = 460 nm, oven 
temperature 40 °C, injection volume 20 µL, runtime 60 min, column: NUCLEODUR C18 Pyramid column, 
(250 mm * 4 mm, 5 µm), Solvent A: 0.1 M sodium acetate solution containing 0.044 % triethylamine at 
pH 6.5, Solvent B: methanol. 
Runtime [min] Solvent A [%] Solvent B [%] 
0.0 90.0 10.0 
5.0 90.0 10.0 
40.0 40.0 60.0 
45.0 0.0 100.0 
50.0 0.0 100.0 
55.0 90.0 10.0 
60.0 90.0 10.0 
 
2.5.4 Peptide analysis using liquid chromatography-mass spectrometry (LC-MS) 
For LC-MS analysis a VARIAN 320 Triple Quad LC-MS2 (Palo Alto, California, USA) 
equipped with a NUCLEODUR C18 Gravity column (250 mm * 4 mm, 5 µm, 40 °C) was used. 
Elution was performed at 300 µL/min using a gradient (Table 2.5-3) of solvent A  
(water containing 0.1 % formic acid) and pure ethanol as solvent B.  
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Table 2.5-3: Gradient profile of the LC-MS method for peptide analysis. Flow rate: 300 µL min-1, 
NUCLEODUR C18 Gravity column (250 mm * 4 mm, 5 µm, 40 °C), solvent A: water containing 0.1 % 
acetic acid, solvent B: pure ethanol. 
Runtime [min] Solvent A [%] Solvent B [%] 
0.0 95.0 5.0 
15.0 95.0 5.0 
20.0 40.0 60.0 
25.0 40.0 60.0 
30.0 20.0 80.0 
35.0 20.0 80.0 
40.0 95.0 5.0 
45.0 95.0 5.0 
 
A six port valve equipped with a 20 µL sample loop was used for manual injection. Detection 
was achieved spectrophotometrically at λ = 210 nm and subsequent MS analysis: Electrospray 
ionisation (ESI) in the positive and negative mode: capillary + 30 V/- 40 V; needle voltage 
5000 V/- 4500 V; nebuliser gas pressure 379 kPa; drying gas 138 kPa at 200 °C. 
2.5.5 Ultra-Performance Liquid Chromatography (UPLC) coupled with  
High-Resolution Mass-Spectrometry 
A HILIC column (TOSOH BIOSCIENCE; TSKgel Amide; 3 µm; 4.6 * 150 mm) was installed 
in a Jasco XLC ULPC system. The column outlet was directly connected to the ESI interface 
of a QTOF device (MaXis Impact; Bruker). Elution was performed using a gradient  
(Table 2.5-4) with a flow rate of 0.3 mL min-1 (eluent A was ddH2O and eluent B was 
acetonitrile, both containing 0.1 % formic acid). Injection volume was set to 5 µL and the 
column oven was set to 25 °C. Centroid mass spectra were recorded over a range of  
m/z 50-700. ESI parameters were 4500 V capillary voltage, 3 L min-1 dry gas at 180 °C. Tune 
parameters were set to get maximal ion yield in the m/z range from 150 to 300 at an average 
mass resolution of 25,000. CID was carried out at 31 eV.  
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Table 2.5-4: Gradient profile of the UPLC-HR-MS/MS method for peptide analysis. Flow rate:  
300 µL min-1, HILIC column (TOSOH BIOSCIENCE; TSKgel Amide; 3 µm; 4.6 * 150 mm), eluent A was 
acetonitrile and eluent B was ddH2O, both containing 0.1 % formic acid. 
Runtime [min] Solvent A [%] Solvent B [%] 
0.0 95.0 5.0 
5.0 95.0 5.0 
30.0 40.0 60.0 
32.0 40.0 60.0 
40.0 95.0 5.0 
45.0 95.0 5.0 
2.5.6 Determination of peptide composition of sub-fractions generated by  
Size Exclusion Chromatography via Ultra-Performance Liquid Chromatography 
(UPLC) coupled with High-Resolution Mass-Spectrometry  
A HILIC column (TOSOH BIOSCIENCE; TSKgel Amide-80; 3µm; 4.6 x 150 mm) was 
installed in a Jasco XLC device. The column outlet was directly connected to the ESI interface 
of the QTOF (MaXis Impact, Bruker). Isocratic elution was performed with a flow rate of  
0.3 mL min-1 with a mixture of water and acetonitrile (30/70) with the addition of 0.1 % formic 
acid. The injection volume was set to 20 µL and the column was tempered at 25 °C. Centroid 
mass spectra were recorded over a range of m/z 50-700. ESI parameters were 4500 V capillary, 
3 L min-1 dry gas at 180 °C. Tune parameters were set to get maximal ion yield in the m/z range 
from 150 to 300 CID was carried at 31 eV. 
2.5.7 Liquid chromatography-mass spectrometry (LC-MS) analysis for identification of 
synthesised 2,5-diketopiperazines 
Chemical synthesis (2.8) of several 2,5-diketopiperazines was verified. Therefore, moderately 
diluted products were directly injected into Varian Triple Quadrupole MS-system  
(Varian, Palo Alto, California, USA). Ionisation was realised by ESI and the most feasible 
system setting were used (Table 2.5-5). 
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Table 2.5-5: Method settings for MS device used for the verification of chemically synthesised  
2,5-diketopiperazines.  
Parameter Setting 
Detector Voltage 1200 V 
Needle Voltage Negative -4500 V 
Spray Shield Voltage Negative -600 V 
Spray Chamber Temperature 50 °C 
Drying Gas Temperature 350 °C 
Nebulising Gas Pressure 379 kPa 
Drying Gas Pressure 207 kPa 
m/z Ratio (Quadrupole) 150 – 350 
Capillary Voltage (Positive) 30 V 
Capillary Voltage (Negative) -40 V 
2.5.8 Purification of synthesis products by flash chromatography 
Chemically synthesised N-terminally-Boc protected dipeptide methyl ester had to be purified 
before cyclisation reaction took place. Therefore, flash chromatography of the intermediate 
products was performed (Tullberg, Grøtli et al. 2006). A 10 cm chromatography glass column 
with 1.5 cm diameter was wet packed with three grams of silica  
(Silica gel 60 (0.040-0.063 mm), E. Merck) as stationary phase. The sample was loaded onto 
the column with a flow rate of one to two drops per second. Elution was performed with three 
column volumes of a mixture of dichloromethane:methanol:hexane (6:1:5).  
2.5.9 Gas Chromatography-Mass Spectrometry (GC-MS) analysis of derivatised  
2,5-diketopiperazines 
Prior to GC-MS measurement a derivatisation of the 2,5-diketopiperazines was necessary. 
Silylation was performed with SILYL-911 (Macherey-Nagel, Düren, Germany) consisting of 
N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) and 1 % trimethylchlorosilane (TMCS). 
This potent derivatisation reagent is suitable for the silylation of compounds which are difficult 
to silylate like secondary amines.  
To 10 mg of the sample (cyclo(Leu-Pro), cyclo(Pro-Tyr) and cyclo(Glu-Glu)) 0.5 µL of the 
silylation reagent were added. The mixture was incubated for 3 h at 70 °C. After the silylation 
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reaction 0.5 µL were injected on-column into a VF-5ms column  
(30 m x, 0.25 mm i.d. x 0.25 µm; Agilent Technologies) installed in an Agilent-GC 7890B 
(Agilent, Waldbronn, Germany) coupled to an Agilent 5977A mass selective detector (MSD) 
operating in EI (70 eV) mode. Helium 5.0 was the carrier gas at a constant flow rate  
(1 mL min-1). Oven temperature program: 40 °C held for 3 min; heating rate, 8 °C min-1 to 
230 °C held for 3 min; heating rate, 25 °C min-1 to 325 °C held for 10 min. The temperatures 
of the transfer line, the source and the quadrupole were set to 330 °C, 230 °C and 150 °C, 
respectively.  
The scan range of the MSD was set between m/z 71 to 700 with a scan speed of  
1.562 scans sec-1. Recording of ions started after a solvent delay of 12 min. Identification of the 
signals was achieved by comparison of the acquired mass spectra with the commercial mass 
spectral database NIST 14. Moreover, the plausibility of the results was verified by the 
comparison of the silylated masses of the commercial standards with the calculated m/z ratios 
for each possible silylated state of the 2,5-diketopiperazines.  
2.6 Sensory analyses of sample stock solutions and SEC-fractions 
A panel consisting of 15 healthy untrained subjects with no known taste or olfactory perception 
disorder was asked to evaluate umami taste enhancing properties of samples and fractions 
thereof. To calibrate the panel, three aqueous monosodium glutamate (MSG) standard solutions 
were offered (1, 10 and 50 mM). Each subject tasted the standard solutions to get an impression 
of the umami taste caused by different MSG concentrations. Due to the colouration of the 
sample stock solutions (100 mg mL-1) the participants wore completely darkened glasses during 
the sensory analysis. 
The sensory tests considered of two sample solutions and a standard solution (10 mM; MSG) 
or the other way round (A, A, B; A, B, B; duo-trio-test). Firstly each sample was evaluated for 
genuine umami taste. In a second test series the samples were rated with regard to umami taste 
enhancing qualities. Hence, according to the glutamic acid content analysed by HPLC, samples 
of lower MSG concentration were adjusted to 10 mM glutamic acid to exclude the impact of 
MSG. The subjects were asked to identify samples of equal/different umami taste impression 
and to rank them according to the MSG standard solution row. The sensory analyses of  
SEC-fractions was performed in the same manner, but because of the high genuine glutamic 
acid concentration in some of them, no MSG was added. 
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2.7 Identification approaches for detected mass to charge ratios 
2.7.1 Evaluation of abundant signals 
The evaluation of each sample was performed using four different software tools, three of them 
supplied by Bruker and an additional self-programmed VBA (Visual Basic for Application) 
Excel calculation program developed by M. Sc. Irina Santourian, Institute of Food Chemistry. 
 
1. DataAnalysis 4.4 SR1  accurate mass determination, elemental composition 
2. ProfileAnalysis 2.3  bucket table generation for data processing 
3. MetaboScape Version 1.1.0  elemental composition (accurate mass, isotopic pattern) 
and spectral library (SL) search 
4. Excel VBA  accurate masses determined aligned against calculated masses of all 
proteinogenic di-, tri-, and tetrapeptides, pyroglutamyl dipeptides, and 2,5-diketo-
piperazines 
In order to confirm these preliminary identifications which based on accurate mass 
determination and biochemical/chemical plausibility, MS/MS analyses in the positive and 
negative mode were carried out and evaluated using software tools mentioned above. However, 
a few identifications succeeded only using automated routine evaluation methods. Most of the 
identifications required manual structure elucidation.  
2.7.2 Identification using spectral library 
Recorded MS/MS spectra were processed by the software tools 1-3 mentioned in 2.7.1. The last 
step included the automatic comparison of the detected MS/MS spectra with the spectra 
included in the commercial spectral library. If a recorded MS/MS spectrum matched the 
fragmentation pattern of a library spectrum it was automatically annotated as identified. 
However, spectral data had to fit several quality parameters (Table 2.7-1); otherwise they were 
not considered for the comparison.  
  
Material and methods 36 
  
Table 2.7-1: List of quality parameters used for the preselection of MS data. 
Parameter Narrow Wide 
Precursor m/z 2 mDa 5 mDa 
Precursor mSigma 25 75 
MS/MS 900 700 
2.7.3 Identification by manual comparison with fragmentation patterns from literature 
MS/MS experiments were performed in the positive and negative mode, and respective 
fragmentation patterns of potential pyroglutamyl-dipeptides were compared with published 
data (Frerot and Chen 2013).  
2.7.4 Preliminary identification of peptides, pyroglutamyl dipeptides, and  
2,5-diketopiperazines according to accurate mass determination and 
biochemical/chemical plausibility 
Due to known processing of the sample with regard to hydrolysis conditions and the origin of 
the sample each result has been assessed if it was biochemical/chemical plausible. Additional 
parameter for the plausibility of the identified substances were the performed methods, for 
example the ultrafiltration with a 3 kDa cut-off and size-exclusion chromatography. Visual 
Basic for Applications (VBA) from Excel was used to calculate the accurate mass of all possible 
di-, tri- and tetrapeptides out of the 20 proteinogenic amino acids. Based on process parameters 
of gluten hydrolysis a formation of condensation products of released small peptides, such as 
diketopiperazines (cyclic dipeptides) and pyroglutamyl peptides was expected. Hence, data set 
of VBA search program was extended by calculated accurate masses of all possible  
2,5-diketopiperazines and pyroglutamyl dipeptides out of the 20 proteinogenic amino acids.  
2.8 Chemical synthesis of 2,5-diketopiperazines  
2.8.1 Synthesis of 2,5-diketopiperazines performed with microwave assisted heating 
The synthesis of the 2,5-diketopiperazines (DKPs) (Figure 2.8-1) was performed according to 
the method published by (Tullberg, Grøtli et al. 2006).  
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Figure 2.8-1: Chemical reaction scheme of the formation of 2,5-diketopiperazines. In the first step an  
N-terminal BOC-protected amino acid forms a peptide bound with a C-terminal amino acid methyl ester 
(condensation reaction). After deprotecting the N-BOC-dipeptide methyl ester a cyclisation reaction takes 
part. A: Coupling reaction of N-terminal Boc protected amino acid with C-terminal amino acid methyl ester 
dissolved in DCM and addition of 1 mmol of N-methylmorpholine and 1-Ethyl-3-(dimethylaminopropyl) 
carbodiimid, respectively. Reaction product is an N-Boc protected dipeptide methyl ester. B: Deprotection 
of the product using 10 % aqueous citric acid, results in dipeptide methyl ester. C: Cyclisation reaction for 
10 min at 140 °C in the microwave.  
 
One millimole of each C-terminal amino acid methyl ester was dissolved in 10 mL dry 
dichloromethane (DCM) and 1 mmol of N-methylmorpholine was added. During the reaction 
time of 40 min the mixture was stirred at 0 °C. Afterwards 1 mmol of N-Boc-Glu and 1-Ethyl-
3-(dimethylaminopropyl) carbodiimid (EDC) were added. Thereafter, the reaction was stirred 
at 0 °C for 3 hours and overnight at room temperature. After dilution with 10 mL DCM the 
sample was washed three times with 10 % aqueous citric acid (10 mL) to remove the 
Boc protection group. The organic phase was dried over magnesium sulfate and concentrated 
using rotary evaporation. To purify the crude product a flash chromatography was performed 
(method 2.5.8). The second step of the synthesis was the cyclisation of the formed dipeptides. 
Around 50 mg of the deprotected dipeptide was dissolved in 3 mL of water and 2.5 equiv of 
triethylamine was added. All cyclisation reactions were carried out in the microwave  
Discover S-Class (CEM GmbH, Kamp-Lintfort, Germany) at 140 °C for 10 min  
(Tullberg, Grøtli et al. 2006). Subsequently the reaction mixture was again concentrated using 
rotary evaporation, and the precipitated product was finally dissolved in 750 µL of water.  
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2.9 Cultivation  
2.9.1 Basidiomycota strains 
Selected strains of Laetiporus sulphureus and Fistulina hepatica (Table 2.9-1) were either 
purchased from Deutsche Stammsammlung für Mikroorganismen und Zellkulturen  
(DSMZ, Braunschweig, Germany) or were self-isolated and identity verified by ITS 
sequencing.  
 
Table 2.9-1: List of Basidiomycota strains used in this work including the names, abbreviations and internal 
strain numbers of the Institute of Food Chemistry as well as their origin. 
Organism Internal strain number Origin  
Laetiporus sulphureus Lsul 235 DSMZ 11211 
Laetiporus sulphureus Lsu 279 Self-isolated (ITS verified) 
Laetiporus sulphureus Lsu 294 DSMZ 2785 
Fistulina hepatica  Fhe 205 DSMZ 4987 
2.9.2 Culture media 
Cultivation was performed on standard nutrition solution agar plates. For this, a small piece of 
mycelium was transferred from tilted agar tubes onto the surface of a standard nutrition solution 
(SNS) agar plate. Plates were incubated at 24 °C until a sufficient amount of mycelia covered 
the surface of the SNS agar plate. When the fungi covered the whole surface, plates were stored 
at 4 °C.  
 
Standard nutrition solution agar plates 
Standard nutrition solution was prepared according to Sprecher (Sprecher 1959). Adjustment 
of the pH value to pH 6.0 was done using sodium hydroxide solution (1 M). The media was 
autoclaved for 20 min at 121 °C.  
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Table 2.9-2: Composition of standard nutrition solution for the preparation of agar plates.  
Compound  Compound amount 
D-(+)-Glucose × H2O 30.0 g L
-1 
L-Asparagine × H2O 4.5 g L
-1 
Yeast extract 3.0 g L-1 
KH2PO4 1.5 g L
-1 
MgSO4 0.5 g L
-1 
Trace element solution (see below) 1.0 mL L-1 
Agar-Agar 20 g L-1 
 
Table 2.9-3: Composition of the trace element solution used for the preparation of standard nutrition 
solution. 
Compound  Compound amount 
FeCl3 × 6 H2O 0.08 g L
-1 
ZnSO4 × 7 H2O 0.09 g L
-1 
MnSO4 × H2O 0.03 g L
-1 
CuSO4 × 5 H2O 0.005 g L
-1 
EDTA 0.4 g L-1 
2.10 Molecular biological work 
2.10.1 In-silico screening for glutamyl-specific peptidase genes in Basidiomycota 
Several amino acid sequences of glutamyl endopeptidases were described in literature  
(Liu, Zhao et al. 2016). A glutamyl endopeptidase of Thermoactinomyces sp.  
(GenBank accession number WP_049719689) was thermostable and capable of hydrolysing 
proteins at high temperatures. Based on its accession number, the peptide sequence of the 
glutamyl endopeptidase was extracted. Subsequently, a Standard Protein BLAST at the 
National Center for Biotechnology Information (NCBI) against the taxis of the Basidiomycota 
was performed using the blastp algorithm.  
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2.10.2 Isolation of genomic DNA from fungal mycelium  
The DNA was extracted with phenol/chloroform/isoamyl alcohol (PCI) and precipitated by 
adding ethanol. For harvesting, approximately 200 mg mycelium was scraped off from the top 
of the standard nutrition solution-agar plate and transferred into a reaction vessel containing 
glass beads, 400 µL digestion buffer and PCI, respectively. Cell disruption of the re-suspended 
pellet was accomplished according to the manufacturer´s instructions of the Precellys 
homogenizer (PEQLAB, Germany) (5,800 rpm; 3 times 20 sec with a 20 sec break between 
each step). The mixture was centrifuged at 17,000 x g for 5 min. Supernatant was transferred 
into a new reaction vial, mixed with 400 µL TRIS/EDTA (TE)-buffer and inverted 
5 to 10 times. Centrifugation of the sample (17,000 x g, 5 min; 4 °C) led to the formation of 
two phases. The aqueous phase was transferred into a new vial, mixed with 200 µL PCI, 
inverted 5 to 10 times and centrifuged (17,000 x g, 5 min; 4 °C). Again, the aqueous phase was 
transferred into a new vial, mixed with 1 mL 99.5 % ethanol and inverted 5 to 10 times and 
centrifuged (17,000 x g; 10 min; room temperature). Supernatant was discarded and the pellet 
washed with 70 % ethanol. The ethanol was decanted and the pellet was dried in a thermoshaker 
at 50 °C. The pellet was re-suspended in 60 µL aqua bidest and DNA concentration was 
calculated from the absorbance measured at 260 nm using UV/VIS BioSpectrometer 
(Eppendorf, Germany).  
2.10.3 PCR conditions for the amplification of glutamyl-specific peptidase gen 
Primers for the amplification were designed with SnapGene® version 4.2.4 based on the 
annotated genomes of Laetiporus sulphureus (Lsu) and Fistulina hepatica (Fhe). For the 
amplification of the gene of interest the primers Lsu_start_fwd 
(5´ atggttaggaggaaattactccttcctgatgaag 3´) and Lsu_ende_rev 
(5´ tcaatttatagaatcctcgaaacagaagtcggtgaa 3´) were used as well as Fhe_start_fwd 
(5´ atggcgggcgccgatttcgaagattgg3 ´) and Fhe_ende_rev 
(5´ ttacgcaaagctgaacttgacgaactgaagtag 3´) for Fistulina hepatica and Laetiporus sulphureus, 
respectively. Polymerase chain reaction (PCR) was performed with Phusion® High-Fidelity 
DNA polymerase (Thermo Scientific, St. Leon-Rot, Germany) according to the manufacturer’s 
instructions in a thermocycler (pegSTAR 2X Gradient Thermocycler, Peqlab, Erlangen, 
Germany). The protocol was as follows: Initiation: 98 °C for 30 s, denaturation at 98 °C for 
30 s, annealing at 62 °C for 30 s, elongation at 72 °C for 60 s. Thirty cycles including 
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denaturation, annealing and elongation were performed and a final extension step for 5 min at 
72 °C. 
2.10.4 Verification of the amplification on agarose-gels  
To verify the length of the amplified fragments, an agarose-gel (1 %) was performed. For this, 
2.5 g agarose were dissolved in 250 mL boiling TRIS-Acetate-EDTA (TAE)-buffer, mixed 
with 12.5 µL rotisafe (Roth, Germany) and the gel was solidified. 20 µL of each sample was 
pipetted into one gel-pocket. The gel was run for 20 min at 100 V. As DNA-ladder, the 
O´GeneRuler™ 1 kb was used. Expected fragments were cut out of the gel and the DNA was 
extracted according to the standard protocol of innuPrep DOUBLEpure Kit  
(Analytik Jena, Germany). 
2.10.5 Ligation of the peptidase genes into the vector (pUC57) and transformation of the 
constructs into E. coli Top 10 
Ligation of the gene of interest was performed in a 0.2 mL reaction vial at 4 °C overnight. 
Components of the ligation mixture were as follows: 500 ng insert, 50 ng pUC57, 2 µL 
PEG4000, 2 µL 10 x T4 DNA ligase buffer, 5 U T4 DNA ligase ad 20 µL with water. 5 µL of 
the ligation mixture were added to 50 µL chemically competent E. coli cells. The mixture was 
incubated on ice for 15 min before the cells were heated to 42 °C for 45 to 60 s. Head shock 
was stopped on ice for 2 min. LB-medium (500 µL) was added to the reaction and the bacteria 
incubated at 37 °C for 30 to 45 min. After incubation, blue/white screening of the clones was 
performed on LB-Amp-x-Gal plates, which were incubated at 37 °C overnight.  
2.10.6 Verifcation the peptidase genes 
Clones were picked and used as template for a colony PCR. Colony PCR was performed 
according to the standard protocol for the Dream Taq DNA Polymerase  
(Thermo Scientific, St. Leon-Rot, Germany). PCR conditions were as follows: Initiation at 
95 °C for 10 min; denaturation at 94 °C for 1 min; annealing at 55 °C for 1 min and elongation 
at 72 °C for 2 min. Thirty-five cycles of denaturation, annealing and elongation were performed 
and a final extension step for 10 min at 72 °C. Amplification of the expected fragments was 
examined using agarose-gel electrophoresis (see section 2.10.4). Clones containing the 
fragment of interest were transferred to overnight cultures. The next day, the plasmids were 
Material and methods 42 
  
isolated according to the standard protocol of the innuPREP Plasmid Mini Kit  
(Analytik Jena AG, Germany). Isolated plasmids were sent to Seqlab/Microsynth to verify the 
fragments by sequencing using M13 primers.  
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3 Results 
Planned work-flow 
Due to the complexity of the performed work and very similar sample description this work-flow 
chart was designed. It should enable the reader to follow the work easily. Each of the four fields 
(grey) shows the work packages performed at the different stages of sample treatment.  
 
3.1 Evaluation of optical and olfactory properties of the raw material 
The Nestlé Product Technology Center (Lebensmittelforschung GmbH; Singen) delivered three 
different samples to the Institute of Food Chemistry in Hannover. All samples were treated 
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differently (Table 3.1-1). Variations of the crystal structure and olfactory properties were 
estimated.  
All samples were hydrolysed for 16 hours. Flavourzyme (FZ) was added to the samples 1 and 2 
and Protease P “Amano” 6S (P6SD) was added to sample 3. Sample 1 acted as reference, whereas 
sample 2 was additionally treated for four hours with a glutaminase. FZ and P6SD are proteolytic 
enzyme preparations from different Aspergillus strains. Flavourzyme is from Aspergillus oryzae 
(Merz, Eisele et al. 2015) and P6SD from Aspergillus melleus (Amano-Enzyme 2003). 
 
Table 3.1-1: Information received from Nestlé according to the treatment of the samples used for this work. 
Sample No.  Hydrolysis Additive Additional Information 
1 16 h FZ Reference 
2 16 h FZ + 4 h Protein Glutaminase 
3 16 h P6SD / 
 
Overall, the raw materials were inhomogeneous products that varied in terms of the particle size, 
and colour. The colour of the sample particles ranged from light orange over red to green. The 
colour of the samples produced under different thermal conditions varied from light yellow to an 
intensive orange. It became more intense with each additional thermal treatment step.  
No difference in the odour of the samples was detected. A brothy and savoury odour was perceived 
for each sample.  
3.2 HPLC analyses of the free amino acid content of the sample stock 
solutions 
Samples were prepared according to section 2.3 (materials and methods). All data in this section 
were observed by the HPLC method 2.5.3. In this case, the system was calibrated with a five point 
calibration instead of eight point calibration, as described in the methods section. Calibration 
points were 10; 20; 62.5; 75 and 100 µM of each amino acid. An external calibration with linear 
regression was calculated using the linear equation (𝑦 = 𝑚𝑥 + 𝑏). The coefficient of 
determination varied between 0.9786 for lysine 2 to 0.9984 for lysine 1 (Figure 3.2-1). Due to the 
two amino functions of lysine, which both can react with the oPA reagent, lysine gave two different 
fluorescence signals.  
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Figure 3.2-1: Exemplary presentation of a five point calibration curve of lysine 1 used for the calculation of the 
concentration of free lysine in the sample solution. Y-axis shows the peak area in mAU*s and the x-axis shows 
the lysine concentration [µM] of each calibration point. Linear equation and regression coefficient (R2) are 
shown above. 
 
Each amino acid was calculated (Table 3.2-1) with the linear equation of the associated calibration 
curve. Samples were diluted 1:10 and 1:100, respectively. Depending on evaluable peak areas 
either the areas of the 1:10 dilution or the areas of the 1:100 dilution were used for the calculation.  
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Table 3.2-1: Concentration [mM] and composition of free amino acids in samples 1 to 3 (delivered by Nestlé). 
Analysis was performed using permeate of the ultra-filtration of the sample stock solutions (100 mg mL-1). 
Abbreviation n.d. means that no signal was detected at the expected retention time. 
Amino acid 
(order of retention) 
Sample 1 
concentration [mM] 
Sample 2 
concentration [mM] 
Sample 3 
concentration [mM] 
Aspartic acid (Asp) 0.6 0.6 1.0 
Glutamic acid (Glu) 1.1 8.2 1.7 
Asparagine (Asn) 1.1 0.7 1.6 
Serine (Ser) 6.1 4.9 8.5 
Glutamine (Gln) 21.1 2.5 23.7 
Histidine (His) 0.9 0.8 1.3 
Glycine (Gly) 1.0 0.5 2.4 
Threonine (Thr) 1.9 1.9 3.7 
Arginine (Arg) 1.4 1.6 3.6 
Alanine (Ala) 2.4 2.5 4.6 
Tyrosine (Tyr) 1.8 1.7 2.2 
Methionine (Met) 0.7 0.9 1.7 
Valine (Val) 5.1 5.2 8.1 
Tryptophan (Trp) n.d. n.d. n.d. 
Phenylalanine (Phe) 3.3 2.4 4.6 
Isoleucine (Ile) 3.5 4.0 5.7 
Leucine (Leu) 9.3 9.6 12.0 
Lysine 1 (Lys1) 0.2 0.2 0.5 
Lysine 2 (Lys2) 3.4 0.4 1.0 
Sum of total free 
amino acids 
64.9 48.7 87.9 
 
Except of tryptophan all amino acids were detected in each sample. The sum of total free amino 
acid concentration varied between 48.7 mM in sample 2 to 87.9 mM in sample 3 (Table 3.2-1). 
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3.3 Sensory analysis of the ultra-filtered sample stock solutions 
At the beginning of the project the overall umami taste enhancing properties of the three samples 
delivered by Nestlé were reviewed. The samples were prepared each as a 100 mg mL-1 solution 
(stock solution). Afterwards ultrafiltration with a cut-off membrane of 3 kDa was performed. The 
free amino acid concentration (Table 3.2-1) of the ultra-filtrates was determined using HPLC. To 
mask the impact of free glutamic acid, the stock solution samples were adjusted to 10 mM with 
added monosodium glutamate (MSG).  
The majority of the subjects ranked the umami taste of the samples (adjusted to 10 mM MSG) 
more intense than the 10 mM standard of MSG (Figure 3.3-1). For sample 1 and 2 72 % of the 
participants scored the umami taste of the ultra-filtered stock solutions more intense than a 50 mM 
MSG standard solution. In sample 3 at least 50 % had the impression that the umami taste was 
more intense than 50 mM. The impression that the stock solution tasted as strong as the 10 mM 
MSG solution or less was reported by two out of 14 panellists, only.  
 
 
Figure 3.3-1: Pie chart of the taste distribution examined by sensory analysis of sample stock solutions  
(samples adjusted to 10 mM MSG). Each sample was tested by 14 subjects. Parts highlighted in red show a 
taste impression more intense than 50 mM (MSG), light orange shows taste impression of 50 mM (MSG), taste 
impression between 10 and 50 mM MSG is shown in yellow, green shows taste impression of 10 mM MSG and 
grey was not classified by the subjects.  
 
Sensory evaluation clearly showed that all samples contained umami taste enhancing substances 
or substances which had an inherent umami taste. 
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3.4 Determination of the peptide composition of sample stock solutions by 
UPLC-HR-MS 
Mass spectrometry (section 2.5.5) was performed with each ultra-filtered (3 kDa cut-off) sample 
stock solution (100 mg mL-1). Most abundant signals were identified based on their mass to charge 
ratios and mass spectra, respectively.  
The designed VBA program (2.7.1) calculated the exact masses of di-, tri-, and tetrapeptides, 
pyroglutamyl dipeptides, and 2,5-diketopiperazines, which were compared with the detected  
m/z ratios of the most abundant peaks (Figure 3.4-1). In addition, the biochemical and chemical 
plausibility of the proposed compounds was verified with regard to the known processing steps 
and conditions.  
 
Figure 3.4-1: Base peak chromatogram of sample 1 (yellow), sample 2 (red) and sample 3 (blue). Numbers of 
peaks indicate the examined signals of each sample and correspond with the numbering in Table 3.7-1. 
Separation was performed on a HILIC column (2.5.5)  
 
Using this calculation approach, the most abundant peaks turned out to be pyroglutamyl dipeptides 
and 2,5-diketopiperazines (Table 3.4-1) with the exception of the free amino acids Phe, Pro, and 
Tyr. In this evaluation only the most intense ions were considered.  
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Table 3.4-1: Calculated results of the most intense peaks. Peak numbers correlate with the peak numbering in 
Figure 3.4-1.  
Peak 
number 
Compound Sample Peak 
number 
Compound Sample 
1 diketo(Ile-Pro) 1, 2, 3 11 diketo(Val-Tyr) 
Phe-Pro 
1, 2 
2 diketo(Ile-Pro) 1, 2, 3 12 pyro(Glu-Pro) 1, 2, 3 
3 diketo(Phe-Pro) 1, 2, 3 13 diketo(His-Ala) 
diketo(Glu-Gly) 
1, 2 
4 diketo(Pro-Val) 1, 2, 3 14 Val-Pro-Leu 1, 2 
5 diketo(Tyr-Pro) 1, 2, 3 15 Phe-Pro 
Ile-Pro 
1, 3 
1, 2, 3 
6 diketo(Glu-Leu) 1, 2, 3 16 Phe 1, 2, 3 
7 5-Oxo-L-proline 1, 2, 3 17 Pro 1, 2, 3 
8 pyro(Glu-Ile-Pro) 1, 3 18 pyro(Glu-Gln) 1, 3 
9 Phe 1, 3 19 Tyr  
10 Pro 1, 3 20 Formate clusters 1, 2, 3 
 
For the complete analytical description of the compound composition of all samples, MS/MS 
analyses were performed afterwards.  
3.5 Determination of the peptide composition of sample stock solutions by 
UPLC-HR-MS/MS 
The sample solutions investigated in section 3.4 were also used for this analysis via  
HPLC-HR-MS/MS. Hydrolysed vegetable proteins often consist of a complex mixture of amino 
acids, small – to oligopeptides, as well as reaction products of the process like pyroglutamyl 
peptides and 2,5-diketopiperazines, for example. Identification of the signals was achieved by 
three different calculation approaches (2.7). The calculation approach ´Spectral Library` (SL) was 
an automatical approach, as well as ´SmartFormula` (SF). SmartFormula proposed the most 
plausible empirical formulas based on the accuracy of the detected m/z ratios. A manual approach 
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(LSc*, Lars Schmidt) included the calculation of exact masses by a VBA program and their 
comparison with detected m/z ratios. Additionally, detected ms/ms spectra were compared with 
published fragmentation pattern, and the chemical and biochemical plausibility of occurrence was 
evaluated. The amount of calculated signals varied between the samples. In total, 175 to 197 
signals (Figure 3.5-1) were identified in each sample by at least one of the mentioned calculation 
approaches including the manual investigation of the signals, which were not identified by the 
automatic routine calculation. 
 
 
Figure 3.5-1: Bar chart of identified signals in sample stock solution of sample 1 to 3. The first row shows the 
number of identified substances in sample 1 by the three different calculation approaches. Calculation 
approach 1 spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown 
in light blue, and calculation approach 3 SmartFormula (SF) is shown in dark blue. Row 2 shows sample 2 and 
row 3 shows sample 3. Y-axis shows the number of identified substances, x-axis shows the sample name and  
z-axis shows the different calculation approaches.  
 
Following the identification approaches, the samples were compared with each other. The aim was 
to present in detail, if potential umami substances were identified, which of them were exclusively 
detected in only one sample, in two of the samples or detected in all analysed samples. This 
strategy should outline the uniqueness of each sample. Moreover, it was possible to rapidly 
compare the exclusively detected substances with known umami active substances. Thereby, 
substances with known activity were excluded to rather focus on unique substances with unknown 
taste properties. The number of exclusively detected peptides (Figure 3.5-2) in sample 1 to 3 varied 
between two and seventeen. 
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Figure 3.5-2: Bar chart of identified substances, which uniquely appeared in one sample, and substances which, 
were detected at least in two of the three samples. These results are based on the results of Figure 3.5-1. The 
first, third, and fifth row shows the number of uniquely identified substances by the three different calculation 
approaches in sample 1, 2, and 3. Calculation approach 1 spectral library (SL) is shown in blue-grey, calculation 
approach 2 Lars Schmidt (LSc*) is shown in light blue, and calculation approach 3 SmartFormula (SF) is 
shown in dark blue. Row two, four, and six shows substances detected in two of the three samples ranging from 
sample 1 to sample 3. Y-axis shows the number of identified substances, x-axis shows the sample name, and  
z-axis shows the different calculation approaches. 
 
Uniqueness of the samples: 
 Exclusively detected in sample 1: 
 Glu-Gly-Thr and Phe-Pro-Gln 
 Exclusively detected in sample 2: 
 Acetyl-DL-Leucine; Thr-Gln-Gly; Ser-Gln-Gly; Val-Met; Ile-Pro-Glu; Pro-Gln; 
Glu-Ser; Glu-Glu-Gln; Met-Ser-Ser; m/z 287.12376; 505.26434; 485.18782; 
292.10269; 310.11233; 234.09855; 472.16608; 454.15552 
 Exclusively detected in sample 3: 
 Ala-Pro-Gln; Diketo-Ser-Gln; Gly-Gln-Gln; 489.24860; 325.17580; 314.13466; 
269.99105 
Based on the multitude of detected signals a fractionation approach needed to be performed. A 
successful fractionation led to lower signal density, and increase the likelihood of the identification 
of substances, which contribute to the umami taste by sensory analysis.  
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3.6 Size Exclusion Chromatography of sample stock solutions 
Size Exclusion Chromatography was the beginning of the second work package. 
 
Due to the variety of signals appearing in the sample stock solutions, a SEC was performed 
(Method 2.5.1). For this purpose, the permeate of the ultra-filtration (method 2.3) with a 3 kDa 
cut-off was used. The focus was on small compounds with molecular masses smaller than 3 kDa. 
A three-point calibration with Val-Tyr-Val (379 Da), Tyr-Ala (252 Da), and tyrosine (181 Da) was 
performed (Figure 3.6-1). Therefore, the partition coefficient (Kav) was plotted against the 
logarithm of the molecular mass (logM).  
 
Figure 3.6-1: External calibration of SEC system using Val-Tyr-Val, Tyr-Ala, and tyrosine. Y-axis shows 
partition coefficient (Kav) and x-axis shows logarithm of molecular mass (logM). Linear equation and coefficient 
of determination (R2) are shown in the diagram.  
 
Sample 1 to 3 were injected six times each with a volume of 250 µL per injection. Fractions were 
collected for five minutes and pooled, which resulted in the SEC-fractions A1/2 to A8  
(Figure 3.6-2) with a total volume of 15 mL.  
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Figure 3.6-2: Chromatogram of Size-Exclusion Chromatography (SEC) of sample 1 (blue), sample 2 (red), and 
sample 3 (orange). Each fraction was collected for five minutes. Numbering of the fraction is shown on top of 
the figure (A/1 to A/8). Molecular masses of the most abundant peaks were calculated (425 – 176 Da), and 
corresponding fractions are framed in green.  
 
Each sample showed the same elution pattern but had differences in the peak intensities. Detected 
peaks showed molecular masses between 425 to 176 Da. This indicated the presence of the 
expected di – and tripeptides, pyroglutamyl dipeptides and 2,5-diketopiperazines. Before a sensory 
analysis of the SEC-fractions was performed, the concentration of free glutamic acid of the 
fractions had to be measured. The glutamic acid concentration of the SEC-fractions, which were 
sensory analysed, was crucial for the experiment due to the inherent umami taste of glutamic acid. 
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3.7 HPLC analyses of the free glutamic acid content of the SEC-fractions 
In this step a steeper gradient profile was used, which decreased the run time to 32 minutes. The 
method was calibrated in the range of 10 to 100 µM, and the corresponding coefficient of 
determination for glutamic acid was 0.9930. 
 
Figure 3.7-1: Exemplary presentation of a eight point calibration curve of glutamic acid used for the calculation 
of the concentration of free glutamic acid in SEC-fractions. Y-axis shows the peak are in mV*s and the x-axis 
shows the glutamic acid concentration [µM] of each calibration point. Linear equation and regression 
coefficient (R2) are shown. 
 
Since glutamic acid has an inherent umami taste, the concentration of glutamic acid was measured 
in the SEC-fractions of each sample Table 3.7-1. Based on these data the sensory analysis (2.6) of 
these fractions was planned.  
 
Table 3.7-1: Glutamic acid concentration [mM] of SEC-fractions A/1 to A/8 of sample 1 to sample 3. 
Abbreviation n.d. means that no signal was detected at the expected retention time. 
 SEC-
fraction 
A1/2 
SEC-
fraction 
A3 
SEC-
fraction 
A4 
SEC-
fraction 
A5 
SEC-
fraction 
A6 
SEC-
fraction 
A7 
SEC-
fraction 
A8 
Sample 1 n.d. n.d. n.d. 0.46 mM 0.01 mM n.d. n.d. 
Sample 2 n.d. n.d. n.d. 4.31 mM 0.06 mM n.d. n.d. 
Sample 3 n.d. n.d. n.d. 0.99 mM 0.02 mM n.d. n.d. 
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SEC-fractions A5 and A6 were the only fractions containing glutamic acid. However, the main 
portion of free glutamic acid was detected in SEC-fraction A5 (0.5 to 4.3 mM) of each sample. 
Based on these results the design of experiment for the sensory analysis of the SEC-fractions was 
done.  
3.7.1 Sensory analysis of the SEC-fractions 
To ensure that umami taste effects as well as umami taste enhancing activities were detected, 
samples without glutamic acid were adjusted to 10 mM with MSG.  
All SEC-fractions of sample 1 to 3 were sensory evaluated by a panel of 14 (sample 1 and 3),  
or 15 (sample 2) untrained subjects. Except fractions A5 and A6, all fractions were adjusted to 
10 mM with MSG. For all samples (Figure 3.7-2 to Figure 3.7-4), fractions A5 and A6 turned out 
as the most taste intensive ones. Eleven to fourteen subjects evaluated the fractions A5 and A6 
with a higher umami taste compared to a 50 mM MSG standard solution even though these two 
fractions were not adjusted to a level of 10 mM MSG. Nevertheless, seven to eleven participants 
also rated SEC-fraction A4 of sample 1 to 3 as more taste intensive than 50 mM, although it was 
adjusted to 10 mM MSG, only.  
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Figure 3.7-2: Bar chart of the results of sensory analysis of the SEC-fractions A1 to A8 of sample 1. Bars 
highlighted in red shows a taste impression, which is perceived more intense than a 50 mM mono sodium 
glutamate (MSG) solution. The yellow bars show taste impression between 10 and 50 mM MSG, the green bars 
show taste impression ≤ 10 mM and the grey bars show the number of participants, which were not able to rate 
the sample clearly (not rated). Y-Axis shows the fraction numbers and x-axis show the taste impression in mM 
compared with the MSG standard solutions.  
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Figure 3.7-3: Bar chart of the results of sensory analysis of the SEC-fractions A1 to A8 of sample 2. Bars 
highlighted in red shows a taste impression, which is perceived more intense than a 50 mM mono sodium 
glutamate (MSG) solution. The yellow bars show taste impression between 10 and 50 mM MSG, the green bars 
show taste impression ≤ 10 mM and the grey bars show the number of participants, which were not able to rate 
the sample clearly (not rated). Y-Axis shows the fraction numbers and x-axis show the taste impression in mM 
compared with the MSG standard solutions. 
 
Figure 3.7-4: Bar chart of the results of sensory analysis of the SEC-fractions A1 to A8 of sample 3. Bars 
highlighted in red shows a taste impression, which is perceived more intense than a 50 mM mono sodium 
glutamate (MSG) solution. The yellow bars show taste impression between 10 and 50 mM MSG, the green bars 
show taste impression ≤ 10 mM and the grey bars show the number of participants, which were not able to rate 
the sample clearly (not rated). Y-Axis shows the fraction numbers and x-axis show the taste impression in mM 
compared with the MSG standard solutions. 
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These promising results of SEC-fractions A4, A5 and A6 of all three samples led to the exclusion 
of the other SEC-fractions for the subsequent experiments. The main focus was to identify the 
substance composition of the fractions of interest and potentially discover substances with inherent 
and yet unknown umami attributes. 
3.8 Determination of the peptide composition of the SEC-fractions by 
UPLC-HR-MS/MS 
The permeates of the sample stock solutions were fractionated by SEC (2.5.1) to separate the small 
molecules. This step facilitated the identification of the molecules and increased the likelihood of 
the detection of potential umami active substances. UPLC-HR-MS/MS was performed as before 
(2.5.5) as well as the identification based on the three mentioned calculation approaches (2.7). 
Additionally, MS/MS experiments in the negative ionisation mode were performed 
(Supplementary figure 4, 6, 8, 10, 12, 14, 16, 18, 20) to confirm the results of the positive MS/MS 
mode. Furthermore, more acidic substances became detectable in the negative mode. Only the 
most umami taste intense SEC-fractions A4 to A6 (3.7.1) of all samples were analysed  
via UPLC-HR-MS/MS. The number of identified peptides with at least one of the calculation 
approaches varied in each sample as well as in-between the SEC-fractions. In sample 1 SEC A4 a 
number of twelve peptides were identified, 15 peptides in sample 2 SEC A4 and eleven peptides 
in sample 3 SEC A4 (Figure 3.8-1), respectively.  
 
Figure 3.8-1: Bar chart of identified signals in SEC-fraction A4 of sample 1 to sample 3. The first row shows 
the number of identified substances by the three different calculation approaches in SEC-fraction A4 of sample 
1. Calculation approach 1 spectral library (SL) is shown in black, calculation approach 2 Lars Schmidt (LSc*) 
is shown in light blue and calculation approach 3 SmartFormula (SF) is shown in dark blue. Row 2 shows  
SEC-fraction A4 of sample 2 and row 3 shows SEC-fraction A4 of sample 3. Y-axis shows the number of 
identified substances, x-axis shows the sample name, and z-axis shows the different calculation approaches. 
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None of the twelve identified signals in sample 1 SEC A4 was a peptide exclusively occurring in 
this sample. In contrast, four of the signals identified in sample 2 SEC A4 were unique peptides in 
this sample and two unique peptides were detected in sample 3 SEC A4. 
Uniqueness of SEC A4: 
 Exclusively detected peptides in sample 1 SEC A4: 
 None 
 Exclusively detected in sample 2: 
 Gln-Tyr-Lys; Gln-Arg-Ala; Ala-Thr-Arg-Arg; Glu-Lys-His-Ile 
 Exclusively detected in sample 3: 
 Diketo-Pro-Pro; Gln-Lys-Ile 
The same procedure was performed with SEC A5 and A6 of sample 1 to 3. The number of 
identified substances in SEC A5 varied from 91 in sample 1 to 141 in sample 3 (Figure 3.8-2).  
 
Figure 3.8-2: Bar chart of identified signals in SEC-fraction A5 of sample 1 to sample 3. The first row shows 
the number of identified substances by the three different calculation approaches in SEC-fraction A5 of sample 
1. Calculation approach 1 spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt 
(LSc*) is shown in light blue and calculation approach 3 SmartFormula (SF) is shown in dark blue. Row 2 
shows SEC-fraction A5 of sample 2 and row 3 shows SEC-fraction A5 of sample 3. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
The fractions were compared with each other to determine their uniqueness. SEC A5 (sample 1) 
showed three unique peptides, SEC A5 (sample 2) 15 and SEC A5 (sample 3) 26 exclusively 
detected substances (Figure 3.8-3). 
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Figure 3.8-3: Bar chart of identified substances, which uniquely appeared in one sample and substances, which 
were detected at least in two of the three samples. These results are based on the results of Figure 3.8-2. The 
first, third and fifth row show the number of uniquely identified substances by two different calculation 
approaches in sample SEC-fraction A5 of 1, 2 and 3. Calculation approach 1 spectral library (SL) is shown in 
blue-grey and in case of no identified substance in black, calculation approach 2 Lars Schmidt (LSc*) is shown 
in light blue, calculation approach three is not shown, because no substance was identified by this approach 
appearing uniquely. Row two, four and six show substances detected in two of the three samples ranging from 
SEC-fraction A5 of sample 1 to sample 3. Y-axis shows the number of identified substances, x-axis shows the 
sample name and z-axis shows the different calculation approaches. 
 
Uniqueness of SEC A5: 
 Exclusively detected in sample 1: 
 Diketo-Ala-Ala; Diketo-Glu-Gly; Gln-Ile 
 Exclusively detected in sample 2: 
 Diketo-His-Cys; Diketo-Thr-Thr; Diketo-Thr-Phe; γ-Glu-Ile; L-Glutamate;  
Diketo-Tyr-Pro; Ile-Pro-Phe; Ile-Pro-Met; Pro-Phe-Ala; Diketo-Gln-Arg;  
Cys-Gln-Cys; Ile-Pro-Glu; Diketo-Asp-Tyr; Diketo-His-Pro; Diketo-Asn-His 
 Exclusively detected in sample 3: 
 Diketo-Val-Val; Phe-Ala-Ser; Phe-Ala-Pro; Ile-Pro; Ile-Ala; Diketo-Asp-Thr; 
Diketo-Glu-Gln; Gln-Ser; Tyr-Arg-Met; Asn-Gln-Thr; Glu-Asn-Gln;  
Glu-Arg-Phe; Ile-Gly-Phe; Ile-Pro-Tyr; Ile-Pro-Pro; Glu-Gln-Leu; Tyr-Pro;  
Val-Pro-Pro; Pro-Ser-Val; Ile-Pro-Gln; Gln-Pro-Ser; Gln-Asn; Diketo-Glu-Ser; 
Ser-Ser-Gly; Gln-Gln-Gly; Gln-Asn-Ser 
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In SEC A6 of sample 1 36 peptides were identified, 40 peptides in SEC A6 of sample 2 and 45 
peptides in SEC A6 of sample 3 (Figure 3.8-4).  
 
 
Figure 3.8-4: Bar chart of identified signals in SEC-fraction A6 of sample 1 to sample 3. The first row shows 
the number of identified substances by the three different calculation approaches in SEC-fraction A6 of sample 
1. Calculation approach 1 spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt 
(LSc*) is shown in light blue and calculation approach 3 SmartFormula (SF) is shown in dark blue. Row 2 
shows SEC-fraction A6 of sample 2 and row 3 shows SEC-fraction A6 of sample 3. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
Two substances of the 36 identified in SEC A6 of sample 1 were unique for this sample, five 
substances were unique for SEC A6 of sample 2, and eight substances were exclusively detected 
in SEC A6 of sample 3 (Figure 3.8-5). 
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Figure 3.8-5: Bar chart of identified substances, which uniquely appeared in one sample and substances, which 
were detected at least in two of the three samples. These results are based on the results of Figure 3.8-4. The 
first, third and fifth row show the number of uniquely identified substances by two different calculation 
approaches in sample SEC-fraction A6 of 1, 2 and 3. Calculation approach 1 spectral library (SL) is shown in 
blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is not 
shown, because no substance was identified by this approach appearing uniquely. In case of no identified 
substances bars are shown in black. Row two, four and six show substances detected in two of the three samples 
ranging from SEC-fraction A6 of sample 1 to sample 3. Y-axis shows the number of identified substances, x-
axis shows the sample name and z-axis shows the different calculation approaches. 
 
Uniqueness of SEC A6: 
 Exclusively detected in sample 1: 
 Gln-Phe; Tyr-Pro-Phe 
 Exclusively detected in sample 2: 
 Tyr-Pro-Leu; Diketo-Ala-Ser; Cys-Met-Gly; Glu-Tyr; Diketo-Ala-Pro 
 Exclusively detected in sample 3: 
 Trp-Arg-Gln; Diketo-Met-Pro; Diketo-Glu-Trp; Met-Met; Lys-Tyr-Cys;  
Diketo-His-Phe; Tyr-Asn-Gly; Met-Ser 
Size exclusion chromatography was a promising tool for the fractionation of the sample stock 
solutions. Nonetheless, the multitude of detected and, to some extent, identified substances did not 
allow to draw any more specific conclusion about individual umami active substances. For this 
reason, a sub-fractionation method was developed and performed.  
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3.9 Sub-fractionation of the umami taste active SEC-fractions by 
preparative HPLC 
The third work package started with the development of a “food-grade” sub-fractionation method. 
 
Sub-fractionation of the taste active SEC-fractions on a preparative scale was considered in order 
to correlate compounds identified with umami taste activity. The practicability of this approach 
was reviewed with SEC-fraction A5 of sample 2 of the respective gluten hydrolysate. A reversed 
phase preparative HPLC-method was set up using “food-grade” equipment and solvents. The main 
goal was to keep the samples free from toxic and harmful ingredients. Sub-fractionation of the 
umami taste active SEC-fraction A5 of sample 2 was performed (2.5.2). Focus was laid on this 
sample because of the multitude of detected potential umami active substances.  
An overlay of three consecutive runs of 200 µL sample injection at a time is shown in Figure 3.9-1 
(fractionation pattern highlighted in red frames). Instantly after injection, sub-fractions were 
collected every 10 min, which resulted in sub-fractions of 80 mL. Respective fractions of the runs 
were pooled, concentrated and freeze dried (2.4), reconstituted with a volume (ddH2O), which was 
equivalent with the total injection volume and finally analysed via UPLC-QTOF-HR-MS/MS 
(2.5.5). 
 
Figure 3.9-1: Typical chromatogram of sub-fractionation of SEC-fraction A5 of sample 2 via prepHPLC. 
Separation was performed on prepHPLC system AZURA (Knauer, Germany) on a preparative column 
(NUCLEODUR C18 Pyramid, 5 µm; 16 * 250 mm; MACHEREY-NAGEL, Düren, Germany). Gradient 
composition is shown in light blue and yellow. Fractions were cut every ten minutes. Single fractions are red 
framed from sub-fraction 1 to sub-fraction 6. SEC-fraction A5 of sample 1 is shown in green, sample 2 in blue 
and sample 3 in red.  
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Even though 210 nm is the most appropriate wavelength for the detection of peptides, in the UV 
spectra no significant peak was detected. The success of the fractionation was controlled 
afterwards using HR-MS.  
3.10 HPLC analyses of the free glutamic acid content of the  
prepHPLC sub-fractions 
HPLC was performed as before (method 2.5.3). In view of the ensuing sensory analyses, 
glutamic acid concentration was determined, a seven point calibration was performed  
(10 – 100 µM), correlation coefficient R2 = 0.9982.  
 
Table 3.10-1: Glutamic acid concentration [mM] of prepHPLC sub-fraction 1 from SEC A5 of sample 1 to 
sample 3.  
Sample name Glutamic acid concentration [mM] 
prepHPLC sub-fraction 1 (sample 1; SEC A5) 0.01 
prepHPLC sub-fraction 1 (sample 2; SEC A5) 0.10 
prepHPLC sub-fraction 1 (sample 3; SEC A5) 0.03 
 
According to the measured glutamic acid concentration (Table 3.10-1) of the prepHPLC  
sub-fraction 1 (SEC A5 of sample 1 to sample 3), all of them were adjusted to 10 mM MSG for 
the subsequent sensory analysis.  
3.11 Sensory analysis of the prepHPLC sub-fractions 
Of the 14 participants, two were taken out of the evaluation. Neither one of these two panellists 
tasted any test series correctly. In the performed triangle test the panel did not find a significant 
increase of the umami taste by any of the samples (Figure 3.11-1). 
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Figure 3.11-1: Triangle-test of the prep-HPLC sub-fraction 1 of each sample adjusted to 10 mM MSG. Taste 
impression higher than 50 mM monosodium glutamate (MSG) in grey, taste impression higher than 10 mM 
but lower than 50 mM in orange, taste impression below 10 mM in blue, and taste impression from candidates, 
who were not able to distinguish between sample, and standard solution are shown in yellow and were rated as 
not evaluated. The numbers in the bars show the number of given answers. 
 
Around 50 % of the participants were able to taste a difference between the standard solution 
(10 mM MSG), and the sample solution. Since only 50 % had the impression of a strong umami 
taste, the enhancing effect was not strong enough to give the samples a taste impression clearly 
distinguishable from the standards. 
 
3.12 Determination of the peptide composition of the prepHPLC  
sub-fractions from SEC-fraction A5 of all samples by  
UPLC-HR-MS/MS 
The peptide composition of the sub-fractions was determined (2.5.6)  
(Figure 3.12-1 to Figure 3.12-3). Comparison of each constituent of all sub-fractions led to a 
specific overview of the separation feasibility of the preparative HPLC method. Sub-fraction 1 had 
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the highest number of peptides, which decreased from sub-fraction to sub-fraction. This 
distribution pattern was evident for all three samples.  
 
Figure 3.12-1: Bar chart of identified signals in sub-fraction 1 to sub-fraction 6 of sample 1. The first row shows 
the number of identified substances by the three different calculation approaches. Calculation approach 1 
spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, 
calculation approach 3 SmartFormula (SF) is shown in dark blue, and in case of no identified substance bars 
are shown in black. From row two to row six, sub-fractions two to six are shown. Y-axis shows the number of 
identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
 
Figure 3.12-2: Bar chart of identified signals in sub-fraction 1 to sub-fraction 6 of sample 2. The first row shows 
the number of identified substances by the three different calculation approaches. Calculation approach 1 
spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, 
calculation approach 3 SmartFormula (SF) is shown in dark blue, and in case of no identified substance bars 
are shown in black. From row two to row six, sub-fractions two to six are shown. Y-axis shows the number of 
identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
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Figure 3.12-3: Bar chart of identified signals in sub-fraction 1 to sub-fraction 6 of sample 3. The first row shows 
the number of identified substances by the three different calculation approaches. Calculation approach 1 
spectral library (SL) is shown in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, 
calculation approach 3 SmartFormula (SF) is shown in dark blue, and in case of no identified substance bars 
are shown in black. From row two to row six, sub-fractions two to six are shown. Y-axis shows the number of 
identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
Due to the occurrence of the highest number of peptides in the sub-fraction one of each sample 
they were compared with each other to underline their uniqueness based on the exclusively 
detected substances (Figure 3.12-4). 
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Figure 3.12-4: Bar chart of identified substances, which uniquely appeared in sub-fraction 1, and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 1 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. Row two, four and six shows substances detected in two of the three samples. Y-axis shows 
the number of identified substances, x-axis shows the sample name and z-axis shows the different calculation 
approaches. 
 
 Exclusively detected in sub-fraction 1 of sample 1 SEC A5: 
 Ala-Arg-Ala; 295.21152; Ser-Val-Arg; 339.23773; 356.26293; 405.24561; 
400.28781; 383.26260; 135.00115; 410.11538; L-Isoleucine; Thr-Cys-Gly;  
Pro-Gln; 266.11085 
 Exclusively detected in sub-fraction 1 of sample 2 SEC A5: 
 149.06002; 271.18820; 303.08381; Phe-Arg-Gly; Diketo-Trp-Lys; 257.13566; 
233.07815; 229.14075; 505.33576; 447.29555; 194.11487; 365.19452; 267.12001; 
299.14757; 259.15131; Diketo-His-Gly; 215.12510; 455.22621; Asp-Arg-Pro; 
625.32119; 455.22786; Phe-Phe-Gln; 245.13566; Trp-Trp-Gln; 514.32218; 
219.17434; Diketo-Tyr-Pro; 239.15025; 305.15813; 283.17647; 301.28495; 
Phe-Ile-Asn; 343.29552; Diketo-Ser-Pro; 249.08296; Ile-Ile; 281.07413; 
328.22308; 203.13902; 157.13354; 285.18088; Glu-Leu; Ile-Glu;  
Ile-Pro-Glu; Diketo-Glu-Val; Val-Gly; Pro-Glu; 310.12985; Pro-Gly;  
Ser-Glu; Glu-Gln; L-Methionine S-oxide; 162.07608; 180.08665; 156.97976 
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 Exclusively detected in sub-fraction 1 of sample 3 SEC A5: 
 304.29988; 468.41999; 388.13639; Val-Gln-Pro; Diketo-Gln-Pro;  
Diketo-Glu-Gly; 231.17032; Diketo-His-Cys; Diketo-Pro-Asn; Thr-Gly-Phe; 
Diketo-Glu-Thr; 251.13633; Diketo-Pro-Ile; Pro-Pro-Ile; Pro-Ile-Ala; 355.16255; 
240.09788; Tyr-Pro; 355.16121; Pro-Pro-Val; 133.03178; L-Methionine; Ile-Asp; 
Gly-Leu-Ala; Pro-Ala; Ile-Pro-Gln; Diketo-Arg-Pro; Diketo-Glu-Thr;  
Diketo-Lys-Pro; Pro-Ser; 244.13052; 293.14556; Gln-Gln; Ser-Gln;  
Diketo-Glu-Ser; 273.10945; Gly-Gln-Gln  
 
 
Figure 3.12-5: Bar chart of identified substances, which uniquely appeared in sub-fraction 2 and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 2 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. If none of the calculation approaches led to identification of a substance bars are shown in 
black. Row two, four and six shows substances detected in two of the three samples. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
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 Exclusively detected in sub-fraction 2 of sample 1 SEC A5: 
 251.18664; 249.08430; Pro-Val-Val; 156.97976 
 Exclusively detected in sub-fraction 2 of sample 2 SEC A5: 
 149.05971; 337.10436; 381.13192; 233.07815; 229.14075; Glu-Pro-Asn;  
Glu-Asp-Ile; 215.12779; 625.32319; 603.33946; 620.36504; 611.30620; 
597.28817; Diketo-Met-Val; 198.14886; Diketo-Phe-His; Diketo-Ile-Cys; 
130.04987; 343.29552; Arg-Tyr-Asp; Ile-Ile; Val-Pro-Leu; Pro-Ile-Tyr;  
Pro-Ala-Phe; pyro-Glu-Phe; 485.18697; 145.04954; 163.06010; 365.10784; 
155.97499 
 Exclusively detected in sub-fraction 2 of sample 3 SEC A5: 
 468.41999; 209.09207; 453.19830; 475.18131; Thr-Phe-Gly; 120.08078 
 
Figure 3.12-6: Bar chart of identified substances, which uniquely appeared in sub-fraction 3 and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 3 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. If none of the calculation approaches led to identification of a substance bars are shown in 
black. Row two, four and six shows substances detected in two of the three samples. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
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 Exclusively detected in sub-fraction 3 of sample 1 SEC A5: 
 493.35102; 185.11454; 267.12001; Arg-Tyr-Phe 
 Exclusively detected in sub-fraction 3 of sample 2 SEC A5: 
 149.05971; 337,10436; Gln-Met-Cys; 271.18770; 257.13566; 233.07815; 
207.15909; 229.14075; Glu-Asp-Ile; 251.18664; 273.16696; 365.19452; 
308.18697; 259.15131; 215.12510; Diketo-Met-Val; 210.10978;  
Diketo-Ile-Cys; Diketo-Tyr-Pro; Ile-Pro; 598.29704; 505.26483; 489.23303; 
145.05087 
 Exclusively detected in sub-fraction 3 of sample 3 SEC A5: 
 Gln-Gln-Ser; 326.16836; Leu-Pro-Phe 
 
 
Figure 3.12-7: Bar chart of identified substances which, uniquely appeared in sub-fraction 4 and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 4 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. If none of the calculation approaches led to identification of a substance bars are shown in 
black. Row two, four and six shows substances detected in two of the three samples. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
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 Exclusively detected in sub-fraction 4 of sample 1 SEC A5: 
 155.97499 
 Exclusively detected in sub-fraction 4 of sample 2 SEC A5: 
 149.05971; 337,10436; Gln-Met-Cys; 233.07815; Diketo-Asp-Tyr; 273.16696; 
251.18664; Diketo-His-Gly; 215.12510; 144.98550; Diketo-Phe-Pro; 210.10978; 
Diketo-Ile-Cys; 365.10649; 145.04954; 163.06144 
 Exclusively detected in sub-fraction 4 of sample 3 SEC A5: 
 468.41999; 340.18803 
 
Figure 3.12-8: Bar chart of identified substances which, uniquely appeared in sub-fraction 5 and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 5 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. If none of the calculation approaches led to identification of a substance bars are shown in 
black. Row two, four and six shows substances detected in two of the three samples. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
 Exclusively detected in sub-fraction 5 of sample 1 SEC A5: 
 332.33118; 155.97499 
 Exclusively detected in sub-fraction 5 of sample 2 SEC A5: 
 323.14587; 271.18770; Diketo-Asp-Tyr; 228.19581; 250.17747; Gln-Met-Cys; 
Glu-Pro-Asn; Glu-Asp-Ile; 273.16696; Diketo-His-Gly; 215.12510; 226.18016; 
266.17238; 212.16451; Diketo-Met-Ile; 201.10945; 174.05495; Diketo-Ile-Cys; 
130.04987; 316.21319; 180,13829; Phenylalanine 
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 Exclusively detected in sub-fraction 5 of sample 3 SEC A5: 
 None  
 
 
Figure 3.12-9: Bar chart of identified substances, which uniquely appeared in sub-fraction 6 and substances, 
which were detected at least in two of the three samples. These results are based on the results of Figure 3.12-3. 
The first, third and fifth row show the number of uniquely identified substances by the three different 
calculation approaches in sub-fraction 6 of sample 1 to 3. Calculation approach 1 spectral library (SL) is shown 
in blue-grey, calculation approach 2 Lars Schmidt (LSc*) is shown in light blue, calculation approach three is 
shown in dark blue. If none of the calculation approaches led to identification of a substance bars are shown in 
black. Row two, four and six shows substances detected in two of the three samples. Y-axis shows the number 
of identified substances, x-axis shows the sample name and z-axis shows the different calculation approaches. 
 
 Exclusively detected in sub-fraction 6 of sample 1 SEC A5: 
 521.37964 
 Exclusively detected in sub-fraction 6 of sample 2 SEC A5: 
 149.05971; 337.10436; 233.07815; 229.14075; Glu-Pro-Asn; Glu-Glu-Val;  
Gln-Met-Cys; 215.12510; 266.17238; 226.18016; 188.12812; 170.11756; 
210.10978; Diketo-Ile-Cys; 283.17647; 197.16484: 167.11789; 145.04954; 
365.10783; 156.98550 
 Exclusively detected in sub-fraction 6 of sample 3 SEC A5: 
 343.29552; 240.23219: 158.96813; 226.94673 
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This section summarises biomolecules identified so far, and the sub-fraction in which they were 
found. Besides biomolecules which occurred exclusively in one of the six sub-fractions, there were 
biomolecules detected in two consecutive sub-fractions, and some molecules detected in each  
sub-fraction (Table 3.12-1 and Table 3.12-2).  
Results are presented in ascending order. The detailed evaluation of the samples including MS/MS 
analyses in the ESI-positive mode with all detected m/z ratios of the compounds identified are 
presented in the appendix (Supplementary figure 28 to Supplementary figure 33 and corresponding 
Supplementary table 28 to Supplementary table 33). 
Listed data were received in the positive ionisation (ESI) MS/MS mode. Each molecule was 
annotated with SmartFormula (SF). If SF and LSc are mentioned in the same row, both approaches 
led to the same molecular formula. ´Origin unknown` means that the identified substance was not 
identified in the starting material. In some cases, identified substances were detected in each of the 
sub-fractions, but were not detected in SEC A5, which was used to generate these sub-fractions. 
One can hypothesise that newly detected biomolecules became visible due to the additional 
fractionation step. If these substances were co-eluting with others in the SEC-fractions, they 
possibly were hidden by higher concentrated substances. 
Moreover, literature research was done for the exclusively detected molecules to figure out, 
whether they had known umami attributes or not. All results in this section were based on the  
SEC-fraction A5 of sample 2 that exhibits the strongest umami taste.  
Sub-fraction 1 contained eight different known umami taste active biomolecules (Table 3.12-1) 
Glu-Leu (Ohyama, Ishibashi et al. 1988), Val-Glu; Pro-Glu (Dang, Gao et al. 2015), Val-Asp;  
Val-Gly (Ishibashi, Ono et al. 1988), Glu-Ser (Arai, Yamashita et al. 1972), Pro-Gly and Pro-Thr 
(Yamamoto, Shiga et al. 2014).  
 
Table 3.12-1: Biomolecules detected and identified by operator (LSc), spectral library (SL), or SmartFormula 
(SF). Each of the four sections (separated by a massive black line) of the table contains biomolecules exclusively 
in one sub-fraction. Unknown means not detected in respective donor fraction.  
 Sub- 
fraction 
Origin RT 
[min] 
Name Molecular 
Formula 
m/z calc. Annotations 
1 1 unknown 6.42 Phe-Arg-Gly C17H26N6O4 379.20951 LSc 
2 1 unknown 6.79 Diketo-Trp-Lys C17H22N4O2 315.18212 LSc 
3 1 unknown 10.34 Asp-Arg-Pro C15H26N6O6 387.19935 LSc 
4 1 unknown 10.74 Phe-Phe-Gln C23H28N4O5 441.21393 LSc 
5 1 unknown 10.87 Trp-Trp-Gln C27H30N6O5 519.27212 LSc 
6 1 unknown 17.51 Phe-Ile-Asn C19H28N4O5 393.21393 LSc 
7 1 SEC-A5 19.07 diketo(Ser-Pro) C8H12N2O3 185.09263 SF/LSc 
8 1 SEC-A5 
also 
SEC-A6 
20.37 pyro(Glu-Glu) C10H14N2O6 259.09322 LSc 
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 Sub- 
fraction 
Origin RT 
[min] 
Name Molecular 
Formula 
m/z calc. Annotations 
9 1 SEC-A5 21.37 Pro-Val C10H18N2O3 215.13902 SF/SL 
10 1 SEC-A5 21.63 Val-Pro-Val C15H27N3O4 314.20743 SF/SL 
11 1 SEC-A5 21.71 Ala-Leu C9H18N2O3 203.13092 SF/SL 
12 1 unknown 21.98 L-Norleucine C6H13NO2 132.10191 SF/SL 
13 1 SEC-A5 22.19 Glu-Leu C11H20N2O5 261.14450 SF/SL 
14 1 unknown 22.27 Gly-Ile C8H16N2O3 189.12337 SF/SL 
15 1 SEC-A5 22.57 diketo(Thr-Ile) C10H18N2O3 215.1396 LSc 
16 1 SEC-A5 22.96 Glutamic acid C5H9NO4 148.05651 LSc 
17 1 SEC-A5 22.96 Ile-Glu C11H20N2O5 261.14450 SF/SL 
18 1 SEC-A5 23.30 Ile-Pro-Glu C16H27N3O6 358.19726 SF/SL 
19 1 SEC-A5 23.34 Ile-Glu C11H20N2O5 261.14450 SF/SL 
20 1 SEC-A5 23.35 Pro-Val C10H18N2O3 215.13902 SF 
21 1 SEC-A5 23.81 Ile-Ser C9H18N2O4 219.13461 LSc 
22 1 SEC-A5 23.84 Leu-Pro-Thr C15H27N3O5 330.20235 SF/SL 
23 1 SEC-A5 24.55 Glutamic acid C5H9NO4 148.05651 LSc 
24 1 SEC-A5 24.57 Val-Glu C10H18N2O5 247.12885 SF/SL 
25 1 SEC-A5 24.81 Val-Gly C7H14N2O3 175.10772 SF/SL 
26 1 SEC-A5 25.24 Pro-Glu C10H16N2O5 245.11320 SF/SL 
27 1 SEC-A5 25.31 Val-Asp C9H16N2O5 233.11320 SF/SL 
28 1 SEC-A5 25.53 diketo(His-Pro) C11H14N4O2 235.11951 LSc 
29 1 SEC-A5 25.89 Pro-Gly C7H12N2O3 173.09207 SF/SL 
30 1 SEC-A5 25.97 Pro-Thr C9H16N2O4 217.11828 SF/SL 
31 1 SEC-A5 26.11 Val-Ser C8H16N2O4 205.11828 SF/SL 
32 1 SEC-A5 26.13 diketo(Glu-Ala) C8H12N2O4 201.08755 LSc 
33 1 SEC-A5 
Also 
SEC-A6 
26.64 pyro(Glu-Glu) C10H14N2O6 259.09322 LSc 
34 1 SEC-A5 27.92 Glutamic acid C5H9NO4 148.05651 LSc 
35 1 SEC-A5 27.92 Ser-Glu C8H14N2O6 235.09246 SF/SL 
36 1 SEC-A5 
also 
SEC-A6 
28.34 Glutamine C5H10N2O3 147.07250 LSc 
37 1 SEC-A5 28.36 diketo(Glu-Gln) 
(pyro-Glu-Gln) 
C10H15N3O5 258.10901 LSc 
38 1 SEC-A5 28.36 Glu-Gln 
Ala-Asp-Ala 
C10H17N3O6 
C10H17N3O6 
276.11901 
276.1197 
SF/SL 
LSc 
39 1 SEC-A5 28.75 L-Methionine 
S-oxide 
C5H11NO3S 166.05324 SF/SL 
40 1 SEC-A5 31.32 Lysine C6H14N2O2 147.10888 LSc 
41 1 SEC-A5 
also 
SEC-A6 
31.31 Arginine C6H14N4O2 175.11895 SF/SL 
42 1 SEC-A5 
also 
SEC-A6 
31.41 Histidine C6H9N3O2 156.07283 LSc 
43 2 unknown 11.03 diketo(Phe-His) C15H16N4O2 285.13516 LSc 
44 2 unknown 19.38 Arg-Tyr-Asp C19H28N6O7 453.20991 LSc 
45 2 SEC-A6 21.29 Pro-Ile-Tyr C20H29N3O5 392.21800 SF/SL 
46 2 SEC-A5 22.08 Pro-Ala-Phe C17H23N3O4 334.17666 SF/SL 
47 2 SEC-A5 
also 
SEC-A6 
22.40 pyro(Glu-Phe) C11H20N2O3 227.11828 LSc 
48 3 SEC-A5 9.70 diketo(Pro-Ile) C11H18N2O2 211.14467 SF/LSc 
49 3 SEC-A5 10.12 diketo(Pro-Ile) C11H18N2O2 211.14467 SF/LSc 
50 3 SEC-A5 10.81 diketo(Pro-Val) C10H16N2O2 197.12902 SF/LSc 
51 3 SEC-A5 16.68 diketo(Pro-Val) C10H16N2O2 197.12902 SF/LSc 
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 Sub- 
fraction 
Origin RT 
[min] 
Name Molecular 
Formula 
m/z calc. Annotations 
52 3 SEC-A5 16.68 diketo(Glu-Ile) C11H18N2O4 243.1345 SF/LSc 
53 3 unknown 17.76 Leu; Ile C6H13NO2 132.09798 SF/LSc 
54 3 SEC-A6 18.95 Tyrosine C9H11NO3 182.07725 SF/LSc 
55 3 unknown 18.96 Glu-Gln-Asn C14H23N5O8 390.16262 LSc 
56 3 SEC-A5 20.00 Leu-Pro-Ile C17H31N3O4 342.23873 SF/SL 
57 3 SEC-A5 20.63 Val-Pro-Phe C19H27N3O4 362.20743 SF/SL 
58 5 unknown 10.97 diketo(Met-Ile) C11H20N2O2S 245.13239 LSc 
 
Moreover, the diketo- or pyro(Glu-Gln) dipeptide was detected, which is also known to enhance 
the umami taste (Kiyono, Hirooka et al. 2013). This highly potent substance was exclusively 
detected in sub-fraction 1, which made this sub-fraction the most interesting one. The sub-fractions 
4 and 6 did not exhibit biomolecules detected exclusively in one of these fractions.  
Other small biomolecules were detected in more than one sub-fraction. Generally, they eluted in 
2 consecutive sub-fractions. Taken into account that sub-fractionation was done according to the 
time and not by detected signals it was conceivable that substances were part of two consecutive 
fractions. Very few substances eluted in more than four consecutive sub-fractions.  
 
Table 3.12-2: Biomolecules detected and identified by the operator (LSc), spectral library (SL), or 
SmartFormula (SF). The table is seperated into three sections by massive black lines. Section one includes 
biomolecules that were detected in two consecutive sub-fractions with the exception of number 6 that were 
detected in sub-fraction 1, and 3. Section two includes biomolecules detectd in more than two not consecutive 
sub-fractions. Section three includes biomolecules detected in sub-fractions 1 to 4 and 1 to 6, respectively.  
 Sub- 
fraction 
Origin RT [min] Name Molecular 
Formula 
m/z calc. Annotations 
1 1; 2 SEC-A5 17.52 diketo(Glu-Pro) C10H14N2O4 227.1032 LSc 
2 1; 2 SEC-A5 19.36 
19.38 
diketo(Glu-Pro) 
(pyro-Glu-Pro) 
C10H14N2O4 227.1032 LSc 
3 1; 2 SEC-A5 19.66 
19.65 
Ile-Ile C12H24N2O3 245.18597 SF/SL 
4 1; 2 SEC-A5 20.99 
20.84 
Ile-Pro-Val C16H29N3O4 328.22308 SF/SL 
5 1; 2 unknown 23.82 
17.27 
diketo(Glu-Val) C10H16N2O4 229.11845 LSc 
6 1; 3 SEC-A5 16.65 
16.81 
diketo(Tyr-Pro) C14H16N2O3 261.1239 LSc 
7 2; 3 unknown 10.88 
10.85 
diketo(Met-Val) C10H18N2O2S 231.11674 LSc 
8 4; 5 SEC-A5 7.48 
7.53 
diketo(Asp-Tyr) C13H14N2O5 279.0981 LSc 
9 4; 5 SEC-A6 17.69 
22.34 
Phenylalanine C9H11NO2 166.08233 SF/LSc 
10 2; 5; 6 unknown 7.94 
7.93 
8.04 
Glu-Pro-Asn C14H22N4O7 359.15681 LSc 
11 1; 4; 5 SEC-A5 10.05 
10.10 
10.14 
diketo(His-Gly) C8H10N4O2 195.0882 LSc 
12 2; 3; 5; 6 unknown 7.94 Asp-Glu-Leu C15H25N3O8 376.17213 LSc 
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 Sub- 
fraction 
Origin RT [min] Name Molecular 
Formula 
m/z calc. Annotations 
7.93 
7.93 
8.04 
13 1-4 SEC-A5 20.18 
21.73 
21.68 
18.44 
Pro-Phe C14H18N2O3 263.13902 SF/SL 
14 1-4 SEC-A5 20.34 
21.93 
19.00 
18.72 
Pro-Ile C11H20N2O3 229.15467 SF/SL 
LSc 
LSc 
LSc 
15 1-6 unknown 7.86 
7.94 
5.82 
5.78 
7.92 
8.04 
Gln-Met-Cys C13H24N4O5S2 381.12677 LSc 
16 1-6 SEC-A4 16.07 
16.38 
16.35 
16.30 
16.38 
16.49 
diketo(Ile-Cys) C9H16N2O5S 217.10487 LSc 
 
The umami active substance pyro(Glu-Pro) (Schlichtherle-Cerny and Amadò 2002) was detected 
in sub-fractions 1 and 2. Furthermore, the umami active tripeptide Asp-Glu-Leu  
(Dang, Gao et al. 2015) was detected in the sub-fractions 2, 3, 5 and 6. At least one known umami 
active substance was detected in each sub-fraction, except of sub-fraction 4.  
Fractionation based on elution time segments did not lead to the separation of the majority of small 
biomolecules. Most of the substances eluted in sub-fraction one, or two, respectively. The majority 
of known umami taste active biomolecules was solely present in sub-fraction 1. In addition, this 
fraction contained a myriad of substances compared to the five other sub-fractions  
(Supplementary figure 28 - Supplementary figure 33).  
Based on the results of the prepHPLC, the corresponding MS/MS results and the results of the 
sensory analysis of the prepHPLC sub-fractions, it was concluded that the performed  
sub-fractionation method was not a suitable sub-fractionation approach for the taste intense  
SEC-fractions. Obviously, a better sub-fractionation method had to be performed, taking again 
into consideration that the resulting samples had to be “food-safe”. 
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3.13 Sub-fractionating of the most taste intense SEC-fraction A5 and A6 of  
sample 2 via refined Size Exclusion Chromatography 
A refined SEC was the starting point of the fourth work package.  
 
Based on results of the sub-fractionation via prepHPLC another sub-fractionation method was 
applied. Sub-fractionation of taste intense SEC-fractions was performed with a refined SEC. 
Fraction A5 and A6 of sample 2 were sub-fractionated, and sub-fractions were collected every 
minute, which resulted in 35 sub-fractions per sample (Figure 3.13-1). 
 
Figure 3.13-1: SEC chromatograms of sub-fractionation of SEC-A5 of sample 2 (on top of the figure) and  
SEC-A6 of sample 2 (bottom). Sub-fractions were cut every minute (nsub-fractions = 35). Red framed sub-fractions 
are the fractions showing a signal in the chromatogram (λ = 280 nm). 
 
Only few sub-fractions gave signals in the SEC chromatogram, which are highlighted in red frames 
(Figure 3.13-1). SEC A5 showed six, and SEC A6 seven interesting sub-fractions. Respective  
sub-fractions were pooled from 20 injections (total volume of one sub-fraction = 20 mL),  
freeze-dried, reconstituted in 5 mL ddH2O (total injection volume), and analysed via amino acid 
HPLC, UPLC-QTOF-MS/MS, and sensorally evaluated. 
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3.14 Determination of the free amino acid content of SEC-sub-fractions 
Calibration was performed at eight calibration points (10; 20; 30; 40; 50; 62.5; 75; 100 µM). Each 
standard solution contained all amino acids but proline and cysteine. β-alanine was used as internal 
standard. Sub-fractions A16 to 21 of SEC A5, and sub-fractions A20-A26 of SEC A6 (sample 2) 
were analysed. These were the only sub-fractions showing signals in SEC, so it was expected to 
detect free amino acids in these fractions. Surprisingly, in none of these analysed  
sub-fractions (A16 – A21 of SEC A5, sample 2, and A20 – A26 of SEC A6, sample 2) amino acids 
were detected with concentrations above 10 µM (data not shown). Since 10 µM was equivalent to 
the lowest standard concentration, no quantification of concentrations below this level was 
possible.  
This information was crucial for the sensory analysis design. Usually, the detected concentration 
of free glutamic acid had to be taken into account for the triangle test. As mentioned before, each 
solution was spiked with MSG to a concentration of 10 mM before sensory analysis. More 
information on the effect of the absence of free glutamic acid in the SEC sub-fractions concerning 
sensory analysis can be found in the section sensory analysis of SEC sub-fractions (3.15).  
The combination of the SEC sub-fractionation approach, and HPLC results of the sub-fractions 
(free amino acids) led to a new question. If the signals detected in the SEC sub-fractions were 
generated from the most taste intense SEC-fractions A5, and A6 of sample 2, devoid of amino 
acids, what kind of compounds were they? According to the SEC procedure, it was surmised that 
these were smaller molecules with umami attributes. The most promising sub-fractions were A19 
of SEC A5, sample 2, and A24 of SEC A6, sample 2. These two fractions gave the highest SEC 
signals, but did not contain free amino acids with a concentration in the calibration range  
(10 to 100 µM). These sub-fractions (A19 of SEC A5 and A24 of SEC A6, both from sample 2) 
were sensorial analysed as well as evaluated using the UPLC-HR-QTOF-MS/MS. 
3.15 Sensory analysis of SEC sub-fractions 
Sensory analysis was performed with the most promising SEC sub-fractions A19 of SEC A5, 
sample 2 and A24 of SEC A6, sample 2. Triangle tests were performed as before with one 
exception. In this series of experiments, the samples were tasted twice. Once with the addition of 
10 mM MSG, because no glutamic acid was detected, as described above, and one without the 
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addition of MSG. The aim was to figure out, whether the sub-fractions contained compounds that 
had an umami taste enhancing effect, or whether they contained compounds with an own umami 
taste. 
 
 
Figure 3.15-1: Triangle test of the SEC sub-fraction A19 of SEC A5, sample 2 with and without the addition of 
mono sodium glutamate (MSG), and SEC sub-fraction A24 of SEC A6, sample 2 with and without the addition 
of MSG. Taste impression higher than 50 mM MSG is shown in grey, taste impression higher than 10 mM but 
lower than 50 mM orange, taste impression below 10 mM in blue, and taste impression from candidates who 
were not able to distinguish between sample and standard solution are yellow and were rated as not evaluated. 
The numbers in the bars show the number of given answers. 
 
The bar at the bottom (Figure 3.15-1) shows the results of sub-fraction A19 without the addition 
of 10 mM MSG. 54 % of the participants had the impression that the taste of this sub-fraction was 
more intense or equal to 10 mM MSG, 43 % out of the 54 % even had the impression that the taste 
intensity was above 50 mM MSG. Since no MSG was present, it was assumed that this sub-fraction 
contained compounds possessing umami taste. Furthermore, the taste impression of this  
sub-fraction increased with the addition of MSG. For this sample, 77 % of the panellists rated the 
taste more intense than 10 mM MSG. Of these 77 %, even 50 % of the subjects had the impression 
that the taste was more intense than 50 mM. It was concluded that sub-fraction A19 not only 
contained compounds possessing umami taste, but also compounds with umami taste enhancing 
properties.  
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Sub-fraction A24 of SEC A6, sample 2 was evaluated in the same way. Without the addition of 
10 mM MSG 70 % of the participants had the impression that the taste was more intense than 
10 mM MSG. Of these 70 %, even 55 % had the impression that sub-fraction A24 without MSG 
tasted more intense than 50 mM MSG. With the addition of 10 mM MSG to sub-fraction A24 the 
percentage of participants who rated the sample more intense than 10 mM MSG increased to 77 %. 
This suggested that it contained umami active compounds, but none that enhanced the umami taste, 
since the addition of MSG did not cause a significant increase in taste perception. To identify the 
compounds in these highly promising sub-fractions (A19 of SEC A5 and A24 or SEC A6, both 
from sample 2) in depth UPLC-HR-QTOF-MS/MS analyses were performed. 
3.16 Identification of potential umami active compounds by  
UPLC-HR-QTOF-MS/MS 
Analyses were performed as described in section 2.5.6. Detailed information regarding the 
procedure for evaluating the signals can be found in section 2.7. Base peak chromatograms were 
recorded, and the most abundant signals were evaluated (Figure 3.16-1). 
 
Figure 3.16-1: Base Peak chromatogram (positive MS/MS mode) of reconstituted sub-fraction A19 of SEC A5 
from sample 2. The numbering of the peaks correlates with the numbering in Table 3.16-1. 
 
In sub-fraction A19 of SEC A5, originating from sample 2, 17 dipeptides and their condensation 
products were detected (Table 3.16-1). All of them were already found in at least one of the  
SEC-fractions, which showed that the sample pre-treatment, freeze-drying and following analyses 
were reproducible, and did not result in significant losses or chemical alterations. 
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Table 3.16-1: Identification of the most abundant signals of sub-fraction A19 of SEC-fraction A5, sample 2. 
Annotation was done by two of the three calculation approaches (SF = SmartFormula, and LSc* = manually 
by operator). Numbering in the table correlates with the numbering of the signals in Figure 3.16-1. 
 
Annotation of the signal was done by SmartFormula (SF) and the operator (LSc*). The third 
calculation approach by spectral library (SL) was not applicable due to the low signal intensity of 
CID mass spectra. Two known umami active compounds were among the 17 identified 
compounds. The umami taste of Glu-Leu was described by Ohyama et al. 1988, and the taste of 
pyro(Glu-Pro) was described by Kiyono et al. 2013. It was likely that these compounds contributed 
to the intense umami taste of sub-fraction A19 of SEC A5, sample 2.  
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Several other dipeptides with one amino acid being Glu, Val or Pro were detected. Many of the 
previously described umami active peptides carried one of these amino acids in their sequence, for 
example Val-Glu, Pro-Glu (Dang, Gao et al. 2015), Val-Asp, Val-Gly (Ishibashi, Ono et al. 1988), 
Pro-Gly or Pro-Thr (Yamamoto, Shiga et al. 2014).  
Sub-fraction A24, SEC A6, sample 2 was evaluated the same way. The numbering in Figure 3.16-2 
correlates with the numbering in Table 3.16-2. 
 
Figure 3.16-2: Base Peak chromatogram (positive MS/MS mode) of reconstituted sub-fraction A24 of SEC A6 
from sample 2. The numbering of the peaks correlates with the numbering in Table 3.16-2. 
 
One compound was identified in sub-fraction A24, but it was not known to evoke umami taste. 
Four further compounds of different m/z ratios were measured but were not identified by one of 
the three calculation approaches. 
 
Table 3.16-2: Identification of the most abundant signals of sub-fraction A24 of SEC-fraction A6, sample 2. 
Annotation was done by two of the three calculation approaches (SF = SmartFormula, and LSc* = done by 
operator). Numbering in the table correlates with the numbering of the signals in Figure 3.16-2: Base Peak 
chromatogram (positive MS/MS mode) of reconstituted sub-fraction A24 of SEC A6 from sample 2. The 
numbering of the peaks correlates with the numbering in Table 3.16-2. 
 
The umami taste of sub-fraction A24 could not be explained at present by the detected compound. 
It is still questionable, if one of the detected, but unidentified compound ion molecules stands for 
a potential umami active compound. Di- or tripeptides did not fit to the suggested molecular 
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formula. Another spectroscopy, preferably NMR, would be needed to shed more light into this 
mystery. 
3.17 Determination of the peptide composition of samples from different 
processing steps by UPLC-HR-MS/MS 
Since it was hypothesised that thermal treatment during the process favours the formation of  
2,5-diketo- and pyro-glutamylpeptides new samples were analysed. Samples were taken after each 
of four consecutive processing steps. Moreover, their treatment was different compared to the 
samples discussed above.  
The influence of different process steps on the taste of gluten hydrolysate was examined.  
 Sample 1: not pasteurised 
 Sample 2: pasteurised 
 Sample 3: pasteurised and evaporated 
 Sample 4: pasteurised, evaporated and treated in vacuum oven 
Sample preparation was done as described (2.3). Thereafter, the samples were analysed via  
UPLC-HR-Q-TOF-MS/MS (2.5.5) in the positive ionisation mode. The overlay (Figure 3.17-1) of 
the BPC of the four samples showed nearly identical elution pattern. With a few exceptions, even 
the signal intensities were comparable. Only sample 4 (pasteurised, evaporated and treated in 
vacuum oven) showed signals that were not detected in any other sample. Both, the different signal 
intensities, and the exclusively occurring signals are highlighted with red frames in Figure 3.17-1. 
 
 
Figure 3.17-1: Overlay of the BPC (positive MS/MS mode) of the four differently treated samples. Different 
signal intensities and exclusively occuring signals are highlighted with red frames.  
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As chromatograms of sample 1 to 3 looked similar, only sample 1 and 4 were compared. These 
two samples differed most in their respective processing steps, and it was assumed that they differ 
in their composition, especially in thermally formed condensation products. (Figure 3.17-2). 
Most abundant signals were calculated with the three different calculation approaches (2.7). 
 
 
Figure 3.17-2: Overlay of the BPC (positive MS/MS mode) of sample 1 (shown in green) and sample 4 (shown 
in orange). Numbering of the signals indicate the signals which were calculated and correlate with the 
numbering in Table 3.17-1.  
 
In total, 27 substances were identified in sample 1 (Table 3.17-1). Among them, several peptides 
and cyclic peptides, containing glutamic acid, valine or proline were detected. All of them are 
possible candidates for umami taste or umami taste enhancing characters.  
 
Table 3.17-1: Results of the three calculation approaches for the most abundant signals in sample stock solution 
(100 mg mL-1) of sample 1 (not pasteurised). Calculation approach 1 is SmartFormula (SF); calculation 
approach 2 is done by operator Lars Schmidt (LSc), calculation approach 3 is the automatic approach by 
Spectral Library (SL) and not detected (n.d.) indicates signals that were not identified in sample 1 but in sample 
4. A hook in the MS/MS column indicates that an ms/ms spectrum was recorded, and a slash that no ms/ms 
spectrum was recorded. “Equivalent to SF” means that proposed molecular formula by operator is the same 
like the molecular formula calculated by SF. Numbering in the table correlates with the numbering of the 
corresponding Figure 3.17-2. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
1 6.45 282.27850 / Oleamide C18H35NO / / n.d.  
2 8.62 182.11704 182.11756 / C10H15NO2 √ 0.51101 SF 
3 8.83 216.10137 / / / / / n.d. 
3 8.83 262.10669 / 
262.10404 
262.10403 
/ 
Glu-Asn 
Glu-Gly-Gly 
C14H15NO4 
C9H15N3O6 
C9H15N3O6 
/ 
/ 
/ 
/ 
/ 
/ 
n.d. 
n.d. 
n.d. 
3 8.96 284.08893 284.08905 / C12H9N7O2 / 0.12308 SF 
4 9.88 211.14356 211.14410 
211.14467 
/ 
Diketo-Pro-Leu 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.54568 
0.95 
SF 
LSc 
5 10.32 211.14372 211.14410 / C11H18N2O2 / 0.63158 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
211.14467 Diketo-Pro-Leu equivalent to SF / 0.95 LSc 
6 10.66 245.12799 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.46868 
1.03 
SF 
LSc 
7 11.12 197.12789 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.56068 
1.13 
SF 
LSc 
7 11.19 333.14147 333.14181 
333.14115 
333.14115 
/ 
Glu-Gly-Gln 
Glu-Asn-Ala 
C13H16N8O3 
C12H20N4O7 
C12H20N4O7 
√ 
√ 
√ 
0.34546 
0.32 
0.32 
SF 
LSc 
LSc 
7 11.21 212.12749 / / C11H17NO3 / / n.d. 
8 11.28 246.11188 / / C14H15NO3 / / n.d. 
8 11.33 232.09637 / / C13H13NO3 / / n.d. 
9 15.75 261.12300 261.12337 
261.12393 
/ 
Diketo-Tyr-Pro 
C14H16N2O3 
equivalent to SF 
√ 
√ 
0.36706 
0.93 
SF 
LSc 
9 15.84 169.09663 / 
169.09772 
/ 
Diketo-Ala-Pro 
 
C8H12N2O2 
/ 
/ 
/ 
/ 
n.d. 
n.d. 
10 17.05 197.12817 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.28780 
0.85 
SF 
LSc 
10 17.03 243.13392 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.01293 
0.58 
SF 
LSc 
10 17.03 485.26041 485.25925 / C21H40O12 √ 1.15491 SF 
11 19.61 227.10266 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.62703 
0.54 
SF 
LSc 
11 19.62 453.19803 453.19696 / C14H29N8O7P √ 1.07115 SF 
11 19.61 679.29291 679.29201 / C29H46N2O16 √ 0.90387 SF 
12 20.14 342.23867 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.05875 SF/SL 
13 20.33 181.09679 / / C9H12N2O2 / / n.d. 
13 20.35 209.09178 209.09372 / C8H17O4P √ 1.9444 SF 
13 20.34 451.22964 451.22861 / C17H22N16 / 1.02608 SF 
14 20.50 263.13916 263.13902 Pro-Phe C14H18N2O3 √ 0.13800 SF/SL 
14 20.51 187.07127 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.06455 
0.62 
SF 
LSc 
14 20.60 229.15455 229.15467 Pro-Ile C11H20N2O3 √ 0.12117 SF/SL 
14 20.67 362.20719 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.24031 SF/SL 
15 20.98 328.22316 328.22308 Ile-Pro-Val C16H29N3O4 √ 0.07498 SF/SL 
15 21.01 392.21815 392.21800 Leu-Pro-Tyr C20H29N3O5 √ 0.15686 SF/SL 
15 21.02 215.13873 215.13902 Pro-Val C10H18N2O3 √ 0.28420 SF/SL 
16 21.34 120.08071 120.08078 / C8H9N / 0.06546 SF 
16 21.35 263.13933 263.13902 Phe-Pro C14H18N2O3 √ 0.31568 SF/SL 
16 21.36 525.27048 525.26942 / C27H40O10 √ 1.05474 SF 
17 23.34 258.10819 258.11010 
258.10901 
/ 
Diketo-Glu-Gln 
C8H20NO6P 
C10H15N3O5 
√ 
√ 
1.90665 
0.82 
SF 
LSc 
17 23.33 515.20901 515.20828 / C19H34N2O14 √ 0.72690 SF 
17 23.37 241.08157 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.32539 
5.64 
SF 
LSc 
18 28.47 187.07134 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.00767 
0.55 
SF 
LSc 
18 28.47 204.09774 204.09788 Gln-Gly C7H13N3O4 √ 0.14653 SF/SL 
18 28.79 147.07639 147.07642 D-Glutamine C5H10N2O3 √ 0.03076 SF/SL 
19 29.52 275.1505 275.13500 Gln-Gln C10H18N4O5 √ 0.05906 SF/SL 
20 32.87 241.03114 241.03113 L-Cysteine C6H12N2O4S2 √ 0.01237 SF/SL 
20 32.94 262.15096 262.15098 Arg-Ser C9H19N5O4 √ 0.10224 SF/SL 
20 32.91 337.17138 337.17178 / C12H24N4O7 √ 0.39178 SF 
20 32.90 318.12913 318.12958 
318.12764 
/ 
Diketo-Met-Trp 
C12H19N3O7 
C16H19N3O2S 
/ 
/ 
0.44260 
1.49 
SF 
LSc 
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Sample 4 was evaluated in the same way, and identified substances were compared with the 
substances identified in sample 1. The aim was to clarify if the different processing steps had an 
influence on the composition of the samples.  
 
Table 3.17-2: Results of the three calculation approaches for the most abundant signals in sample stock solution 
(100 mg mL-1) of sample 4 (pasteurised, evaporated, and treated in vacuum oven). Calculation approach 1 is 
SmartFormula (SF); calculation approach 2 is done by operator Lars Schmidt (LSc), calculation approach 3 is 
the automatic approach by Spectral Library (SL) and not detected (n.d.) indicates signals that were not 
identified in sample 1 but in sample 4. A hook in the MS/MS column indicates that an ms/ms spectrum was 
recorded, and a slash that no ms/ms spectrum was recorded. “Equivalent to SF” means that proposed 
molecular formula by operator is the same like the molecular formula calculated by SF. Numbering in the table 
correlates with the numbering of the corresponding Figure 3.17-2. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
1 6.45 282.27850 282.27914 Oleamide C18H35NO √ 0.63644 SF/SL 
2 8.52 182.11714 182.11756 / C10H15NO2 √ 0.41139 SF 
3 8.83 216.10137 216.10191 / C13H13NO2 √ 0.53325 SF 
3 8.83 262.10669 262.10738 
262.10404 
262.10403 
/ 
Glu-Asn 
Glu-Gly-Gly 
C14H15NO4 
C9H15N3O6 
C9H15N3O6 
√ 
√ 
√ 
0.69831 
2.65 
2.65 
SF 
LSc 
LSc 
3 8.83 284.08853 284.08905 / C12H9N7O2 √ 0.52058 SF 
4 9.78 211.14372 211.14410 
211.14467 
/ 
Diketo-Pro-Leu 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.38816 
0.95 
SF 
LSc 
5 10.21 211.14372 211.14410 
211.14467 
/ 
Diketo-Pro-Leu 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.38744 
0.95 
SF 
LSc 
6 10.54 245.12797 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.47918 
1.05 
SF 
LSc 
7 11.06 197.12795 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.49904 
1.07 
SF 
LSc 
7 11.14 333.14166 333.14181 
333.14115 
333.14115 
/ 
Glu-Gly-Gln 
Glu-Asn-Ala 
C13H16N8O3 
C12H20N4O7 
C12H20N4O7 
√ 
√ 
√ 
0.15295 
0.51 
0.51 
SF 
LSc 
LSc 
7 11.21 212.12749 212.12812 / C11H17NO3 √ 0.63419 SF 
8 11.28 246.11188 246.11247 / C14H15NO3 √ 0.59228 SF 
8 11.33 232.09637 232.09682 / C13H13NO3 √ 0.45384 SF 
9 15.66 261.12315 261.12502 
261.12393 
/ 
Diketo-Tyr-Pro 
C12H21O4P 
C14H16N2O3 
√ 
√ 
1.87362 
0.78 
SF 
LSc 
9 15.84 169.09663 169.09715 
169.09772 
/ 
Diketo-Ala-Pro 
C8H12N2O2 
equivalent to SF 
√ 
√ 
0.52414 
1.09 
SF 
LSc 
10 17.05 197.12811 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.34801 
1.07 
SF 
LSc 
10 17.05 243.13400 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.07143 
0.5 
SF 
LSc 
10 17.05 485.26065 485.25956 / C16H37N8O7P √ 1.08952 SF 
11 19.60 227.10263 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.65703 
0.57 
SF 
LSc 
11 19.60 453.19800 453.19861 / C12H34N6O8P2 √ 0.60738 SF 
11 19.60 679.29259 679.29335 / C30H42N6O12 √ 0.75681 SF 
12 20.12 342.23826 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.47471 SF/SL 
13 20.33 181.09679 181.09715 / C9H12N2O2 √ 0.35930 SF 
13 20.33 209.09192 209.09372 / C8H17O4P √ 1.80042 SF 
13 20.33 451.22923 451.22996 / C20H30N6O6 √ 0.73002 SF 
14 20.47 263.13895 263.13902 Pro-Phe C14H18N2O3 √ 0.06942 SF/SL 
14 20.49 187.07120 187.07133 / C7H10N2O4 √ 0.13111 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
187.07189 Diketo-Glu-Gly equivalent to SF √ 0.69 LSc 
14 20.57 229.15451 229.15467 Pro-Leu C11H20N2O3 √ 0.16217 SF 
14 20.66 362.20711 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.31784 SF/SL 
15 20.95 328.22299 328.22308 Ile-Pro-Val C16H29N3O4 √ 0.08973 SF/SL 
15 20.99 392.21767 392.21800 Leu-Pro-Tyr C20H29N3O5 √ 0.32788 SF/SL 
16 21.33 120.08065 120.08078 / C8H9N √ 0.12970 SF 
16 21.33 263.13918 263.13902 Phe-Pro C14H18N2O3 √ 0.16150 SF/SL 
16 21.34 525.27089 525.26973 / C22H37N8O5P √ 1.15927 SF 
17 23.29 258.10844 258.11010 
258.10901 
/ 
Diketo-Glu-Gln 
C8H20NO6P 
C10H15N3O5 
√ 
√ 
1.66387 
0.57 
SF 
LSc 
17 23.29 515.20930 515.21127 / C18H35N4O11P √ 1.96614 SF 
17 23.32 241.08162 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.27583 
5.69 
SF 
LSc 
18 28.42 187.07113 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.20776 
0.76 
SF 
LSc 
18 28.71 147.07634 147.07642 D-Glutamine C5H10N2O3 √ 0.08099 SF/SL 
19 29.48 275.13498 275.13500 Gln-Gln C10H18N4O5 √ 0.01781 SF/SL 
20 32.82 241.03069 241.03113 L-Cysteine C6H12N2O4S2 √ 0.43513 SF/SL 
20 32.86 262.15070 262.15098 Arg-Ser C9H19N5O4 √ 0.27706 SF/SL 
20 32.86 337.17169 337.17178 / C12H24N4O7 √ 0.08542 SF 
20 32.87 318.12944 318.13123 
318.12764 
/ 
Diketo-Met-Trp 
C10H24NO8P 
C16H19N3O2S 
√ 
√ 
1.78573 
1.8 
SF 
LSc 
 
A total of 29 different amino acids, di- or tripeptides as well as their condensation products were 
detected. Just as like in sample 1 almost all identified substances contained either glutamic acid, 
valine or proline. These amino acids are known to occur in the group of umami active peptides.  
The comparison of sample 1 and sample 4 illustrates that the different processing steps had no 
significant influence on the composition of the sample. Only three substances  
(oleamide, Glu-Asn and diketo-Ala-Pro) were detected in sample 4, which were not detected in 
sample 1. 
3.18 Gas chromatography-mass spectrometry (GC-MS) results of derivatised 
2,5-diketopiperazines standard solutions 
To facilitate the identification of 2,5-diketopiperazines a derivatisation by silylation was 
performed. The derivatised products were measured via GC-MS (2.5.9). This analysis should 
show, if there were specific and characteristic fragmentation patterns of 2,5-diketopiperazines. If 
so, the identification of these molecule class could be easily done in crude sample solutions 
containing multitude signals. Therefore cyclo(Leu-Pro), cyclo(Pro-Tyr) and cyclo(Glu-Glu) were 
silylated.  
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Figure 3.18-1: Gas chromatographic mass spectra of three different cyclic dipeptides. A: Mass spectrum (red) 
of silylated cyclo(-Leu-Pro); m/z 282; B: Mass spectrum (black) of di-silylated cyclo(-Leu-Tyr); m/z 404; C: 
Mass spectrum (green) of tetra-silylated cyclo(-Glu-Glu); m/z 546. Molecule ions are red framed.  
 
Each 2,5-diketo compound was silylated successfully and the intact molecule ions were detected. 
Only the mass spectra of the highly silylated forms are shown (Figure 3.18-1). Expected fragments 
from silylated compounds were detected, such as m/z 73 (trimethylsilyl group), or fragments with 
a loss of m/z 15 (methyl group). Characteristic fragmentation pattern for 2,5-diketo compounds 
were not detected. No conclusion could be drawn for specific fragmentation patterns, which do 
allow the operator to easily identify 2,5-diketo compounds in complex matrices.  
3.19 Liquid chromatography-mass spectrometry (LC-MS) data of 
synthesised 2,5-diketopiperazines 
Three different 2,5-diketopiperazines were synthesised using the microwave assisted technology 
(2.8.1).  
1. 2,5-diketo-Glu-Gly exact mass 186.06406 
2. 2,5-diketo-Glu-Leu exact mass 242.12666 
3. 2,5-diketo-Glu-Pro exact mass 226.09536 
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Figure 3.19-1: Structural formulas of the three cyclic dipeptides synthesised. 1: 2,5-diketo-Glu-Gly;  
2: 2,5-diketo-Glu-Leu; 3: 2,5-diketo-Glu-Pro. 
 
To analyse, if the synthesis of the 2,5-diketopiperazines (Figure 3.19-1) was successful, a LC-MS 
was performed (2.5.7) in the ESI positive and negative mode.  
 
Figure 3.19-2: In positive MS mode (A) the spectrum of 2,5-diketo-Glu-Gly is shown. Spectrum B shows the 
2,5-diketo-Glu-Gly in the negative mode. Molecule ions of the products are framed in red. 
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Figure 3.19-3: In positive MS mode (A) the spectrum of 2,5-diketo-Glu-Leu is shown. Spectrum B shows the 
2,5-diketo-Glu-Leu in the negative mode. Molecule ions of the products are framed in red. 
 
 
Figure 3.19-4: In positive MS mode (A) the spectrum of 2,5-diketo-Glu-Pro is shown. Spectrum B shows the 
2,5-diketo-Glu-Pro in the negative mode. Molecule ions of the products are framed in red. 
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The synthesis of all 2,5-diketopiperazines was successful. The molecule ions were detected in both 
the positive and negative mode at the expected m/z ratio. As shown by these results this reaction 
was a powerful and fast tool to generate cyclic dipeptides, which could potentially have umami 
enhancing properties. A sufficient purification strategy was developed to remove unwanted 
remainders of the reaction before sensory analysis. 
3.20 In-silico screening for glutamyl-specific peptidase genes in 
Basidiomycota  
The majority of umami active compounds is generated by fermentation processes and hydrolysis 
of food constituents. In both cases glutamyl-specific peptidases could be responsible for the 
formation of umami taste imparting glutamyl peptides. The targeted use of such peptidases could 
increase the degree of hydrolysis of vegetable protein sources and might lead to an increased 
formation of umami active compounds. Since Basidiomycota express a variety of peptidases  
in-silico screening for glutamyl-specific peptidase genes has been performed based on published 
sequences.  
Thermoactinomyces sp. exhibit a serine protease (accession number: WP_049719689), which has 
a V8-like Glu-specific endopeptidase region. It is a member of the trypsin superfamily. The protein 
sequence has been taken in FASTA format and the blastp search on NCBI resulted in two hits in 
the taxa of Basidiomycota. Both, Laetiporus sulphureus and Fistulina hepatica showed a 
hypothetical protein (Table 3.20-1). 
 
Table 3.20-1: Results of the blastp search on NCBI. The main scores and values as well as the published 
accession numbers are listed. 
Organism Total score Query cover E value Ident Accession  
Laetiporus 
sulphureus 
41.6 38 % 0.033 32 % KZT11210.1 
Fistulina 
hepatica  
37.0 40 % 0.95 25 % KIY45975.1 
 
Reported sequences were blasted on Joint Genome Institute (JGI) against the annotated genomes 
of Lsu and Fhe. This resulted in protein sequences and corresponding potential mRNA sequences, 
which were used to design specific primers for the start and the end of the potential coding 
sequences (CDS).  
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Amplification of the possible glutamyl-specific peptidase genes was verified on a 1 % agarose-gel 
(data not shown). The purified and from gel eluted DNA was ligated into the pUC57 vector and 
successfully transformed into E.coli TOP 10. Colony PCR of the positive clones  
(blue/white screening) showed the presence of the amplified fragments, which were verified by 
sequencing (Seqlab/Microsynth; Göttingen; Germany) using M13 primers.  
3.21 Sequencing results of Lsul 235, Lsu 279, Lsu 294 and Fhe 205 
The amplification of the glutamyl-specific peptidase genes of all four selected strains was 
successful. The four tested strains were sequenced using M13 primer pairs. Resulting sequence 
information on gDNA level was aligned against glutamyl-specific peptidase genes of four different 
Basidiomycota. The results showed that the sequence identity was below 100 %, which was 
explained by the presence of introns on gDNA level. For each of the tested strains the whole gDNA 
of the hypothetical glutamyl-specific peptidase gene was sequenced.  
Number of base pairs (bp) of the sequenced genes (gDNA level) for Fhe 205 was 1392, 1251 for 
Lsul235, and Lsu294, and 1332 for Lsu279, which corresponds to 464, 417, 417 and 444 amino 
acids, respectively. 
 
>Fhe205 hypothetical glutamyl-specific peptidase CDS 
ATGAAAGATGGCAAAGAAAAAACCGGCAGCGGCTTTTTTGTGGATATTGATCTGCCGACC 
GATTATGTGATTCTGACCGCGGCGCATAACCTGTGGAGCCTGGAAAGCGATACCCCGAGC 
ACCGATATTAAAATTGAATATCCGAGCAGCACCGGCAGCGGCATTGAAATGGCGGGCGCG 
GATTTTGAAGATTGGATGGATCCGAGCTGGGATGATGATGCGGAATATACCGTGCCGCCG 
GGCCTGATTTATGTGGATGTGCTGGCGATGCGCGGCTGGAGCGTGAAATTTACCTTTATG 
AAAGATGGCAAAGAAAAAACCGGCAGCGGCTTTTTTGTGGATATTGATCTGCCGACCGAT 
TATGTGATTCTGACCGCGGCGCATAACCTGTGGAGCCTGGAAAGCGATACCCCGAGCACC 
GATATTAAAATTGAATATCCGAGCAGCACCGGCAGCGGCATTGAAAGCTATACCATTGCG 
CAGCAGACCCAGGATAGCGTGTATGTGAACAAACCGTATCATGAAAAAAGCAGCCAGCAG 
CGCGGCGAACCGGAAGTGGATTATGGCTTTCTGCGCATTCCGCGCAAACCGGGCGAACCG 
CGCCGCGGCTTTGGCCTGAGCCTGAAACTGGCGTATGCGGATTTTTTTACCGGCGATATG 
CATATTCAGGGCTTTCAGGATAAAAGCAAACCGGGCCAGCCGATTCAGAGCAGCGGCGCG 
TGCGTGGAATGCTATCCGGCGCGCGTGGAATATAGCATTAAAACCCAGCCGGGCATTAGC 
GGCAGCGTGGTGTGGGTGGAATTTGCGGGCAGCCCGTTTGCGGTGGCGATTCAGAGCGTG 
AGCTGCTTTTGCTTTCTGTTTATGAGCGATAGCCTGGCGAGCAGCAACAACGGCCCGGAA 
TATGCGGGCGGCGGCAGCCGCGGCGCGCGCATTACCGAAGCGATGATGCGCGAAGTGTTT 
AAATGGCTGGGCGATGCGAAACTGAAAGAAAACGTGCGCCTGCAGGTGGTGGATCTGCGC 
CGCCAGGCGCGCCCGGGCCAGCCGAGCCTGGCGCCGCCGAACGGCCTGTTTCTGAGCTTT 
GAAACCAGCTTTGGCTTTGGCCGCGTGCGCCTGGGCACCGGCACCAGCTTTGATCTGATT 
CCGGCGCAGCTGCTGAACGGCCCGGAAGAACTGTATGTGCTGAAAGCGCATGCGAGCGGC 
AAATGGCTGAAATTTGAACCGATGAAAAACCGCGTGGTGCTGGAAGATAAATGGAACGAT 
AACTGCACCTTTCGCATGGATACCAGCAGCCCGACCGCGAAACAGCCGTGGGGCAGCCTG 
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GTGGTGCCGGAACGCGATCCGAACATGGATAAACTGAAAGGCGAAAGCTATGTGCTGCGC 
ATGGAAGCGAACTATCTGAGCCTGACCGAACCGGAAGCGGAAAGCAGCGAAGTGAGCCTG 
GTGCGCTATCCGACCCAGGATCTGGTGAGCCGCTGCCAGACCATGAGCTGCTTTAAAGTG 
CTGCTGCTGTTTAGCGCGGATTTTAGCCTGCTGCAGTTTGTGAAATTTAG 
>Fhe205 hypothetical glutamyl-specific peptidase protein 
sequence 
MAGADFEDWMDPSWDDDAEYTVPPGLIYVDVLAMRGWSVKFTFMKDGKEKTGSGFFVDID 
LPTDYVILTAAHNLWSLESDTPSTDIKIEYPSSTGSGIESYTIAQQTQDSVYVNKPYHEK 
SSQQRGEPEVDYGFLRIPRKPGEPRRGFGLSLKLAYADFFTGDMHIQGFQDKSKPGQPIQ 
SSGACVECYPARVEYSIKTQPGISGSVVWVEFAGSPFAVAIQSVSCFCFLFMSDSLASSN 
NGPEYAGGGSRGARITEAMMREVFKWLGDAKLKENVRLQVVDLRRQARPGQPSLAPPNGL 
FLSFETSFGFGRVRLGTGTSFDLIPAQLLNGPEELYVLKAHASGKWLKFEPMKNRVVLED 
KWNDNCTFRMDTSSPTAKQPWGSLVVPERDPNMDKLKGESYVLRMEANYLSLTEPEAESS 
EVSLVRYPTQDLVSRCQTMSCFKVLLLFSADFSLLQFVKFSFA* 
 
>Lsu235 hypothetical glutamyl-specific peptidase CDS 
ATGGTGCGCCGCAAACTGCTGCTGCCGGATGAAGTGAAACATGATGGCTGGGCGGGCCGC 
CTGCAGACCCCGCTGGCGAACCTGGATGGCCGCCGCGCGTTTCATGATGCGAGCTTTGAA 
GCGCGCAACGTGATTAAACTGGTGTTTTATAGCGGCCCGGGCCGCAACCTGACCTATGGC 
AGCGGCTTTATTCTGCGCCCGCCGGATGTGACCGGCGTGGTGATTCTGACCGCGGCGCAT 
AACCTGCTGCCGATTCTGGATGCGGCGGATGAACCGACCGGCCAGCAGAGCAACAGCACC 
CAGCCGAGCGTGAACATTCTGGGCGTGGAACATCCGATTACCAAAGATAACTGCCGCGTG 
AGCGATACCTATCGCACCGGCGATAAACCGCCGGAAGCGGATTATGGCGCGATTATTCTG 
AGCAGCCTGCCGGTGGGCGATCTGGAAGGCTTTGGCTTTAGCATTTGCCTGGGCTATGAA 
CAGAGCCTGCCGGGCGAACTGTGCGTGACCGGCTATCGCGCGACCGATGTGGCGGGCCAG 
CCGAAAACCAGCACCGGCCATTGCATGGGCTGCTATACCCGCCGCCTGGAATATGATGCG 
CAGACCGAACAGGGCATTAGCGGCAGCCCGGTGTGGATGTATCATCGCGGCTGCCCGACC 
GTGGTGGCGATTCAGATGGAAGTGTTTTATTGGCTGGGCATTGGCGATTTTGGCATGCGC 
ATTCGCGCGTGCGCGAGCAAACATGCGGCGCTGGGCACCCTGCCGCCGCGCGGCCTGTAT 
CTGAACTTTAGCAAACATTTTAGCTTTGCGCGCGTGCGCGTGGGCAACGGCACCCGCTTT 
AACATTCTGCCGGCGGAACGCCGCAAAGATAACGTGACCCTGTATACCCTGCAGGTGGCG 
GATGCGGAATTTCTGAACAAATGGCTGGTGTTTGATGTGGTGAAAAACGAAATTCAGCTG 
GATGATAAACTGAGCACCGAAGGCCTGTTTAGCTATCGCAACAAAAAAAAAAACACCTTT 
AAAATTGTGATTGAACGCATTAGCCCGAGCGAAGTGCAGCTGGGCTGCCAGTGCAAACGC 
ATTGAAGAAATTGATGGCGAAGATGCGGAAAGCAGCGAAGTGAGCCTGGTGCCGTATCCG 
ATTGGCGAAAAATATGCGGTGCGCTGGAGCGTGCTGCCGAACAACAGCATTACCTATCTG 
ACCCCGATTAAATTTACCGATTTTTGCTTTGAAGATAGCATTAACTAA 
>Lsu235 hypothetical glutamyl-specific peptidase protein 
sequence 
MVRRKLLLPDEVKHDGWAGRLQTPLANLDGRRAFHDASFEARNVIKLVFYSGPGRNLTYG 
SGFILRPPDVTGVVILTAAHNLLPILDAADEPTGQQSNSTQPSVNILGVEHPITKDNCRV 
SDTYRTGDKPPEADYGAIILSSLPVGDLEGFGFSICLGYEQSLPGELCVTGYRATDVAGQ 
PKTSTGHCMGCYTRRLEYDAQTEQGISGSPVWMYHRGCPTVVAIQMEVFYWLGIGDFGMR 
IRACASKHAALGTLPPRGLYLNFSKHFSFARVRVGNGTRFNILPAERRKDNVTLYTLQVA 
DAEFLNKWLVFDVVKNEIQLDDKLSTEGLFSYRNKKKNTFKIVIERISPSEVQLGCQCKR 
IEEIDGEDAESSEVSLVPYPIGEKYAVRWSVLPNNSITYLTPIKFTDFCFEDSIN* 
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>Lsu294 hypothetical glutamyl-specific peptidase CDS 
ATGGTGCGCCGCAAACTGCTGCTGCCGGATGAAGTGAAACATGATGGCTGGGCGGGCCGC 
CCGCAGGCGCCGCTGGCGAACCTGGATGGCCGCCGCACCTTTCATGATGCGAGCTTTGAA 
GCGCGCAACGTGATTAAACTGGTGTTTTATAGCGGCCCGGGCCATAACCTGACCTATGGC 
AGCGGCTTTATTTTTCGCCCGCCGGATGTGACCGGCGTGGTGATTCTGACCGCGGCGCAT 
AACCTGCTGCCGATTCTGGATGCGGCGAACGATCCGACCGATCAGCCGAGCAACAGCACC 
TATCCGTATGTGAACATTCTGGGCGTGGAACATCCGATTACCAAAGATAACTGCCGCGTG 
AGCGATGCGTATTGCCGCGGCGATCGCACCCCGGATGCGGATTATGGCGCGATTATTCTG 
AGCAGCCTGGCGGTGGGCGATCTGGAAGGCTTTGGCTTTAGCATTTGCGTGGGCTATGAA 
GAAAGCCTGCCGGGCGAACTGTGCGTGACCGGCTATCGCGCGGCGGATGTGGCGGGCCAG 
CCGAAAACCAGCACCGGCCATTGCATGGGCTGCTATACCCGCCTGCTGGAATATGATGCG 
CAGACCGAACAGGGCATTAGCGGCAGCCCGGTGTGGATGTATCATCGCGGCTGCCCGACC 
GTGGTGGCGATTCAGATGGAAGTGTTTAGCTGGCTGGATATTGGCGATTTTGGCCGCCGC 
ATTCGCGCGTGCGCGAGCAAAAAACATGCGGCGCTGGGCACCCTGCCGCCGCGCGGCCTG 
TATCTGAACTTTAGCAAACATTTTAGCTTTGCGCGCGTGCGCGTGGGCAACGGCACCCGC 
TTTAACATTCTGCCGGCGGAACGCCGCAAAGATAACGTGACCCTGTATGCGCTGCAGGTG 
GCGGATGCGGAATTTCTGAACAAATGGCTGGTGTTTGATGTGGTGAAAAACGAAATTCAG 
CTGGATGATAAACTGAGCACCGAAGGCCTGTTTAGCTTTCGCAACAAAAAAAAAAACACC 
TTTAAAATTGTGATTGAACGCATTAGCCCGAGCGAAGTGCAGCTGGGCTGCCAGTGCAAA 
CGCATTCAGGAAATTGATGGCGAAGATGCGGAAAGCAGCGAAGTGAGCCTGGTGCCGTAT 
CCGATTGGCGAAAAATATGCGGTGCGCTGGAGCGTGCTGCCGAACAACCCGATTGCGTAT 
CTGACCCCGATTAAATTTACCGATTTTTGCTTTGAAGATAGCATTAACTAA 
>Lsu294 hypothetical glutamyl-specific peptidase protein 
sequence 
MVRRKLLLPDEVKHDGWAGRPQAPLANLDGRRTFHDASFEARNVIKLVFYSGPGHNLTYG 
SGFIFRPPDVTGVVILTAAHNLLPILDAANDPTDQPSNSTYPYVNILGVEHPITKDNCRV 
SDAYCRGDRTPDADYGAIILSSLAVGDLEGFGFSICVGYEESLPGELCVTGYRAADVAGQ 
PKTSTGHCMGCYTRLLEYDAQTEQGISGSPVWMYHRGCPTVVAIQMEVFSWLDIGDFGRR 
IRACASKKHAALGTLPPRGLYLNFSKHFSFARVRVGNGTRFNILPAERRKDNVTLYALQV 
ADAEFLNKWLVFDVVKNEIQLDDKLSTEGLFSFRNKKKNTFKIVIERISPSEVQLGCQCK 
RIQEIDGEDAESSEVSLVPYPIGEKYAVRWSVLPNNPIAYLTPIKFTDFCFEDSIN* 
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>Lsu279 hypothetical glutamyl-specific peptidase CDS 
ATGGTGCGCCGCAAACTGCTGCTGCCGGATGAAGTGAAACATGATGGCTGGGCGGGCCGC 
CCGCAGGCGCCGCTGGCGAACCTGGATGGCCGCCGCGCGTTTCATGATGCGAGCTTTGAA 
GCGCGCAACGTGGTGAAACTGGTGTTTTATACCGATCCGGGCCGCAACGTGACCCATGGC 
AGCGGCTTTATTTTTCGCCCGCCGGATGTGACCGGCGTGGTGATTCTGACCGCGGCGCAT 
AACCTGCTGCCGATTCTGGATGTGGCGGATGATCCGACCGGCGATAGCAGCAACAGCCCG 
TATCCGAGCGTGAACATTCCGGGCGCGGAACATCCGATTACCAAAGATAACTGCCGCATT 
AGCGATGCGTATCGCCGCGGCGATCGCAGCGCGGAAGCGGATTATGGCGCGATTATTGTG 
AGCAGCCCGCTGCATGCGTTTGATGATATTGAAGGCTTTGGCTTTAGCATTTGCCTGGGC 
TATGAACAGAGCCTGCCGGGCGAACTGAGCGTGACCGGCTATCGCGCGGCGGATCTGGCG 
GGCCAGCCGAAAACCAGCACCGGCAACTGCGTGGGCTGCTATACCCGCTGGCTGGAATAT 
GGCGCGAAAACCGAACAGGGCATTAGCGGCAGCCCGGTGTGGATGTATCATCGCGGCTTT 
CCGACCGTGGTGGCGATTCAGATGCCGAACAGCAGCAACAACGGCCCGGCGGGCCGCCGC 
GGCGGCAGCCGCGGCGCGCGCATTACCCTGGCGCTGCTGATGGAAGTGTTTAGCTGGCTG 
GGCATTGGCAAATTTGGCAAAAGCATTCGCGCGTGCACCAGCAAAAAACATGCGGCGCTG 
GGCACCCTGCCGCCGCGCGGCCTGTATCTGAACTTTAGCAAACATTTTAGCTTTGCGCGC 
GTGCGCGTGGGCAGCGGCACCCGCTTTAACGTGTTTCCGGCGGAAGTGACCAAAGATAAA 
GTGCTGTATGCGCTGCAGATTGCGAACGCGGAATTTCTGAACAAATGGCTGGTGTTTGAT 
GTGGTGAAAAACGAAATTCAGCTGGATGATAAACTGAGCACCGAAGGCCTGTTTAGCTAT 
GGCAACAAAAAAAAAAACAGCTTTAAAATTGTGATGGAACGCACCTTTCCGAGCGAAGTG 
CAGCTGGGCTGCCAGTGCAAACGCATTGATGAAATTGATGGCGAAGATGCGGAAAGCAGC 
GAAGTGAGCCTGGTGCCGTATCCGGCGGGCGAAAAATATGTGGTGCGCTTTAGCGTGCTG 
AGCAGCCCGGATAACCTGACCGCGTATAGCACCAGCATTAAATTTACCGATTTTTGCTTT 
GAAGATAG 
>Lsu279 hypothetical glutamyl-specific peptidase protein  
sequence 
MVRRKLLLPDEVKHDGWAGRPQAPLANLDGRRAFHDASFEARNVVKLVFYTDPGRNVTHG 
SGFIFRPPDVTGVVILTAAHNLLPILDVADDPTGDSSNSPYPSVNIPGAEHPITKDNCRI 
SDAYRRGDRSAEADYGAIIVSSPLHAFDDIEGFGFSICLGYEQSLPGELSVTGYRAADLA 
GQPKTSTGNCVGCYTRWLEYGAKTEQGISGSPVWMYHRGFPTVVAIQMPNSSNNGPAGRR 
GGSRGARITLALLMEVFSWLGIGKFGKSIRACTSKKHAALGTLPPRGLYLNFSKHFSFAR 
VRVGSGTRFNVFPAEVTKDKVLYALQIANAEFLNKWLVFDVVKNEIQLDDKLSTEGLFSY 
GNKKKNSFKIVMERTFPSEVQLGCQCKRIDEIDGEDAESSEVSLVPYPAGEKYVVRFSVL 
SSPDNLTAYSTSIKFTDFCFEDSI* 
 
Protein sequence analysis and classification was done on the webpage of the European 
Bioinformatics Institute and showed that the sequenced genes belonged to the peptidase family S1 
(clan PA). This family includes cysteine and serine peptidases  
(European Bioinformatics Institute 2018). The superfamily was predicted to be trypsin-like serine 
peptidases based on the amino acid sequences 35 to 222 (Fhe 205), 20 to 233 (Lsul 235), 22 to 214 
(Lsu279), and 20 to 232 (Lsu294). The theoretical molecular mass of 21 kDa, 25 kDa, 20 kDa, 
and 23 kDa was calculated by (ExPASy Bioinformatics Resource Portal n.d.) for Fhe 205, 
Lsul 235, Lsu 279, and Lsu 294, respectively.  
Lsul 235 shared 84 % sequence identity with Lsu 279, and 93 % with Lsu 294, whereas Lsu 279, 
and Lsu 294 shared 84 % sequence identity (European Bioinformatics Institute 2018). 
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4 Discussion 
In the present work, small biomolecules imparting or enhancing the umami taste of wheat gluten 
hydrolysates should be identified. For this purpose, the Nestlé Product Technology Center, 
Lebensmittelforschung GmbH (Singen, Germany) kindly provided wheat gluten hydrolysates. The 
hydrolysates were produced using different peptidase preparations. The composition of the 
hydrolysates was investigated, and they were sensorially analysed. To identify the substances 
eliciting the umami taste, hydrolysates were fractionated with Size Exclusion Chromatography 
and preparative HPLC, respectively. The composition of promising fractions and sub-fractions 
thereof and the sensory relevance were investigated. The aim was to find out which of the 
substances identified in the sub-fractions contributed to the umami taste.  
4.1 Optical properties and odour of enzymatically hydrolysed wheat gluten 
Wheat gluten is a protein rich vegetable source, whose hydrolysates are widely used as seasoning 
of culinary products due to their umami taste (Schlichtherle-Cerny and Amadò 2002). Since wheat 
gluten is a by-product of wheat starch production it is easily obtained (Hardt, Janssen et al. 2014), 
and used in industrial applications. 
The difference of the hydrolysates in term of particle size and colour (result section 3.1) is not 
explainable by the use of different enzyme preparations in the manufacturing process. Since the 
other process conditions remained unchanged, there is no indication which factors influenced the 
outcome of the optical properties.  
In addition, samples from different processing steps were analysed to compare the impact of 
temperature and drying on the composition of peptides and temperature-induced condensation 
products thereof. The variation in terms of the colour of the samples from different processing 
steps is partially explainable by the process parameter in combination with the enzyme preparation 
used. Flavourzyme contains an α-Amylase (Merz, Eisele et al. 2015) that degrades the starch of 
wheat gluten. Thereby maltose is generated (Whan, Dielen et al. 2014) that can undergo Maillard 
reactions with amine compounds under thermal conditions (Kanzler, Schestkowa et al. 2017). The 
differences in the thermal treatment and the resulting degree of Maillard reactions explains the 
different colouration of the samples.  
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4.2 Influence of peptidase preparation on the outcome of wheat gluten 
hydrolysis 
It is widely known that the enzymatic hydrolysis of plant proteins leads to products showing better 
functional properties compared to the original isolate. Thus, the water absorption, oil-holding, and 
foaming capacity as well as emulsion activity can be improved, which however, depends on the 
degree of hydrolysis and the used enzyme preparation (Vioque, Sánchez-Vioque et al. 2000). This 
work is focused on the released umami active substances. They include a variety of amino acids 
and oligopeptides (Su, Cui et al. 2012) as well as pyro- and cyclic peptides  
(Chen, Dewis et al. 2009). Soy sauce contains, among others, Asp-Ala (Oka and Nagata 1974) 
which has an intense umami taste. Glu-Ser (Noguchi, Arai et al. 1975) is contained in fish protein 
hydrolysate, which also imparts umami flavour. Condensation products of di- or tripeptides, e.g. 
pGlu-Pro; pGlu-Pro-Gln; pGlu-Pro-Glu and pGlu-Pro-Ser, which taste monosodium  
glutamate-like, were found in deaminated wheat gluten hydrolysate. The sequences of their 
precursor amino acids are very common motives of glutenin and gliadin, the main components of 
wheat gluten (Schlichtherle-Cerny and Amadò 2002). It is not surprising that pGlu-Pro was 
identified in the latest umami tasting sub-fractions. 
Various studies regarding the enzymatic hydrolysis of wheat gluten are published. Almost all 
publications concern the improvement of the degree of hydrolysis by changing process parameters, 
and the enzyme preparation used for hydrolysis. Examinations of quite a few enzyme preparations 
or technical enzymes, such as Alcalase, Flavourzyme, Protamex (Koo, Bae et al. 2014), papain 
(Li, Yu et al. 2016), Debitrase HYW20, Corolase PP (Nongonierma, Hennemann et al. 2017), 
Validase FP concentrate, and Pronase (Widyarani, Sari et al. 2016) show that the selection of the 
enzyme preparation has a great influence on the outcome of the hydrolysis. However, none of 
these enzymatic hydrolyses has the same efficiency compared to acid-catalysed chemical 
hydrolysis. 
Hydrolysis of the samples for this work was either performed with Flavourzyme, a mixture of 
Flavourzyme and Glutaminase, or P6SD, which most likely stands for Protease P “Amano” 6 
(Table 3.1-1). These different hydrolysis approaches led to differences in the peptide composition 
and taste, which was disclosed in this work.  
Protease P “Amano” 6 has not been used before to hydrolyse wheat gluten. Only a working group 
from Reykjavík, Iceland, published hydrolysis studies of fish protein with Protease P 
(Halldorsdottir, Kristinsson et al. 2013, Halldorsdottir, Sveinsdottir et al. 2014). The manufacturer 
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indicates that this proteolytic enzyme preparation has its pH-optimum at pH 8, a temperature 
optimum at 45 °C, a residual activity over 50 % in the pH range of 5 to 9, and in the temperature 
range of 10 to 45 °C. Furthermore, the manufacturer claims that this proteolytic enzyme 
preparation manufactured by fermentation with Aspergillus mellus can be used for flavour 
improvement of meat extract and fish juice (Amano-Enzyme 2003). Due to its broad application 
possibilities Protease P “Amano” 6 was a promising tool for the hydrolysis of wheat gluten. At 
best, the use of this enzyme preparation led to an increased yield of umami active substances like 
glutamyl-dipeptides or cyclic-dipeptides compared with Flavourzyme. 
4.3 The umami peptides of the sample stock solutions 
The varying concentration of free amino acids in the three samples is explainable by the use of the 
different enzyme preparations for the wheat gluten hydrolysis. Samples treated with glutaminase 
showed a lower concentration of glutamine than the other samples. Since glutaminase belongs to 
the enzyme group of amidases it catalyses the conversion of L-glutamine to L-glutamic acid 
(Nanga, DeBrosse et al. 2014). Approximately 60 % of L-glutamic acid in soy sauce fermented 
with Aspergillus sojae, can be produced by a glutaminase reaction (Ito, Koyama et al. 2013). This 
reaction explains the high concentration of L-glutamic acid in sample 2. It can be hypothesised that 
the taste intensity of the samples correlates with the concentration of free glutamic acid  
(Table 3.2-1). The differences in the absolute values of Gln and Glu between the samples is 
explainable by the process conditions of sample preparation. The glutamine in sample 2 is partially 
converted to glutamic acid by the added glutaminase. Thermal treatment of aqueous solutions 
containing glutamic acid can lead to the condensation reaction of equimolar proportions of 
glutamic acid to pyroglutamic acid (Harada and Fox 1958). However, no pyroglutamic acid was 
detected in the sample stock solutions. This was due to the overloaded chromatogram and the 
myriad of detected MS signals. The measurement of the subsequently generated sub-fractions A5 
in the negative ESI mode, however, confirmed the hypothesis of pyroglutamic acid formation  
(Supplementary figure 6, Supplementary figure 8, Supplementary figure 12, and Supplementary 
figure 18).  
The degree of hydrolysis, as determined by the sample treatment, is the cause of the release of 
amino acids. The higher the degree of hydrolysis the higher the concentration of free amino acids 
should be (Giesler, Linke et al. 2013). In 2016 it was shown that with increasing casein hydrolysis 
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in ripened Parmesan cheese, the concentration of taste-active enzymatically formed γ-glutamyl 
dipeptides increased (Hillmann, Behr et al. 2016). Accordingly, effective enzymatic protein 
hydrolysis should result in a more flavourful hydrolysate.  
Umami taste of sample stock solutions: Different standardised sensory tests (2.6) were 
combined, which led to the highest possible information content of the sample taste. The test 
included parts of the triangle-tests, alternative forced choice test, and the ranking test.  
Although glutamic acid is primarily responsible for umami taste (Yamaguchi and Ninomiya 2000), 
the intense umami taste of the samples cannot be explained by the detected concentration. Beside 
glutamic acid, various substances are known, which evoke an umami taste sensation, like  
p(Glu-Pro-Ser), p(Glu-Pro), Asp-Glu-Ser and Thr-Glu (Suess, Festring et al. 2015). The 
composition of wheat gluten, which consists of 80 to 85 % protein, and is rich in proline and 
glutamine (Van Der Borght, Goesaert et al. 2005), indicates that such substances are produced 
during sample processing using enzyme preparations and thermal treatment. Since a more than 
fivefold increase (Figure 3.3-1) in the taste strength was detected, umami taste-enhancing or 
modulating compounds must also be present in the samples. To confirm this assumption the 
peptide composition of the sample stock solutions was analysed.  
Determination of peptide composition of the sample stock solutions via UPLC-HR-Q-TOF-
MS/MS: Successful separation (Supplementary figure 1, Supplementary figure 2, and 
Supplementary figure 3) using the most feasible conditions for the complex matrices was achieved 
by method 2.5.5. The MSG-like tasting substances Glu-Ser and Glu-Gln-Glu  
(Noguchi, Arai et al. 1975) were solely present in sample stock solution 2 and explained its umami 
taste. The solely detected substances in the other samples are not known to evoke the umami taste. 
However, umami taste is elicited by Glu-Leu; Val-Asp (Ohyama, Ishibashi et al. 1988); pGlu-Pro 
(Schlichtherle-Cerny and Amadò 2002); Pro-Thr (Yamamoto, Shiga et al. 2014); pGlu-Gln;  
pGlu-Gly (Kaneko, Kumazawa et al. 2011), Val-Val; Val-Glu (Ishibashi, Ono et al. 1988);  
Glu-Tyr, Pro-Ala-Gln (Dang, Gao et al. 2015) which were present in the samples. The presence of 
monosodium glutamate and umami peptides may lead to synergistic effects, which increase the 
umami taste. MSG has three different effects on the umami taste receptor. It enables the small 
peptides to bind to the T1R3 part of the receptor. The binding cavity of the T1R1/T1R3 receptor 
is enlarged by MSG, and binding residues are increased, which are important for the hydrogen 
bonding (Dang, Hao et al. 2019).  
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Beside the umami active compounds identified in the samples, the umami taste activity of 165, 
167, and 163 substances in sample 1, 2, and 3 is not known. Among them there might be substances 
whose umami taste or enhancing effect has not previously been described.  
A fractionation was performed to increase the likelihood of the identification of not described 
umami active substances. It was necessary to generate fractions containing less substances, but 
still possessing a distinct umami taste.  
4.4 Fractionation of samples stock solutions 
Size Exclusion Chromatography (method 2.5.1.) is a common technique for the separation of 
molecules according to their size. It is feasible, especially if the samples are very complex with 
molecules of different size. SEC was already successfully used for the separation of umami active 
peptides (Su, Cui et al. 2012). The majority of umami active substances are di- to tetrapeptides 
with masses up to 450 Da (Zhang, Venkitasamy et al. 2017). The distinct umami taste of Korean 
soy sauce is evoked by small substances of less than 500 Da (Kim, Kim et al. 2017). Exactly in 
this range (170 to 430 Da) the separation of the molecules occurred (Figure 3.6-2). 
Since the used SEC “NGC Chromatography System” from Bio RAD (Hercules, California, USA) 
was equipped with a fixed wavelength detector with two different selectable wavelength the most 
suitable wavelength (λ = 280 nm) for this approach was chosen  
(Schlichtherle-Cerny and Amadò 2002). At this wavelength the aromatic amino acids Phe, Trp, 
Tyr, and His are detectable. However, the almost identical elution patters of the SEC 
chromatograms suggested that the samples did not differ much in composition, although they were 
produced differently. 
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4.5 Umami taste of SEC fractions from sample stock solutions 
Determination of glutamic acid concentration in SEC-fractions: The concentration of free 
glutamic acid (Table 3.7-1) was determined with a rapid HPLC method. The ratio of the detected 
free glutamic acid in the SEC-fractions of the different samples was the same as in the sample 
stock solutions. Comparable ratios of glutamic acid concentration in wheat gluten hydrolysates 
treated with and without glutaminase are described in literature  
(Schlichtherle-Cerny and Amadò 2002). 
Even though the initial concentration of glutamic acid was not fully recovered, the separation was 
successful. The “Superdex Peptide 10/300 Gl” column (GE Healthcare, Little Chalfont, United 
Kingdom) was able to separate proteins, peptides and other small biomolecules in a range of 
100 to 7000 Da, like glutamic acid with a mass of 147 Da, dipeptides and their condensation 
products. Since glutamic acid was only present in two of the eight SEC-fractions a carryover 
during the chromatography can be precluded.  
Peptide composition and umami taste of SEC-fractions: Most commonly peptides are 
identified using databases and libraries. The identification of peptides using an automatic approach 
is limited, since it is affected by the size of the search space of the used databases  
(Shanmugam and Nesvizhskii 2015). To significantly increase the number of identified or 
predicted peptides, a manual approach is necessary. However, the order of the amino acids in the 
peptides remains unknown. In order to improve the sequence prediction, an alignment with the 
protein sequence of the protein, which was used for the hydrolysis, can be carried out. A complete 
de novo sequencing requires a MS/MS analysis of every single peptide (Standing 2003) and the 
manual interpretation of the complete ion series. 
For the first time, the peptide composition of SEC-fractions of hydrolysed wheat gluten samples 
is described here in such a detail. A number of 91, 118, and 141 small biomolecules were identified 
in samples 1, 2, and 3 (SEC A5), respectively. Their umami taste, which is five fold higher  
(sample 1; Figure 3.7-2, sample 2; Figure 3.7-3, and sample 3; Figure 3.7-4) compared with the 
standard solution is evoked by several known umami active compounds like Glu-Leu, Val-Asp 
(Ohyama, Ishibashi et al. 1988), Glu-Ser (Noguchi, Arai et al. 1975) Glu-Val (Maehashi, 
Matsuzaki et al. 1999), Pro-Glu (Dang, Gao et al. 2015), Pro-Thr (Yamamoto, Shiga et al. 2014), 
diketo-, or pyro(Glu-Gln), diketo-, or pyro(Glu-Gly) (Kaneko, Kumazawa et al. 2011), and 
pyro(Glu-Pro) (Schlichtherle-Cerny and Amadò 2002). In contrast, one umami active substance 
Glu-Tyr (Dang, Gao et al. 2015) is present in SEC A6 of sample 2. The two other samples do not 
103  Discussion 
 
 
exhibit known umami active compounds. Moreover it has been hypothesised that SEC A6 contains 
more substances with umami attributes or substances having a higher umami taste enhancing 
potential than SEC A5 because SEC A6 contained less glutamic acid but evoked a more intense 
umami taste. Remarkably, these solutions have an intense umami taste even though no MSG was 
added.  
The taste strength of SEC A4 was also increased by a factor of five. This fraction was adjusted to 
10 mM MSG. Due to the lower percentage of panellists who have perceived the intense umami 
taste, it is considered that these fractions contain substances with lower umami activity compared 
with SEC A5 and A6, respectively. 
Instead of conducting sensory analyses with all identified substances with unknown umami 
attributes, it was decided to generate sub-fractions showing a lower number of small molecules 
but still possessing an intense umami taste.  
4.6 Composition of prepHPLC sub-fractions and how they taste 
Preparative HPLC is a common LC method for the isolation of non-volatile compounds from 
complex food preparations, as well as High Speed Countercurrent Chromatography, or Fast 
Centrifugal Partition Chromatography. With regard to subsequent sensory analysis, the use of 
solvents that are harmful and toxic for humans (Reichelt, Peter et al. 2010) has to be renounced in 
order not to violate ethical standards for human consumption. The use of “food-grade” solvents 
has another advantage. The implementation of time consuming procedures that remove the toxic 
solvents, such as thermal processes or extractions, which could lead to extreme stress for the 
peptides and may alter them (New Hope NETWORK an informa business 2005), is not necessary. 
Peptide bonds can be detected at 205 nm. Due to the UV cut off of the ethanol used in the gradient 
the detection wavelength was set to 210 nm. At this wavelength, the absorption of the peptide 
bonds is still sufficiently high and it is far enough away from the ethanol cut off. The success of 
fractionation via prepHPLC was examined using the UPLC-HR-MS/MS, because no statement 
about the composition of the sub-fractions could be derived from the UV chromatograms from the 
prepHPLC. The composition of the sub-fractions will be discussed below.  
The performed gradient and the reversed phase C18 column led to an early elution of polar 
substances (Schlichtherle-Cerny and Amadò 2002). Since the majority of the taste active 
molecules elute early, it is assumed that they are comparatively polar. Furthermore, the 
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fractionation time of 10 min resulted in a poor separation of the molecules. To optimise the result, 
the fractions could have been cut at shorter time intervals. However, without the use of toxic 
solvents the chromatographic options for the separation of small peptides by reversed phase 
chromatography are limited. Chromatographic approaches using nontoxic solvents, such as water 
and ethanol are called “green chromatography” (Płotka, Tobiszewski et al. 2013). 
The German flavour company Symrise (Holzminden) developed the so called LC Taste® method, 
which is comparable to gas chromatography-olfactometry. Unfortunately, this method is barely 
described in literature. Nevertheless, this approach is a combination of High Temperature Liquid 
Chromatography with non-toxic eluents and sensory analysis. High temperatures up to 200 °C are 
necessary to change the physicochemical properties of ethanol and water. These changes make the 
“green” solvents a proper alternative for the separation of complex natural products  
(Reichelt, Peter et al. 2010). This technique has not been used for the analysis of hydrolysed wheat 
gluten. Since it requires relatively high temperatures, which in turn require special equipment and 
rarely available temperature stable stationary phases, it is excluded from further consideration.  
Determination of free glutamic acid concentration in prepHPLC sub-fractions and sensory 
analysis: Taken into account that glutamic acid is the major compound eliciting umami taste, its 
concentration was determined by HPLC (2.5.3). The total concentration of glutamic acid in the 
prepHPLC sub-fractions was lower than in the SEC-fraction used for the sub fractionation. A 
dilution effect can be excluded, since each prepHPLC sub-fraction was freeze dried and 
reconstituted to the initial volume. The “food-safe” solvents used for the elution of the compounds 
might be an explanation for the discrepancy in the glutamic acid concentration.  
Both the detected diketo- or p(Glu-Gln) which are known to increase the umami taste of Japanese 
soy sauce by one fifth (Kaneko, Kumazawa et al. 2011) and the added MSG (10 mM) are not 
sufficient to generate the intense umami taste as in SEC-fraction A5. The intrinsic taste of  
p(Glu-Gln) is not strong enough to give the sub-fractions the typical umami taste or its 
concentration is below the taste threshold. Based on their results, Kaneko et al. claimed in 2011 
that there must be an optimum of the ratio of umami compounds and their enhancers. This 
hypothesis indicates that the presence of an umami enhancing compound and MSG did not 
necessarily lead to an intense enhancement of the umami taste. A concentration dependency was 
shown for MSG and IMP mixtures. The enhancement of the umami taste was clearly related to the 
added amount of IMP. To find the mixture with the most intense umami taste, 47 different 
solutions were sensory analysed (Yamaguchi 1967). Although an enlargement of the size of the 
binding cavity of the umami receptor by MSG was described, no synergistic effect with  
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p(Glu-Gln) was observed. It can be assumed that the conformation of p(Glu-Gln) leads to steric 
hindrance at the receptor, which prevents more molecules from binding to it. This hypothesis is 
confirmed by the fact that it is known that the addition of MSG only promotes an improved binding 
of small peptides to the receptor (Dang, Hao et al. 2019).  
In order to further optimise the accuracy of the sensory results, the training period and frequency 
for the panellists could be increased (Mittermeier, Dunkel et al. 2018). These trainings enable the 
panellist to describe their taste impressions of aqueous reference solutions even more clearly. 
(Ottinger and Hofmann 2003). 
Determination of the peptide composition of prepHPLC sub-fractions: The number of 
identified substances was highest in sub-fraction 1 and decreased from sub-fraction 2 to  
sub-fraction 6. This separation pattern was similar for all three samples. Furthermore, the total 
number of detected molecules was highest in sample 2 (258 molecules) (Figure 3.12-2), followed 
by sample 3 (146 molecules) (Figure 3.12-3), and sample 1 (92 molecules) (Figure 3.12-1). 
Detailed information of all identified substances can be found in Supplementary figure 22 to 
Supplementary figure 39 and Supplementary table 22 to Supplementary table 39. Compared with 
the total number of identified substances in the SEC-fractions of the same samples, the number of 
identified substances decreased by 47 for sample 1, and 51 for sample 3, but increased for sample 
2 by 85. 
Among the multitude of identified substances in sub-fraction one of sample 2, eight substances, 
namely (Glu-Leu (Ohyama, Ishibashi et al. 1988); Val-Glu; Pro-Glu (Dang, Gao et al. 2015);  
Val-Asp; Val-Gly (Ishibashi, Ono et al. 1988); Glu-Ser (Arai, Yamashita et al. 1972); Pro-Gly and 
Pro-Thr (Yamamoto, Shiga et al. 2014)) showing umami attributes as well as one diketopiperazine 
(diketo(Glu-Gln) (Kiyono, Hirooka et al. 2013) were present (Table 3.12-1). The sub-fractions 
2, 3, 5, and 6 showed one umami active substance (Table 3.12-2).  
4.7 Umami taste of SEC sub-fractions 
The formerly performed sub-fractionation via prepHPLC did not lead to sub-fractions, which 
elicited an intense umami taste. For this reason a refined SEC was performed. Since the two  
sub-fractionation methods are based on different separation principles, they are not directly 
comparable. In the reversed phase prepHPLC the compounds are separated according to their 
polarity and their behaviour on the reversed phase column. In contrast, SEC is based on the 
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separation by the size of the molecules. Also, the detection in the two different chromatographic 
methods could not be compared, since both were carried out at different wavelengths due to 
selectable system settings.  
The refined SEC method led to a better separation of the small molecules. The sub-fractions were 
collected every minute instantly after injection (n = 35). Based on the UV trace, six sub-fractions 
were taken from SEC-A5 and seven from SEC-A6 of sample 2 (Figure 3.13-1) for further sensory 
analysis.  
Determination of free amino acid concentration in SEC sub-fractions and sensory analysis: 
The SEC chromatograms of sub-fraction A19 of SEC A5 and sub-fraction A26 of SEC A6 showed 
signals at λ = 280 nm. However, according to the HPLC analysis, these were no quantifiable free 
amino acids. It is obvious that these sub-fractions had to be analysed further to describe their 
composition and to identify potentially unknown umami active substances.  
The umami taste of both sub-fractions was fivefold higher compared with the MSG standard 
solution (10 mM), according to 23 to 38% of the panellists, although the sub-fractions did not 
contain MSG. Because of this, it must be assumed that these sub-fractions contained substances 
that have an intrinsic and intense umami taste. Another series of experiments with the addition of 
MSG confirmed this assumption. Again, a significant enhancement of taste was found. This was 
due to the presence of two umami active compounds. UPLC-HR-QTOF-MS/MS shows the 
presence of diketo-Glu-Pro, which is known to enhance the umami taste in Japanese rice wine 
(Kiyono, Hirooka et al. 2013), and the dipeptide Glu-Leu that elicits umami taste  
(Ohyama, Ishibashi et al. 1988) as well in sub-fraction A19 of SEC-A5 (sample 2). 
However, the intense umami taste of sub-fraction A26 of SEC A6 of sample 2, without 10 mM 
MSG added, remains unexplained, since it contained no known umami compounds. If this  
sub-fraction contained substances with umami enhancing attributes, which are still unknown, they 
had to be very powerful due to the intense umami taste they evoked without clear  
UPLC-HR-QTOF-MS/MS signals. 
Since the umami taste sensing is highly complex and has a myriad of substances that can contribute 
to the umami taste (Suess, Festring et al. 2015), an electronic-tongue could be a possible alternative 
to the conventional sensory analysis (Liu, Zhu et al. 2017). Since this system was developed to 
distinguish between the five basic tastes, it could also be used as a complementary method. 
Compared to the traditional sensory analysis this system would not suffer from fatigue during the 
tests and be independent on daily physical conditions like the human sensory system. Some studies 
show possible applications for this system. Thus, the sensory quality of apple juice was assessed 
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(Bleibaum, Stone et al. 2002), and the taste properties of brown rice were analysed  
(Uyen Tran, Suzuki et al. 2004). Furthermore, the umami taste of edible mushrooms was 
differentiated (Phat, Moon et al. 2016). The use of the electronic tongue in the field of umami 
analysis has risen in recent years. Different working principles build the core part of the system. 
Soluble components and global characteristic response signals of the taste substances are measured 
potentiometrically, voltammetrcally, and via impedance spectroscopy sensors. Their recognition 
threshold is much lower than human threshold perception and can be used for discrimination of 
the five basic tastes, astringency quantification, and the evaluation of binary interactions of basic 
tastes (Jiang, Zhang et al. 2018). The optimisation of the sensor is ongoing to enable the electronic 
tongue to mimic the human sense of taste. Nano-vesicles that carry the human umami taste receptor 
T1R1/T1R3 on their membranes were immobilised on the micropatterned graphene surface of the 
latest sensor generation. These sensors were used for the detection of umami taste  
(Ahn, An et al. 2016).  
4.8 How thermal treatment influences the composition of wheat gluten 
hydrolysates  
Samples of four different processing procedures were analysed to describe the influence of a 
thermal treatment on the composition of wheat gluten hydrolysates. The base peak chromatogram 
of the sample treated most harshly varied the most from the sample without thermal treatment. The 
evaluation of the most intense signals shows that the majority of the identified substances were 
proline-containing diketo-compounds (diketo-Leu-Pro, diketo-Pro-Phe, diketo-Pro-Val, and 
diketo-Glu-Pro for example) with increasing signal intensity from sample 1 to sample 4. Thermal 
treatment for 1 hour at 130 °C is known to be responsible for the increase of proline based 
diketopiperazines in chicken essence (Chen, Liou et al. 2004). This observation is confirmed in 
this work, according to the increased signal intensity of the detected diketo-Pro-compounds after 
additional thermal treatment steps.  
Moreover, it is described in literature that roasting of fermented cocoa beans led to the generation 
of diketopiperazines from hydrophobic amino acids (Stark and Hofmann 2005). Also a comparison 
of cocking time for stewed beef and dry aged grilled beef showed that a prolonged cocking time 
generates a number of diketopiperazines and their concentration increased, respectively  
(Chen, Dewis et al. 2009). This is not surprising, since their major route of formation are chemical 
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reactions of peptides and proteins during thermal processing (Borthwick and Da Costa 2017). But 
obviously, the different thermal treatment of the hydrolysed wheat gluten did not lead to the 
generation of various diketo-compounds. Only sample 4 (most thermally treated) contained one 
additional diketopiperazine (diketo-Ala-Pro) compared with sample 1. It can be concluded that the 
use of different enzyme preparations for the hydrolysis of wheat gluten had a greater influence on 
the composition of peptides and their condensation products than the different thermal treatment 
steps.  
4.9 The umami taste of hydrolysed wheat gluten 
The analytical and sensory analyses performed in this work used state of the art methods and 
instrumentation. Several actual studies concerning the identification of umami compounds in 
different food preparations have followed a similar procedure. One of the key points is the 
fractionation of the highly complex food matrices. Most commonly, as in this work, ultrafiltration 
is used, followed by gel filtration chromatography (Xu, Xu et al. 2019). Fine fractionation of the 
ultra-filtrated and chromatographically fractionated food preparations by preparative HPLC has 
also been performed by some research groups (Kong, Yang et al. 2017)  
(Charve, Manganiello et al. 2018) (Shibata, Hirotsuka et al. 2017). For a few years, more and more 
research groups are using high-resolution mass spectrometry for the identification of taste 
modulating compounds (Zhang, Ayed et al. 2019) (Yang, Sun-Waterhouse et al. 2017)  
(Yu, Zhang et al. 2017) (Yu, Jiang et al. 2018). Due to its high selectivity, low-concentration 
compounds in complex matrices can be analysed better. The use of a Q-TOF HR-MS method has 
led to reliable results on a higher level compared with results gained by LC-MS methods used in 
several publications from the last decade. The application of simple LC-MS methods continues to 
decrease in this field of research for several reasons. Compared to the HR-MS-techniques the 
resolution and the mass accuracy of MS/MS methods is relatively low. Looking at this method, it 
must be assumed, that it can hardly be further optimised, since the boundaries defined by the laws 
of physics are nearly reached (Kaufmann 2012). 
The high number of recent publications illustrates the great scientific interest in the identification 
of umami taste modulating compounds that are so far unknown. Researchers have focused on the 
identification of umami active substances in fermented foods like corn sauce  
(Charve, Manganiello et al. 2018), Tianyou, a traditional fermented wheat flour condiment  
(Gao, Zhang et al. 2018), modernized Korean soy sauce (Kim, Kim et al. 2017), protein 
hydrolysates of mung beans (Sonklin, Laohakunjit et al. 2018) bovine muscle, porcine plasma  
109  Discussion 
 
 
(Fu, Liu et al. 2018), wheat gluten (Liu, Zhu et al. 2017) (Wang, Xu et al. 2016), peanuts  
(Zhang, Zhao et al. 2019), silkworm pupa (Yu, Jiang et al. 2018) and mushrooms like Volvariella 
volvacea (Xu, Xu et al. 2019), Agaricus bisporus (Tao Feng, Yang Wu et al. 2019), and Pleurotus 
geesteranus (Zhang, Zhang et al. 2019). Furthermore, the taste modulating substances in meat and 
fish products like chicken soup (Kong, Yang et al. 2017), pork meat (Ngapo and Vachon 2016), 
dry-cured ham (Paolella, Prandi et al. 2018) and Takifugu obscurus (Zhang, Ayed et al. 2019) were 
studied.  
Often the umami active compounds are not described in detail, but instead a mass range is specified 
in which they were found e. g. 1 – 5 kDa (Gao, Zhang et al. 2018). The most promising umami 
taste modulating substances (n = 17), identified in this work, including sequence information were 
found in a mass range between 0.2 and 0.3 kDa. In 2017, it was shown that a fraction of Korean 
soy sauce elicited a distinct umami taste. Its taste was attributed to the presence of free amino acids 
and Glu-enriched oligopeptides of less than 0.5 kDa. However, the umami taste was not attributed 
to any single substance. The umami taste might have correlated with the compounds of the fraction 
that had the ability of bitter masking, which in turn could possibly have evoked a strong umami 
taste by lowering the bitter taste (Kim, Kim et al. 2017). Wheat gluten hydrolysates showed a 
stronger umami taste the higher the degree of hydrolysis, the concentration of free amino acids 
and the protein content was. Again, the umami taste could not be assigned to any single substance 
(Wang, Xu et al. 2016). Most of the umami eliciting peptides, clearly identified in the past five 
years consisted of 7 – 8 amino acids, like Ala-Ser-Asn-Met-Ser-Asp-Leu,  
Tyr-Tyr-Gly-Ser-Asn-Ser-Ala, Leu-Gln-Pro-Leu-Asn-Ala-His (Xu, Xu et al. 2019),  
Pro-Val-Ala-Arg-Met-Cys-Arg, Tyr-Gly-Gly-Thr-Pro-Pro-Phe-Val (Zhang, Ayed et al. 2019). 
We focused on sensory guided fractionation of amino acids and  
di – tripeptides. The sub-fraction A19 of sample 2, which had an intense umami taste, contained 
17 small molecules, among them amino acids, di – tripeptides, and their condensation products. 
Diketo-Glu-Pro and Glu-Leu partially explain the intense umami taste, however the taste activity 
of Diketo-Glu-Ile, Diketo-Glu-Glu, Diketo-Glu-Ile, Diketo-Pro-Val, Diketo-Glu-Val,  
Diketo-Pro-Arg, Diketo-Cys-Lys, Pro-Phe, Val-Ile, Pro-Leu, Pro-Val, Ile-Ala, Pro-Leu-Val, and 
Val-Pro-Val remains unknown. Until now, there is little information about the composition of 
wheat gluten hydrolysates, fractionated twice and still imparting an intense umami taste. Of 
particular note is the detailed description of the small molecules in the mass range ≤ 0.3 kDa. This 
might be the basis for the development of deeper flavour analysis of wheat gluten hydrolysates. 
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Since a myriad of umami active compounds are known but no reports of a full reconstitution of 
the taste using combinations of these compounds, more research needs to be done. 
4.10 Mass spectrometric analysis of 2,5-diketopiperazines 
In this work, no specific fragmentation patterns of silylated 2,5-diketopiperazines were found. 
Although a specific fragmentation pattern after cleavage of the side chains and the rupture of the 
2,5-diketopiperazine ring using EI mode is described in literature (Szafranek, Palacz et al. 1976), 
it could not be confirmed. It was hypothesised that fragments could be detected that, without a 
doubt, would allow the identification of an existing diketopiperazines ring. But specific 
diketopiperazines fragmentation was not observed (Nagarajan, Occolowitz et al. 1969). The only 
recurrent fragments were (m/z -15) after the cleavage of CH3 and the fragment of the trimethylsilyl 
group (m/z 73) (Figure 3.18-1). In general, silylation of organic compounds is a powerful tool to 
gain structural information about the position of functional groups. Furthermore, functional groups 
can be identified by the use of different silylation reagents with different abilities of derivatising 
functional groups (Halket and Zaikin 2003). However, beside the expected ions of silylated 
compounds, no fragment, characteristic for the rupture of the 2,5-diketopiperazine was found. Not 
much topical is known about the specific fragmentation of the diketopiperazine ring in the EI 
mode, and a literature search showed only results published decades ago.  
Researchers focus on the fragmentation of diketopiperazines using the ESI mode. Different studies 
in positive (Furtado, Vessecchi et al. 2007) and negative ESI mode (Guo, Cao et al. 2009) showed 
that there is no specific fragment of a 2,5-diketopiperazine, which enabled the operator to clearly 
predict the presence of a diketo compound. Several fragmentation pathways are described. In some 
cases, elimination of both amino acid residues leads to a specific fragment. However, this was not 
the case for the tested compounds. To date, diketo compounds can only be identified by automated 
methods or by the manual evaluation of individual spectra. It should be noted that almost any 
change in ionisation settings can influence the spectra. Based on that it was summarised that the 
generated results did not lead to a calculation approach for a reliable prediction of the presence of 
2,5-diketopiperazines in complex food matrices.  
Verification of chemically synthesised diketopiperazines: In this work, three different  
2,5-diketopiperazines were chemically synthesised. To verify the identity of the products LC-MS 
was performed (section 2.5.7.). The success of the chemical synthesis was confirmed by the 
presence of the parent ions in positive and negative ionisation mode  
(Figure 3.19-2 to Figure 3.19-4). Additional verification steps were not performed but could have 
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been the determination of the melting point or structural identification via nuclear magnetic 
resonance spectrometry or HPLC analysis (Tullberg, Grøtli et al. 2006, Tullberg, Luthman et al. 
2006).  
4.11 Molecular biological findings 
Since a variety of umami active compounds contain glutamic acid, a glutamyl-specific peptidase 
was sought after in this work. Specific glutamyl endopeptidases from various microorganism, 
which hydrolyse peptide bonds formed by α-carboxyl groups of Glu and Asp residues are 
described in literature. The majority of this enzymes was found in bacterial strains, such as 
Staphylococcus epidermidis (Ohara-Nemoto, Ikeda et al. 2002), Bacillus amyloliquefaciens 
(Balaban, Mardanova et al. 2008), Enterococcus faecalis (Kawalec, Potempa et al. 2005), 
Streptomyces fradiae (Kitadokoro, Nakamura et al. 1993), or Thermoactinomyces sp.  
(Liu, Zhao et al. 2016). Based on the published sequence of a glutamyl endopeptidase from 
Thermoactinomyces with the molecular mass of 26 kDa hypothetical proteins from  
Fistulina hepatica (Fhe) and Laetiporus sulphureus (Lsu) were found in silico. The gene of interest 
was successfully amplified and sequenced from one Fhe strain and three different Lsu strains.  
In silico protein sequence analysis shows that all sequenced genes of Fhe 205, Lsul 235, Lsu 279, 
and Lsu 294 contain a trypsin-like serine peptidase domain like the gene of  
Thermoactinomyces sp. The theoretical molecular mass of the potential glutamyl endopeptidases 
from Lsu und Fhe are in the same order of magnitude as the molecular mass published for the 
glutamyl endopeptidase of Thermoactinomyces, of which-glutamyl-specific activity was shown 
(Liu, Zhao et al. 2016). According to this results, it was assumed that the amplified genes might 
have the same glutamyl-specific hydrolysation activity. However, for this purpose they have to be 
expressed in a suitable expression host, such as E. coli or Komagatella phaffii, purified, and 
characterised. Such an enzyme would be highly applicable in the food industry. Vegetable proteins 
could be pre-hydrolysed by specific glutamyl endopeptidases to increase the yield of  
glutamyl-peptides and the precursors of cyclic peptides.  
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4.12 Glutamate as food additive  
The amino acid glutamic acid naturally occurs in all foods from living cells. Glutamic acid and its 
salts (glutamic acid E 620; sodium glutamate E 621; potassium glutamate E 622; 
calcium glutamate E 623; ammonium glutamate E 624; and magnesium glutamate E 625) are 
particularly high in tomatoes, soy sauce, and long-ripened cheeses. These are potent umami active 
substances, authorised food additives in the European Union, and listed in Annex II of Regulation 
(EC) No 1333/2008. Glutamates are widely used as taste enhancers in several food preparations 
to evoke the typical umami taste. In 1990 the Scientific Committee on Food (SCF) published that 
the acceptable daily intake (ADI) for glutamates was not specified. This was confirmed in 2006 
by the Joint FAO/WHO Expert Committee on Food Additives (JECFA), since glutamic acid and 
its salts possess low acute toxicity. However, negative effects in humans were described associated 
with glutamate, such as headache (85.8 mg/kg body weight per day), blood pressure increase 
(150 mg/kg body weight per day) and insulin increase (> 143 mg/kg body weight per day). The 
ADI status (not specified) was re-evaluated by the European Food Safety Authority (EFSA) Panel 
on Food Additives and Nutrient Sources added to Food (ANS) in 2017  
(Mortensen, Aguilar et al. 2017). This evaluation led to an ADI of 30 mg/kg body weight per day 
for each of the six different glutamate additives. The value was based on the highest dose that did 
not lead to an adverse effect in humans. At present, the maximum permitted level of glutamate in 
the EU, which may be added to food preparations, is 10 g per kg food.  
Glutamate and some umami active peptides can be a solution for two research fields. It is known 
that these compounds not only evoke umami taste, but also can help to reduce the salt content of 
processed food. According to reports of the World Health Organization, the recommended daily 
intake of salt (2 g per day) is exceeded worldwide (World Health Organization 2012). Thus, the 
daily intake of sodium chloride represents a significant health risk. A variety of diseases, such as 
coronary heart disease, cardiovascular diseases, stroke and increased blood pressure are thereby 
promoted. Vegetable soup tastes more pleasant and saltier if 1 % MSG is added, compared to soup 
without the addition of MSG (van Stokkom, de Graaf et al. 2018). White mushrooms  
(Agaricus bisporus) do evoke umami taste due to the presence of 5´-ribonucleotides, aspartic and 
glutamic acids. It can be used for the substitution of up to 80 % of meat in a meat-based dish like 
beef taco blend. The flavour profile of the resulting dish was not dramatically altered, even though 
the salt content was reduced by 25 %. The obtained increased saltiness, based on the use of white 
mushrooms containing umami active compounds, can be a “healthy flavour” principle  
(Myrdal Miller, Mills et al. 2014). However, the utilization of umami peptides for salt reduction 
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of food preparations is not straightforward. Although peptides are known which either enhance the 
umami taste or the saltiness in various hydrolysed food, no synergistic effects are known which 
enhances the umami taste and allows the reduction of added sodium chloride to food products. 
This might be due to their low concentration in the used hydrolysates (Hoppu, Hopia et al. 2017). 
Flavour profiles of food products are evoked by a myriad of different taste active compounds. 
Reducing saltiness by enhancing the umami taste might lead to an increased bitterness of food 
preparations. The number of possible combinations of taste-active substances in highly complex 
foods is almost limitless. Taste-enhancing properties of a substance in a model broth do not 
necessarily lead to an intensification of the desired taste in a food which contains innumerable 
taste-active compounds. Much more work has to be done to evaluate synergistic effects that evoke 
the typical flavour profiles of foods accepted by consumers.  
4.13 Awareness of umami in the European population 
World’s population is familiar with the four basic tastes salty, bitter, sour, and sweet, but what 
about the fifth basic taste, umami? Since umami means savoury, and delicious and describes a 
pleasant mouthfeel it might be differently interpreted by different populations. However, natural 
glutamate is a big part of the daily diet due to its presence in different foods like seaweed, tea, 
vegetables, beans, potatoes, mushrooms, seafood, eggs and meats, dairy products and fermented 
products (Umami Information Center 2017). Research has shown that the awareness of the umami 
taste is low in the European population. A survey published in 2010 by Singh and co-workers 
compared the umami taste perception in the German and Norwegian population. They found out 
that only 3.8 % of the German participants and 10.3 % of the Norwegian participants were familiar 
with the umami taste. In addition, they claimed that the participants were sceptic to MSG. It was 
concluded that is essential to educate people about the umami taste and MSG  
(Singh, Schuster et al. 2010). A survey published in 2019 maintains that public recognition of the 
umami taste increased only recently. Participants for this study were from Finland, Germany, and 
Italy. Even though the majority of the European participants were sensitive to MSG, only a few 
were familiar with this taste (15 % of the Finnish group and 2 % of Germans and Italians, 
respectively) or were able to describe their taste perception correctly. Participants used up to 106 
different classes of verbal descriptors trying to describe the umami taste in their own words. Often 
the umami taste is described as savoury, meaty, soupy or brothy by the Europeans or even reduced 
to salty, sour and sweet. Both studies showed results in the same order of magnitude, but still the 
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umami taste is not well known yet in the European culture (Paola, Antti et al. 2019). Many 
consumers are unaware that HVP seasonings like the famous MAGGI® are an umami product and 
part of many convenience foods, which are bought because of their pleasant flavour. Foods that 
taste like umami are often eaten, without the consumers being able to describe the taste sensation 
or being aware that the taste they prefer is umami (Paola, Antti et al. 2019).  
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5 Conclusion 
Contrary to the state of the art techniques, which all require toxic solvents (Wang, Zhao et al. 2007, 
Deng, Wang et al. 2016, Wang, Xu et al. 2016, Liu, Zhu et al. 2017), in this work all fractions 
were successfully produced “food-safe”. Sensory analysis of fractions and sub-fractions from 
wheat gluten hydrolysates showed intense umami taste in some specific fractions and  
sub-fractions, respectively. For the first time the composition of umami active sub-fractions is 
described in detail with regard to small peptides and their condensation products. Several 
substance classes are known to enhance the umami taste. So it was not surprising, that substances 
already described in literature to evoke the umami taste were among them. Besides them, a large 
number of additional substances were identified. However, it has not been possible to clearly 
establish which individual components contribute to the umami taste and were not described yet.  
The smallest sub-fraction, which showed umami taste contained only 17 substances. Two of them 
are already known to evoke umami taste (diketo-Glu-Pro and Glu-Leu). It is very likely, that there 
are more umami active compounds among the 15 remaining substances (L-Norleucine; Pro-Phe; 
Val-Ile; Pro-Leu; Pro-Val; Ile-Ala; Pro-Leu-Val; Val-Pro-Val; diketo(Glu-Ile); diketo(Glu-Glu); 
diketo(Glu-Ile); diketo(Pro-Val); diketo(Glu-Val); diketo(Pro-Arg), and diketo(Cys-Lys). Most of 
the known umami active peptides have Glu, Val, or Pro in their sequence. The composition of the 
identified peptides and their condensation products, supports this hypothesis. The results presented 
may contribute to identify to date unknown umami active substances.  
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6 Outlook 
The sensory activity of the 15 substances identified in the latest SEC-fractions can now be tested. 
The probability of discovering a hitherto unknown umami active peptide is high due to the 
presence of Glu, Val, or Pro in the identified sequences. After the identification of substances the 
umami activity of which is undescribed yet, studies can be performed regarding the synergistic 
effects of MSG and umami active compounds. Synergistic effects could be analysed by mixing 
the substances in different concentrations before sensory analysis. On one hand, it could be 
examined, which substances show synergistic effects, and on the other hand, the concentrations 
with the highest umami enhancing potential could be determined. Small target molecules with 
umami taste may be accessible through a more concerted hydrolysis. The aim would be to increase 
the yield of the umami active substances. One possibility would be to optimise the performed 
hydrolysis process. Another approach would be the use of representative peptidase cocktails from 
the very versatile edible Basidiomycota or from other microorganisms. It would be also 
conceivable to screen the Basidiomycota for glutamyl-specific peptidases. These peptidases could 
be heterologously produced as described above in first steps. This biotechnological approach could 
possibly complement the traditional production process of vegetable plant source hydrolysis or 
even replace it, if the obtained degree of hydrolysis is sufficient. 
To generate more reliable results in sensory analysis the panellists could be trained more frequently 
over a long period of time, to increase the significance of their taste impressions. 
Moreover, the electronic tongue system could be used to increase the reproducibility as well as the 
detectable taste thresholds, since the umami taste is hardly describable. 
The food industry is interested in substances with umami properties, as these could reduce the use 
of MSG in food preparations, since MSG is not appreciated by some consumers. Many consumers 
enjoy the taste of umami, but are not aware of it.  
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Supplementary figure 1: Base Peak chromatogram (BPC) of the positive MS/MS mode of sample 1. The 
numbering of the peaks correlates with the numbering in Supplementary table 1. 
 
Supplementary table 1: Results of the three calculation approaches for the most abundant signals in sample 
stock solution (100 mg mL-1) of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 
2 is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 1. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
1 9.93 211.14399 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.11355 
0.68 
SF 
LSc* 
1 9.93 549.41263 549.41362 / C30H48N10 √ 0.98397 SF 
1 9.94 493.34975 493.35102 / C26H40N10 √ 1.26293 SF 
1 9.94 521.38101 521.38232 / C21H49N10O3P √ 1.05699 SF 
2 10.72 245.12831 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.14582 
0.71 
SF 
LSc* 
2 10.72 267.11014 267.11012 
267.10934 
/ 
Diketo-Glu-His 
C12H10N8 
C11H14N4O4 
√ 
√ 
0.01883 
0.8 
SF 
LSc* 
3 11.17 197.12812 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.33097 
0.9 
SF 
LSc* 
3 11.20 381.14255 381.14181 / C17H16N8O3 / 0.73619 SF 
3 11.22 296.08930 296.08905 
296.09176 
/ 
Ser-Cys-Ser 
C13H9N7O2 
C9H17N3O6S 
√ 
√ 
0.25267 
2.46 
SF 
LSc* 
4 11.46 326.37782 326.37813 / C22H47N √ 0.30367 SF 
4 11.50 284.13875 284.13935 
284.13992 
/ 
Diketo-Pro-Trp 
C16H17N3O2 
equivalent to SF 
√ 
√ 
0.60113 
1.17 
SF 
LSc* 
4 11.50 306.12157 306.12102 
306.1125 
306.13025 
306.13026 
/ 
Ser-Pro-Cys 
Glu-Gly-Thr 
Ala-Asp-Thr 
C14H11N9 
C11H19N3O5S 
C11H19N3O7 
C11H19N3O7 
√ 
√ 
√ 
√ 
0.54871 
9.07 
8.68 
8.69 
SF 
LSc* 
LSc* 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
5 15.80 261.12300 261.12337 
261.12393 
/ 
Diketo-Tyr-Pro 
C14H16N2O3 
equivalent to SF 
√ 
√ 
0.36362 
0.93 
SF 
LSc* 
5 15.80 283.10502 283.10503 / C12H10N8O √ 0.01499 SF 
5 15.80 521.23873 521.23946 / C28H32N4O6 √ 0.73487 SF 
5 15.96 169.09667 169.09715 
169.09772 
/ 
Diketo-Ala-Pro 
C8H12N2O2 
equivalent to SF 
√ 
√ 
0.48502 
1.05 
SF 
LSc* 
6 16.60 378.19960 378.19832 
378.20303 
/ 
Val-Tyr-Pro 
C14H27N5O7 
C19H27N3O5 
√ 
√ 
1.27384 
3.43 
SF 
LSc* 
6 16.61 132.10162 132.10191 L-Norleucine C6H13NO2 √ 0.28863 SF/LSc
* 
6 16.61 356.21744 356.21800 / C17H29N3O5 √ 0.55746 SF 
7 17.06 277.11788 277.11828 
277.11885 
/ 
Diketo-Glu-Phe 
C14H16N2O4 
equivalent to SF 
√ 
√ 
0.40761 
0.97 
SF 
LSc* 
7 17.10 197.12791 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.54509 
1.11 
SF 
LSc* 
7 17.10 203.13381 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.12467 
0.69 
SF 
LSc* 
7 17.10 485.26033 485.26224 / C20H41N2O9P √ 1.91232 SF 
8 17.68 130.04970 130.04987 (R)-(+)-2-
Pyrrolidone-5-
carboxyylic acid 
C5H7NO3 √ 0.17281 SF/SL 
8 17.68 388.13448 388.13506 
388.12921 
/ 
His-Glu-Cys 
C15H21N3O9 
C14H21N5O6S 
√ 
√ 
0.57457 
5.27 
SF 
LSc* 
8 17.69 259.09199 259.09246 
259.09303 
/ 
Diketo-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.46916 
1.04 
SF 
LSc* 
8 17.83 340.18609 340.18670 / C16H25N3O5 √ 0.60816 SF 
8 17.93 371.22660 371.22756 / C16H34O9 √ 0.96341 SF 
8 17.98 231.16970 231.17032 
231.16982 
/ 
Val-Ile 
C11H22N2O3 
equivalent to SF 
/ 
/ 
0.61888 
0.12 
SF 
LSc* 
8 18.00 374.17035 374.17002 / C13H24N7O4P √ 0.33756 SF 
8 18.03 209.09144 209.09207 / C10H12N2O3 √ 0.62334 SF 
9 18.26 476.30563 476.30684 / C15H42N9O6P √ 1.21797 SF 
9 18.26 459.27897 459.27730 
459.27933 
/ 
Arg-Arg-Gln 
C16H38N6O9 
C17H34N10O5 
√ 
√ 
1.67149 
0.36 
SF 
LSc* 
9 18.27 481.26098 481.26196 / C13H33N14O4P / 0.97718 SF 
9 18.40 503.30502 503.30620 / C22H46O12 / 1.18221 SF 
9 18.40 520.33192 520.33306 / C17H46N9O7P √ 1.13680 SF 
9 18.40 293.11225 293.11320 
293.11376 
/ 
Diketo-Glu-Tyr 
C14H16N2O5 
equivalent to SF 
√ 
√ 
0.94308 
1.51 
SF 
LSc* 
9 18.42 326.17034 326.17105 / C15H23N3O5 √ 0.70590 SF 
9 18.48 213.08638 213.08832 
213.08755 
/ 
Diketo-Asp-Pro 
C10H8N6 
C9H12N2O4 
/ 
/ 
1.94501 
1.17 
SF 
LSc* 
9 18.50 564.35765 564.35628 / C20H49N7O11 √ 1.36948 SF 
9 18.66 493.20442 493.20414 / C21H28N6O8 √ 0.28581 SF 
9 18.72 471.22291 471.22278 / C18H31N8O5P √ 0.12972 SF 
9 18.73 263.13860 263.13902 Pro-Phe C14H18N2O3 √ 0.41705 SF/SL 
10 19.00 437.23851 437.23678 / C17H28N10O4 √ 1.72962 SF 
10 19.03 459.22026 459.21979 / C18H30N6O8 √ 0.46715 SF 
10 19.25 148.06033 148.06043 
148.05651 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
/ 
/ 
0.10054 
3.82 
SF 
LSc* 
10 19.26 390.16506 390.16328 
390.16262 
/ 
Gln-Gln-Asp 
C15H19N9O4 
C14H23N5O8 
√ 
√ 
1.78722 
2.44 
SF 
LSc* 
10 19.66 227.10246 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.82336 
0.74 
SF 
LSc 
10 19.67 453.19775 453.19696 / C14H29N8O7P √ 0.78776 SF 
10 19.76 279.16939 279.17032 Phe-Ile C15H22N2O3 √ 0.92628 SF/SL 
10 19.89 410.20660 410.20743 Phe-Pro-Phe C23H27N3O4 √ 0.83021 SF/SL 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
10 19.94 245.18532 245.18597 NH-
DVal(NMe)-
Val-OMe 
C12H24N2O3 √ 0.64751 SF/SL 
11 20.09 279.13323 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.70298 
1.38 
SF 
LSc* 
11 20.09 405.17559 405.17551 / C16H16N14 √ 0.07990 SF 
11 20.11 376.22229 376.22308 Leu-Pro-Phe C20H29N3O4 √ 0.79728 SF/SL 
11 20.23 415.23284 415.23398 Leu-Pro-Trp C22H30N4O4 √ 1.14321 SF/SL 
11 20.28 342.23801 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.72238 SF/SL 
11 20.40 248.10001 248.09894 / C7H13N5O5 √ 1.06281 SF 
11 20.41 209.09159 209.09207 / C10H12N2O3 √ 0.48291 SF 
11 20.41 226.11811 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.50493 
1.07 
SF 
LSc* 
11 20.58 187.07096 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.36884 
0.93 
SF 
LSc* 
11 20.58 373.13438 373.13539 
373.12954 
/ 
Asn-His-Cys 
C14H20N4O8 
C13H20N6O5S 
√ 
√ 
1.01147 
4.84 
SF 
LSc* 
11 20.66 263.13853 263.13902 Pro-Phe C14H18N2O3 √ 0.48954 SF/SL 
11 20.71 259.09158 259.09246 
259.09303 
259.08661 
/ 
Diketo-Glu-Glu 
His-Cys 
C10H14N2O6 
equivalent to SF 
C9H14N4O3S 
√ 
√ 
√ 
0.88387 
1.45 
4.97 
SF 
LSc* 
LSc* 
11 20.77 229.15401 229.15467 Pro-Ile C11H20N2O3 √ 0.65795 SF/SL 
11 20.79 195.07552 195.07642 / C9H10N2O3 √ 0.90165 SF 
11 20.81 324.15427 324.15271 
324.15607 
324.15608 
/ 
Phe-Thr-Gly 
Ala-Tyr-Ala 
C11H17N9O3 
C15H21N3O5 
C15H21N3O5 
√ 
√ 
√ 
1.56234 
1.8 
1.81 
SF 
LSc* 
LSc* 
11 20.84 346.13612 346.13706 / C13H15N9O3 √ 0.93824 SF 
11 20.84 295.16403 295.16523 
295.16591 
/ 
Tyr-Leu 
C15H22N2O4 
equivalent to SF 
/ 
/ 
1.20535 
1.88 
SF 
LSc* 
11 20.88 362.20632 362.20743 Val-Pro-Phe C19H27N3O4 √ 1.11399 SF/SL 
12 21.00 360.19269 360.19178 Pro-Pro-Phe C19H25N3O4 √ 0.90868 SF/SL 
12 21.16 328.22235 328.22308 Ile-Pro-Val C16H29N3O4 √ 0.73495 SF/SL 
12 21.20 392.21675 392.21800 Leu-Pro-Tyr C20H29N3O5 √ 1.24436 SF/SL 
13 21.45 217.15381 217.15467 Val-Val C10H20N2O3 √ 0.86305 SF/SL 
13 21.49 120.08046 120.08078 / C8H9N √ 0.31346 SF 
13 21.49 263.13859 263.13902 Phe-Pro C14H18N2O3 √ 0.42646 SF/SL 
13 21.57 215.13849 215.13902 Pro-Val C10H18N2O3 √ 0.52391 SF/SL 
13 21.61 188.07019 188.07060 / C11H9NO2 √ 0.41779 SF 
13 21.61 205.09668 205.09715 D-Tryptophan C11H12N2O2 √ 0.47256 SF/SL 
13 21.64 314.20675 314.20743 Val-Pro-Val C15H27N3O4 √ 0.68566 SF/SL 
13 21.68 203.13851 203.13902 
203.1397 
/ 
Ile-Ala 
C9H18N2O3 
equivalent to SF 
√ 
√ 
0.50937 
1.19 
SF 
LSc* 
13 21.76 132.10167 132.10191 L-Norleucine C6H13NO2 √ 0.23623 SF/SL 
14 21.90 331.16464 331.16420 
331.16189 
/ 
Ser-Pro-Gln 
C12H23N6O3P 
C13H22N4O6 
√ 
√ 
0.44130 
2.75 
SF 
LSc* 
14 21.92 166.08597 166.08626 L-Phenylalanine C9H11NO2 √ 0.28909 SF/SL 
14 22.01 300.19096 300.19178 Leu-Pro-Ala C14H25N3O4 √ 0.82435 SF/SL 
14 22.01 187.10693 187.10772 
187.10828 
187.1084 
/ 
Diketo-Val-Ser 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.79324 
1.35 
1.47 
SF 
LSc* 
LSc* 
14 22.02 223.10698 223.10772 
223.10726 
/ 
Phe-Gly 
C11H14N2O3 
equivalent to SF 
/ 
/ 
0.74188 
0.28 
SF 
LSc* 
14 22.22 132.10152 132.10191 L-Norleucine C6H13NO2 √ 0.37988 SF/SL 
14 22.39 326.20680 326.20743 
326.20812 
/ 
Pro-Pro-Ile 
C16H27N3O4 
equivalent to SF 
√ 
√ 
0.51450 
1.32 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
15 22.60 189.12276 189.12337 Ile-Gly C8H16N2O3 √ 0.60471 SF/SL 
15 22.63 261.14355 261.14450 Leu-Glu C11H20N2O5 √ 0.94859 SF/SL 
15 22.81 279.13312 279.13125 
279.13461 
/ 
Tyr-Pro 
C10H14N8O2 
equivalent to SF 
√ 
√ 
1.87174 
1.49 
SF 
LSc* 
15 22.83 316.18590 316.18670 
316.18568 
/ 
Pro-Ser-Leu 
C14H25N3O5 
equivalent to SF 
/ 
/ 
0.89462 
0.22 
SF 
LSc* 
15 22.83 215.13869 215.13902 Pro-Val C10H18N2O3 √ 0.32775 SF/SL 
15 22.88 312.19086 312.19178 Pro-Pro-Val C15H25N3O4 √ 0.92283 SF/SL 
16 22.93 213.12280 213.12337 
213.12405 
/ 
Pro-Pro 
C10H16N2O3 
equivalent to SF 
√ 
√ 
0.57213 
1.25 
SF 
LSc* 
16 23.01 286.17534 286.17613 
286.17681 
286.17682 
/ 
Pro-Ile-Gly 
Val-Ala-Pro 
C13H23N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.79215 
1.1 
1.11 
SF 
LSc* 
LSc* 
16 23.07 173.12777 173.12845 / C8H16N2O2 √ 0.68442 SF 
16 23.07 219.13330 219.13393 Leu-Ser C9H18N2O4 √ 0.63403 SF/SL 
16 23.11 229.11744 229.11828 
229.11885 
/ 
Diketo-Glu-Val 
C10H16N2O4 
equivalent to SF 
√ 
√ 
0.84068 
1.41 
SF 
LSc* 
16 23.13 330.20146 330.20235 Leu-Pro-Thr C15H27N3O5 √ 0.88748 SF/SL 
17 23.31 182.08047 182.08117 L-Tyrosine C9H11NO3 √ 0.69753 SF/SL 
17 23.36 150.05771 150.05833 L-Methionine C5H11NO2S √ 0.61379 SF/SL 
17 23.44 280.08954 280.08877 / C7H13N5O7 √ 0.77096 SF 
17 23.45 258.10787 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.58056 
1.14 
SF 
LSc* 
17 23.48 241.08136 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.53943 
5.43 
SF 
LSc* 
17 23.73 217.11743 217.11828 Pro-Thr C9H16N2O4 √ 0.85671 SF/SL 
17 23.78 391.19706 391.19760 Phe-Pro-Gln C19H26N4O5 √ 0.53292 SF/SL 
18 24.11 355.16027 355.15853 / C11H18N10O4 √ 1.74036 SF 
18 24.12 147.07570 147.07642 D-Glutamine C5H10N2O3 √ 0.71967 SF/SL 
18 24.24 254.16035 254.16115 
254.16172 
/ 
Diketo-Arg-Pro 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.79948 
1.37 
SF 
LSc* 
19 24.65 182.08037 182.08117 L-Tyrosine C9H11NO3 √ 0.79882 SF/SL 
19 24.67 165.05391 165.05462 / C9H8O3 √ 0.70844 SF 
19 24.70 136.07524 136.07569 / C8H9NO √ 0.44953 SF 
20 25.25 226.04424 226.04585 / C8H7N3O5 √ 1.60469 SF 
20 25.36 314.08397 314.08569 / C10H7N11O2 / 1.72153 SF 
21 25.34 357.21224 357.21325 Ile-Pro-Gln C16H28N4O5 √ 1.00888 SF/SL 
21 25.41 257.10023 257.10062 / C9H8N10 / 0.38988 SF 
21 25.42 235.11813 235.11761 
235.11951 
/ 
Diketo-His-Pro 
C10H18O6 
C11H14N4O2 
√ 
√ 
0.51908 
1.38 
SF 
LSc* 
21 25.63 233.11230 233.11320 
233.11388 
/ 
Val-Asp 
C9H16N2O5 
equivalent to SF 
√ 
√ 
0.89437 
1.58 
SF 
LSc* 
21 25.64 162.04949 162.05093 / C4H7N3O4 √ 1.44575 SF 
21 25.64 298.02399 298.02400 / C8H13NO7P √ 0.00905 SF 
22 26.51 205.11737 205.11828 Val-Ser C8H16N2O4 √ 0.91731 SF/SL 
23 27.41 147.07573 147.07642 D-Glutamine C5H10N2O3 √ 0.68727 SF/SL 
23 27.41 244.12857 244.12918 Pro-Ala-Gly C10H17N3O4 √ 0.61092 SF/SL 
23 27.41 266.10993 266.11085 / C8H11N9O2 √ 0.91246 SF 
23 27.52 203.10176 203.10263 
203.10331 
 
Pro-Ser 
C8H14N2O4 
equivalent to SF 
√ 
√ 
0.86937 
1.55 
SF 
LSc* 
24 28.32 364.15980 364.16021 
364.15437 
364.15437 
364.1656 
/ 
Ile-Glu-Cys 
Asp-Met-Val 
Asn-Lys-Cys 
C15H25NO9 
C14H25N3O6S 
C14H25N3O6S 
C13H25N5O5S 
√ 
√ 
√ 
√ 
0.40762 
5.43 
5.43 
5.8 
SF 
LSc* 
LSc* 
LSc* 
24 28.46 249.09712 249.09822 / C11H12N4O3 √ 1.09999 SF 
24 28.46 267.10742 267.10744 
267.10934 
/ 
Diketo-Glu-His 
C10H18O8 
C11H14N4O4 
√ 
√ 
0.01960 
1.92 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
25 28.69 204.09654 204.09788 Gln-Gly C7H13N3O4 √ 1.33775 SF/SL 
25 28.83 276.11808 276.11901 
276.11901 
/ 
Glu-Gln 
C10H17N3O6 
equivalent to SF 
/ 
/ 
0.93541 
0.93 
SF 
LSc* 
25 28.89 293.14456 293.14556 / C10H20N4O6 √ 0.99811 SF 
25 28.90 147.07588 147.07642 D-Glutamine C5H10N2O3 √ 0.53369 SF/SL 
25 29.12 375.14922 375.14835 / C10H18N10O6 √ 0.86745 SF 
25 29.20 166.05227 166.05324 
166.05324 
/ 
DL-Methionine 
sulfoxide 
C5H11NO3S 
equivalent to SF 
√ 
√ 
0.96657 
0.97 
SF 
LSc* 
25 29.25 207.09659 207.09755 
207.09822 
/ 
Ser-Thr 
C7H14N2O5 
equivalent to SF 
√ 
√ 
0.95402 
1.63 
SF 
LSc* 
26 29.33 331.15932 331.16121 Ser-Pro-Gln C13H22N4O6 √ 1.89428 SF/SL 
26 29.34 265.11278 265.11426 
265.11884 
/ 
Diketo-Tyr-Thr 
C8H16N4O6 
C13H16N2O4 
√ 
√ 
1.48142 
6.06 
SF 
LSc* 
26 29.35 133.06009 133.06077 
133.05685 
/ 
Asparagine 
C4H8N2O3 
equivalent to SF 
√ 
√ 
0.68194 
3.24 
SF 
LSc* 
26 29.49 170.04398 170.04478 / C7H7NO4 √ 0.80638 SF 
27 29.76 275.13394 275.13500 Gln-Gln C10H18N4O5 √ 1.05737 SF/SL 
28 30.02 193.08101 193.08190 Ser-Ser C6H12N2O5 √ 0.88353 SF/SL 
28 30.07 234.10670 234.10845 Ser-Gln C8H15N3O5 √ 1.74799 SF/SL 
28 30.08 147.07579 147.07642 D-Glutamine C5H10N2O3 √ 0.63052 SF/SL 
28 30.08 217.08098 217.08190 
217.08246 
/ 
Diketo-Glu-Ser 
C8H12N2O5 
equivalent to SF 
√ 
√ 
0.91385 
1.48 
SF 
LSc* 
28 30.27 424.17964 424.18133 
424.17682 
/ 
His-His-Met 
C15H17N15O 
C17H25N7O4S 
/ 
/ 
1.68765 
2.82 
SF 
LSc* 
29 30.57 291.11780 291.11599 / C7H14N8O5 √ 1.81326 SF 
29 30.62 273.10718 273.10543 / C7H12N8O4 √ 1.74972 SF 
29 30.63 309.12825 309.12656 / C7H16N8O6 √ 1.69096 SF 
29 30.75 250.09105 250.09213 
250.08625 
/ 
Ala-Cys-Gly 
C9H15NO7 
C8H15N3O4S 
√ 
√ 
1.07322 
4.77 
SF 
LSc* 
29 30.93 162.07543 162.07608 / C6H11NO4 √ 0.65838 SF 
29 30.93 359.16440 359.16602 
359.15681 
359.15681 
/ 
Asn-Glu-Pro 
Asp-Gln-Pro 
C12H26N2O10 
C14H22N4O7 
C14H22N4O7 
√ 
√ 
√ 
1.62184 
7.59 
7.59 
SF 
LSc* 
LSc* 
29 30.94 180.08586 180.08665 / C6H13NO5 √ 0.78958 SF 
29 30.94 319.14843 319.14863 / C10H14N12O √ 0.20331 SF 
29 31.08 295.11251 295.11359 / C10H18N2O8 / 1.08546 SF 
29 31.11 274.18639 274.18737 
274.18636 
/ 
Val-Arg 
C11H23N5O3 
equivalent to SF 
/ 
/ 
0.96640 
0.03 
SF 
LSc* 
30 31.58 253.12846 253.12952 
253.13019 
/ 
Pro-His 
C11H16N4O3 
equivalent to SF 
√ 
√ 
1.06070 
1.73 
SF 
LSc* 
30 31.61 272.17116 272.17172 Pro-Arg C11H21N5O3 √ 0.70332 SF/SL 
30 31.67 246.15511 246.15607 Arg-Ala C9H19N5O3 √ 0.96017 SF/SL 
30 31.74 349.22943 349.23063 / C12H28N8O4 √ 1.20114 SF 
30 31.76 175.11835 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.60569 
3.32 
SF 
LSc* 
30 31.88 330.18692 330.18843 / C12H23N7O4 √ 1.51261 SF 
30 31.96 311.14487 311.14489 
311.13958 
/ 
Diketo-Tyr-Phe 
C11H22N2O8 
C18H18N2O3 
√ 
√ 
0.01935 
5.29 
SF 
LSc* 
30 31.98 156.07603 156.07675 L-Histidine C6H9N3O2 √ 0.72089 SF/SL 
30 31.99 304.16041 304.16155 
304.16074 
/ 
Arg-Glu 
C11H21N5O5 
equivalent to SF 
√ 
√ 
1.13531 
0.33 
SF 
LSc* 
30 32.09 147.11231 147.11280 L-Lysine C6H14N2O2 √ 0.58422 SF/SL 
31 32.61 232.13943 232.14042 
232.14109 
/ 
Arg-Gly 
C8H17N5O3 
equivalent to SF 
√ 
√ 
1.01295 
1.66 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
31 32.67 213.09728 213.09822 His-Gly C8H12N4O3 √ 0.94704 SF/SL 
31 33.04 318.12825 318.12689 
318.12764 
/ 
Diketo-Trp-Met 
C8H15N9O5 
C16H19N3O2S 
√ 
√ 
1.35467 
0.61 
SF 
LSc* 
31 33.05 262.15010 262.15098 Arg-Ser C9H19N5O4 √ 0.89233 SF/SL 
31 33.24 289.16090 289.16188 Asn-Arg C10H20N6O4 √ 0.97743 SF/SL 
32 33.46 159.96853 159.96991 / C4HNO4S √ 1.37577 SF 
32 33.73 309.16461 309.16563 / C12H24N2O7 / 1.01473 SF 
32 34.74 182.98422 182.98417 / C7H3O3P √ 0.05170 SF 
 
 
Supplementary figure 2: Base Peak chromatogram (BPC) of the positive MS/MS mode of sample 2. The 
numbering of the peaks correlates with the numbering in Supplementary table 2. 
 
Supplementary table 2: Results of the three calculation approaches for the most abundant signals in sample 
stock solution (100 mg mL-1) of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 
2 is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 2. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
1 9.72 521.38004 521.37830 / C23H44N12O2 √ 1.74269 SF 
1 9.72 549.41135 549.41010 / C30H61O4PS √ 1.25781 SF 
1 9.74 211.14353 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.57001 
0.68 
SF 
LSc* 
2 10.20 231.11210 231.11280 
231.11674 
/ 
Diketo-Met-Val 
C13H14N2O2 
C10H18N2O2S 
√ 
√ 
0.70439 
4.64 
SF 
LSc* 
3 10.52 245.12763 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.82448 
1.39 
SF 
LSc* 
4 11.04 197.12781 197.12845 
197.12902 
/ 
Diketo-Val-Pro 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.64446 
1.21 
SF 
LSc* 
4 11.07 174.11206 174.11247 Acetyl-DL-
Leucine 
C8H15NO3 √ 0.41072 SF/SL 
5 11.33 284.13854 284.13935 
284.13992 
/ 
Diketo-Pro-Trp 
C16H17N3O2 
equivalent to SF 
√ 
√ 
0.81588 
1.38 
SF 
LSc* 
5 11.33 326.37747 326.37813 / C22H47N √ 0.65484 SF 
5 11.34 305.14850 305.14690 
305.14623 
/ 
Thr-Gln-Gly 
C12H16N8O2 
C11H20N4O6 
√ 
√ 
1.60517 
2.27 
SF 
LSc* 
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[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
305.14624 Ser-Gln-Ala C11H20N4O6 √ 2.27 LSc* 
5 11.57 291.13322 291.13393 
291.13058 
291.13059 
/ 
Ser-Gln-Gly 
Ala-Asn-Ser 
C15H18N2O4 
C10H18N4O6 
C15H18N2O4 
√ 
√ 
√ 
0.71333 
2.64 
2.64 
SF 
LSc* 
LSc* 
6 15.57 124.03895 124.03930 / C6H5NO2 √ 0.35632 SF 
6 15.61 283.10427 283.10503 / C12H10N8O / 0.76407 SF 
6 15.63 521.23842 521.23696 / C32H32N4OS √ 1.46107 SF 
6 15.63 261.12310 261.12502 
261.12393 
/ 
Diketo-Tyr-Pro 
C12H21O4P 
C14H16N2O3 
√ 
√ 
1.91731 
0.83 
SF 
LSc* 
6 15.83 169.09642 169.09715 
169.09772 
/ 
Diketo-Ala-Pro 
C8H12N2O2 
equivalent to SF 
√ 
√ 
0.73701 
1.05 
SF 
LSc* 
7 16.51 132.10161 132.10191 Norleucine C6H13NO2 / 0.29687 SF/LSc
* 
7 16.51 356.21738 356.21800 / C17H29N3O5 √ 0.61862 SF 
7 16.51 378.19937 378.19966 
378.20303 
/ 
Val-Tyr-Pro 
C15H23N9O3 
C19H27N3O5 
√ 
√ 
0.29163 
3.66 
SF 
LSc* 
8 16.98 277.11753 277.11828 
277.11885 
/ 
Diketo-Glu-Phe 
C14H16N2O4 
equivalent to SF 
√ 
√ 
0.74831 
1.32 
SF 
LSc* 
8 17.01 197.12794 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.51290 
1.08 
SF 
LSc* 
8 17.01 243.13367 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.26041 
0.83 
SF 
LSc* 
8 17.01 485.26014 485.25925 / C21H40O12 √ 0.89153 SF 
9 17.58 130.04966 130.04987 (R)-(+)-2-
Pyrrolidone-5-
carboxyylic acid 
C5H7NO3 √ 0.21260 SF/SL 
9 17.58 259.09199 259.09246 
259.09303 
/ 
Diketo-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.47174 
1.04 
SF 
LSc* 
9 17.58 388.13458 388.13371 
388.12921 
/ 
His-Glu-Cys 
C12H13N13O3 
C14H21N5O6S 
√ 
√ 
0.86935 
5.37 
SF 
LSc* 
10 17.84 227.10236 227.10263 
227.1032 
/ 
Diketo-Glu-Pro 
C10H14N2O4 
equivalent to SF 
√ 
√ 
0.27276 
0.84 
SF 
LSc* 
10 17.85 371.22690 371.22786 / C11H31N8O4P √ 0.96271 SF 
10 17.86 209.09155 209.09207 / C10H21N2O3 √ 0.52189 SF 
10 17.95 374.17013 374.16836 / C15H19N9O3 √ 1.76739 SF 
10 18.03 340.18596 340.18670 / C16H25N3O5 √ 0.73459 SF 
11 18.19 476.30593 476.30684 / C15H42N9O6P √ 0.90882 SF 
11 18.20 459.27906 459.27730 
459.27933 
/ 
Arg-Arg-Gln 
C16H38N6O9 
C17H34N10O5 
√ 
√ 
1.75718 
0.27 
SF 
LSc* 
11 18.20 481.26114 481.26165 / C18H36N6O9 / 0.51025 SF 
11 18.34 503.30540 503.30620 / C22H46O12 √ 0.80003 SF 
11 18.34 520.33194 520.33306 / C17H46N9O7P √ 1.12119 SF 
11 18.35 293.11319 293.11051 
293.11376 
/ 
Diketo-Glu-Tyr 
C10H12N8O3 
C14H16N2O5 
√ 
√ 
1.91348 
0.57 
SF 
LSc* 
11 18.41 213.08633 213.08698 
213.08755 
/ 
Diketo-Asp-Pro 
C9H12N2O4 
equivalent to SF 
√ 
√ 
0.65678 
1.22 
SF 
LSc* 
11 18.47 564.35813 564.35927 / C19H50N9O8P √ 1.14699 SF 
12 18.66 493.20481 493.20548 / C22H24N10O4 / 0.66946 SF 
12 18.68 263.13892 263.14067 
263.13958 
263.1397 
/ 
Diketo-Tyr-Val 
Phe-Pro 
C12H23O4P 
C14H18N2O3 
C14H18N2O3 
√ 
√ 
√ 
1.74940 
0.66 
0.78 
SF 
LSc* 
LSc* 
12 18.68 471.22343 471.22278 / C18H31N8O5P √ 0.65168 SF 
12 18.76 326.17041 326.17105 / C15H23N3O5 √ 0.63350 SF 
13 18.97 459.22032 459.22113 / C19H26N10O4 √ 0.80193 SF 
13 18.98 437.23898 437.23812 / C20H36O10 √ 0.85414 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
13 18.99 229.15427 229.15467 Pro-Leu C11H20N2O3 √ 0.39691 SF/SL 
13 19.19 148.05993 148.06177 
148.05651 
/ 
Glutamic acid 
C6H5N5 
C5H9NO4 
/ 
/ 
1.84369 
3.42 
SF 
LSc* 
13 19.19 182.08085 182.08117 L-Tyrosine C9H11NO3 √ 0.31673 SF/SL 
13 19.20 390.16524 390.16596 
390.16262 
/ 
Gln-Gln-Asp 
C19H23N3O6 
C14H23N5O8 
√ 
√ 
0.72174 
2.62 
SF 
LSc* 
14 19.59 227.10255 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.73821 
0.65 
SF 
LSc* 
14 19.59 453.19757 453.19696 / C14H29N8O7P √ 0.61096 SF 
14 19.77 279.16946 279.17032 Leu-Phe C15H22N2O3 √ 0.86190 SF/SL 
14 19.85 287.12305 287.12376 / C12H18N2O6 √ 0.71718 SF 
15 19.89 410.20576 410.20743 
410.20660 
/ 
Phe-Pro-Phe 
C23H27N3O4 
equivalent to SF 
/ 
/ 
1.67689 
0.84 
SF 
LSc* 
15 19.99 245.18567 245.18597 NH-
DVal(NMe)-
Val-OMe 
C12H24N2O3 √ 0.29610 SF/SL 
15 20.03 279.13351 279.13527 
279.13461 
/ 
Tyr-Pro 
C15H14N6 
C14H18N2O4 
√ 
√ 
1.76168 
1.1 
SF 
LSc* 
15 20.12 376.22263 376.22308 Ile-Pro-Phe C20H29N3O4 √ 0.44889 SF/SL 
16 20.21 415.23360 415.23398 Leu-Pro-Trp C22H30N4O4 √ 0.38271 SF/SL 
16 20.29 342.23849 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.24010 SF/SL 
16 20.33 209.09178 209.09372 / C8H17O4P √ 1.93976 SF 
16 20.33 248.09993 248.10028 / C8H9N9O / 0.35164 SF 
16 20.33 226.11822 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.39756 
0.96 
SF 
LSc* 
17 20.49 187.07099 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.34676 
0.9 
SF 
LSc* 
17 20.52 346.13697 346.13706 / C13H15N9O3 / 0.08855 SF 
17 20.60 259.09223 259.09412 
259.09303 
/ 
Diketo-Glu-Glu 
C8H19O7P 
C10H14N2O6 
√ 
√ 
1.88441 
0.8 
SF 
LSc* 
17 20.60 241.08141 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H21N2O5 
C9H12N4O2S 
√ 
√ 
0.48590 
5.48 
SF 
LSc* 
17 20.64 231.16982 231.17032 Val-Ile C11H22N2O3 √ 0.49654 SF/SL 
17 20.64 263.13875 263.13902 Pro-Phe C14H18N2O3 √ 0.26366 SF/SL 
18 20.71 195.07601 195.07642 / C9H10N2O3 √ 0.40759 SF 
18 20.73 324.15477 324.15540 
324.15607 
324.15608 
/ 
Phe-Thr-Gly 
Ala-Tyr-Ala 
C15H21N3O5 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.6328 
2 
1.3 
1.3 
SF 
LSc* 
LSc* 
18 20.76 229.15447 229.15467 Pro-Leu C11H20N2O3 √ 0.20203 SF/SL 
18 20.79 362.20699 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.44567 SF/SL 
18 20.85 360.19443 360.19178 Pro-Pro-Phe C19H25N3O4 √ 2.65157 SF/SL 
18 20.86 295.16481 295.16420 
295.16591 
/ 
Tyr-Leu 
C9H23N6O3P 
C15H22N2O4 
/ 
/ 
0.60592 
1.1 
SF 
LSc* 
19 21.03 328.22306 328.22308 Pro-Leu-Val C16H29N3O4 √ 0.02608 SF/SL 
19 21.06 392.21746 392.21800 Ile-Pro-Tyr C20H29N3O5 √ 0.53835 SF/SL 
19 21.09 505.26523 505.26434 / C24H40O11 √ 0.89608 SF 
20 21.27 249.12586 249.12674 Val-Met C10H20N2O3S √ 0.87738 SF/SL 
20 21.34 217.15422 217.15467 Val-Val C10H20N2O3 √ 0.44680 SF/SL 
20 21.37 263.13883 263.13902 Phe-Pro C14H18N2O3 √ 0.19215 SF/SL 
21 21.46 215.13891 215.13902 Pro-Val C10H18N2O3 √ 0.11160 SF/SL 
21 21.49 188.07059 188.07060 / C11H9NO2 √ 0.01567 SF 
21 21.49 205.09707 205.09715 D-Tryptophan C11H12N2O2 √ 0.08833 SF/SL 
21 21.50 229.15471 229.15467 Pro-Leu C11H20N2O3 √ 0.03818 SF/SL 
21 21.53 314.20723 314.20743 Val-Pro-Val C15H27N3O4 √ 0.19886 SF/SL 
21 21.57 203.13882 203.13902 
203.1397 
/ 
Ile-Ala 
C9H18N2O3 
equivalent to SF 
√ 
√ 
0.19512 
0.88 
SF 
LSc* 
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21 21.63 132.10171 132.10191 L-Norleucine C6H13NO2 √ 0.19678 SF/SL 
22 21.76 331.16472 331.16523 
331.16189 
/ 
Ser-Pro-Gln 
C18H22N2O4 
C13H22N4O6 
√ 
√ 
0.51455 
2.83 
SF 
LSc* 
22 21.78 120.08066 120.08078 / C8H9N √ 0.11877 SF 
22 21.78 166.08613 166.08626 L-Phenylalanine C9H11NO2 √ 0.12588 SF/SL 
22 21.86 223.10726 223.10772 Phe-Gly C11H14N2O3 √ 0.46207 SF/SL 
22 21.88 300.19144 300.19178 Leu-Pro-Ala C14H25N3O4 √ 0.34378 SF/SL 
22 21.89 326.20688 326.20743 
326.20812 
/ 
Pro-Pro-Ile 
C16H27N3O4 
equivalent to SF 
/ 
/ 
0.55547 
1.24 
SF 
LSc* 
23 22.27 189.12299 189.12337 Ile-Gly C8H16N2O3 √ 0.38273 SF/SL 
24 22.52 215.13891 215.13902 Pro-Val C10H18N2O3 √ 0.10630 SF/SL 
24 22.59 279.13339 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.54488 
1.22 
SF 
LSc* 
24 22.61 350.17041 350.17105 Ser-Pro-Phe C17H23N3O5 √ 0.63950 SF/SL 
24 22.62 189.12285 189.12337 Ile-Gly C8H16N2O3 √ 0.51368 SF/SL 
24 22.62 261.14385 261.14450 Ile-Glu C11H20N2O5 √ 0.64331 SF/SL 
24 22.65 316.18568 316.18670 Pro-Ser-Leu C14H25N3O5 √ 1.01908 SF/SL 
24 22.68 358.19639 358.19726 Ile-Pro-Glu C16H27N3O6 √ 0.87077 SF/SL 
24 22.70 312.19122 312.19178 Pro-Pro-Val C15H25N3O4 √ 0.56692 SF/SL 
25 22.74 286.17558 286.17613 
286.17681 
286.17682 
/ 
Pro-Ile-Gly 
Val-Ala-Pro 
C13H23N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.55500 
1.1 
1.11 
SF 
LSc* 
LSc* 
25 22.75 213.12283 213.12337 
213.12405 
/ 
Pro-Pro 
C10H16N2O3 
equivalent to SF 
√ 
√ 
0.54108 
1.22 
SF 
LSc* 
25 22.82 187.10720 187.10772 
187.10828 
187.1084 
/ 
Diketo-Val-Ser 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.51659 
1.08 
1.2 
SF 
LSc* 
LSc* 
25 22.84 150.05797 150.05833 L-Methionine C5H11NO2S √ 0.35219 SF/SL 
25 22.87 485.18725 485.18782 / C20H28N4O10 √ 0.57223 SF 
25 22.96 219.13357 219.13393 Leu-Ser C9H18N2O4 √ 0.36336 SF/SL 
25 22.96 173.12786 173.12845 / C8H16N2O2 √ 0.59530 SF 
25 23.01 229.11782 229.11828 
229.11885 
/ 
Diketo-Glu-Val 
C10H16N2O4 
equivalent to SF 
√ 
√ 
0.46721 
1.03 
SF 
LSc* 
25 23.01 247.12823 247.12885 Glu-Val C10H18N2O5 √ 0.62111 SF/SL 
25 23.05 330.20179 330.20235 Leu-Pro-Thr C15H27N3O5 √ 0.55613 SF/SL 
26 23.15 136.07528 136.07569 / C8H9NO √ 0.40694 SF 
26 23.15 165.05422 165.05462 / C9H8O3 √ 0.39796 SF 
26 23.16 182.08088 182.08117 L-Tyrosine C9H11NO3 √ 0.29041 SF/SL 
26 23.24 150.05784 150.05833 L-Methionine C5H11NO2S √ 0.48880 SF/SL 
27 23.48 241.08129 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.60744 
5.36 
SF 
LSc* 
27 23.48 258.10798 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.46575 
1.03 
SF 
LSc* 
27 23.67 217.11761 217.11828 Pro-Thr C9H16N2O4 √ 0.67336 SF/SL 
27 24.07 247.12811 247.12885 Val-Glu C10H18N2O5 √ 0.73635 SF/SL 
27 24.19 311.12359 311.12376 Tyr-Glu C14H18N2O6 √ 0.17097 SF/SL 
27 24.32 254.16051 254.16115 
254.16172 
/ 
Diketo-Arg-Pro 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.64360 
1.21 
SF 
LSc* 
28 25.15 182.08059 182.08117 DL-o-Tyrosine C9H11NO3 √ 0.58038 SF/SL 
28 25.15 226.04436 226.04585 / C8H7N3O5 √ 1.48390 SF 
28 25.39 235.11822 235.11895 
235.11951 
/ 
Diketo-His-Pro 
C11H14N4O2 
equivalent to SF 
√ 
√ 
0.73585 
1.29 
SF 
LSc* 
28 25.38 257.10003 257.10062 / C9H8N10 √ 0.58540 SF 
28 25.57 162.04958 162.05093 / C4H7N3O4 √ 1.35110 SF 
28 25.57 298.02408 298.02400 / C8H13NO7P √ 0.08248 SF 
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28 25.60 233.11249 233.11320 
233.11388 
/ 
Val-Asp 
C9H16N2O5 
equivalent to SF 
/ 
/ 
0.70456 
1.39 
SF 
LSc* 
29 26.40 217.11750 217.11828 Pro-Thr C9H16N2O4 √ 0.78399 SF/SL 
29 26.47 205.11754 205.11828 
205.11737 
/ 
Val-Ser 
C8H16N2O4 
equivalent to SF 
/ 
/ 
0.74757 
0.17 
SF 
LSc* 
30 27.42 148.05966 148.06043 L-Glutamate C5H9NO4 √ 0.76933 SF/SL 
30 27.42 244.12813 244.12918 Pro-Gln C10H17N3O4 √ 1.04985 SF/SL 
30 27.42 295.11224 295.11359 / C10H18N2O8 √ 1.35564 SF 
30 27.47 266.11016 266.11085 / C8H11N9O2 / 0.68494 SF 
30 27.58 203.10163 203.10263 
203.10331 
 
Pro-Ser 
C8H14N2O4 
equivalent to SF 
√ 
√ 
0.47572 
1.68 
SF 
LSc* 
31 28.19 258.14378 258.14483 
258.1454 
/ 
Diketo-Glu-Lys 
C11H19N3O4 
equivalent to SF 
/ 
/ 
1.05001 
1.62 
SF 
LSc* 
31 28.29 364.16009 364.15886 
364.15437 
364.15437 
364.1656 
/ 
Asp-Met-Val 
Ile-Glu-Cys 
Asn-Lys-Cys 
C12H17N11O3 
C14H25N3O6S 
C14H25N3O6S 
C13H25N5O5S 
√ 
√ 
√ 
√ 
1.22662 
5.72 
5.72 
5.51 
SF 
LSc* 
LSc* 
LSc* 
         
31 28.30 156.07606 156.07675 L-Histidine C6H9N3O2 √ 0.69730 SF/SL 
31 28.41 267.10748 267.10878 
267.10934 
/ 
Diketo-Glu-His 
C11H14N4O4 
equivalent to SF 
√ 
√ 
1.30331 
1.86 
SF 
LSc* 
31 28.42 249.09711 249.09822 / C11H12N4O3 / 1.10667 SF 
32 28.52 235.09177 235.09246 Ser-Glu C8H14N2O6 √ 0.69081 SF/SL 
32 28.52 148.05981 148.06043 L-Glutamate C5H9NO4 √ 0.62124 SF/SL 
32 28.53 217.08098 217.08190 
217.08246 
/ 
Diketo-Glu-Ser 
C8H12N2O5 
equivalent to SF 
√ 
√ 
0.91690 
1.48 
SF 
LSc* 
33 28.78 293.14468 293.14556 / C10H20N4O6 √ 0.87619 SF 
33 28.80 147.07582 147.07642 L-Glutamine C5H10N2O3 √ 0.59821 SF/SL 
33 28.97 276.11802 276.11901 Glu-Gln C10H17N3O6 √ 0.99080 SF/SL 
33 28.98 258.10758 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.86923 
1.43 
SF 
LSc* 
33 28.98 241.08106 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.84024 
5.13 
SF 
LSc* 
34 29.12 166.05259 166.05324 DL-Methionine 
sulfoxide 
C5H11NO3S √ 0.65141 SF/SL 
34 29.14 375.14985 375.14969 / C11H14N14O2 √ 0.15875 SF 
35 29.25 265.11327 265.11426 
265.11884 
/ 
Diketo-Tyr-Thr 
C7H14N2O5 
C13H16N2O4 
√ 
√ 
0.98629 
5.57 
SF 
LSc* 
35 29.27 133.06025 133.06077 L-Asparagine C4H8N2O3 √ 0.51965 SF/SL 
35 29.27 207.09669 207.09755 
207.09822 
/ 
Ser-Thr 
C7H14N2O5 
equivalent to SF 
√ 
√ 
0.85311 
1.53 
SF 
LSc* 
36 29.54 405.15992 405.16160 Glu-Glu-Gln C15H24N4O9 √ 1.68011 SF/SL 
37 29.55 204.09692 204.09788 
204.09855 
204.09855 
/ 
Gln-Gly 
Gly-Ala-Gly 
C7H13N3O4 
equivalent to SF 
equivalent to SF 
/ 
/ 
/ 
0.96092 
1.63 
1.63 
SF 
LSc* 
LSc* 
37 29.55 170.04402 170.04478 / C7H7NO4 / 0.76078 SF 
36 29.69 292.10211 292.10269 / C11H17NO8 √ 0.58751 SF 
36 29.69 310.11233 310.11057 / C7H15N7O7 √ 1.75853 SF 
37 29.85 275.13418 275.13500 
275.13394 
/ 
Gln-Gln 
C10H18N4O5 
equivalent to SF 
/ 
/ 
0.82050 
0.24 
SF 
LSc* 
37 30.02 234.09782 234.09855 / C10H11N5O2 √ 0.73114 SF 
37 30.09 193.08114 193.08190 Ser-Ser C6H12N2O5 √ 0.76024 SF/SL 
37 30.20 424.17972 424.18134 
424.17682 
/ 
His-His-Met 
C17H29NO11 
C17H25N7O4S 
√ 
√ 
1.61632 
2.9 
SF 
LSc* 
37 30.38 291.11874 291.12001 / C12H14N6O3 / 1.26963 SF 
38 30.40 180.08585 180.08665 / C6H13NO5 √ 0.79745 SF 
38 30.47 273.10750 273.10945 / C12H12N6O2 / 1.95133 SF 
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38 30.54 309.12797 309.12924 / C11H20N2O8 √ 1.26875 SF 
38 30.68 250.09112 250.09213 
250.08625 
/ 
Ala-Cys-Gly 
C9H15NO7 
C8H15N3O4S 
√ 
√ 
1.00775 
4.87 
SF 
LSc* 
38 30.98 359.16472 359.16602 
359.15681 
359.15681 
/ 
Asn-Glu-Pro 
Asp-Gln-Pro 
C12H26N2O10 
C14H22N4O7 
C14H22N4O7 
√ 
√ 
√ 
1.30026 
7.91 
7.91 
SF 
LSc* 
LSc* 
38 30.99 162.07557 162.07608 / C6H11NO4 √ 0.51227 SF 
38 31.04 319.14889 319.14863 / C10H14N12O √ 0.26283 SF 
39 31.38 274.18636 274.18737 Val-Arg C11H23N5O3 √ 1.00976 SF/SL 
39 31.46 472.16519 472.16608 / C17H29NO14 √ 0.89555 SF 
39 31.48 454.15463 454.15552 / C17H27NO13 √ 0.88208 SF 
40 31.75 253.12868 253.12952 Pro-His C11H16N4O3 √ 0.83412 SF/SL 
40 31.78 272.17102 272.17172 Pro-Arg C11H21N5O3 √ 0.83572 SF/SL 
40 31.87 246.15522 246.15607 Arg-Ala C9H19N5O3 √ 0.85006 SF/SL 
40 31.90 349.22961 349.23063 / C12H28N8O4 √ 1.01510 SF 
40 31.92 175.11852 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.43019 
3.49 
SF 
LSc* 
40 32.05 330.18729 330.18843 / C12H23N7O4 √ 1.13840 SF 
         
40 32.15 311.14480 311.14623 
311.13958 
/ 
Diketo-Tyr-Phe 
C12H18N6O4 
C18H18N2O3 
√ 
√ 
1.42903 
5.22 
SF 
LSc* 
40 32.16 156.07614 156.07675 L-Histidine C6H9N3O2 √ 0.61130 SF/SL 
40 32.32 147.11239 147.11280 L-Lysine C6H14N2O2 √ 0.50284 SF/SL 
41 32.44 304.16074 304.16155 Arg-Glu C11H21N5O5 √ 0.91619 SF/SL 
42 32.74 324.12808 324.12622 
324.12306 
/ 
Met-Ser-Ser 
C8H17N7O7 
C11H21N3O6S 
√ 
√ 
1.85707 
5.02 
SF 
LSc* 
42 32.93 232.13972 232.14042 
232.14109 
/ 
Arg-Gly 
C8H17N5O3 
equivalent to SF 
√ 
√ 
0.77233 
0.96 
SF 
LSc* 
42 32.99 213.09726 213.09822 His-Gly C8H12N4O3 √ 0.96009 SF/SL 
43 33.00 241.03039 241.03113 L-Cystine C6H12N2O4S2 √ 0.73889 SF/SL 
44 33.28 243.10809 243.10878 His-Ser C9H14N4O4 √ 0.88146 SF/SL 
44 33.36 300.11828 300.11901 / C12H17N3O6 √ 0.90993 SF 
44 33.36 318.12873 318.12689 
318.12764 
/ 
Diketo-Trp-Met 
C8H15N9O5 
C16H19N3O2S 
√ 
√ 
1.84221 
1.09 
SF 
LSc* 
44 33.44 234.14409 234.14483 
234.14551 
/ 
Ser-Lys 
C9H19N3O4 
equivalent to SF 
/ 
/ 
1.28243 
1.42 
SF 
LSc* 
44 33.50 262.15021 262.15098 Arg-Ser C9H19N5O4 √ 0.84210 SF/SL 
44 33.79 289.16084 289.16188 Arg-Asn C10H20N6O4 √ 1.03603 SF/SL 
45 33.88 309.16466 309.16563 / C12H24N2O7 √ 0.98684 SF 
46 34.34 159.96857 159.96991 / C4HNO4S √ 1.33947 SF 
46 34.35 182.98441 182.98417 / C7H3O3P √ 0.23405 SF 
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Supplementary figure 3: Base Peak chromatogram (BPC) of the positive MS/MS mode of sample 3. The 
numbering of the peaks correlates with the numbering in Supplementary table 3. 
 
Supplementary table 3: Results of the three calculation approaches for the most abundant signals in sample 
stock solution (100 mg mL-1) of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 
2 is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 3. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
1 9.74 211.14382 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.28202 
0.85 
SF 
LSc* 
1 9.80 521.38027 521.37879 / C28H57O4PS √ 1.47659 SF 
1 9.80 549.41162 549.41228 / C29H52N6O4 √ 0.66021 SF 
2 10.17 231.11273 231.11280 
231.11674 
/ 
Diketo-Met-Val 
C13H14N2O2 
C10H18N2O2S 
√ 
√ 
0.07104 
4.01 
SF 
LSc* 
2 10.17 493.34901 493.34968 / C25H44N6O4 √ 0.66742 SF 
3 10.49 245.12831 245.13011 
245.12902 
/ 
Diketo-Phe-Pro 
C12H21O3P 
C14H16N2O2 
√ 
√ 
1.80218 
0.71 
SF 
LSc* 
3 10.50 489.24911 489.24860 / C22H33N8O3P √ 0.51010 SF 
3 10.69 325.17502 325.17580 / C16H24N2O5 √ 0.78174 SF 
4 11.03 197.12786 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.59151 
1.16 
SF 
LSc* 
4 11.03 296.08915 296.08905 
296.09176 
/ 
Ser-Cys-Ser 
C17H16N8O3 
C9H17N3O6S 
/ 
/ 
0.09936 
2.61 
SF 
LSc* 
4 11.04 381.14121 381.14181 / C17H16N8O3 √ 0.60393 SF 
4 11.09 359.15931 359.16015 
359.15681 
359.15681 
/ 
Asn-Glu-Pro 
Asp-Gln-Pro 
C19H22N2O5 
C14H22N4O7 
C14H22N4O7 
√ 
√ 
√ 
0.84035 
2.5 
2.5 
SF 
LSc* 
LSc* 
4 11.33 326.37765 326.37813 / C22H47N √ 0.47172 SF 
4 11.33 284.13863 284.13935 
284.13992 
/ 
Diketo-Pro-Trp 
C16H17N3O2 
equivalent to SF 
√ 
√ 
0.72233 
1.29 
SF 
LSc* 
5 15.55 521.23953 521.23946 / C28H32N4O6 √ 0.07197 SF 
5 15.58 124.03899 124.03930 / C6H5NO2 √ 0.31540 SF 
5 15.56 261.12334 261.12502 
261.12393 
/ 
Diketo-Tyr-Pro 
C12H21O4P 
C14H16N2O3 
√ 
√ 
1.68150 
0.59 
SF 
LSc* 
5 15.77 169.09667 169.09715 
169.09772 
/ 
Diketo-Ala-Pro 
C8H12N2O2 
equivalent to SF 
√ 
√ 
0.48502 
1.05 
SF 
LSc* 
6 16.46 132.10148 132.10191 Norleucine C6H13NO2 √ 0.42630 SF 
129  Attachment 
 
 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
LSc* 
6 16.45 356.21776 356.21933 / C18H25N7O √ 1.57345 SF 
6 16.93 277.11827 277.11994 
277.11885 
/ 
Diketo-Glu-Phe 
C12H21O5P 
C14H16N2O4 
√ 
√ 
1.67121 
0.58 
SF 
LSc* 
6 16.94 243.13383 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.10028 
0.67 
SF 
LSc* 
6 16.95 485.26050 485.25956 / C16H37N8O7P √ 0.94143 SF 
6 16.95 197.12803 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.42282 
0.99 
SF 
LSc* 
7 17.50 259.09228 259.09412 
259.09303 
/ 
Diketo-Glu-Glu 
C8H19O7P 
C10H14N2O6 
√ 
√ 
1.83317 
0.75 
SF 
LSc* 
7 17.50 388.13467 388.13536 
388.12921 
/ 
His-Glu-Cys 
C10H18N11O4P 
C14H21N5O6S 
√ 
√ 
0.68759 
5.46 
SF 
LSc* 
7 17.51 130.04973 130.04987 (R)-(+)-2-
Pyrrolidone-5-
carboxylic acid 
C5H7NO3 √ 0.14179 SF/SL 
7 17.54 374.17079 374.17270 / C17H28NO6P √ 1.91018 SF 
8 17.70 340.18666 340.18567 / C10H26N7O4P √ 0.99906 SF 
8 17.80 371.22718 371.22756 / C16H34O9 √ 0.37743 SF 
8 17.92 209.09163 209.09207 / C10H12N2O3 √ 0.43591 SF 
8 18.14 476.30654 476.30684 / C15H42N9O6P √ 0.30753 SF 
8 18.14 459.27994 459.28029 
459.27933 
/ 
Arg-Arg-Gln 
C15H39N8O6P 
C17H34N10O5 
√ 
√ 
0.35832 
0.61 
SF 
LSc* 
8 18.14 481.26110 481.26299 / C19H32N10O5 / 1.89382 SF 
9 18.27 503.30592 503.30651 / C17H43N8O7P / 0.58399 SF 
9 18.27 520.33284 520.33306 / C17H46N9O7P √ 0.21982 SF 
9 18.27 293.11276 293.11320 
293.11376 
/ 
Diketo-Glu-Tyr 
C14H16N2O5 
equivalent to SF 
√ 
√ 
0.44231 
1.0 
SF 
LSc* 
9 18.35 213.08641 213.08832 
213.08755 
/ 
Diketo-Asp-Pro 
C10H8N6 
C9H12N2O4 
/ 
/ 
1.90625 
1.14 
SF 
LSc* 
9 18.40 564.35862 564.35927 / C19H50N9O8P √ 0.64840 SF 
9 18.44 471.22375 471.22278 / C18H31N8O5P √ 0.96631 SF 
9 18.46 493.20477 493.20548 / C22H24N10O4 √ 0.70097 SF 
9 18.48 263.13863 263.13902 Pro-Phe C14H18N2O3 √ 0.38362 SF 
9 18.68 326.17063 326.17105 / C15H23N3O5 √ 0.41977 SF 
9 18.81 437.23922 437.24111 / C19H37N2O7P √ 1.89033 SF 
9 18.87 459.22087 459.22246 / C20H22N14 √ 1.59157 SF 
10 19.14 390.16538 390.16493 
390.16262 
/ 
Gln-Gln-Asp 
C13H24N7O5P 
C14H23N5O8 
√ 
√ 
0.45132 
2.76 
SF 
LSc* 
10 19.52 227.10267 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.61554 
0.53 
SF 
LSc* 
10 19.52 453.19833 453.19861 / C12H34N6O8P2 √ 0.28595 SF 
10 19.72 279.16975 279.17032 Leu-Phe C15H22N2O3 √ 0.57100 SF/SL 
10 19.84 410.20685 410.20743 Phe-Pro-Phe C23H27N3O4 √ 0.57931 SF/SL 
10 19.90 215.13839 215.13902 
215.1397 
/ 
Pro-Val 
C10H18N2O3 
equivalent to SF 
√ 
√ 
0.62730 
1.31 
SF 
LSc* 
10 19.90 415.23311 415.23264 
415.23284 
/ 
Leu-Pro-Trp 
C21H34O8 
C22H30N4O4 
/ 
/ 
0.47091 
0.27 
SF 
LSc* 
10 19.92 245.18520 245.18597 NH-
DVal(NMe)-
Val-OMe 
C12H24N2O3 √ 0.76653 SF/SL 
11 19.96 405.17549 405.17551 / C16H16N14 √ 0.02240 SF 
11 20.06 376.22313 376.22308 Leu-Pro-Phe C20H29N3O4 √ 0.05075 SF/SL 
12 20.26 226.11868 226.12027 
226.11918 
/ 
Diketo-Gln-Pro 
C8H20NO4P 
C10H15N3O3 
√ 
√ 
1.59473 
0.5 
SF 
LSc* 
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12 20.26 342.23873 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.00012 SF/SL 
12 20.28 209.09198 209.09372 / C8H17O4P √ 1.73731 SF 
12 20.44 373.13504 373.13691 
373.12954 
/ 
Asn-His-Gly 
C23H20N2OP 
C13H20N6O5S 
/ 
/ 
1.87427 
5.5 
SF 
LSc* 
12 20.49 346.13690 346.13706 / C13H15N9O3 / 0.16364 SF 
13 20.56 259.09215 259.09246 
259.09303 
/ 
Diketo-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.33124 
0.88 
SF 
LSc* 
13 20.58 231.16970 231.17032 
231.16982 
/ 
Val-Ile 
C11H22N2O3 
equivalent to SF 
/ 
/ 
0.62312 
0.12 
SF 
LSc* 
13 20.59 263.13893 263.13902 Pro-Phe C14H18N2O3 √ 0.08467 SF/SL 
13 20.61 362.20693 362.20877 
362.20632 
/ 
Val-Pro-Phe 
C20H23N7 
C19H27N3O4 
/ 
/ 
1.84322 
0.61 
SF 
LSc* 
13 20.65 195.07597 195.07642 / C9H10N2O3 √ 0.45042 SF 
13 20.66 324.15522 324.15705 
324.15607 
324.15608 
/ 
Thr-Phe-Gly 
Ala-Tyr-Ala 
C13H26NO6P 
C15H21N3O5 
C15H21N3O5 
√ 
√ 
√ 
1.83356 
0.85 
0.86 
SF 
LSc* 
LSc* 
13 20.70 229.15454 229.15467 Pro-Leu C11H20N2O3 √ 0.12663 SF/SL 
13 20.81 295.16461 295.16523 Tyr-Leu C15H22N2O4 √ 0.62207 SF/SL 
13 20.87 328.22259 328.22308 Ile-Pro-Val C16H29N3O4 √ 0.48978 SF/SL 
13 20.99 229.11722 229.11828 
229.11885 
/ 
Diketo-Glu-Val 
C10H16N2O4 
equivalent to SF 
/ 
/ 
1.06646 
1.63 
SF 
LSc* 
13 21.01 392.21743 392.21800 Ile-Pro-Tyr C20H29N3O5 √ 0.56649 SF/SL 
13 21.15 360.19217 360.19344 
360.19269 
/ 
Pro-Pro-Phe 
C17H30NO5P 
C19H25N3O4 
/ 
/ 
1.26647 
0.52 
SF 
LSc* 
14 21.30 120.08065 120.08078 / C8H9N √ 0.13017 SF 
14 21.30 263.13915 263.13902 Phe-Pro C14H18N2O3 √ 0.13523 SF/SL 
14 21.43 188.07038 188.07060 / C11H9NO2 √ 0.22205 SF 
14 21.43 205.09689 205.09715 D-Tryptophan C11H12N2O2 √ 0.26417 SF/SL 
14 21.44 229.15462 229.15467 
229.15535 
/ 
Pro-Leu 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.05145 
0.73 
SF 
LSc* 
14 21.48 214.20712 314.20743 
314.20723 
/ 
Val-Pro-Val 
C15H27N3O4 
equivalent to SF 
/ 
/ 
0.31636 
0.11 
SF 
LSc* 
14 21.48 203.13862 203.13902 
203.1397 
/ 
Ile-Ala 
C9H18N2O3 
equivalent to SF 
/ 
/ 
0.39714 
1.08 
SF 
LSc* 
14 22.54 350.17042 350.17105 
350.17041 
/ 
Ser-Pro-Phe 
C17H23N3O5 
equivalent to SF 
√ 
√ 
0.63080 
0.01 
SF 
LSc* 
14 21.56 326.20692 326.20743 Pro-Pro-Ile C16H27N3O4 √ 0.51450 SF/SL 
14 21.59 132.10167 132.10191 L-Norleucine C6H13NO2 √ 0.22978 SF/SL 
15 21.70 331.16474 331.16420 
331.16189 
/ 
Ser-Pro-Gln 
C12H23N6O3P 
C13H22N4O6 
√ 
√ 
0.53725 
2.85 
SF 
LSc* 
15 21.71 166.08604 166.08626 L-Phenylalanine C9H11NO2 √ 0.21552 SF/SL 
15 21.79 223.10706 223.10772 
223.10726 
/ 
Phe-Gly 
C11H14N2O3 
equivalent to SF 
√ 
√ 
0.65567 
0.20 
SF 
LSc* 
15 21.81 300.19115 300.19178 
300.19096 
/ 
Leu-Pro-Ala 
C14H25N3O4 
equivalent to SF 
√ 
√ 
0.63662 
0.19 
SF 
LSc* 
16 21.96 132.10167 132.10191 L-Norleucine C6H13NO2 √ 0.23398 SF/SL 
16 22.20 286.17571 286.17613 
286.17681 
286.17682 
/ 
Pro-Ile-Gly 
Val-Ala-Pro 
C13H23N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.42471 
1.1 
1.11 
SF 
LSc* 
LSc* 
16 22.22 189.12296 189.12337 Ile-Gly C8H16N2O3 √ 0.40962 SF/SL 
17 22.42 215.13887 215.13902 
215.13869 
/ 
Pro-Val 
C10H18N2O3 
equivalent to SF 
√ 
√ 
0.15305 
0.18 
SF 
LSc* 
17 22.59 279.13380 279.13559 
279.13461 
/ 
Tyr-Pro 
C12H23O5P 
C14H18N2O4 
√ 
√ 
1.78410 
0.81 
SF 
LSc* 
18 22.63 261.14399 261.14450 Ile-Glu C11H20N2O5 √ 0.50708 SF/SL 
18 22.64 316.18601 316.18670 
316.18738 
/ 
Pro-Ser-Leu 
C14H25N3O5 
equivalent to SF 
√ 
√ 
0.68565 
1.37 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
18 22.69 312.19105 312.19178 Pro-Pro-Val C15H25N3O4 √ 0.73072 SF/SL 
18 22.71 213.12287 213.12337 
213.12405 
/ 
Pro-Pro 
C10H16N2O3 
equivalent to SF 
√ 
√ 
0.49773 
1.18 
SF 
LSc* 
18 22.79 187.10714 187.10772 
187.10828 
187.1084 
/ 
Diketo-Val-Ser 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.57803 
1.14 
1.26 
SF 
LSc* 
LSc* 
18 22.80 150.05781 150.05833 L-Methionine C5H11NO2S √ 0.51536 SF/SL 
18 22.93 219.13333 219.13393 
219.13461 
/ 
Leu-Ser 
C9H18N2O4 
equivalent to SF 
√ 
√ 
0.60626 
1.28 
SF 
LSc* 
18 22.94 173.12806 173.12845 / C8H16N2O2 / 0.39782 SF 
18 23.02 330.20175 330.20235 Leu-Pro-Thr C15H27N3O5 √ 0.59911 SF/SL 
19 23.11 165.05414 165.05462 / C9H8O3 √ 0.47723 SF 
19 23.11 182.08079 182.08117 L-Tyrosine C9H11NO3 √ 0.37992 SF/SL 
19 23.19 314.13397 314.13466 / C13H19N3O6 √ 0.69562 SF 
19 23.23 150.05796 150.05833 L-Methionine C5H11NO2S √ 0.36948 SF/SL 
20 23.38 280.09010 280.09011 / C8H9N9O3 / 0.00936 SF 
20 23.41 258.10823 258.11010 
258.10901 
/ 
Diketo-Glu-Gln 
C8H20NO6P 
C10H15N3O5 
√ 
√ 
1.86819 
0.78 
SF 
LSc* 
20 23.42 241.08156 241.08190 
241.07593 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H14N4O3S 
√ 
√ 
0.33749 
5.63 
SF 
LSc* 
21 24.07 147.07601 147.07642 
147.07570 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.40415 
0.31 
SF 
LSc* 
21 24.07 355.16060 355.15987 / C14H26O10 √ 0.72602 SF 
21 24.17 247.12847 247.12885 Val-Glu C10H18N2O5 √ 0.37816 SF/SL 
21 24.25 311.12320 311.12376 Tyr-Glu C14H18N2O6 √ 0.56295 SF/SL 
21 24.34 254.16038 254.16115 
254.16172 
/ 
Diketo-Arg-Pro 
C11H19N5O2, 
equivalent to SF 
√ 
√ 
0.77265 
1.34 
SF 
LSc* 
22 24.67 182.08053 182.08117 DL-o-Tyrosine C9H11NO3 √ 0.64266 SF/SL 
22 24.69 136.07536 136.07569 / C8H9NO √ 0.33262 SF 
23 25.08 165.05410 165.05462 / C9H8O3 √ 0.51626 SF 
23 25.08 182.08070 182.08117 L-Tyrosine C9H11NO3 √ 0.46844 SF/SL 
23 25.09 226.04448 226.04585 / C8H7N3O5 √ 1.36530 SF 
23 25.23 314.08406 314.08569 / C10H7N11O2 / 1.63776 SF 
23 25.24 357.21243 357.21325 Leu-Pro-Gln C16H28N4O5 √ 0.81127 SF/SL 
23 25.36 235.11833 235.11761 
235.11951 
/ 
Diketo-His-Pro 
C10H18O6 
C11H14N4O2 
√ 
√ 
0.71185 
1.18 
SF 
LSc* 
23 25.38 257.10009 257.10062 / C9H8N10 / 0.52648 SF 
24 25.52 162.04965 162.05093 / C4H7N3O4 √ 1.28116 SF 
24 25.52 298.02425 298.02400 / C8H13NO7P2 √ 0.24764 SF 
24 25.58 233.11249 233.11320 Val-Asp C9H16N2O5 √ 0.70896 SF/SL 
25 26.46 205.11779 205.11828 Val-Ser C8H16N2O4 √ 0.49510 SF/SL 
25 26.79 217.11740 217.11828 
217.11896 
/ 
Pro-Thr 
C9H16N2O4 
equivalent to SF 
√ 
√ 
0.88165 
1.56 
SF 
LSc* 
26 27.21 203.10216 203.10263 Pro-Ser C8H14N2O4 √ 0.47572 SF/SL 
26 27.72 269.99286 269.99105 / C8H4N3O6P √ 1.81545 SF 
27 27.39 266.11045 266.11085 / C8H11N9O2 √ 0.39552 SF 
27 27.41 244.12872 244.12918 Pro-Ala-Gly C10H17N3O4 √ 0.46603 SF/SL 
27 28.19 258.14413 258.14483 
258.1454 
/ 
Diketo-Glu-Lys 
C11H19N3O4 
equivalent to SF 
√ 
√ 
0.70702 
1.27 
SF 
LSc* 
28 28.30 364.16107 364.16021 
364.15437 
364.15437 
364.1656 
/ 
Asp-Met-Val 
Ile-Glu-Cys 
Lys-Asn-Cys 
C15H25NO9 
C14H25N3O6S 
C14H25N3O6S 
C13H25N5O5S 
√ 
√ 
√ 
√ 
0.85769 
6.7 
6.7 
4.53 
SF 
LSc* 
LSc* 
LSc* 
28 28.42 267.10836 267.10744 
267.10934 
/ 
Diketo-Glu-His 
C10H18O8 
C11H14N4O4 
√ 
√ 
0.91283 
0.98 
SF 
LSc* 
Attachment 132 
  
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
28 28.42 249.09753 249.09822 / C11H12N4O3 √ 0.68186 SF 
28 28.46 315.16570 315.16630 Ala-Pro-Gln C13H22N4O5 √ 0.59437 SF/SL 
29 28.77 147.07611 147.07642 D-Glutamine C5H10N2O3 √ 0.31220 SF/SL 
29 28.78 276.11817 276.11901 
276.11901 
/ 
Glu-Gln 
C10H17N3O6 
equivalent to SF 
/ 
/ 
0.83958 
0.83 
SF 
LSc* 
29 28.79 293.14520 293.14556 / C10H20N4O6 √ 0.35845 SF 
29 29.09 166.05239 166.05324 DL-Methionine 
sulfoxide 
C5H11NO3S √ 0.85171 SF/SL 
29 29.10 216.09681 216.09788 
216.09844 
/ 
Diketo-Ser-Gln 
C8H13N3O4 
equivalent to SF 
√ 
√ 
1.07592 
1.63 
SF 
LSc* 
30 29.24 133.06030 133.06077 L-Asparagine C4H8N2O3 √ 0.47156 SF/SL 
30 29.24 207.09678 207.09755 
207.09822 
/ 
Ser-Thr 
C7H14N2O5 
equivalent to SF 
√ 
√ 
0.76522 
1.44 
SF 
LSc* 
30 29.25 265.11340 265.11426 
265.11884 
/ 
Diketo-Tyr-Thr 
C8H16N4O6 
C13H16N2O4 
√ 
√ 
0.85700 
5.44 
SF 
LSc* 
31 29.49 204.09732 204.09788 
204.09855 
204.09855 
/ 
Gln-Gly 
Gly-Ala-Gly 
C7H13N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.56572 
1.23 
1.23 
SF 
LSc* 
LSc* 
31 29.50 170.04421 170.04478 / C7H7NO4 √ 0.57521 SF 
31 29.50 187.07082 187.07133 
187.07189 
/ 
Diketo-Glu-Gly 
C7H10N2O4 
equivalent to SF 
√ 
√ 
0.50897 
1.07 
SF 
LSc* 
31 29.79 275.13418 275.13500 Gln-Gln C10H18N4O5 √ 0.73566 SF/SL 
31 30.03 193.08145 193.08190 
193.08257 
/ 
Ser-Ser 
C6H12N2O5 
equivalent to SF 
√ 
√ 
0.44254 
1.12 
SF 
LSc* 
32 30.08 217.08158 217.08190 
217.08246 
/ 
Diketo-Glu-Ser 
C8H12N2O5 
equivalent to SF 
√ 
√ 
0.31698 
0.88 
SF 
LSc* 
32 30.08 234.10786 234.10845 Ser-Gln C8H15N3O5 √ 0.59089 SF/SL 
33 30.47 332.15617 332.15646 Gly-Gln-Gln C12H21N5O6 √ 0.29324 SF/SL 
33 30.50 291.11973 291.11868 / C11H18N2O7 √ 1.05712 SF 
33 30.52 309.12903 309.12924 / C11H20N2O8 √ 0.21306 SF 
33 30.53 273.10811 273.10811 / C11H16N2O6 √ 0.00008 SF 
33 30.70 250.09164 250.09213 
250.08625 
/ 
Ala-Cys-Gly 
C9H15NO7 
C8H15N3O4S 
√ 
√ 
0.49160 
5.39 
SF 
LSc* 
34 30.82 295.11276 295.11359 / C10H18N2O8 / 0.83444 SF 
34 30.95 319.14918 319.14863 / C10H14N12O √ 0.54632 SF 
34 30.98 162.07570 162.07608 / C6H11NO4 √ 0.38095 SF 
34 30.99 180.08625 180.08665 / C6H13NO5 √ 0.39835 SF 
35 31.38 232.13920 232.14042 
232.14109 
/ 
Arg-Gly 
C8H17N5O3 
equivalent to SF 
/ 
/ 
1.21995 
1.89 
SF 
LSc* 
35 31.51 253.12902 253.12952 
253.13019 
/ 
Pro-His 
C11H16N4O3 
equivalent to SF 
/ 
/ 
0.49267 
1.17 
SF 
LSc* 
35 31.55 272.17161 272.17172 Pro-Arg C11H23N5O3 √ 0.16485 SF/SL 
35 31.63 246.15559 246.15607 
246.15522 
/ 
Arg-Ala 
C9H19N5O3 
equivalent to SF 
√ 
√ 
0.47053 
0.37 
SF 
LSc* 
35 31.69 349.22966 349.23063 / C12H28N8O4 √ 0.96700 SF 
35 31.71 175.11854 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.40861 
3.51 
SF 
LSc* 
35 31.92 330.18762 330.18709 / C11H27N3O8 √ 0.52458 SF 
35 32.03 311.14567 311.14623 
311.13958 
/ 
Diketo-Tyr-Phe 
C12H18N6O4 
C18H18N2O3 
√ 
√ 
0.56220 
6.09 
SF 
LSc* 
35 32.05 156.07632 156.07675 L-Histidine C6H9N3O2 √ 0.43492 SF/SL 
35 32.32 147.11250 147.11280 L-Lysine C6H14N2O2 √ 0.42306 SF/SL 
35 32.34 304.16092 304.16155 Arg-Glu C11H21N5O5 √ 0.62087 SF/SL 
35 32.62 159.96851 159.96991 / C4HNO4S / 1.39052 SF 
36 33.03 213.09771 213.09822 Gly-His C8H12N4O3 √ 0.50784 SF/SL 
36 33.03 241.03093 241.03113 L-Cystine C6H12N2O4S2 √ 0.19185 SF/SL 
37 33.40 318.12915 318.12958 / C12H19N3O7 √ 0.42222 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/ 
MS 
IΔm/zI 
[mDa] 
Anno-
tations 
318.12764 Diketo-Trp-Met C16H19N3O2S2 √ 1.51 LSc* 
37 33.40 300.11856 300.11901 / C12H17N3O6 √ 0.57153 SF 
37 33.48 243.10835 243.10878 Ser-His C9H14N4O4 √ 0.70815 SF/SL 
37 33.49 262.15053 262.15098 Ser-Arg C9H19N5O4 √ 0.45036 SF/SL 
37 33.51 234.14394 234.14483 Ser-Lys C9H19N3O4 √ 0.88931 SF/SL 
38 33.97 309.16511 309.16563 / C12H24N2O7 √ 0.52108 SF 
38 34.44 182.98456 182.98417 / C7H3O4P / 0.38574 SF 
 
Chromatograms and tables of SEC-fractions A4 to A6 of all three samples.  
 
 
Supplementary figure 4: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A4 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 4. 
 
Supplementary table 4: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A4 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 4. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.41 112.98509 112.98858 / C4H2O4 / 2.94466 SF 
1 10.41 130.99226 130.99262 / C3H4N2O2S / 0.18296 SF 
1 10.41 68.99469 68.99875 / C3H2O2 / 3.51696 SF 
2 11.10 146.96553 146.96978 / C3H4N2OS2 / 3.69812 SF 
3 14.51 112.98501 112.98858 / C4H2O4 / 3.01790 SF 
3 14.52 68.99461 68.99875 / C3H2O2 / 3.59186 SF 
3 14.55 130.99224 130.99262 / C3H4N2OS2 / 0.16959 SF 
4 33.25 190.92793 190.93062 / C5H4O2S3 / 2.13928 SF 
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Supplementary figure 5: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A4 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 5. 
 
Supplementary table 5: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A4 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 5. 
 RT 
[min] 
m/z meas. m/z calc. Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 16.0 217.1050 217.10109 Diketo-Ile-Cys C9H16N2O2S / 3.91 LSc* 
2 17.50 550.32001 550.31931 / C32H44N3O3P √ 0.70493 SF 
3 17.71 481.26027 481.26165 / C18H36N6O9 / 1.37999 SF 
4 17.84 520.33165 520.33324 
520.3249 
/ 
Val-Val-Arg-
Phe 
C25H50N3O4PS √ 1.59587 
6.75 
SF 
LSc* 
5 31.02 200.97084 / / / √ / / 
 
 
Supplementary figure 6: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A5 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 6. 
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Supplementary table 6: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A5 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 6. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.53 68.99466 68.99875 / C3H2O2 / 3.53911 SF 
2 11.01 121.02887 121.03005 / C7H6NO2 √ 0.63139 SF 
3 14.41 117.01879 117.01988 / C4H6O4 / 0.54189 SF 
4 16.54 241.11805 241.11724 
241.12115 
/ 
diketo(Glu-Ile) 
C7H14N8O2 
C11H18N2O4 
√ 
√ 
1.35750 
3.1 
SF 
LSc* 
4 16.5 275.1013 275.1016 pyro(Glu-Phe) C14H16N2O4 / 0.0003 LSc* 
5 17.25 128.03491 128.03587 pyroglutamic 
acid 
C5H7NO3 √ 0.40646 SF/SL 
5 17.25 257.0764 257.08051 pyro(Glu-Glu) C10H14N2O6 / 4.11 LSc* 
6 18.36 469.20652 469.20609 / C14H27N14O3P √ 0.97436 SF 
6 18.42 324.15438 324.15601 / C9H24N7O4P / 1.08589 SF 
7 19.31 181.09756 181.09880 / C9H14N2O2 √ 0.69188 SF 
7 19.31 225.08706 225.08863 
225.091 
/ 
pyro(Glu-Pro) 
C10H14N2O4 
equivalent to SF 
√ 
√ 
1.01951 
3.94 
SF 
LSc* 
8 20.17 141.06636 141.0665 diketo(Ala-Ala) C6H10N2O3 √ 0.14 LSc* 
8 20.17 185.05618 185.0653 diketo(Glu-Gly) C17H10N2O4 √ 9.12 LSc* 
9 23.09 238.08193 238.08388 / C10H13N3O4 √ 1.40356 SF 
9 23.08 513.19237 513.19458 / C14H31N10O9P √ 1.66183 SF 
10 23.82 148.04309 148.04432 L-Methionine C5H11NO2S √ 0.68032 SF/SL 
11 28.23 145.06152 145.06608 Glutamine C5H10N2O3 √ 0.00456 SF 
12 31.34 173.10370 173.10495 L-Arginine C6H14N4O2 √ 0.70451 SF/SL 
12 31.48 154.06162 154.06275 L-Histidine C6H9N3O2 √ 0.58290 SF/SL 
 
 
Supplementary figure 7: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A5 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 7. 
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Supplementary table 7: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A5 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 7. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 9.47 211.14413 211.14410 
211.14467 
/ 
diketo(Pro-Ile) 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.02346 
0.54 
SF 
LSc* 
1b 10.6 197.1280 197.12902 diketo(Pro-Val) C10H16N2O2 / 1.02 LSc* 
2 16.58 277.11829 277.11828 
277.11885 
/ 
diketo(Glu-Phe) 
C14H16N2O4 
equivalent to SF 
√ 
√ 
0.00999 
0.56 
SF 
LSc* 
2 16.60 243.13411 243.13393 
243.1345 
/ 
diketo(Glu-Ile) 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.17995 
0.89 
SF 
LSc* 
3 17.27 259.09260 259.09380 
259.09303 
259.09303 
/ 
diketo(Glu-Glu) 
pyro(Glu-Glu) 
C11H10N6O2 
C10H14N2O6 
C10H14N2O6 
√ 
√ 
√ 
1.20418 
0.43 
0.43 
SF 
LSc* 
LSc* 
3 17.51 374.17101 374.17105 / C19H23N3O5 √ 0.03751 SF 
3 17.59 340.18604 340.18670 
340.19401 
/ 
Ile-His-Ala 
C16H25N3O5 
C15H25N5O4 
√ 
√ 
0.65729 
7.97 
SF 
LSc* 
4 17.99 213.08654 213.08698 
213.08755 
/ 
diketo(Pro-Asp) 
C9H12N2O4 
equivalent to SF 
√ 
√ 
0.44054 
0.57 
SF 
LSc* 
4 18.3 263.1386 263.1396 diketo(Val-Tyr) C14H18N2O3 / 1.0 LSc* 
4b 18.89 185.09136 185.09207 
185.09263 
/ 
diketo(Ser-Pro) 
C8H12N2O3 
equivalent to SF 
√ 
√ 
0.71271 
0.56 
SF 
LSc* 
4b 18.9 201.0866 201.08755 diketo(Glu-Ala) C8H12N2O4 / 0.95 LSc* 
5 19.28 227.10267 227.10263 
227.1032 
/ 
pyro(Glu-Pro) 
C10H14N2O4 
equivalent to SF 
√ 
√ 
0.04082 
0.53 
SF 
LSc* 
6 19.8 245.1864 245.18665 Ile-Ile 
Ile-Leu 
Leu-Leu 
C12H24N2O3 
equivalent to SF 
equivalent to SF 
/ 0.25 LSc* 
6 19.90 209.09189 209.09207 
209.10386 
/ 
diketo(His-Ala) 
C10H12N2O3 
C9H12N4O2 
√ 
√ 
0.17530 
11.97 
SF 
LSc* 
6 19.90 226.11862 226.11862 
226.11918 
/ 
diketo(Gln-Pro) 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.00090 
0.56 
SF 
LSc* 
6 19.95 342.23810 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.63608 SF/SL 
7 20.2 187.0709 187.07189 
187.0719 
diketo(Glu-Gly) 
diketo(Asp-Ala) 
C7H10N2O4 
C7H10N2O4 
/ 
/ 
0.99 
1.0 
LSc* 
LSc* 
7 20.27 212.10271 212.10297 
212.10353 
/ 
diketo(Pro-Asn) 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.25837 
0.82 
SF 
LSc* 
7 20.3 195.0758 195.0882 diketo(His-Gly) C8H10N4O2 / 12.4 LSc* 
7 20.46 263.13907 263.13902 
263.13958 
263.1397 
263.14307 
/ 
diketo(Tyr-Val) 
Pro-Phe 
Met-Ile 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
C11H22N2O3S 
√ 
√ 
0.04999 
0.51 
0.63 
4.0 
SF 
LSc* 
LSc* 
LSc* 
7 20.55 362.20710 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.33628 SF/SL 
8 20.8 231.0977 231.09811 diketo(Glu-Thr) C9H14N2O5 / 0.41 LSc* 
8 20.79 328.22277 328.22308 Val-Pro-Leu C16H29N3O4 √ 0.31742 SF/SL 
9 21.2 324.1549 324.15607 Thr-Gly-Phe C15H21N3O5 / 1.17 LSc* 
9 21.3 215.1386 215.13958 
215.1397 
diketo(Thr-Ile) 
Pro-Val 
C10H18N2O3 
C10H18N2O3 
/ 
/ 
0.98 
1.1 
LSc* 
LSc* 
9 21.3 229.1544 229.15535 Ile-Pro C11H20N2O3 / 0.95 LSc* 
9 21.34 263.13924 263.13902 
263.13958 
263.1397 
/ 
Diketo-Tyr-Val 
Phe-Pro 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.22450 
0.34 
0.46 
SF 
LSc* 
LSc* 
10 21.6 203.1388 203.1397 Ile-Ala C9H18N2O3 / 0.9 LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
10 21.61 229.15488 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.21103 
0.47 
SF 
LSc* 
10 21.64 314.20697 314.20743 Val-Pro-Val C15H27N3O4 √ 0.00046 SF/SL 
11 22.19 263.19654 263.19653 / C12H26N2O4 √ 0.01068 SF 
12 22.97 261.14468 261.14450 
261.14058 
/ 
γ-Glu-Leu 
C11H20N2O5 
equivalent to SF 
√ 
√ 
0.18124 
4.1 
SF 
LSc* 
12 23.38 258.10852 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.07481 
0.49 
SF 
LSc* 
13 23.69 215.1386 215.13902 
215.13958 
215.1397 
/ 
Diketo-Thr-Ile 
Pro-Val 
C10H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.01039 
0.98 
1.1 
SF 
LSc* 
LSc* 
14 23.9 189.1227 189.12405 Val-Ala C8H16N2O3 / 1.35 LSc* 
14 23.98 330.20186 330.20235 Ile-Pro-Thr C15H27N3O5 √ 0.48333 SF/SL 
15 24.05 260.16044 260.16048 
260.16116 
/ 
Gln-Ile 
C11H21N3O4 
equivalent to SF 
√ 
√ 
0.03812 
0.72 
SF 
LSc* 
15 24.07 219.13394 219.13393 
219.13461 
/ 
Ile-Ser 
C9H18N2O4 
equivalent to SF 
√ 
√ 
0.00392 
0.67 
SF 
LSc* 
16 24.12 150.05738 150.05833 
150.05440 
/ 
Methionine 
C5H11NO2S 
equivalent to SF 
√ 
√ 
0.92447 
2.98 
SF 
LSc* 
16 24.14 247.12889 247.12885 
247.12953 
/ 
Glu-Val 
C10H18N2O5 
equivalent to SF 
√ 
√ 
0.04109 
0.64 
SF 
LSc* 
17 24.82 187.10721 187.10772 
187.10828 
187.1084 
/ 
Diketo-Ser-Val 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.50549 
1.07 
1.19 
SF 
LSc* 
LSc* 
17
b 
25.1 213.1230 213.12405 Pro-Pro C10H16N2O3 / 1.05 LSc* 
17
b 
25.17 175.10662 175.10772 
175.11503 
/ 
Arginine 
C7H14N2O3 
C6H14N4O2 
√ 
√ 
1.10195 
8.41 
SF 
LSc* 
17
b 
25.6 233.1130 233.11388 Asp-Val C9H16N2O5 √ 0.88 LSc* 
17
b 
25.61 245.11307 245.11320 
245.11388 
/ 
Glu-Pro 
C10H16N2O5 
equivalent to SF 
√ 
√ 
0.13130 
0.81 
SF 
LSc* 
18 26.2 161.0925 261.09275 Ala-Ala C6H12N2O3 / 0.25 LSc* 
18 26.34 173.09103 173.09207 
173.09263 
173.09274 
/ 
Diketo-Ala-Thr 
Pro-Gly 
C7H12N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
1.04221 
1.6 
1.71 
SF 
LSc* 
LSc* 
18 26.35 217.11847 217.11828 
217.11896 
/ 
Thr-Pro 
C9H16N2O4 
equivalent to SF 
√ 
√ 
0.19032 
0.49 
SF 
LSc* 
18 26.40 205.11827 205.11962 
205.11896 
/ 
Val-Ser 
C9H12N6 
C8H16N2O4 
√ 
√ 
1.35222 
0.69 
SF 
LSc* 
18
b 
26.57 246.14533 246.14483 
246.14551 
246.1455 
246.14551 
/ 
Gln-Val 
Gly-Ile-Gly 
Ala-Val-Gly 
C10H19N3O4 
equivalent to SF 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
√ 
0.49662 
0.18 
0.17 
0.18 
SF 
LSc* 
LSc* 
LSc* 
19 28.1 235.0921 235.09314 
235.09314 
Glu-Ser 
Asp-Thr 
C8H14N2O6 
C8H14N2O6 
/ 
/ 
1.04 
1.04 
LSc* 
LSc* 
19 28.12 177.08576 177.08698 
177.08765 
177.08765 
/ 
Thr-Gly 
Ser-Ala 
C6H12N2O4 
equivalent to SF 
equivalent to SF 
/ 
/ 
/ 
1.21821 
1.89 
1.89 
SF 
LSc* 
LSc* 
19 28.25 218.11328 218.11353 
218.11421 
218.11421 
/ 
Gln-Ala 
Ala-Ala-Gly 
C8H15N3O 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.25316 
0.93 
0.93 
SF 
LSc* 
LSc* 
19 28.3 191.0394 191.04905 Diketo-Ser-Cys C6H10N2O3S / 9.65 LSc* 
19 28.38 147.07522 147.07642 
147.07250 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
1.20184 
2.72 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
20 28.6 276.1190 276.11969 Glu-Gln C10H17N3O6 / 0.69 LSc* 
20 28.75 166.05360 166.05324 / C5H11NO3S √ 0.35539 SF 
21 28.9 207.0970 207.09822 Thr-Ser C7H14N2O5 / 1.22 LSc* 
21 29.0 163.0723 163.072 Ser-Gly C5H10N2O4 / 0.3 LSc* 
21 29.06 204.09767 204.09922 
204.09855 
/ 
Gln-Gly 
C8H9N7 
C7H13N3O4 
√ 
√ 
1.55261 
0.88 
SF 
LSc* 
22 29.34 275.13500 275.13500 
275.13567 
/ 
Gln-Gln 
C10H18N4O5 
equivalent to SF 
√ 
√ 
0.00803 
0.67 
SF 
LSc* 
23 29.60 193.08126 193.08190 
193.08257 
/ 
Ser-Ser 
C6H12N2O5 
equivalent to SF 
√ 0.63536 
1.31 
SF 
LSc* 
23 29.63 234.10842 234.10845 
234.10912 
234.10912 
234.10912 
234.10911 
/ 
Gln-Ser 
Asn-Thr 
Ala-Ser-Gly 
Gly-Thr-Gly 
C8H15N3O5 
equivalent to SF 
equivalent to SF 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
√ 
√ 
0.03118 
0.7 
0.7 
0.7 
0.69 
SF 
LSc* 
LSc* 
LSc* 
LSc* 
24 29.87 291.12761 291.12607 
291.13058 
291.13058 
/ 
Asn-Thr-Gly 
Ser-Gln-Gly 
C13H22O5S 
C10H18N4O6 
C10H18N4O6 
√ 
√ 
√ 
1.53991 
2.97 
2.97 
SF 
LSc* 
LSc* 
24 29.95 309.12908 309.12924 / C11H20N2O8 √ 0.15794 SF 
25 30.40 250.09229 250.09213 / C9H15NO7 √ 0.16254 SF 
25 30.52 162.07696 162.07608 / C6H11NO4  / 0.87510 SF 
25 30.52 180.08582 180.08665 / C6H13NO5 √ 0.82983 SF 
26 31.8 147.1113 147.10888 Lysine C6H14N2O2 / 2.4 LSc* 
26 31.84 156.07667 156.07675 
156.07283 
/ 
Histidine 
C6H9N3O2 
equivalent to SF 
√ 
√ 
0.02097 
3.84 
SF 
LSc* 
26 31.64 175.11806 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.88700 
3.03 
SF 
LSc* 
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Supplementary figure 8: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A6 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 8. 
 
Supplementary table 8: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A6 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 8. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.46 112.98519 112.98858 / C4H2O4 / 2.84023 SF 
1 10.41 68.99466 68.99875 / C3H2O2 / 3.54378 SF 
2 11.06 146.96569 146.96978 / C3H4N2OS2 / 3.54296 SF 
3 14.45 112.98521 112.98858 / C4H2O4 / 2.82333 SF 
4 17.25 128.03502 128.03587 / C5H7NO3 / 0.29284  
5 24.22 180.06600 180.06717 L-Tyrosine C9H11NO3 √ 0.61812 SF/SL 
6 28.20 127.05115 127.05185 
127.05185 
/ 
Diketo-Gly-Ala 
C5H8N2O2 
equivalent to SF 
√ 
√ 
0.15287 
0.7 
SF 
LSc* 
6 28.20 145.06185 145.06241 
145.06186 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.01826 
0.01 
SF 
LSc* 
7 31.34 131.08218 131.08315 / C5H12N2O2 √ 0.42234 SF 
7 31.34 173.10398 173.10495 L-Arginine C6H14N4O2 √ 0.42442 SF/SL 
7 31.48 154.06178 154.06275 L-Histidine C6H9N3O2 √ 0.42382 SF/SL 
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Supplementary figure 9: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A6 of 
sample 1. The numbering of the peaks correlates with the numbering in Supplementary table 9. 
 
Supplementary table 9: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A6 of sample 1. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 9. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.19 245.12888 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.42689 
0.14 
SF 
LSc* 
1 10.19 267.11061 267.11012 
267.10934 
/ 
Diketo-Glu-His 
C12H10N8 
C11H14N4O4 
√ 
√ 
0.48831 
1.27 
SF 
LSc* 
1b 10.70 231.12020 231.12001 
231.11674 
/ 
Diketo-Met-Val 
C7H14N6O3 
C10H18N2O2S 
√ 
√ 
0.18167 
3.46 
SF 
LSc* 
2 16.65 277.11818 277.11828 
277.1143 
277.11493 
/ 
pyro-Glu-Phe 
Ser-Asn-Gly 
C14H16N2O4 
equivalent to SF 
C9H16N4O6 
√ 
√ 
√ 
0.10130 
3.88 
3.25 
SF 
LSc* 
LSc* 
3 17.36 259.09274 259.09246 
259.09322 
/ 
pyro-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.27713 
0.48 
SF 
LSc* 
4 17.99 293.11338 293.13320 
293.11376 
/ 
Diketo-Glu-Tyr 
C14H16N2O5 
equivalent to SF 
√ 
√ 
0.18337 
0.38 
SF 
LSc* 
4b 19.0 185.0913 185.09263 Diketo-Ser-Pro C8H12N2O3 / 1.33 LSc* 
5 19.94 209.09175 209.09207 / C10H12N2O3 √ 0.32316 SF 
5 19.96 226.11866 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.03785 
0.52 
SF 
LSc* 
5 20.34 212.10288 212.10699 
212.10353 
/ 
Diketo-Pro-Asn 
C14H13NO 
C9H13N3O3 
√ 
√ 
4.10848 
0.65 
SF 
LSc* 
5 20.54 426.20140 426.20235 Tyr-Pro-Phe C23H27N3O5 √ 0.94263 SF/SL 
6 21.45 263.13912 263.13902 
263.13958 
263.1397 
/ 
Diketo-Tyr-Val 
Pro-Phe 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.10152 
0.46 
0.58 
SF 
LSc* 
LSc* 
7 22.06 166.08759 166.08626 
166.08233 
/ 
Phenylalanine 
C9H11NO2 
equivalent to SF 
√ 
√ 
1.44882 
5.26 
SF 
LSc* 
7b 23.73 279.13378 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.14993 
0.83 
SF 
LSc* 
7b 23.74 294.14494 294.14483 Gln-Phe C14H19N3O4 √ 0.11083 SF/SL 
7b 24.01 253.11838 253.11828 
253.11896 
253.11896 
/ 
Tyr-Ala 
Ser-Phe 
C12H16N2O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.09293 
0.58 
0.58 
SF 
LSc* 
LSc* 
8 24.7 147.0425 147.07250 Glutamine C5H10N2O3 / 30.0 LSc* 
8 24.69 182.08079 182.08117 
182.07725 
/ 
Tyrosine 
C9H11NO3 
equivalent to SF 
√ 
√ 
0.38285 
3.54 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
8 24.7 221.0920 221.0926 
221.09612 
221.09612 
Diketo-Tyr-Gly 
Met-Ala 
Cys-Val 
C11H17N3O5 
C8H16N2O3S 
C8H16N2O3S 
/ 
/ 
/ 
0.6 
4.12 
4.12 
LSc* 
LSc* 
LSc* 
9 25.13 254.16155 254.16115 
254.16172 
/ 
Diketo-Pro-Arg 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.40268 
0.17 
SF 
LSc* 
10 28.4 147.0753 147.07250 Glutamine C5H10N2O3 / 2.8 LSc* 
10 28.41 169.05766 169.05291 / C5H12O4S √ 4.75245 SF 
10 28.44 191.03965 191.03859 
191.04905 
/ 
Diketo-Cys-Ser 
C8H6N4S 
C6H10N2O3S 
/ 
/ 
1.02360 
9.4 
SF 
LSc* 
11 31.7 156.0764 156.07283 Histidine C6H9N3O2 / 3.57 LSc* 
11 31.75 175.11829 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.66498 
3.26 
SF 
LSc* 
 
 
Supplementary figure 10: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A4 
of sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 10. 
 
Supplementary table 10: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A4 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 10. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.45 68.99485 68.99875 / C3H2O2 / 3.35671 SF 
1 10.45 112.98515 112.98858 / C4H2O4 / 2.88355 SF 
2 11.03 121.02911 121.03005 / C7H6O2 √ 0.39385 SF 
2 11.03 165.01912 165.01988 / C8H6O4 √ 0.21352 SF 
3 14.45 68.99479 68.99875 / C3H2O2 / 3.41042 SF 
3 14.45 112.98509 112.98858 / C4H2O4 / 2.94539 SF 
4 33.20 190.92809 190.93062 / C5H4O2S3 √ 1.97747 SF 
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Supplementary figure 11: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A4 of 
sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 11. 
 
Supplementary table 11: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A4 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 11. 
 RT 
[min] 
m/z meas. m/z calc. Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 16.2 217.1041 217.10109 Diketo-Ile-Cys C9H16N2O2S / 3.01 LSc* 
2 17.78 432.28071 432.27898 / C15H33N11O4 √ 1.73828 SF 
2 17.84 438.2398 438.23539 Gln-Tyr-Lys C20H21N4O6 / 4.41 LSc* 
3 18.0 459.2797 459.27933 Gln-Arg-Arg C17H30N6O3 / 3.7 LSc* 
3 17.95 476.3068 476.30788 / C21H41N5O7 √ 1.24476 SF 
4 18.1 503.3068 503.30555 Ala-Thr-Arg-
Arg 
C19H38N10O6 / 1.25 LSc* 
4 18.10 520.33316 520.33409 
520.3249 
/ 
Val-Val-Arg-
Phe 
C23H45N5O8 
C25H31N7O7 
/ 
/ 
0.92655 
8.26 
SF 
LSc* 
4 18.1 526.2913 526.29906 Glu-Lys-His-Ile C23H39N7O7 / 7.76 LSc* 
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Supplementary figure 12: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A5 
of sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 12. 
 
Supplementary table 12: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A5 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 12. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.50 68.99647 68.99875 / C3H2O2 / 1.73816 SF 
1 10.50 112.98571 112.98858 / C4H2O4 / 2.32611 SF 
2 11.04 121.02963 121.03005 / C7H6O2 √ 0.12672 SF 
2 11.03 165.01931 165.01988 / C8H6O4 √ 0.02570 SF 
3 14.46 68.99644 68.99875 / C3H2O2 / 1.76617 SF 
3 14.46 112.98565 112.98858 / C4H2O4 / 2.38512 SF 
3 14.55 89.02472 89.02497 / C3H6O3 / 0.29753 SF 
4 17.28 128.03537 128.03587 Pyroglutamic 
acid 
C5H7NO3 √ 0.04825 SF/SL 
4 17.28 257.07811 257.08011 
257.07847 
/ 
pyro-Glu-Glu 
C8H19O7P 
C10H14N2O6 
√ 
√ 
1.45506 
0.36 
SF 
LSc* 
5 18.37 469.21034 469.21146 / C22H35N2O7P √ 0.57737 SF 
5 18.42 324.15666 324.15870 / C13H28NO6P / 1.49170 SF 
6 19.32 225.08783 225.09028 
225.0876 
/ 
pyro-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.90306 
0.23 
SF 
LSc* 
6 19.33 181.09807 181.10045 / C7H19O3P √ 1.83870 SF 
7 20.32 128.03536 128.03587 / C5H7NO3 √ 0.04649 SF 
7 20.32 239.06705 
 
239.06789 
239.0603 
/ 
Diketo-His-Cys 
C10H12N2O5 
C9H12N4O2S 
√ 
√ 
0.29465 
6.75 
SF 
LSc* 
7 20.32 257.07780 257.08011 
257.0774 
/ 
Diketo-Glu-Glu 
C8H19O7P 
C10H14N2O6 
√ 
√ 
1.76513 
0.4 
SF 
LSc* 
8 21.47 201.12421 201.12501 
201.08863 
/ 
Diketo-Thr-Thr 
C9H18N2O3 
C8H14N2O4 
√ 
√ 
0.25653 
35.58 
SF 
LSc* 
8 21.48 237.10110 237.10152 
237.1083 
/ 
Diketo-Thr-Phe 
C8H19N2O4P 
C15H16N2O3 
/ 
/ 
0.13334 
7.2 
SF 
LSc* 
9 21.89 166.06397 166.06440 / C5H14NO3P √ 0.11134 SF 
10 22.07 259.12956 259.13049 
259.1287 
/ 
γ-Glu-Ile 
C11H20N2O5 
C11H20N2O5 
√ 
√ 
0.38356 
0.86 
SF 
LSc* 
11 23.78 148.04360 148.04432 L-Methionine C5H11NO2S √ 0.17149 SF/SL 
12 26.87 146.04568 146.04643 L-Glutamate C5H9NO4 √ 0.20251 SF/SL 
13 28.21 127.05128 127.05185 / C5H8N2O2 √ 0.02514 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
13 28.21 145.06170 145.06241 
145.06186 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.16891 
0.16 
SF 
LSc* 
13 28.35 200.02309 200.02360 / C6H8N3O3P √ 0.03655 SF 
13 28.40 172.02223 172.02319 / C10H7NS √ 0.41561 SF 
14 31.35 173.10423 173.10495 L-Arginine C6H14N4O2 √ 0.17286 SF/SL 
14 31.54 154.06200 154.06275 L-Histidine C6H9N3O2 √ 0.19602 SF/SL 
 
 
Supplementary figure 13: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A5 of 
sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 13. 
 
Supplementary table 13: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A5 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 13. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 9.61 421.28001 421.28093 / C22H36N4O4 √ 0.92054 SF 
1 9.66 211.14409 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.01529 
0.58 
SF 
LSc* 
1b 10.7 197.1277 197.12902 Diketo-Pro-Val C16H16N2O2 / 1.32 LSc* 
2 16.77 243.13427 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
/ 
/ 
0.33560 
0.23 
SF 
LSc* 
2 16.8 261.1316 261.1239 Diketo-Tyr-Pro C14H16N2O3 / 7.7 LSc* 
2 16.8 277.1192 277.1189 Diketo-Glu-Phe C14H16N2O4 / 0.3 LSc* 
3 17.58 277.10257 277.10263 / C10H14N2O4 √ 0.05805 SF 
3 17.47 259.09268 259.09246 
259.09322 
/ 
pyro-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.22274 
0.54 
SF 
LSc* 
4 17.76 340.18615 340.18670 
340.19401 
/ 
Ile-His-Ala 
C16H25N3O5 
C15H25N5O4 
√ 
√ 
0.07679 
7.86 
SF 
LSc* 
4 17.72 374.17105 374.17105 / C19H23N3O5 √ 0.07679 SF 
5 18.2 195.0757 195.0882 Diketo-His-Gly C8H10N4O2 / 12.5 LSc* 
5 18.19 213.08683 213.08698 
213.08755 
/ 
Diketo-Pro-Asp 
C9H12N2O4 
equivalent to SF 
√ 
√ 
0.15346 
0.72 
SF 
LSc* 
5 18.56 326.17052 326.17105 / C15H23N3O5 √ 0.52666 SF 
6 19.1 185.0916 185.09263 Diketo-Ser-Pro C8H12N2O3 / 1.03 LSc* 
6 19.13 201.08699 201.08832 
201.08755 
/ 
Diketo-Glu-Ala 
C9H8N6 
C8H12N2O4 
√ 
√ 
1.33133 
0.56 
SF 
LSc* 
6 19.53 227.10291 227.10263 
227.1032 
/ 
Diketo-Glu-Pro 
C10H14N2O4 
equivalent to SF 
√ 
√ 
0.27606 
0.29 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
7 19.9 245.1862 245.18665 Ile-Ile 
Leu-Ile 
Leu-Leu 
C12H24N2O3 
C12H24N2O3 
C12H24N2O3 
√ 
√ 
√ 
0.45 
0.45 
0.45 
LSc* 
LSc* 
LSc* 
7 19.98 376.22310 376.22308 Ile-Pro-Phe C20H29N3O4 √ 0.01506 SF/SL 
8 20.09 209.09195 209.09207 
209.10386 
/ 
Diketo-His-Ala 
C10H12N2O3 
C9H12N4O2 
√ 
√ 
0.11479 
11.91 
SF 
LSc* 
8 20.10 226.11863 226.11862 
226.1192 
/ 
Diketo-Pro-Gln 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.01270 
0.57 
SF 
LSc* 
8 20.12 248.10081 248.10462 / C10H18NO4P √ 3.80985 SF 
8 20.15 342.23815 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.58172 SF/SL 
9 20.4 187.0702 187.0719 
187.0719 
Diketo-Asp-Ala 
Diketo-Glu-Gly 
C7H10N2O4 
C7H10N2O4 
/ 
/ 
1.7 
1.7 
LSc* 
LSc* 
9 20.46 212.10276 212.10297 
212.10353 
/ 
Diketo-Pro-Asn 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.20506 
0.77 
SF 
LSc* 
9 20.67 324.15453 324.15540 
324.15607 
/ 
Thr-Gly-Phe 
C15H21N3O5 
equivalent to SF 
√ 
√ 
0.87036 
1.54 
SF 
LSc* 
9 20.67 263.13919 263.13902 
263.13958 
263.1397 
/ 
Diketo-Val-Tyr 
Pro-Phe 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.16869 
0.39 
0.51 
SF 
LSc* 
LSc* 
9 20.73 229.15454 229.15535 Ile-Pro C11H20N2O3 √ 0.00081 LSc* 
9 20.78 259.09244 259.09246 
259.09322 
/ 
pyro-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.02167 
0.78 
SF 
LSc* 
9 20.75 362.20692 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.51349 SF/SL 
9 20.83 360.19446 360.19515 Ile-Pro-Met C16H29N3O4S √ 0.69239 SF/SL 
10 21.00 328.22251 328.22308 Val-Pro-Leu C16H29N3O4 √ 0.56902 SF/SL 
11 21.9 203.1381 203.1032 
203.1397 
Diketo-Thr-Thr 
Ile-Ala 
C8H14N2O4 
C9H18N2O3 
/ 
/ 
0.0349 
0.0016 
LSc* 
LSc* 
11 21.87 229.1548 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.15597 
0.55 
SF 
LSc* 
11 21.87 314.20709 314.20743 Val-Pro-Val C15H27N3O4 √ 0.33811 SF/SL 
11 21.9 334.1767 334.17682 Pro-Phe-Ala C17H23N3O4 / 0.12 LSc* 
12 22.40 263.19670 263.19653 / C12H26N2O4 √ 0.16440 SF 
12 22.4 285.1788 285.1675 Diketo-Gln-Arg C11H20N6O3 / 11.3 LSc* 
12 22.4 353.0930 353.09547 Cys-Gln-Cys C11H13N4O3S / 2.47 LSc* 
13 23.2 197.1278 197.12902 Diketo-Pro-Val C10H16N2O2 / 1.22 LSc* 
13 23.18 243.13398 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.04580 
0.52 
SF 
LSc* 
13 23.18 261.14465 261.14450 γ-Glu-Leu C11H20N2O5 √ 0.15433 LSc* 
14 23.4 189.1229 189.12405 Val-Ala C8H16N2O3 / 1.15 LSc* 
14 23.43 261.14482 261.14450 
261.14518 
/ 
Glu-Leu 
C11H20N2O5 
equivalent to SF 
√ 
√ 
0.32213 
0.36 
SF 
LSc* 
14 23.41 314.13444 314.13466 / C13H19N3O6 √ 0.22442 SF 
15 23.72 358.19700 358.19726 Ile-Pro-Glu C16H27N3O6 √ 0.25997 SF/SL 
15 23.81 215.13910 215.13902 
215.1396 
215.1397 
/ 
Diketo-Thr-Ile 
Val-Pro 
C10H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.07824 
0.5 
0.6 
SF 
LSc* 
LSc* 
15 23.8 247.1289 247.12953 Glu-Val C10H18N2O5 / 0.63 LSc* 
16 24.17 330.20198 330.20235 Ile-Pro-Thr C15H27N3O5 √ 0.36261 SF/SL 
17 24.40 150.05749 150.05495 
150.06609 
/ 
Methionine 
C8H7NO2 
C5H11NO2S 
√ 
√ 
2.53754 
8.6 
SF 
LSc* 
17 24.49 279.10086 279.10092 
279.0981 
279.1016 
/ 
Diketo-Asp-Tyr 
Glu-Met 
C10H18N2O5S 
C13H14N2O5 
equivalent to SF 
√ 
√ 
√ 
0.05417 
2.76 
0.74 
SF 
LSc* 
LSc* 
18 25.07 187.10707 187.10772 
187.10828 
/ 
Diketo-Ser-Val 
C8H14N2O3 √ 
√ 
0.57766 
1.21 
SF 
LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
187.1084 Pro-Ala equivalent to SF 
equivalent to SF 
√ 1.33 LSc* 
18 25.09 247.12903 247.12885 Glu-Val C10H18N2O5 √ 0.18275 LSc* 
19 25.33 213.12318 213.12337 
213.12405 
/ 
Pro-Pro 
C10H16N2O3 
equivalent to SF 
√ 
√ 
0.18352 
0.87 
SF 
LSc* 
19 25.35 175.10661 175.10772 
175.11503 
/ 
Arginine 
C7H14N2O3 
C6H14N4O2 
√ 
√ 
1.10950 
8.42 
SF 
LSc* 
19 25.4 219.1338 219.13461 Ile-Ser C9H18N2O4 / 0.81 LSc* 
19 25.43 254.16135 254.16115 
254.1617 
/ 
Diketo-Pro-Arg 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.20051 
0.35 
SF 
LSc* 
20 25.7 233.1132 233.11388 Asp-Val C9H16N2O5 / 0.68 LSc* 
20 25.8 235.1191 235.1195 
235.1118 
Diketo-His-Pro 
Leu-Cys 
C11H14N4O2 
C9H18N2O3S 
/ 
/ 
0.4 
7.3 
LSc* 
LSc* 
20 25.81 245.11362 245.11320 
245.11388 
/ 
Glu-Pro 
C10H16N2O5 
equivalent to SF 
√ 
√ 
0.42041 
0.26 
SF 
LSc* 
21 26.4 161.0928 161.09275 Ala-Ala C6H12N2O3 / 0.05 LSc* 
21 26.5 173.0913 173.0926 
173.0927 
Diketo-Ala-Thr 
Pro-Gly 
C7H12N2O3 
C7H12N2O3 
/ 
/ 
1.3 
1.4 
LSc* 
LSc* 
21 26.65 205.11806 205.11828 
205.11896 
/ 
Val-Ser 
C8H16N2O4 
equivalent to SF 
√ 
√ 
0.22119 
0.9 
SF 
LSc* 
21 26.55 217.11840 217.11962 
217.11896 
/ 
Thr-Pro 
C10H12N6 
C9H16N2O4 
√ 
√ 
1.21990 
0.56 
SF 
LSc* 
21 26.75 246.14504 246.14483 
246.14551 
246.1455 
/ 
Gln-Val 
Gly-Ile-Gly 
C10H19N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.20435 
0.47 
0.46 
SF 
LSc* 
LSc* 
21
b 
27.22 148.05909 148.06043 
148.05990 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
√ 
√ 
1.34674 
0.81 
SF 
LSc* 
22 28.33 177.08589 177.08698 
177.08765 
177.08766 
/ 
Thr-Gly 
Ser-Ala 
C6H12N2O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
1.09651 
1.76 
1.77 
SF 
LSc* 
LSc* 
22 28.30 235.09247 235.09246 
235.09314 
235.09314 
/ 
Glu-Ser 
Asp-Thr 
C8H14N2O6 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.00287 
0.67 
0.67 
SF 
LSc* 
LSc* 
22 28.29 257.07430 257.07431 / C14H12N2OS √ 0.01105 SF 
23 28.4 218.1130 218.11421 
218.11421 
Gln-Ala 
Ala-Ala-Gly 
C8H15N3O4 
C8H15N3O4 
/ 
/ 
1.21 
1.21 
LSc* 
LSc* 
23 28.5 191.0392 191.04905 Diketo-Ser-Cys C6H10N2O3S / 9.85 LSc* 
23 28.59 147.07518 147.07642 
147.07642 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
1.23821 
1.24 
SF 
LSc* 
23 28.72 276.11909 276.11901 
276.11969 
/ 
Glu-Gln 
C10H17N3O6 
equivalent to SF 
√ 
√ 
0.07809 
0.6 
SF 
LSc* 
24 28.71 258.10859 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.13979 
0.42 
SF 
LSc* 
24 28.82 456.20672 456.20755 / C18H33NO12 √ 0.83391 SF 
25 28.95 166.05398 166.05324 / C5H11NO3S √ 0.73803 SF 
25 29.01 207.09730 207.09755 
207.09822 
/ 
Thr-Ser 
C7H14N2O5 
equivalent to SF 
√ 
√ 
0.24944 
0.92 
SF 
LSc* 
26 29.13 163.07190 163.07133 
163.0720 
/ 
Gly-Ser 
C5H10N2O4 
equivalent to SF 
√ 
√ 
0.56750 
0.1 
SF 
LSc* 
26 29.3 204.0974 204.09855 
204.09855 
Gln-Gly 
Gly-Ala-Gly 
C7H13N3O4 
C7H13N3O4 
/ 
/ 
1.15 
1.15 
LSc* 
LSc* 
26 29.22 365.10531 365.10515 / C10H16N6O9 √ 0.16028 SF 
27 29.59 252.10779 252.10778 
252.1097 
/ 
Diketo-Asn-His 
C9H17NO7 
C10H13N5O3 
√ 
√ 
0.00814 
1.91 
SF 
LSc* 
27 29.57 282.11804 282.11834 / C10H19NO8 √ 0.30174 SF 
27 29.56 310.11273 310.11326 / C11H19NO9 √ 0.52982 SF 
27 29.8 193.0812 193.08257 Ser-Ser C6H12N2O5 / 1.37 LSc* 
27 29.8 234.1068 234.10912 Gln-Ser C8H15N3O5 / 2.32 LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
234.10912 
234.10911 
Ala-Ser-Gly 
Gly-Thr-Gly 
C8H15N3O5 
C8H15N3O5 
/ 
/ 
2.32 
2.31 
LSc* 
LSc* 
28 30.64 202.06799 202.06850 / C12H11NS √ 0.50627 SF 
28 30.56 268.10268 268.10269 / C9H17NO8 √ 0.00756 SF 
28 30.66 359.16517 359.16517 / C14H31O6PS √ 0.00166 SF 
29 31.8 147.1118 147.11281 Lysine C6H14N2O2 / 1.01 LSc* 
29 31.8 156.0772 156.07676 Histidine C6H9N3O2 / 0.44 LSc* 
29 31.82 175.11818 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.76756 
3.15 
SF 
LSc* 
 
 
Supplementary figure 14: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A6 
of sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 14. 
 
Supplementary table 14: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A6 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 14. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.46 68.99484 68.99875 / C3H2O2 / 3.36455 SF 
1 10.46 112.98518 112.98858 / C4H2O4 / 2.84867 SF 
2 11.00 121.02908 121.03005 / C7H6O2 / 0.41910 SF 
2 11.00 165.01900 165.01988 / C8H6O4 / 0.33629 SF 
3 13.99 311.16713 311.16900 / C9H24N6O6 / 1.33014 SF 
3 14.19 297.15141 297.15335 / C8H22N6O6 / 1.39596 SF 
4 24.23 180.06598 180.06717 L-Tyrosine C9H11NO3 √ 0.63838 SF/SL 
5 28.1 127.0503 127.0508 Diketo-Gly-Ala C5H8N2O2 / 0.5 LSc* 
5 28.21 145.06155 145.06241 
145.06186 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
/ 
/ 
0.31764 
0.31 
SF 
LSc* 
6 31.38 173.10403 173.10495 L-Arginine C6H14N4O2 √ 0.33811 SF/SL 
6 31.55 154.06169 154.06275 L-Histidine C6H9N3O2 √ 0.50710 SF/SL 
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Supplementary figure 15: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A6 of 
sample 2. The numbering of the peaks correlates with the numbering in Supplementary table 15. 
 
Supplementary table 15: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A6 of sample 2. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 15. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.27 245.12878 245.12845 
245.12902 
/ 
Diketo-Phe-Pro 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.32483 
0.24 
SF 
LSc* 
1 10.3 267.1113 267.1093 Diketo-Glu-His C11H14N4O4 / 2.0 LSc* 
2 16.4 277.1197 277.11828 pyro-Glu-Phe C14H16N2O4 / 1.42 LSc* 
3 17.6 259.0923 259.09246 pyro-Glu-Glu C10H14N2O6 / 0.16 LSc* 
4 18.07 293.11337 293.11320 
293.11376 
/ 
Diketo-Glu-Tyr 
C14H16N2O5 
equivalent to SF 
√ 
√ 
0.16877 
0.39 
SF 
LSc* 
4b 19.1 185.0916 185.09263 Diketo-Ser-Pro C8H12N2O3 / 1.03 LSc* 
5 20.07 209.09212 209.09207 / C10H12N2O3 √ 0.04759 SF 
5 20.06 226.11902 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.03785 
0.16 
SF 
LSc* 
5 20.07 248.10100 248.10028 / C8H9N9O √ 0.71390 SF 
6 20.44 212.10315 212.10297 
212.10353 
/ 
Diketo-Asn-Pro 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.18616 
0.38 
SF 
LSc* 
6 20.85 392.21786 392.21800 Tyr-Pro-Leu C20H29N3O5 √ 0.14057 SF/SL 
7 21.6 159.0512 159.07698 
159.07697 
Diketo-Ala-Ser 
Diketo-Thr-Gly 
C6H10N2O4 
C6H10N2O4 
/ 
/ 
25.78 
25.77 
LSc* 
LSc* 
7 21.60 288.10770 288.10778 / C12H17NO7 √ 0.07588 SF 
7 21.58 310.08935 310.08963 
310.08965 
/ 
Cys-Met-Gly 
C18H15NO2S 
C10H19N3O4S2 
√ 
√ 
0.27657 
0.3 
SF 
LSc* 
8 21.98 166.08674 166.08626 Phenylalanine C9H11NO2 √ 0.48752 SF/LSc
* 
8 22.05 279.13382 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.11056 
0.79 
SF 
LSc* 
8 22.26 331.16525 331.16523 
331.16189 
/ 
Gln-Pro-Ser 
C18H22N2O4 
C13H22N4O6 
√ 
√ 
0.01863 
3.36 
SF 
LSc* 
9 24.1 253.1190 253.11896 
253.11896 
Tyr-Ala 
Ser-Phe 
C12H16N2O4 
C12H16N2O4 
/ 
/ 
0.04 
0.04 
LSc* 
LSc* 
9 24.8 147.0423 147.07642 Glutamine C5H10N2O3 / 0.03412 LSc 
9 24.80 165.05582 165.05462 / C9H8O3 √ 1.20118 SF 
9 24.80 182.08074 182.08117 Tyrosine C9H11NO3 √ 0.43075 SF/LSc 
9 25.09 311.12353 311.12376 
311.12444 
/ 
Glu-Tyr 
C14H18N2O6 
equivalent to SF 
√ 
√ 
0.23706 
0.91 
SF 
LSc* 
9 24.9 221.0917 221.0926 Diketo-Tyr-Gly C11H17N3O5 / 0.9 LSc* 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
221.09612 
221.09612 
Met-Ala 
Cys-Val 
C8H16N2O3S 
C8H16N2O3S 
/ 
/ 
4.42 
4.42 
LSc* 
LSc* 
10 25.22 254.16152 254.16115 
254.16172 
/ 
Diketo-Pro-Arg 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.36591 
0.2 
SF 
LSc* 
11 28.55 191.03951 191.03859 
191.04905 
/ 
Diketo-Cys-Ser 
C8H6N4S 
C6H10N2O3S 
√ 
√ 
0.91985 
9.54 
SF 
LSc* 
11 28.57 147.07525 147.07642 
147.07642 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
1.16472 
11.7 
SF 
LSc* 
11 28.6 169.0576 169.09772 Diketo-Pro-Ala C8H12N2O2 / 40.12 LSc* 
12 31.95 156.07687 156.07675 
156.07283 
/ 
Histidine 
C6H9N3O2 
equivalent to SF 
√ 
√ 
0.11918 
4.04 
SF 
LSc* 
12 31.79 175.11824 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.71630 
3.21 
SF 
LSc* 
 
 
Supplementary figure 16 Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A4 of 
sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 16Supplementary 
table 10. 
 
Supplementary table 16: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A4 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 16. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.02 68.99466 68.99875 / C3H2O2 / 3.54186 SF 
1 10.02 112.98495 112.98858 / C4H2O4 / 3.08734 SF 
2 10.98 121.02878 121.03005 / C7H6O2 / 0.72514 SF 
3 32.48 146.93777 146.96978 / C4H4S3 / 0.03201 SF 
3 32.48 190.92763 190.93062 / C5H4O2S3 / 0.00299 SF 
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Supplementary figure 17: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A4 of 
sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 17Supplementary 
table 10. 
 
Supplementary table 17: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A4 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 17. 
 RT 
[min] 
m/z meas. m/z calc. Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 16.33 217.10444 217.10436 
217.10109 
/ 
Diketo-Cys-Ile 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.07752 
3.35 
SF 
LSc* 
1 16.4 195.1217 195.11337 Diketo-Pro-Pro C10H14N2O2 / 8.33 LSc* 
2 17.6 388.2534 388.25613 Gln-Lys-Ile C17H33N5O5 / 2.73 LSc* 
2 17.59 393.20918 393.20922 / C14H28N6O7 √ 0.03979 SF 
3 17.80 432.27940 432.28031 / C16H29N15 √ 0.91452 SF 
4 31.22 154.98982 154.98926 / C6H3N3P / 0.56082 SF 
 
 
Supplementary figure 18: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A5 
of sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 18. 
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Supplementary table 18: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A5 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 18. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.46 68.99459 68.99875 / C3H2O2 / 3.61508 SF 
1 10.46 112.98498 112.98858 / C4H2O4 / 3.05269 SF 
1 10.61 89.02367 89.02497 / C3H6O3 / 0.74971 SF 
2 11.03 117.01876 117.01988 / C4H6O4 / 0.57535 SF 
2 10.96 165.01874 165.01988 / C8H6O4 √ 0.59623 SF 
3 13.96 325.18219 325.18465 / C10H26N6O6 / 1.92102 SF 
3 13.98 311.16675 311.16900 / C9H24N6O6 / 1.70181 SF 
3 14.05 297.15109 297.15017 / C19H22O3 / 1.47448 SF 
3 14.43 117.01884 117.01988 / C4H6O4 / 0.49473 SF 
4 16.48 197.12804 197.13010 
197.13011 
/ 
Diketo-Val-Val 
C10H18N2O2 
equivalent to SF 
/ 
/ 
1.50940 
2.07 
SF 
LSc* 
4 16.48 275.10199 275.10325 
275.1016 
/ 
pyro-Glu-Phe 
C8H17N6O3P 
C14H16N2O4 
/ 
/ 
0.71128 
0.39 
SF 
LSc* 
4 16.55 241.11801 241.11724 
241.11994 
/ 
Diketo-Glu-Ile 
C7H14N8O2 
C11H18N2O4 
√ 
√ 
1.29871 
1.93 
SF 
LSc* 
5 17.18 372.15406 372.15467 / C12H28N3O8P √ 0.06764 SF 
5 17.22 128.03483 128.03587 pyro-Glutamic 
acid 
C5H7NO3 
 
√ 0.49088 SF/SL 
5 17.22 257.07655 257.07846 
257.08051 
257.07847 
257.07205 
/ 
pyro-Glu-Glu 
Diketo-Glu-Glu 
His-Cys 
C10H14N2O6 
equivalent to SF 
equivalent to SF 
C9H14N4O3S 
√ 
√ 
√ 
√ 
1.35568 
3.96 
1.92 
4.5 
SF 
LSc* 
LSc* 
LSc* 
5 17.35 338.17021 338.17166 / C10H26N7O4P √ 0.90695 SF 
6 18.16 469.20652 469.20878 / C18H31N8O5P √ 1.70986 SF 
7 19.29 181.09754 181.09880 / C9H14N2O2 √ 0.71525 SF 
7 19.29 225.08710 225.08863 
225.08864 
225.0910 
/ 
Diketo-Glu-Pro 
pyro-Glu-Pro 
C10H14N2O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.97848 
1.54 
3.9 
SF 
LSc* 
LSc* 
7 19.28 451.18075 451.18295 / C14H29N8O7P √ 1.66002 SF 
8 20.48 322.13873 322.14036 
322.14152 
/ 
Phe-Ala-Ser 
C9H22N7O4P 
C15H21N3O5 
√ 
√ 
1.08499 
2.79 
SF 
LSc* 
9 21.10 261.12300 261.12501 Phe-Ala-Pro C14H18N2O3 √ 1.46686 SF/SL 
9 21.37 227.13874 227.13798 
227.14079 
/ 
Ile-Pro 
C7H16N8O 
C11H20N2O3 
√ 
√ 
1.31124 
2.05 
SF 
LSc* 
9 21.41 201.12348 201.12501 
201.12514 
/ 
Ile-Ala 
C9H18N2O3 
equivalent to SF 
/ 
/ 
0.98386 
1.66 
SF 
LSc* 
10 21.95 166.06336 166.06440 / C5H14NO3P √ 0.49271 SF 
10 21.93 215.06609 215.06789 
215.0679 
/ 
Diketo-Asp-Thr 
C8H12N2O5 
equivalent to SF 
√ 
√ 
1.25612 
1.81 
SF 
LSc* 
10 21.93 251.04243 251.04440 / C7H13N2O6P / 1.41762 SF 
11 22.71 353.14441 353.14617 / C9H23N8O5P √ 1.22122 SF 
11 22.82 312.11791 312.11797 / C9H15N9O4 / 0.48188 SF 
11 22.98 256.09239 256.09444 
256.09445 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
1.50932 
2.06 
SF 
LSc* 
11 22.98 513.19282 513.19324 / C13H35N6O13P √ 0.12052 SF 
11 22.99 238.08190 238.08388 / C10H13N3O4 √ 1.42733 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
12 23.60 353.14436 353.14617 / C9H23N8O5P √ 1.26478 SF 
13 23.79 148.04313 148.04432 L-Methionine C5H11NO2S √ 0.63952 SF/SL 
13
. 
22.79 200.05546 200.05699 / C8H11NO5 / 0.98215 SF 
13 22.78 290.08624 290.08600 / C7H13N7O6 / 0.78461 SF 
14 28.24 145.06155 145.06241 
145.06186 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.31531 
0.31 
SF 
LSc* 
14 28.3 313.1107 313.11188 / C7H18N6O8 √ 0.58295 SF 
15 29.34 232.09261 232.09444 
232.09456 
232.09455 
/ 
Gln-Ser 
Gly-Thr-Gly 
C8H15N3O5 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
1.28177 
1.95 
1.94 
SF 
LSc* 
LSc* 
16 31.36 173.10385 173.10495 L-Arginine C6H14N4O2 √ 0.54845 SF/SL 
16 31.50 154.06158 154.06275 L-Histidine C6H9N3O2 √ 0.61926 SF/SL 
 
 
Supplementary figure 19: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A5 of 
sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 19Supplementary 
table 17Supplementary table 10. 
 
Supplementary table 19: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A5 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 19. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 9.53 211.14405 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.11356 
0.62 
SF 
LSc* 
1 9.53 421.28046 421.28093 / C22H36N4O4 √ 0.47541 SF 
2 10.63 197.12797 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.48649 
1.05 
SF 
LSc* 
2 10.63 311.15874 311.15746 / C11H18N8O3 √ 1.27366 SF 
3 16.50 243.13424 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
 √ 
√ 
0.31106 
0.26 
SF 
LSc* 
3 16.49 277.11818 277.11828 
277.1189 
/ 
Diketo-Glu-Phe 
C14H16N2O4 
equivalent to SF 
 √ 
√ 
0.10513 
0.72 
SF 
LSc* 
3 16.48 485.26029 485.26012 / C22H44O7S2 √ 0.17214 SF 
4 17.27 259.09254 259.09246 
259.09303 
259.09303 
/ 
Diketo-Glu-Glu 
pyro-Glu-Glu 
C10H14N2O6 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.07859 
0.49 
0.49 
SF 
LSc* 
LSc* 
4 17.27 469.22929 469.22795 / C20H36O12 √ 1.33871 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
469.22345 Tyr-Arg-Met C20H32N6O5S √ 5.84 LSc* 
4 17.50 374.17116 374.17105 / C19H23N3O5 √ 0.29847 SF 
4 17.53 396.15356 396.15303 / C14H26N3O8P √ 0.53238 SF 
4 17.56 340.18638 340.18803 
340.19401 
/ 
Ile-His-Ala 
C17H21N7O 
C15H25N5O4 
√ 
√ 
1.65852 SF 
LSc* 
5 17.59 362.16785 362.16836 
362.1677 
/ 
Asn-Gln-Thr 
C14H19N9O3 
C13H23N5O7 
√ 
√ 
0.51024 
0.15 
SF 
LSc* 
6 17.92 326.17034 326.17105 / C15H23N3O5 √ 0.63253 SF 
6 18.0 213.0861 213.08755 Diketo-Pro-Asp C9H12N2O4 / 1.45 LSc* 
6 18.10 493.20556 493.20414 / C21H28N6O8 √ 1.64085 SF 
6 18.19 471.22384 471.22246 / C21H22N14 √ 1.37837 SF 
7 18.34 326.17048 326.17105 / C15H23N3O5 / 0.56776 SF 
7 18.28 358.14254 358.14312 / C15H23N3O5S √ 0.58030 SF 
7 18.46 437.23924 437.23946 / C21H32N4O6 √ 0.00445 SF 
8 18.77 390.16613 390.16596 
390.16262 
/ 
Glu-Asn-Gln 
C19H23N3O6 
C14H23N5O8 
√ 
√ 
0.17089 
3.51 
SF 
LSc* 
8 18.90 201.08658 201.08698 
201.08755 
/ 
Diketo-Glu-Ala 
C8H12N2O4 
C8H13N3O3 
√ 
√ 
0.40432 
0.97 
SF 
LSc* 
8 18.98 185.09159 185.09207 
185.09263 
/ 
Diketo-Ser-Pro 
C8H12N2O3 
equivalent to SF 
√ 
√ 
0.47939 
1.04 
SF 
LSc* 
9 19.30 227.10285 227.10397 
227.1032 
227.1032 
/ 
Diketo-Glu-Pro 
pyro-Glu-Pro 
C11H10N6 
C10H14N2O4 
C10H14N2O4 
√ 
√ 
√ 
1.12342 
0.35 
0.35 
SF 
LSc* 
LSc* 
9 19.50 245.1857 245.18665 
245.18665 
245.18665 
Ile-Ile 
Leu-Ile 
Leu-Leu 
C12H24N2O3 
C12H24N2O3 
C12H24N2O3 
√ 
√ 
√ 
0.95 
0.95 
0.95 
LSc* 
LSc* 
LSc* 
10 19.86 342.23815 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.58529 SF/SL 
10 19.92 209.09188 209.09207 
209.10386 
/ 
Diketo-His-Ala 
C10H12N2O3 
C9H12N4O2 
√ 
√ 
0.18645 
11.98 
SF 
LSc* 
10 19.91 226.11871 226.11862 
226.11918 
/ 
Diketo-Pro-Gln 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.09560 
0.47 
SF 
LSc* 
10 19.90 451.22971 451.23130 
451.23065 
/ 
Glu-Arg-Phe 
C21H26N10O2 
C20H30N6O6 
√ 
√ 
1.58638 
0.94 
SF 
LSc* 
11 20.1 187.0704 187.0719 
187.0719 
Diketo-Asp-Ala 
Diketo-Glu-Gly 
C7H10N2O4 
C7H10N2O4 
/ 
/ 
1.5 
1.5 
LSc* 
LSc* 
11 20.29 195.07562 195.07642 
195.0882 
/ 
Diketo-His-Gly 
C9H10N2O3 
C8H10N4O2 
√ 
√ 
0.79456 
12.58 
SF 
LSc* 
11 20.28 212.10252 212.10297 
212.10353 
/ 
Diketo-Pro-Asn 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.44995 
1.01 
SF 
LSc* 
11 20.43 324.15498 324.15540 
324.15607 
/ 
Thr-Gly-Phe 
C15H21N3O5 
equivalent to SF 
√ 
√ 
0.41346 
1.09 
SF 
LSc* 
11 20.44 336.19086 336.19178 
336.19246 
/ 
Ile-Gly-Phe 
C17H25N3O4 
equivalent to SF 
√ 
√ 
0.92354 
1.6 
SF 
LSc* 
12 20.77 231.09772 231.09755 
231.09811 
/ 
Diketo-Glu-Thr 
C9H14N2O5 
equivalent to SF 
√ 
√ 
0.16825 
0.39 
SF 
LSc* 
12 20.88 392.21798 392.21800 Ile-Pro-Tyr C20H29N3O5 √ 0.04529 SF/SL 
13 21.34 263.13922 263.13902 
263.13958 
263.1397 
/ 
Diketo-Val-Tyr 
Pro-Phe 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.19718 
0.36 
0.48 
SF 
LSc* 
LSc* 
13 21.57 229.15487 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.20179 
0.48 
SF 
LSc* 
13 21.8 203.1387 203.1397 Ile-Ala C9H18N2O3 / 1.0 LSc* 
13 21.86 326.20705 326.20743 
326.20812 
/ 
Ile-Pro-Pro 
C16H27N3O4 
equivalent to SF 
√ 
√ 
0.38130 
1.07 
SF 
LSc* 
14 22.81 355.16126 355.16121 / C15H22N4O6 √ 0.05327 SF 
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 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
14 22.81 486.25584 486.25584 / C21H35N5O8 √ 0.00267 SF 
15 23.19 258.10882 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.37578 
0.19 
SF 
LSc* 
15 23.23 389.20393 389.20308 
389.20376 
/ 
Glu-Gln-Leu 
C16H28N4O7 
equivalent to SF 
√ 
√ 
0.85843 
0.17 
SF 
LSc* 
16 23.41 279.13387 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.06334 
0.74 
SF 
LSc* 
16 23.47 215.13908 215.13902 
215.13958 
215.1397 
/ 
Diketo-Ile-Thr 
Pro-Val 
C10H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.06091 
0.5 
0.62 
SF 
LSc* 
LSc* 
16 23.49 261.14436 261.14450 
261.14518 
/ 
γ-Glu-Leu 
C11H20N2O5 
equivalent to SF 
√ 
√ 
0.14138 
0.82 
SF 
LSc* 
17 23.6 189.1227 189.12405 Val-Ala C8H16N2O2 / 1.35 LSc* 
17 23.76 355.16106 355.16121 / C15H22N4O6 √ 0.14862 SF 
17 23.89 312.19144 312.19178 
312.19247 
/ 
Val-Pro-Pro 
C15H25N3O4 
equivalent to SF 
√ 
√ 
0.34703 
1.03 
SF 
LSc* 
17 23.89 330.20177 330.20235 Ile-Pro-Thr C15H27N3O5 √ 0.57525 SF/SL 
18 24.06 150.05733 150.05833 
150.05440 
/ 
Methionine 
C5H11NO2S 
equivalent to SF 
√ 
√ 
0.88993 
2.93 
SF 
LSc* 
18 24.39 274.09200 274.09213 / C11H15NO7 √ 0.13129 SF 
18 24.3 175.1064 175.11503 Arginine C6H14N4O2 / 8.63 LSc* 
19 24.71 247.12910 247.12885 
247.12953 
/ 
Glu-Val 
C10H18N2O5 
equivalent to SF 
√ 
√ 
0.25066 
0.43 
SF 
LSc* 
19 24.90 302.17076 302.17105 
302.17173 
/ 
Pro-Ser-Val 
C13H23N3O5 
equivalent to SF 
√ 
√ 
0.29175 
0.97 
SF 
LSc* 
19 25.0 219.1346 219.13461 Ile-Ser C9H18N2O4 / 0.01 LSc* 
20 25.16 254.16138 254.16115 
254.16172 
/ 
Diketo-Arg-Pro 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.23237 
0.34 
SF 
LSc* 
20 25.21 357.21294 357.21325 Ile-Pro-Gln C16H28N4O5 √ 0.30444 SF/SL 
20 25.28 205.11770 205.11828 
205.11896 
/ 
Val-Ser 
C8H16N2O4 
equivalent to SF 
√ 
√ 
0.58261 
1.26 
SF 
LSc* 
21 25.42 233.11347 233.11320 
233.11388 
/ 
Asp-Val 
C9H16N2O5 
equivalent to SF 
√ 
√ 
0.27425 
0.41 
SF 
LSc* 
21 25.49 580.27238 580.27121 / C24H41N3O13 √ 1.16163 SF 
22 25.37 187.10679 187.10772 
187.10828 
187.1084 
/ 
Diketo-Ser-Val 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
equivalent to SF 
/ 
/ 
/ 
0.93249 
1.49 
1.61 
SF 
LSc* 
LSc* 
22 26.0 161.0924 161.09275 Ala-Ala C6H12N2O3 / 0.35 LSc* 
22 26.1 245.1136 245.11388 Glu-Pro C10H16N2O5 / 0.28 LSc* 
22 26.5 217.1180 217.11896 Thr-Pro C9H16N2O4 / 0.96 LSc* 
22 26.5 246.1449 246.14551 
246.14551 
246.1455 
Gln-Val 
Ala-Val-Gly 
Gly-Ile-Gly 
C10H19N3O4 
C10H19N3O4 
C10H19N3O4 
/ 
/ 
/ 
0.61 
0.61 
0.6 
LSc* 
LSc* 
LSc* 
22 27.00 173.09115 173.09207 
173.09263 
173.09274 
/ 
Diketo-Ala-Thr 
Pro-Gly 
C7H12N2O3 
equivalent to SF 
equivalent to SF 
/ 
/ 
/ 
0.92044 
1.48 
1.59 
SF 
LSc* 
LSc* 
22 27.02 148.05893 148.06043 
148.05651 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
√ 
√ 
1.50062 
2.42 
SF 
LSc* 
23 27.99 177.08592 177.08698 
177.08765 
177.08766 
/ 
Thr-Gly 
Ser-Ala 
C6H12N2O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
1.10601 
1.73 
1.74 
SF 
LSc* 
LSc* 
23 28.0 235.0928 235.09314 
235.09314 
Glu-Ser 
Asp-Thr 
C8H14N2O6 
C8H14N2O6 
/ 
/ 
0.34 
0.34 
LSc* 
LSc* 
23 28.15 218.11342 218.11353 
218.11421 
218.11421 
/ 
Gln-Ala 
Ala-Ala-Gly 
C8H15N3O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.11293 
0.79 
0.79 
SF 
LSc* 
LSc* 
23 28.32 147.07506 147.07642 
147.07709 
/ 
Ala-Gly 
C5H10N2O3 
equivalent to SF 
√ 
√ 
1.36078 
2.03 
SF 
LSc* 
155  Attachment 
 
 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
147.07642 Glutamine equivalent to SF √ 1.36 LSc* 
23 28.31 169.05735 169.06077 / C7H8N2O3 √ 3.42071 SF 
23 28.36 293.14534 293.14556 / C10H20N4O6 √ 0.22269 SF 
23 28.47 276.11882 276.11901 
276.11969 
276.11969 
/ 
Glu-Gln 
Ala-Glu-Gly 
C10H17N3O6 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.19051 
0.87 
0.87 
SF 
LSc* 
LSc* 
24 28.82 331.16043 331.16121 
331.16189 
/ 
Gln-Pro-Ser 
C13H22N4O6 
equivalent to SF 
√ 
√ 
0.78472 
1.46 
SF 
LSc* 
24 28.8 207.0970 207.09822 Thr-Ser C7H14N2O5 / 1.22 LSc* 
24 28.9 163.0719 163.072 Gly-Ser C5H10N2O4 / 0.1 LSc* 
24 28.98 204.09742 204.09788 
204.09855 
/ 
Gln-Gly 
C7H13N3O4 
equivalent to SF 
√ 
√ 
0.46264 
1.13 
SF 
LSc* 
25 29.2 261.1200 261.12002 Gln-Asn C9H16N4O5 / 0.02 LSc* 
25 29.23 275.13514 275.13500 
275.13567 
275.13567 
/ 
Gln-Gln 
Ala-Gln-Gly 
C10H18N4O5 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.14756 
0.53 
0.53 
SF 
LSc* 
LSc* 
26 29.49 193.08140 193.08190 
193.08257 
/ 
Ser-Ser 
C6H12N2O5 
equivalent to SF 
√ 
√ 
0.49290 
1.17 
SF 
LSc* 
26 29.55 234.10850 234.10845 
234.10912 
234.10912 
234.10912 
/ 
Gln-Ser 
Ala-Ser-Gly 
Gly-Thr-Gly 
C8H15N3O5 
equivalent to SF 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
√ 
0.05716 
0.62 
0.62 
0.62 
SF 
LSc* 
LSc* 
LSc* 
26 29.57 217.08182 217.08324 
217.08246 
217.08246 
/ 
Diketo-Glu-Ser 
Diketo-Thr-Asp 
C9H8N6O 
C8H12N2O5 
C8H12N2O5 
√ 
√ 
√ 
1.41006 
0.64 
0.64 
SF 
LSc* 
LSc* 
27 29.77 291.12922 291.12991 
291.13058 
291.13058 
/ 
Asn-Thr-Gly 
Ser-Gln-Gly 
C10H18N4O6 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.68808 
1.36 
1.36 
SF 
LSc* 
LSc* 
27 29.93 250.10263 250.10336 
250.10403 
/ 
Ser-Ser-Gly 
C8H15N3O6 
equivalent to SF 
√ 
√ 
0.73526 
1.4 
SF 
LSc* 
27 29.94 332.15591 332.15646 
332.15713 
/ 
Gln-Gln-Gly 
C12H21N5O6 
equivalent to SF 
√ 
√ 
0.54590 
1.22 
SF 
LSc* 
27 30.18 220.08174 220.08290 / C9H9N5O2 √ 1.16214 SF 
27 30.37 268.10274 268.10269 / C9H17NO8 √ 0.04728 SF 
28 30.31 162.07671 162.07608 / C6H11NO4 / 0.62471 SF 
28 30.34 348.15075 348.14887 
348.15205 
/ 
Gln-Asn-Ser 
C16H21N5O2S 
C12H21N5O7 
√ 
√ 
1.87933 
1.3 
SF 
LSc* 
28 30.40 180.08572 180.08665 / C6H13NO5 √ 0.92752 SF 
29 30.94 200.97186 200.97130 / C4N4O4S √ 0.62554 SF 
30 31.48 175.11811 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.84382 
3.08 
SF 
LSc* 
30 31.53 147.11146 147.11280 
147.10888 
/ 
Lysine 
C6H14N2O2 
equivalent to SF 
√ 
√ 
1.34812 
2.58 
SF 
LSc* 
30 31.62 156.07685 156.07675 
156.07283 
/ 
Histidine 
C6H9N3O2 
equivalent to SF 
√ 
√ 
0.09272 
4.02 
SF 
LSc* 
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Supplementary figure 20: Base Peak chromatogram (BPC) of the negative MS/MS mode of SEC-fraction A6 
of sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 
20Supplementary table 10. 
 
Supplementary table 20: Results of the three calculation approaches for the most abundant signals (negative 
mode) in SEC-fraction A6 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 20. 
 RT  
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.55 68.99485 68.99875 / C3H2O2 / 3.35674 SF 
1 10.63 112.98516 112.98858 / C4H2O4 / 2.87179 SF 
2 11.12 61.98729  / / / / / 
3 17.26 128.03489 128.05387 / C5H7NO3 / 0.00452 SF 
4 24.25 180.06602 180.06717 Tyrosine C9H11NO3 / 0.59443 SF/SL 
5 28.27 127.05115 127.05185 
127.06641 
/ 
Diketo-Gly-Ala 
C5H8N2O2 
equivalent to SF 
√ 
√ 
0.15240 
15.26 
SF 
LSc* 
5 28.27 145.06200 145.06241 
145.06186 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
/ 
/ 
0.31764 
0.14 
SF 
LSc* 
6 31.42 173.10399 173.10495 Arginine C6H14N4O2 √ 0.41470 SF/SL 
6 31.58 154.06190 154.06275 Histidine C6H9N3O2 √ 0.29882 SF/SL 
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Supplementary figure 21: Base Peak chromatogram (BPC) of the positive MS/MS mode of SEC-fraction A6 of 
sample 3. The numbering of the peaks correlates with the numbering in Supplementary table 21Supplementary 
table 17Supplementary table 10. 
 
Supplementary table 21: Results of the three calculation approaches for the most abundant signals (positive 
mode) in SEC-fraction A6 of sample 3. Calculation approach 1 is SmartFormula (SF); calculation approach 2 
is done by operator Lars Schmidt (LSc) and calculation approach 3 is the automatic approach by Spectral 
Library (SL). The hook in the MS/MS column indicates that a mass spectrum was recorded, the strokes 
indicates signals without recorded mass spectrum. Equivalent to SF means that calculated molecular formula 
by operator is the same like the molecular formula calculated by SF. Substances detected in all three samples 
are highlighted in light green, substances detected in two of the three samples are highlighted in light orange 
and exclusively detected substances are highlighted in light blue. Numbering in the table correlates with the 
numbering of the corresponding Supplementary figure 21. 
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
1 10.17 245.12890 245.12845 
245.12902 
/ 
Diketo-Pro-Phe 
C14H16N2O2 
equivalent to SF 
√ 
√ 
0.44192 
0.12 
SF 
LSc* 
1 10.16 267.11081 267.11280 
267.10934 
/ 
Diketo-Glu-His 
C16H14N2O2 
C11H14N4O4 
√ 
√ 
1.99419 
1.47 
SF 
LSc* 
1 10.16 489.24972 489.24829 
489.25753 
/ 
Trp-Arg-Gln 
C27H36O8 
C22H32N8O5 
√ 
√ 
1.42481 
7.81 
SF 
LSc* 
1 10.16 511.23155 511.23261 / C29H34O8 √ 1.09050 SF 
2 10.67 229.10102 229.10053 
229.10109 
/ 
Diketo-Met-Pro 
C10H16N2O2S 
equivalent to SF 
√ 
√ 
0.49607 
0.07 
SF 
LSc* 
3 16.59 277.11852 277.11828 
277.11615 
/ 
Pyro-Glu-Phe 
C14H16N2O4 
equivalent to SF 
√ 
√ 
0.23736 
2.37 
SF 
LSc* 
4 16.8 231.1142 231.11674 Diketo-Met-Val C10H18N2O2S / 2.54 LSc* 
4 16.88 316.12918 316.12918 
316.12975 
/ 
Diketo-Glu-Trp 
C16H17N3O4 
equivalent to SF 
√ 
√ 
0.00207 
0.57 
SF 
LSc* 
5 17.31 259.09270 259.09246 
259.09507 
/ 
Pyro-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.23592 
2.37 
SF 
LSc* 
5 17.31 281.07445 281.07413 
281.09949 
/ 
Met-Met 
C8H8N8O4 
C10H20N2O3S2 
√ 
√ 
0.32068 
25.04 
SF 
LSc* 
5 17.32 539.15926 539.15943 / C25H32O9P2 √ 0.17504 SF 
6 17.72 413.18189 413.18195 
413.186 
/ 
Lys-Tyr-Cys 
C21H24N4O5 
C18H28N4O5S 
√ 
√ 
0.06064 
4.11 
SF 
LSc* 
6 17.93 293.11359 293.11320 
293.11376 
/ 
Diketo-/ 
C14H16N2O5 
equivalent to SF 
√ 
√ 
0.39455 
0.17 
SF 
LSc* 
6 17.94 585.21869 585.21912 / C28H32N4O10 √ 0.42514 SF 
6b 19.0 185.0919 185.09263 Diketo-Ser-Pro C8H12N2O3 / 0.73 LSc* 
7 19.94 209.09211 209.09207 / C10H12N2O3 √ 0.04511 SF 
7 19.92 226.11940 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.78357 
0.22 
SF 
LSc* 
7 19.93 248.10113 248.10028 / C8H9N9O √ 0.84565 SF 
7 20.29 212.10323 212.10297 
212.10353 
/ 
Diketo-Pro-Asn 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.26347 
0.3 
SF 
LSc* 
Attachment 158 
  
 RT 
[min] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Anno-
tations 
8 21.38 263.13931 263.13902 
263.13958 
263.1397 
/ 
Diketo-Tyr-Val 
Pro-Phe 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.29292 
0.27 
0.39 
SF 
LSc* 
LSc* 
8 21.38 285.12151 285.12068 
285.13516 
285.12002 
/ 
Diketo-His-Phe 
Glu-His 
C12H12N8O 
C15H16N4O2 
C11H16N4O5 
√ 
√ 
√ 
0.82910 
13.65 
1.49 
SF 
LSc* 
LSc* 
9 22.06 166.08774 166.08626 
166.08233 
/ 
Phenylalanine 
C9H11NO2 
equivalent to SF 
√ 
√ 
1.64081 
5.41 
SF 
LSc* 
9 22.12 331.16507 331.16523 
331.16189 
331.16189 
/ 
Gln-Pro-Ser 
Thr-Asn-Pro 
C18H22N2O4 
C13H22N4O6 
C13H22N4O6 
√ 
√ 
√ 
0.16774 
3.18 
3.18 
SF 
LSc* 
LSc* 
9 22.11 353.14694 353.14690 
353.14623 
/ 
Tyr-Asn-Gly 
C16H16N8O2 
C15H20N4O6 
√ 
√ 
0.04358 
0.71 
SF 
LSc* 
10 23.55 253.11867 253.11828 
253.11896 
253.11896 
/ 
Tyr-Ala 
Phe-Ser 
C12H16N2O4 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.38357 
0.29 
0.29 
SF 
LSc* 
LSc* 
10 23.59 279.13413 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.19349 
0.48 
SF 
LSc* 
11 24.6 147.0426 147.07250 Glutamine C5H10N2O3 / 29.9 LSc* 
11 24.57 165.05573 165.05462 / C9H8O3 √ 1.10529 SF 
11 24.57 182.08063 182.08117 
182.07725 
/ 
Tyrosine 
C9H11NO3 
equivalent to SF 
√ 
√ 
0.53901 
3.38 
SF 
LSc* 
11 24.66 221.09181 221.09207 
221.0926 
221.09612 
221.09612 
/ 
Diketo-Tyr-Gly 
Met-Ala 
Cys-Val 
C11H12N2O3 
C11H17N3O5 
C8H16N2O3S 
C8H16N2O3S 
√ 
√ 
√ 
√ 
0.25940 
0.79 
4.31 
4.31 
SF 
LSc* 
LSc* 
LSc* 
12 25.1 237.0870 237.09103 Met-Ser C8H16N2O4S / 4.03 LSc* 
12 25.08 254.16163 254.16115 
254.16115 
/ 
Diketo-Pro-Arg 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.48166 
0.48 
SF 
LSc* 
13 28.3 191.0399 191.04905 Diketo-Cys-Ser C6H10N2O3S / 9.15 LSc* 
13 28.4 147.0752 147.07638 Glutamine C5H10N2O3 / 1.18 LSc* 
13 28.40 169.05766 169.06242 / C5H13O4P √ 4.76644 SF 
14 31.52 175.11807 175.11895 
175.11503 
/ 
Arginine 
C6H14N4O2 
equivalent to SF 
√ 
√ 
0.87710 
3.86 
SF 
LSc* 
14 31.72 156.07669 156.07675 
156.07283 
/ 
Histidine 
C6H9N3O2 
equivalent to SF 
√ 
√ 
0.05813 
3.86 
SF 
LSc* 
 
All following results are based on the evaluated UPLC-HR-MS method (positive MS/MS mode). 
Measured sub-fractions were generated by the preparative HPLC. Each sub-fraction was reduced 
by the rotary evaporator resulting in an aqueous and an alcoholic phase. The aqueous phases were 
freeze dried and reconstituted with 600 µL ddH2O. Generated sample were analysed by the UPLC-
HRMS and measured in the positive MS and MS/MS mode. The goal was to determine if the 
developed prepHPLC method is feasible for the sub-fractionation of the SEC-fractions. 
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Supplementary figure 22: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 1 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 22. 
 
Supplementary table 22: Detected mass to charge ratios in sub-fraction 1 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 22Supplementary figure 28. 
Results highlighted in light green were also detected in the starting material. Results highlighted in light yellow 
were not detected in the sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 7.94 381.12877 381.12739 
381.12677 
/ 
Gln-Met-Cys 
C29H16O 
C13H24N4O5S2 
√ 
√ 
1.38211 
2.0 
SF 
LSc 
1 8.02 273.16579 273.16696 / C10H20N6O3 √ 1.17009 SF 
1 8.03 251.18371 251.18530 / C12H26O5 √ 1.59264 SF 
2 8.36 317.19198 317.19318 
317.19387 
/ 
Ala-Arg-Ala 
C12H24N6O4 
equivalent to SF 
√ 
√ 
1.19561 
1.89 
SF 
LSc 
2 8.37 295.20987 295.21152 / C14H30O6 √ 1.64479 SF 
3 8.73 361.21794 361.21939 
361.22008 
/ 
Ser-Val-Arg 
C14H28N6O5 
equivalent to SF 
√ 
√ 
1.45060 
2.14 
SF 
LSc 
3 8.73 339.23588 339.23773 / C16H34O7 √ 1.85334 SF 
3 8.73 356.26262 356.26293 / C13H29N11O √ 0.30965 SF 
4 9.13 405.24370 405.24561 / C16H32N6O6 √ 1.90609 SF 
4 9.14 400.28831 400.28781 / C14H37N7O6 √ 0.49855 SF 
4 9.14 383.26171 383.26260 / C15H30N10O2 √ 0.88290 SF 
5 11.22 326.37665 326.37813 / C22H47N √ 1.47774 SF 
5 11.40 135.00195 135.00115  C6H2N2S √ 0.80373 SF 
6 16.51 217.10314 217.10436 
217.10109 
/ 
Diketo-Cys-Ile 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
1.22710 
2.05 
SF 
LSc 
7 17.43 410.11515 410.11538 / C12H19N5O11 √ 0.23675 SF 
7 17.43 539.15798 539.15798 / C17H26N6O14 √ 1.04925 SF 
7 17.44 130.04902 130.04987 (R)-(+)-2-
Pyrrolidone-5-
carboxylic acid 
C5H7NO3 √ 0.84704 SF/SL 
8 21.40 215.13763 215.13902 Pro-Val C10H18N2O3 √ 1.38808 SF/SL 
9 21.59 229.15322 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
1.44380 
1.45 
SF 
LSc 
9 21.68 314.20572 314.20743 Val-Pro-Val C15H27N3O4 √ 1.71060 SF/SL 
10 21.98 132.10099 132.10191 L-Norleucine C6H13NO2 √ 0.91550 SF/SL 
10 22.26 132.10099 132.10191 L-Norleucine C6H13NO2 √ 0.91836 SF/SL 
11 23.00 132.10093 132.10191 L-Isoleucine C6H13NO2 √ 0.97033 SF/SL 
11 23.12 280.08879 280.09011 
280.09684 
/ 
Thr-Cys-Gly 
C8H9N9O3 
C9H17N3O5S 
√ 
√ 
1.32119 
8.05 
SF 
LSc 
11 23.13 258.10695 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
1.49794 
2.06 
SF 
LSc 
12 25.77 235.11718 235.11895 / C11H14N4O2 √ 1.77416 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
235.11951 Diketo-Pro-His equivalent to SF √ 2.33 LSc 
12 25.80 217.11653 217.11828 Pro-Thr C9H18N2O4 √ 1.74827 SF/SL 
12 26.06 205.11669 205.11828 Val-Ser C8H16N2O4 √ 1.59484 SF/SL 
12 26.08 200.97075 200.96958 / C5HN2O5P √ 1.16893 SF 
13 27.00 147.07491 147.07642 
147.07250 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
1.51317 
2.41 
SF 
LSc 
13 27.00 244.12733 244.12918 Pro-Gln C10H17N3O4 √ 1.85222 SF/SL 
13 27.00 266.10936 266.11085 / C8H11N9O2 √ 1.49124 SF 
 
 
Supplementary figure 23: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 2 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 23. 
 
Supplementary table 23: Detected mass to charge ratios in sub-fraction 2 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 23 Supplementary figure 28. 
Results highlighted in light green were also detected in the starting material. Results highlighted in light yellow 
were not detected in the sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 7.48 185.11431 185.11454 / C6H12N6O √ 0.22367 SF 
2 7.96 251.18478 251.18664 / C13H22N4O √ 1.85700 SF 
2 7.98 273.16666 273.16696 / C10H20N6O3 √ 0.30730 SF 
3 11.34 326.37766 326.37813 / C22H47N √ 0.46367 SF 
4 15.41 304.29929 304.29988 / C21H37N √ 0.59070 SF 
5 19.43 227.10159 227.10263 
227.1032 
/ 
Diketo-Glu-Pro 
C10H14N2O4 
equivalent to SF 
√ 
√ 
1.04553 
1.61 
SF 
LSc 
5 19.43 249.08365 249.08430 / C8H8N8O2 √ 0.64433 SF 
6 20.60 328.22206 328.22308 Pro-Val-Val C16H29N3O4 √ 1.02310 SF/SL 
7 21.24 263.13783 263.13902 L-phenylalanyl-
L-Proline 
C14H18N2O3 √ 1.19093 SF/SL 
8 30.02 156.98132 156.97976 / C4HN2O3P √ 1.56794 SF 
8 30.02 200.97158 200.97130 / C4H4O4S √ 0.27552 SF 
8 30.04 182.96118 182.95690 / C7H2O2S2 √ 4.28051 SF 
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Supplementary figure 24: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 3 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 24. 
 
Supplementary table 24: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 24 Supplementary figure 28. 
Results highlighted in light green were also detected in the starting material. Results highlighted in light yellow 
were not detected in the sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 4.67 326.37770 326.37813 / C22H47N √ 0.42374 SF 
2 6.67 493.34906 493.35102 / C26H40N10 √ 1.96060 SF 
2 6.89 521.38006 521.38116 / C35H52OS √ 1.10285 SF 
3 7.96 185.11422 185.11454 / C6H12N6O √ 0.31923 SF 
4 9.26 304.29899 304.29988 / C21H37N √ 0.89050 SF 
5 11.26 267.11970 267.12001 / C10H14N6O3 √ 0.31658 SF 
6 17.86 243.13322 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.70937 
1.28 
SF 
LSc 
6 17.86 485.25949 485.25924 
485.25138 
/ 
Arg-Tyr-Phe 
C19H28N14O2 
C24H32N6O5 
√ 
√ 
0.24566 
8.11 
SF 
LSc 
6 17.87 197.12783 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.62445 
1.19 
SF 
LSc 
7 18.76 340.18605 340.18567 
340.19401 
/ 
Ile-His-Ala 
C10H26N7O4P 
C15H25N5O4 
√ 
√ 
0.38047 
7.96 
SF 
LSc 
7 18.80 132.10158 132.10191 
132.09798 
/ 
Isoleucine 
C6H13NO2 
equivalent to SF 
√ 
√ 
0.32315 
3.6 
SF 
LSc 
8 19.11 343.29496 343.29552 / C19H38N2O3 √ 0.56391 SF 
8 19.12 240.23167 240.23219 / C15H29NO √ 0.52096 SF 
9 21.22 342.23827 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.46036 SF/SL 
10 21.74 362.20701 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.42331 SF/SL 
11 22.71 120.08052 120.08078 / C8H9N √ 0.25330 SF 
11 22.72 263.13838 263.13902 L-phenylalanyl-
L-proline 
C14H18N2O3 √ 0.63977 SF/SL 
12 32.22 182.96139 182.96027 / C4H6O2S3 √ 1.12496 SF 
12 32.27 200.97183 200.97130 / C4N4O4S √ 0.52696 SF 
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Supplementary figure 25: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 4 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 25. 
 
Supplementary table 25: Detected mass to charge ratios in sub-fraction 4 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 25 Supplementary figure 28. 
Results highlighted in light green were also detected in the starting material. Results highlighted in light yellow 
were not detected in the sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 7.54 185.11428 185.11454 / C6H12N6O √ 0.25569 SF 
2 11.10 326.37784 326.37813 / C22H47N √ 0.28552 SF 
3 11.76 304.29953 304.29988 / C21H37N √ 0.34965 SF 
4 17.89 166.08592 166.08626 
166.08233 
/ 
Phenylalanine 
C9H11NO2 
equivalent to SF 
√ 
√ 
0.33271 
3.59 
SF 
LSc 
4 17.89 209.09146 209.09207 / C10H12N2O3 √ 0.60821 SF 
4 17.89 374.17104 374.17105 / C19H23N3O5 √ 0.01011 SF 
5 18.30 240.23205 240.23219 / C15H29NO √ 0.14239 SF 
6 18.63 263.13865 263.13902 
263.13958 
/ 
Diketo-Tyr-Val 
C14H18N2O3 
equivalent to SF 
√ 
√ 
0.36873 
0.93 
SF 
LSc 
6 18.63 471.22370 471.22381 / C24H30N4O6 √ 0.11084 SF 
6 18.63 493.20540 493.20681 / C23H20N14 √ 1.41627 SF 
7 18.88 229.15413 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.53406 
1.22 
SF 
LSc 
8 31.74 155.97414 155.97499 / C5HNO3S √ 0.84926 SF 
8 31.77 182.96162 182.95690 / C7H2O2S2 √ 4.72405 SF 
8 31.78 200.97201 200.97130 / C4N4O4S √ 0.71245 SF 
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Supplementary figure 26: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 5 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 26. 
 
Supplementary table 26: Detected mass to charge ratios in sub-fraction 5 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 26 Supplementary figure 28. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 11.04 326.37774 326.37813 / C22H47N √ 0.38821 SF 
2 11.63 304.29930 304.29988 / C21H37N √ 0.58034 SF 
3 15.24 332.33055 332.33118 / C23H41N √ 0.62879 SF 
4 18.21 240.23159 240.23219 / C15H29NO √ 0.60102 SF 
4 18.22 343.29481 343.29552 / C19H38N2O3 √ 0.71222 SF 
5 31.60 182.96127 182.95690 / C7H2O2S2 √ 4.36767 SF 
5 31.60 200.97169 182.97130 / C4N4O4S √ 0.39209 SF 
5 31.74 155.97370 155.97499 / C5HNO3S √ 1.29290 SF 
 
 
Supplementary figure 27: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 6 of SEC-A5 from sample 1. The numbering of the peaks correlates with the 
numbering in Supplementary table 27. 
 
Supplementary table 27: Detected mass to charge ratios in sub-fraction 6 of SEC-A5 sample 1. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 27 Supplementary figure 28. 
Results highlighted in light yellow were not detected in the sub-fractionated SEC-fraction but at least in one of 
the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 8.59 273.16639 273.16696 / C10H20N6O3 √ 0.26998 SF 
2 10.55 326.37751 326.37813 / C22H47N √ 0.61859 SF 
3 11.52 304.29942 304.29988 / C21H37N √ 0.45389 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
3 11.67 468.41927 468.41999 / C32H53NO √ 0.72545 SF 
4 12.50 521.38021 521.37964 / C26H52N2O8 √ 0.56719 SF 
5 31.90 200.97152 200.96958 / C5HN2O5P √ 1.93433 SF 
5 31.91 182.96117 182.95690 / C7H2O2S2 √ 4.27727 SF 
 
 
Supplementary figure 28: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 1 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 28. 
 
Supplementary table 28: Detected mass to charge ratios in sub-fraction 1 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 28. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.78 149.06002 149.05971 / C9H8O2 √ 0.31122 SF 
2 6.42 271.18820 271.18770 / C11H22N6O2 √ 0.49628 SF 
2 6.45 303.08477 303.08381 / C20H14OS √ 0.95740 SF 
2 6.42 379.21029 379.21017 
379.20951 
/ 
Phe-Arg-Gly 
C18H22N10 
C17H26N6O4 
√ 
√ 
0.12690 
0.66 
SF 
LSc 
3 6.79 315.17790 315.17887 
315.18212 
/ 
Diketo-Trp-Lys 
C13H18N10 
C17H22N4O2 
√ 
√ 
0.96948 
3.25 
SF 
LSc 
3 6.94 257.13613 257.13566 / C9H16N6O3 √ 0.46688 SF 
4 7.18 233.07849 233.07815 / C9H8N6O2 √ 0.34299 SF 
5 7.73 229.14131 229.14075 / C8H16N6O2 √ 0.56378 SF 
5 7.86 381.13138 381.13326 
381.12677 
/ 
Gln-Met-Cys 
C22H20O6 
C13H24N4O5S2 
√ 
√ 
1.88445 
6.49 
SF 
LSc 
5 7.73 505.33681 505.33576 / C23H40N10O3 √ 1.04825 SF 
6 7.95 251.18591 251.18530 / C12H26O5 √ 0.61377 SF 
6 7.95 273.16767 273.16696 / C10H20N6O3 √ 0.70592 SF 
6 8.00 447.29370 447.29555 / C18H39N8O3P √ 1.85008 SF 
7 8.79 194.11551 194.11487 / C7H11N7 √ 0.64093 SF 
7 8.73 273.16769 273.16696 / C10H20N6O3 √ 0.72698 SF 
7 8.73 365.19409 365.19452 / C17H20N10 √ 0.42946 SF 
8 9.34 267.12069 267.12001 / C10H14N6O3 √ 0.67872 SF 
8 9.41 299.14664 299.14757 / C12H14N10 √ 0.92623 SF 
9 9.73 259.15195 259.15131 / C9H18N6O3 √ 0.63096 SF 
10 10.05 195.08777 195.08765 
195.0882 
/ 
Diketo-His-Gly 
C8H10N4O2 
equivalent to SF 
√ 
√ 
0.12161 
0.43 
SF 
LSc 
10 10.05 215.12555 215.12510 / C7H14N6O2 √ 0.45025 SF 
10 10.15 455.22543 455.22621 / C20H26N10O3 √ 0.78227 SF 
11 10.34 387.19927 387.20000 
387.19935 
/ 
Asp-Arg-Pro 
C16H22N10O2 
C15H26N6O6 
√ 
√ 
0.73003 
0.08 
SF 
LSc 
165  Attachment 
 
 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
11 10.53 625.32065 625.32119 / C22H40N16O4S √ 0.53724 SF 
11 10.54 455.22957 455.22786 / C18H31N8O4P √ 1.89730 SF 
11 10.74 441.21098 441.21056 
441.21393 
/ 
Phe-Phe-Gln 
C19H24N10O3 
C23H28N4O5 
/ 
/ 
0.42105 
2.95 
SF 
LSc 
11 10.88 245.13585 245.13566 / C8H16N6O3 √ 0.18127 SF 
11 10.87 519.27794 519.27646 
519.27212 
/ 
Trp-Trp-Gln 
C23H43N4O5PS 
C27H30N6O5 
√ 
√ 
1.48236 
5.82 
SF 
LSc 
11 10.88 514.32284 514.32218 / C21H35N15O √ 0.66321 SF 
12 13.46 219.17443 219.17434 / C15H22O √ 0.08738 SF 
13 16.07 217.10487 217.10436 
217.10109 
/ 
Diketo-Ile-Cys 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.50301 
3.78 
SF 
LSc 
14 16.65 261.13107 261.13192 
261.1239 
/ 
Diketo-Tyr-Pro 
C9H12N10 
C14H16N2O3 
√ 
√ 
0.84816 
7.17 
SF 
LSc 
14 16.72 239.14946 239.15025 / C11H18N4O2 √ 0.79344 SF 
15 16.92 305.15749 305.15813 / C11H16N10O √ 0.63935 SF 
15 16.93 283.17561 283.17647 / C13H22N4O3 √ 0.85346 SF 
15 17.02 301.28550 301.28495 / C17H36N2O2 √ 0.54306 SF 
16 17.30 130.05010 130.04987 / C5H7NO3 √ 0.23091 SF 
16 17.30 539.16103 539.16066 / C21H30O16 √ 0.37092 SF 
17 17.51 393.21076 393.20922 
393.21393 
/ 
Phe-Ile-Asn 
C14H28N6O7 
C19H28N4O5 
√ 
√ 
1.54124 
3.17 
SF 
LSc 
17 17.52 209.09245 209.09207 / C10H12N2O3 √ 0.38642 SF 
17 17.52 227.10300 227.10397 
227.1032 
/ 
Diketo-Glu-Pro 
C11H10N6 
C10H14N2O4 
√ 
√ 
0.96910 
0.2 
SF 
LSc 
18 18.10 240.23248 240.23219 / C15H29NO √ 0.29343 SF 
18 18.10 343.29622 343.29552 / C19H38N2O3 √ 0.69996 SF 
18 18.12 195.07707 195.07642 / C9H10N2O3 √ 0.65371 SF 
19 19.07 185.09239 185.09207 
185.09263 
/ 
Diketo-Ser-Pro 
C8H12N2O3 
equivalent to SF 
√ 
√ 
0.32417 
0.24 
SF 
LSc 
20 19.35 453.19946 453.20067 / C22H20N12 √ 1.20103 SF 
20 19.36 227.10310 227.10263 
227.1032 
/ 
Diketo-Glu-Pro 
C10H14N2O4 
equivalent to SF 
√ 
√ 
0.46748 
0.1 
SF 
LSc 
20 19.37 249.08490 249.08296 / C7H12N4O6 √ 1.94404 SF 
21 19.66 245.18626 245.18597 Ile-Ile C12H24N2O3 √ 0.29593 SF/SL 
22 20.05 209.09236 209.09207 / C10H12N2O3 √ 0.28929 SF 
22 20.05 248.10100 248.10297 / C12H13N3O3 √ 1.96783 SF 
22 20.18 263.13939 263.13902 Pro-Phe C14H18N2O3 √ 0.36982 SF/SL 
23 20.34 229.15476 229.15467 Pro-Ile C11H20N2O3 √ 0.08682 SF/SL 
23 20.37 259.09289 259.09380 
259.09322 
/ 
pyro-Glu-Glu 
C11H10N6O2 
C10H14N2O6 
√ 
√ 
0.92597 
0.33 
SF 
LSc 
23 20.38 281.07422 281.07413 / C8H8N8O4 √ 0.09364 SF 
24 20.99 328.22410 328.22308 Ile-Pro-Val C16H29N3O4 √ 1.01373 SF/SL 
25 21.37 215.13921 215.13902 Pro-Val C10H18N2O3 √ 0.18799 SF/SL 
26 21.59 229.15491 229.15467 / C11H20N2O3 √ 0.24212 SF 
26 21.63 314.20782 314.20743 Val-Pro-Val C15H27N3O4 √ 0.38509 SF/SL 
26 21.71 203.13926 203.13902 Ala-dl-Leu C9H18N2O3 √ 0.24286 SF/SL 
26 21.71 157.13387 157.13354 / C8H16N2O √ 0.33293 SF 
27 21.98 132.10214 132.10191 L-Norleucine C6H13NO2 √ 0.23805 SF/SL 
27 21.98 263.19726 263.19653 / C12H26N2O4 √ 0.72811 SF 
27 22.00 285.17930 285.18088 / C14H24N2O4 √ 1.58048 SF 
28 22.19 261.14444 261.14450 Glu-Leu C11H20N2O5 √ 0.05816 SF/SL 
28 22.27 189.12356 189.12337 
189.12405 
Gly-Ile 
Val-Ala 
C8H16N2O3 
C8H16N2O3 
√ 
√ 
0.18746 
0.49 
SF/SL 
LSc 
28 22.57 215.13925 215.13902 
215.1396 
/ 
Diketo-Thr-Ile 
C10H18N2O3 
equivalent to SF 
√ 
√ 
0.23497 
0.35 
SF 
LSc 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
29 22.96 148.06084 148.06043 
148.05651 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
√ 
√ 
0.40922 
4.33 
SF 
LSc 
29 22.96 261.14465 261.14450 Ile-Glu C11H20N2O5 √ 0.14726 SF/SL 
30 23.30 358.19784 358.19726 Ile-Pro-Glu C16H27N3O6 √ 0.57516 SF/SL 
30 23.34 261.14429 261.14450 Ile-Glu C11H20N2O5 √ 0.21098 SF/SL 
30 23.35 215.13908 215.13902 / 
Pro-Val 
C10H18N2O3 
detected twice.  
√ 0.05839 SF 
31 23.81 219.13422 219.13527 
219.13461 
/ 
Ile-Ser 
C10H14N6 
C9H18N2O4 
√ 
√ 
1.04695 
0.39 
SF 
LSc 
31 23.82 229.11845 229.11962 
229.11885 
/ 
Diketo-Glu-Val 
C11H12N6 
C10H16N2O4 
√ 
√ 
1.17109 
0.4 
SF 
LSC 
31 23.84 330.20286 330.20235 Leu-Pro-Thr C15H27N3O5 √ 0.50886 SF/SL 
32 24.55 148.06077 148.06043 
148.05651 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
√ 
√ 
0.33221 
4.26 
SF 
LSc 
32 24.57 247.12925 247.12885 Val-Glu C10H18N2O5 √ 0.40426 SF/SL 
33 24.81 175.10779 175.10772 Val-Gly 
Detected in SEC but not 
identified 
C7H14N2O3 √ 0.07312 SF/SL 
34 25.24 245.11350 245.11320 Pro-Glu C10H16N2O5 √ 0.30692 SF/SL 
34 25.31 233.11334 233.11320 Val-Asp C9H16N2O5 √ 0.14622 SF/SL 
35 25.53 235.11895 235.11895 
235.11951 
/ 
Diketo-His-Pro 
C11H14N4O2 
equivalent to SF 
√ 
√ 
0.00099 
0.56 
SF 
LSc 
35 25.67 310.12898 310.12985 / C16H15N5O2 √ 0.86938 SF 
36 25.89 173.09271 173.09207 Pro-Gly C7H12N2O3 √ 0.63690 SF/SL 
36 25.97 217.11847 217.11828 Pro-Thr C9H16N2O4 √ 0.18504 SF/SL 
36 26.01 276.14455 276.14550 / C13H17N5O2 √ 0.95078 SF 
36 26.11 205.11852 205.11828 Val-Ser C8H16N2O4 √ 0.24072 SF/SL 
36 26.13 201.08715 201.08698 
201.08755 
/ 
Diketo-Glu-Ala 
C8H12N2O4 
equivalent to SF 
√ 
√ 
0.17031 
0.4 
SF 
LSc 
37 26.64 259.09299 259.09380 
259.09322 
/ 
pyro-Glu-Glu 
C11H10N6O2 
C10H14N2O6 
√ 
√ 
0.81134 
0.23 
SF 
LSc 
38 27.92 148.06067 148.06043 
148.05651 
/ 
Glutamic acid 
C5H9NO4 
equivalent to SF 
√ 
√ 
0.23210 
4.16 
SF 
LSc 
38 27.92 235.09269 235.09246 Ser-Glu C8H14N2O6 √ 0.22953 SF/SL 
39 28.34 147.07665 147.07642 
147.07250 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.23229 
4.05 
SF 
LSc 
39 28.36 258.10860 258.10978 
258.10901 
/ 
Diketo-Glu-
Gln 
C11H11N7O 
C10H15N3O5 
√ 
√ 
1.17972 
0.41 
SF 
LSc 
39 28.36 276.11939 276.11901 
276.1197 
Glu-Gln 
Ala-Asp-Ala 
C10H17N3O6 
C10H17N3O6 
√ 
√ 
0.37877 
0.31 
SF/SL 
LSc 
40 28.75 166.05324 166.05324 L-Methionine 
S-oxide 
C5H11NO3S √ 0.00266 SF/SL 
41 30.35 162.07614 162.07608 / C6H11NO4 √ 0.05486 SF 
41 30.36 180.08675 180.08665 / C6H13NO5 √ 0.10078 SF 
42 30.82 200.97242 200.97130 / C4N4O4S √ 1.12019 SF 
42 30.82 156.98229 156.97976 / C4HN2O3P √ 2.53130 SF 
42 30.82 182.96188 182.95690 / C7H2O2S2 √ 4.98544 SF 
43 31.32 147.11284 147.11280 
147.10888 
/ 
Lysine 
C6H14N2O2 
equivalent to SF 
√ 
√ 
0.03383 
3.96 
SF 
LSc 
43 31.31 175.11894 175.11895 L-Arginine C6H14N4O2 √ 0.01493 SF/SL 
43 31.41 156.07675 156.07675 
156.07283 
/ 
Histidine 
C6H9N3O2 
equivalent to SF 
√ 
√ 
0.00343 
3.92 
SF 
LSc 
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Supplementary figure 29: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 2 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 29. 
 
Supplementary table 29: Detected mass to charge ratios in sub-fraction 2 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 29. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.82 149.05997 149.05971 / C9H8O2 √ 0.26635 SF 
1 5.82 337.10471 337.10436 / C16H12N6O3 √ 0.34431 SF 
1 5.83 381.13222 381.13192 / C19H12N10 √ 0.30393 SF 
2 6.6 261.1105 / / / / / / 
3 7.23 233.07866 233.07815 / C9H8N6O2 √ 0.51410 SF 
4 7.53 185.11528 185.11722 / C10H16O3 √ 1.93999 SF 
5 7.79 229.14124 229.14075 / C8H16N6O2 √ 0.48992 SF 
5 7.94 359.14948 359.15025 
359.15681 
/ 
Glu-Pro-Asn 
C21H18N4O2 
C14H22N4O7 
√ 
√ 
0.76759 
6.56 
SF 
LSc 
5 7.94 376.17558 376.17680 
376.17213 
/ 
Glu-Asp-Ile 
C21H21N5O2 
C15H25N3O8 
√ 
√ 
1.22472 
4.67 
SF 
LSc 
5 7.94 381.13104 381.13192 
381.12677 
/ 
Gln-Met-Cys 
C19H21N10 
C13H24N4O5S2 
√ 
√ 
0.87829 
5.15 
SF 
LSc 
5 8.03 273.16775 273.16696 / C10H20N6O3 √ 0.78176 SF 
6 8.83 273.16775 273.16696 / C10H20N6O3 √ 0.62387 SF 
7 10.18 215.12601 215.12779 / C11H18O4 √ 1.77698 SF 
8 10.65 625.32130 625.32319 / C33H44N4O8 √ 1.89136 SF 
8 10.66 603.33919 603.33946 / C23H52N6O8P2 √ 0.27080 SF 
8 10.66 620.36545 620.36504 / C18H50N15O5P
S 
√ 0.40545 SF 
8 10.78 611.30479 611.30620 / C31H46O12 √ 1.41231 SF 
8 10.84 597.28971 597.28817 / C21H37N14O5P √ 1.53324 SF 
8 10.88 231.12110 231.12270 
231.11674 
/ 
Diketo-Met-Val 
C11H18O5 
C10H18N2O2S 
√ 
√ 
1.60199 
4.36 
SF 
LSc 
8 10.91 198.14922 198.14886 / C11H19NO2 √ 0.36461 SF 
8 11.03 285.13146 285.13192 
285.13516 
/ 
Diketo-Phe-His 
C11H12N10 
C15H16N4O2 
√ 
√ 
0.45328 
3.7 
SF 
LSc 
9 16.38 217.10515 217.10705 
217.10109 
/ 
Diketo-Ile-Cys 
C10H16O5 
C9H16N2O2S 
√ 
√ 
1.89880 
4.03 
SF 
LSc 
10 17.27 229.11885 229.11828 
229.11885 
/ 
Diketo-Glu-Val 
C10H16N2O4 
equivalent to SF 
√ 
√ 
0.56697 
0.00 
SF 
LSc 
10 17.32 130.05044 130.04987 / C5H7NO3 √ 0.57359 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
11 18.16 240.23290 240.23219 / C15H29NO √ 0.70760 SF 
11 18.16 343.29626 343.29552 / C19H38N2O3 √ 0.74333 SF 
12 18.51 326.17238 326.17238 / C16H19N7O √ 0.52933 SF 
13 19.38 227.10310 227.10397 
227.1032 
/ 
Diketo-Glu-Pro 
C11H10N6 
C10H14N2O4 
√ 
√ 
0.86928 
0.1 
SF 
LSc 
13 19.38 453.20120 453.20270 
453.20991 
/ 
Arg-Tyr-Asp 
C18H28N8O4S 
C19H28N6O7 
√ 
√ 
1.49366 
8.71 
SF 
LSc 
14 19.65 245.18644 245.18597 Ile-Ile C12H24N2O3 √ 0.46971 SF/SL 
15 20.84 328.22372 328.22308 Val-Pro-Leu C16H29N3O4 √ 0.63431 SF/SL 
15 20.85 229.15500 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.33186 
0.35 
SF 
LSc 
16 21.29 392.21910 392.21800 Pro-Ile-Tyr C20H29N3O5 √ 1.10544 SF/SL 
16 21.73 263.13934 263.13902 Phe-Pro C14H18N2O3 √ 0.32508 SF/SL 
17 21.92 229.15510 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.43523 
0.25 
SF 
LSc 
17 22.08 334.17666 334.17613 Pro-Ala-Phe C17H23N3O4 √ 0.52434 SF/SL 
18 22.40 277.11830 277.11962 
227.11828 
/ 
pyro-Glu-Phe 
C15H12N6 
C11H20N2O3 
√ 
√ 
1.31718 
0.02 
SF 
LSc 
18 22.60 485.18894 285.18697 / C22H32N2O6PS √ 1.96847 SF 
19 28.29 145.04997 145.04954 / C6H8O4 √ 0.43282 SF 
19 28.30 163.06042 163.06010 / C6H10O5 / 0.32340 SF 
19 28.30 365.10618 365.10784 / C14H20O11 √ 1.66170 SF 
20 31.31 200.97273 200.97130 / C4N4O4S √ 1.42960 SF 
20 31.32 155.97479 155.97499 / C5HNO3S √ 0.20345 SF 
 
 
Supplementary figure 30: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 3 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 30. 
 
Supplementary table 30: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 30. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.81 149.05942 149.05971 / C9H8O2 √ 0.28767 SF 
1 5.81 337.10400 337.10436 / C16H12N6O3 √ 0.36305 SF 
1 5.82 381.12991 381.13058 
381.12677 
/ 
Gln-Met-Cys 
C18H16N6O4 
C13H24N4O5S2 
√ 
√ 
0.66496 
3.14 
SF 
LSc 
2 6.44 271.18746 271.18770 / C11H22N6O2 √ 0.23807 SF 
3 6.98 257.13569 257.13566 / C9H16N6O3 √ 0.02196 SF 
4 7.22 233.07791 233.07815 / C9H8N6O2 √ 0.24368 SF 
5 7.77 207.15869 207.15909 / C10H22O4 √ 0.39391 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
5 7.77 229.14066 229.14075 / C8H16N6O2 √ 0.09315 SF 
5 7.93 376.17485 376.17296 
376.17213 
/ 
Glu-Asp-Ile 
C24H25NOS 
C25H25N3O8 
√ 
√ 
1.88609 
0.83 
SF 
LSc 
6 8.02 251.18527 251.18664 / C13H22N4O √ 1.36385 SF 
6 8.03 273.16685 273.16696 / C10H20N6O3 √ 0.11741 SF 
7 8.86 365.19260 365.19452 / C17H20N10 √ 1.91997 SF 
7 8.90 308.18565 308.18697 / C18H21N5 √ 1.32050 SF 
8 9.70 211.14357 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.53592 
1.1 
SF 
LSc 
8 9.81 259.15097 259.15131 / C9H18N6O3 √ 0.34483 SF 
9 10.12 211.14358 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.52269 
1.09 
SF 
LSc 
9 10.17 215.12485 215.12510 / C7H14N6O2 √ 0.24533 SF 
10 10.81 197.12822 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.23433 
0.8 
SF 
LSc 
10 10.85 231.11976 231.12001 
231.11674 
/ 
Diketo-Met-Val 
C7H14N6O3 
C10H18N2O2S 
√ 
√ 
0.25006 
3.02 
SF 
LSc 
10 11.14 210.10962 210.10978 / C7H11N7O √ 0.16698 SF 
11 16.35 217.10432 217.10436 
217.10109 
/ 
Diketo-Ile-Cys 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.04125 
3.23 
SF 
LSc 
12 16.68 197.12798 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.46944 
1.04 
SF 
LSc 
12 16.68 243.1335 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.41593 
1.0 
SF 
LSc 
12 16.81 261.13049 261.13192 
261.1239 
/ 
Diketo-Tyr-Pro 
C9H12N10 
C14H16N2O3 
√ 
√ 
1.42744 
6.59 
SF 
LSc 
13 17.74 340.18683 340.18803 / C17H33N7O √ 1.20393 SF 
13 17.76 132.10184 132.10191 
132.09798 
/ 
Leu; Ile 
C6H13NO2 
equivalent to SF 
√ 
√ 
0.06444 
3.86 
SF 
LSc 
14 18.95 182.08112 182.08117 
182.07725 
/ 
Tyr 
C9H11NO3 
equivalent to SF 
√ 
√ 
0.05125 
3.87 
SF 
LSc 
14 18.96 390.16529 390.16461 
390.16262 
/ 
Glu-Gln-Asn 
C16H15N13 
C14H23N5O8 
√ 
√ 
0.67492 
1.37 
SF 
LSc 
14 19.00 229.15398 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.09315 
1.37 
SF 
LSc 
15 19.72 598.29833 598.29704 / C28H43N3O11 √ 1.29309 SF 
16 20.00 342.23837 342.23873 Leu-Pro-Ile C17H31N3O4 √ 0.36617 SF/SL 
17 20.63 362.20722 362.20743 Val-Pro-Phe C19H27N3O4 √ 0.21176 SF/SL 
18 21.29 505.26584 505.26483 / C27H41N2O3PS √ 1.01485 SF 
19 21.68 263.13883 263.13902 Phe-Pro C14H18N2O3 √ 0.18533 SF/SL 
20 22.64 489.23412 489.23303 / C21H24N14O √ 1.09457 SF 
21 28.29 145.04933 145.05087 / C7H4N4 √ 1.54012 SF 
22 31.29 182.96171 182.95690 / C7H2O2S2 √ 4.81172 SF 
22 31.30 200.97214 200.97130 / C4H4O4S √ 0.84178 SF 
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Supplementary figure 31: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 4 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 31. 
 
Supplementary table 31: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 31. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.77 149.05932 149.05971 / C9H8O2 √ 0.38324 SF 
1 5.77 337.10395 337.10436 / C16H12N6O3 √ 0.41349 SF 
1 5.78 381.13037 381.13058 
381.12677 
/ 
Gln-Met-Cys 
C18H16N6O4 
C13H24N4O5S2 
√ 
√ 
0.20949 
3.6 
SF 
LSc 
2 7.18 233.07784 233.07815 / C9H8N6O2 √ 0.30616 SF 
3 7.45 185.11449 185.11454 / C6H12N6O √ 0.04509 SF 
3 7.48 279.09309 279.09167 
279.0981 
/ 
Diketo-Asp-Tyr 
C20H10N2 
C13H14N2O5 
√ 
√ 
1.41931 
5.01 
SF 
LSc 
4 7.97 273.16657 273.16696 / C10H20N6O3 √ 0.39090 SF 
4 7.98 251.18478 251.18664 / C13H22N4O √ 1.85310 SF 
5 8.80 273.16653 273.16696 / C10H20N6O3 √ 0.43808 SF 
6 10.10 195.08693 195.08765 
195.0882 
/ 
Diketo-His-Gly 
C8H10N4O2 
equivalent to SF 
√ 
√ 
0.71915 
1.27 
SF 
LSc 
6 10.11 215.12477 215.12510 / C7H14N6O2 √ 0.32502 SF 
7 10.90 121.96594 / / / √ / / 
7 10.91 144.98174 144.98550 / C7N2S √ 3.75294 SF 
7 10.93 245.13610 245.13566 
245.12902 
/ 
/ 
C8H16N6O3 
C14H16N2O2 
√ 
√ 
0.43925 
7.08 
SF 
LSc 
8 11.10 210.10985 210.10978 / C7H11N7O √ 0.06274 SF 
9 16.30 217.10443 217.10436 
217.10109 
/ 
Diketo-Ile-Cys 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.06580 
3.34 
SF 
LSc 
10 17.69 166.08618 166.08626 
166.08233 
/ 
Phe 
C9H11NO2 
equivalent to SF 
√ 
√ 
0.07751 
3.85 
SF 
LSc 
10 17.69 374.17073 374.17238 / C20H19N7O √ 1.65560 SF 
11 18.12 240.23161 240.23219 / C15H29NO √ 0.57856 SF 
11 18.12 343.29544 343.29552 / C19H38N2O3 √ 0.07428 SF 
12 18.44 263.13901 263.13902 
263.13958 
263.1397 
/ 
Diketo-Tyr-Val 
Pro-Phe 
C14H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.00468 
0.57 
0.69 
SF 
LSc 
LSc 
12 18.44 471.22390 471.22515 / C25H26N8O2 √ 1.24686 SF 
13 18.72 229.15444 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.22872 
0.91 
SF 
LSc 
14 28.24 365.10500 365.10649 / C11H12N10O5 √ 1.49350 SF 
14 28.25 145.04936 145.04954 / C6H8O4 / 0.17785 SF 
14 28.25 163.05988 163.06144 / C7H6N4O √ 1.55522 SF 
15 31.25 156.98222 156.97976 / C4HN2O3P / 2.46804 SF 
15 31.27 182.96165 182.95690 / C7H2O2S2 √ 4.75169 SF 
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Supplementary figure 32: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 5 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 32. 
 
Supplementary table 32: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 32. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.72 323.14587 323.14623 / C13H18N6O4 √ 0.36372 SF 
2 6.46 271.18742 271.18770 / C11H22N6O2 √ 0.28360 SF 
3 7.53 279.09251 279.09167 
279.0981 
/ 
Diketo-Asp-Tyr 
C20H10N2 
C13H14N2O5 
√ 
√ 
0.83185 
5.59 
SF 
LSc 
3 7.54 228.19528 228.19581 / C13H25NO2 √ 0.52365 SF 
3 7.55 250.17747 250.17747 / C11H19N7 √ 0.00373 SF 
4 7.92 381.12985 381.13058 
381.12677 
/ 
Gln-Met-Cys 
C18H16N6O4 
C13H24N4O5S2 
√ 
√ 
0.72680 
3.08 
SF 
LSc 
4 7.93 359.14816 359.14623 
359.15681 
/ 
Glu-Pro-Asn 
C16H18N6O4 
C14H22N4O7 
√ 
√ 
1.93416 
8.65 
SF 
LSc 
4 7.93 376.17406 376.17546 
376.17213 
/ 
Glu-Asp-Ile 
C20H25NO6 
C15H25N3O8 
√ 
√ 
1.40369 
1.93 
SF 
LSc 
5 8.81 273.16670 273.16696 / C10H20N6O3 √ 0.26724 SF 
6 10.14 195.08749 195.08765 
195.0882 
/ 
Diketo-His-Gly 
C8H10N4O2 
equivalent to SF 
√ 
√ 
0.16485 
0.71 
SF 
LSc 
6 10.15 215.12479 215.12510 / C7H14N6O2 √ 0.31372 SF 
7 10.34 226.17967 226.18016 / C13H23NO2 √ 0.48358 SF 
7 10.34 266.17208 266.17238 / C11H19N7O √ 0.30843 SF 
8 10.73 212.16403 212.16451 / C12H21NO2 √ 0.47507 SF 
9 10.97 245.13594 245.13585 
245.13239 
/ 
Diketo-Met-Ile 
C16H20S 
C11H20N2O2S 
√ 
√ 
0.09487 
3.55 
SF 
LSc 
9 11.00 201.10929 201.10945 / C6H12N6O2 √ 0.16368 SF 
10 15.35 174.05468 174.05495 / C10H7NO2 √ 0.26996 SF 
11 16.38 217.10434 217.10436 
217.10109 
/ 
Diketo-Ile-Cys 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.02660 
3.25 
SF 
LSc 
12 17.36 130.04990 130.04987 / C5H7NO3 √ 0.03023 SF 
13 18.16 240.23215 240.23219 / C15H29NO √ 0.04396 SF 
14 18.66 316.21207 316.21319 / C17H25N5O √ 1.11254 SF 
15 19.21 180.13816 180.13829 / C11H17NO √ 0.13008 SF 
16 22.34 166.08628 166.08626 
166.08233 
/ 
Phe 
C9H11NO2 
equivalent to SF 
√ 
√ 
0.02382 
3.95 
SF 
LSc 
17 31.30 200.97227 200.97130 / C4H4O4S √ 0.96633 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
17 31.32 182.96165 182.96027 / C4H6O2S3 √ 1.38018 SF 
 
 
Supplementary figure 33: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 5 of SEC-A5 from sample 2. The numbering of the peaks correlates with the 
numbering in Supplementary table 33. 
 
Supplementary table 33: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 2. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 33. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 5.86 149.05944 149.05971 / C9H8O2 √ 0.27011 SF 
1 5.86 337.10419 337.10436 / C16H12N6O3 √ 0.17098 SF 
2 7.29 233.07816 233.07815 / C9H8N6O2 √ 0.01185 SF 
3 7.85 229.14069 229.14075 / C8H16N6O2 √ 0.05876 SF 
4 8.04 359.14842 359.15025 
359.15681 
/ 
Glu-Pro-Asn 
C21H18N4O2 
C14H22N4O7 
√ 
√ 
1.82948 
8.39 
SF 
LSc* 
4 8.04 376.17547 376.17412 
376.17213 
376.17213 
/ 
Glu-Glu-Val 
Glu-Asp-Ile 
C17H17N11 
C15H25N3O8 
C15H25N3O8 
√ 
√ 
√ 
1.35109 
3.34 
3.34 
SF 
LSc* 
LSc* 
4 8.04 381.13033 381.12839 
381.12677 
/ 
Gln-Met-Cys 
C19H25O4PS 
C13H24N4O5PS
2 
√ 
√ 
1.93695 
3.56 
SF 
LSc* 
5 8.90 273.16693 273.16696 / C10H20N6O3 √ 0.03192 SF 
6 10.27 215.12511 215.12510 / C7H14N6O2 √ 0.00810 SF 
7 10.51 266.17269 266.17238 / C11H19N7O √ 0.30665 SF 
7 10.52 226.17979 226.18016 / C13H23NO2 √ 0.36287 SF 
8 11.17 188.12823 188.12812 / C9H17NO3 √ 0.11051 SF 
8 11.18 170.11753 170.11756 / C9H15NO2 √ 0.02027 SF 
8 11.21 210.10981 210.10978 / C7H11N7O √ 0.03069 SF 
9 16.49 217.10469 217.10436 
217.10109 
/ 
Diketo-Ile-Cys 
C6H12N6O3 
C9H16N2O2S 
√ 
√ 
0.32356 
3.6 
SF 
LSc* 
10 17.20 283.17572 283.17647 / C13H22N4O3 √ 0.74431 SF 
11 21.04 197.16507 197.16484 / C11H20N2O √ 0.22612 SF 
12 21.71 167.11815 167.11789 / C9H14N2O √ 0.25725 SF 
13 28.33 145.04979 145.04954 / C6H8O4 √ 0.25635 SF 
13 28.33 365.10597 365.10783 / C12H8N14O √ 1.85215 SF 
14 31.29 156.98264 156.98550 / C8N2S √ 2.85925 SF 
14 31.29 200.97268 200.97130 / C4N4O4S √ 1.38147 SF 
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Supplementary figure 34: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 1 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 34. 
 
Supplementary table 34: Detected mass to charge ratios in sub-fraction 1 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 34. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 10.71 326.37754 326.37813 / C22H47N √ 0.58807 SF 
2 11.63 304.29956 304.29988 / C21H37N √ 0.31490 SF 
2 11.68 468.41919 468.41999 / C32H53NO √ 0.80327 SF 
3 18.50 130.04962 130.04987 (R)-(+)-
Pyrrolidone-5-
carboxylic acid 
C5H7NO3 √ 0.24669 SF/SL 
3 18.50 259.09209 259.09246 
259.09303 
/ 
Diketo-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.37230 
0.94 
SF 
LSc 
3 18.50 388.13469 388.13639 / C16H17N7O5 √ 1.70215 SF 
4 19.17 240.23194 240.23219 / C15H29NO √ 0.25253 SF 
4 19.17 343.19702 343.19893 
343.19828 
/ 
Val-Gln-Pro 
C19H38N2O3 
C15H26N4O5 
√ 
√ 
0.69228 
1.26 
SF 
LSc 
5 20.12 201.08632 201.08832 
201.08755 
/ 
Diketo-Glu-Ala 
C9H8N6 
C8H12N2O3 
√ 
√ 
1.99942 
1.23 
SF 
LSc 
6 20.43 227.10233 227.10429 
227.1032 
/ 
Diketo-Glu-Pro 
C8H19O5P 
C10H14N2O4 
√ 
√ 
1.95784 
0.87 
SF 
LSc 
6 20.43 453.19753 453.19830 / C15H25N12O3P √ 0.76709 SF 
7 21.16 209.09158 209.09207 / C10H12N2O3 √ 0.49294 SF 
7 21.16 248.09984 248.10028 / C8H9N9O √ 0.44010 SF 
7 21.17 226.11791 226.11862 
226.11918 
/ 
Diketo-Gln-Pro 
C10H15N3O3 
equivalent to SF 
√ 
√ 
0.70488 
1.27 
SF 
LSc 
8 21.31 187.07095 187.07267 
187.0719 
187.0719 
/ 
Diketo-Asp-Ala 
Diketo-Glu-Gly 
C8H6N6 
C7H10N2O4 
C7H10N2O4 
√ 
√ 
√ 
1.72128 
0.95 
0.95 
SF 
LSc 
LSc 
8 21.38 263.13841 263.13902 Pro-Phe C14H18N2O3 √ 0.60743 SF/SL 
8 21.38 231.16932 231.17032 / C11H22N2O3 √ 0.99597 SF 
8 21.42 259.09195 259.09246 
259.09303 
/ 
Diketo-Glu-Glu 
C10H14N2O6 
equivalent to SF 
√ 
√ 
0.51392 
1.08 
SF 
LSc 
8 21.42 241.08154 241.08324 
241.07593 
/ 
Diketo-His-Cys 
C11H8N6O 
C9H12N4O2S 
√ 
√ 
1.69540 
5.61 
SF 
LSc 
8 21.50 229.15420 229.15467 Pro-Leu C11H20N2O3 √ 0.46582 SF/SL 
8 21.55 195.07580 195.07642 / C9H10N2O3 √ 0.62246 SF 
8 21.55 212.10262 212.10297 
212.10353 
/ 
Diketo-Pro-Asn 
C9H13N3O3 
equivalent to SF 
√ 
√ 
0.34302 
0.91 
SF 
LSc 
8 21.59 324.15459 324.15290 / C19H21N3S √ 1.69029 SF 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
324.15608 
324.15608 
Thr-Gly-Phe 
Ser-Phe-Ala 
C15H21N3O5 
C15H21N3O5 
√ 
√ 
1.49 
1.49 
LSc 
LSc 
9 21.90 231.09679 231.09755 
231.09811 
/ 
Diketo-Glu-Thr 
C9H14N2O5 
equivalent to SF 
√ 
√ 
0.75815 
1.32 
SF 
LSc 
10 22.56 251.13609 251.13633 / C9H14N8O √ 0.24368 SF 
10 22.57 229.15419 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.47410 
1.16 
SF 
LSc 
10 22.77 263.19563 263.19653 / C12H26N2O4 √ 0.90763 SF 
10 22.78 132.10165 132.10191 L-Norleucine C6H13NO2 √ 0.25130 SF/SL 
11 23.27 229.15425 229.15467 Pro-Leu C11H20N2O3 √ 0.46582 SF/LSc 
11 23.35 211.14361 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
0.49333 
1.06 
SF 
LSc 
11 23.37 326.20671 326.20743 Pro-Pro-Ile C16H27N3O4 √ 0.72521 SF/SL 
12 23.58 132.10159 132.10191 L-Norleucine C6H13NO2 √ 0.31130 SF/SL 
12 23.58 263.19578 263.19653 / C12H26N2O4 √ 0.75699 SF 
12 23.64 300.19136 300.19178 
300.19247 
/ 
Pro-Ile-Ala 
C14H25N3O4 
equivalent to SF 
√ 
√ 
0.42437 
1.11 
SF 
LSc 
13 23.78 355.16067 355.16255 / C16H18N8O2 √ 1.87534 SF 
13 23.79 240.09727 240.09788 / C10H13N3O4 √ 0.61432 SF 
14 24.02 132.10162 132.10191 L-Norleucine C6H13NO2 √ 0.28529 SF/SL 
14 24.05 258.10819 258.10845 
258.10901 
/ 
Diketo-Glu-Gln 
C10H15N3O5 
equivalent to SF 
√ 
√ 
0.25694 
0.82 
SF 
LSc 
14 24.06 241.08148 241.08190 / C10H12N2O5 √ 0.41710 SF 
15 24.39 215.13857 215.13902 
215.13958 
215.1397 
/ 
Diketo-Thr-Ile 
Val-Pro 
C10H18N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.45212 
1.01 
1.13 
SF 
LSc 
LSc 
15 24.41 279.13323 279.13393 
279.13461 
/ 
Tyr-Pro 
C14H18N2O4 
equivalent to SF 
√ 
√ 
0.69903 
1.38 
SF 
LSc 
15 24.48 189.12281 189.12337 
189.12404 
189.12404 
/ 
Ile-Gly 
Val-Ala 
C8H16N2O3 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.56191 
1.23 
1.23 
SF 
LSc 
LSc 
16 24.59 355.16058 355.16121 / C15H22N4O6 √ 0.62823 SF 
16 24.60 147.07594 147.07642 
147.07250 
/ 
Glutamine 
C5H10N2O3 
equivalent to SF 
√ 
√ 
0.47857 
3.44 
SF 
LSc 
17 24.83 312.19176 312.19178 Pro-Pro-Val C15H25N3O4 √ 0.02404 SF/SL 
17 24.97 330.20167 330.20235 Leu-Pro-Thr C15H27N3O5 √ 0.67446 SF/SL 
17 24.98 133.03129 133.03178 / C5H8O2S / 0.48933 SF 
17 24.99 150.05791 150.05833 L-Methionine C5H11NO2S √ 0.51125 SF/SL 
17 25.10 247.12786 217.12885 Ile-Asp C10H18N2O5 √ 0.99091 SF/SL 
18 25.60 247.12829 247.12885 Val-Glu C10H18N2O5 √ 0.55889 SF/SL 
18 25.61 148.05997 148.06177 
148.05651 
/ 
Glutamic acid 
C6H5N5 
C5H9NO4 
√ 
√ 
1.79727 
3.46 
SF 
LSc 
19 25.89 219.13365 219.13393 Ile-Ser C9H18N2O4 √ 0.28506 SF/SL 
19 25.91 260.16013 260.16048 Gly-Leu-Ala C11H21N3O4 √ 0.35623 SF/SL 
19 25.97 187.10718 187.10772 
187.1084 
/ 
Pro-Ala 
C8H14N2O3 
equivalent to SF 
√ 
√ 
0.53396 
1.22 
SF 
LSc 
19 26.11 357.21254 357.21325 Ile-Pro-Gln C16H28N4O5 √ 0.70561 SF/SL 
19 26.13 205.11789 205.11962 Val-Ser C8H16N2O4 √ 1.73035 SF/SL 
19 26.25 233.11292 233.11320 Val-Asp C9H16N2O5 √ 0.28221 SF/SL 
19 26.36 254.16094 254.16115 
254.16172 
/ 
Diketo-Arg-Pro 
C11H19N5O2 
equivalent to SF 
√ 
√ 
0.20607 
0.78 
SF 
LSc 
20 26.84 217.11771 217.11828 Pro-Thr C9H16N2O4 √ 0.57726 SF/SL 
20 26.91 231.09743 231.09889 
231.09811 
/ 
Diketo-Glu-Thr 
C10H10N6O 
C9H14N2O5 
√ 
√ 
1.45676 
0.68 
SF 
LSc 
20 27.00 226.15450 226.15500 
226.15557 
/ 
Diketo-Lys-Pro 
C11H19N3O2 
equivalent to SF 
√ 
√ 
0.49947 
1.07 
SF 
LSc 
20 27.05 205.11787 205.11828 Val-Ser C8H16N2O4 √ 0.41380 SF/SL 
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 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
20 27.07 276.14349 276.14282 / C9H13N11 √ 0.67071 SF 
21 27.68 203.10200 203.10263 Pro-Ser C8H14N2O4 √ 0.66489 SF/SL 
21 27.83 148.06021 148.06043 L-Glutamate C5H9NO4 √ 0.22046 SF/SL 
21 27.89 244.12873 244.13052 / C11H13N7 √ 1.79366 SF 
22 29.34 130.04956 130.04987 / C5H7NO3 √ 0.31391 SF 
22 29.35 147.07592 147.07642 D-Glutamine C5H10N2O3 √ 0.49918 SF/SL 
22 29.37 293.14508 293.14556 / C10H20N4O6 √ 0.48161 SF 
23 30.39 275.13415 275.13500 Gln-Gln C10H18N4O5 √ 0.84986 SF/SL 
24 30.70 234.10726 234.10845 Ser-Gln C8H15N3O5 √ 1.18248 SF/SL 
24 30.71 217.08161 217.08190 
217.08246 
/ 
Diketo-Glu-Ser 
C8H12N2O5 
equivalent to SF 
√ 
√ 
0.28657 
0.85 
SF 
LSc 
25 31.08 273.10812 273.10945 / C12H12N6O2 √ 1.32765 SF 
25 31.14 332.15589 332.15646 Gly-Gln-Gln C12H21N5O6 √ 0.57193 SF/SL 
26 32.23 182.96141 182.95690 / C7H2O2S2 √ 4.51040 SF 
27 32.79 175.11845 175.11895 L-Arginine C6H14N4O2 √ 0.55057 SF/SL 
27 32.87 147.11278 147.11280 / C6H14N2O2 √ 0.41281 SF 
27 32.87 156.07654 156.07675 L-Histidine C6H9N3O2 √ 0.20987 SF/SL 
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Supplementary figure 35: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 2 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 35. 
 
Supplementary table 35: Detected mass to charge ratios in sub-fraction 2 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 35. Results highlighted in light 
green were also detected in the starting material.  
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 10.56 326.37770 326.37813 / C22H47N √ 0.42842 SF 
2 15.95 304.29933 304.29988 / C21H37N √ 0.54683 SF 
2 15.95 468.41907 468.41999 / C32H53NO √ 0.92182 SF 
3 17.47 229.11759 229.11828 
229.11885 
/ 
Diketo-Asp-Ile 
C10H16N2O4 
equivalent to SF 
√ 
√ 
0.68804 
1.26 
SF 
LSc 
4 18.36 240.23203 240.23219 / C15H29NO √ 0.15988 SF 
5 18.72 209.09188 209.09207 / C10H12N2O3 √ 0.18801 SF 
5 18.72 326.17062 326.17105 / C15H23N3O5 √ 0.42332 SF 
6 19.57 227.10236 227.10263 
227.1032 
/ 
Diketo-Glu-Pro 
C10H14N2O4 
equivalent to SF 
√ 
√ 
0.26942 
0.84 
SF 
LSc 
6 19.57 453.19741 453.19830 / C15H25N12O3P √ 0.88402 SF 
6 19.57 475.17933 475.18131 / C16H27N8O7P √ 1.97366 SF 
7 20.76 324.15478 324.15540 
324.15607 
324.15607 
/ 
Thr-Phe-Gly 
Ala-Tyr-Ala 
C15H21N3O5 
equivalent to SF 
equivalent to SF 
√ 
√ 
√ 
0.62110 
1.29 
1.29 
SF 
LSc 
LSc 
8 21.97 120.08044 120.08078 / C8H9N √ 0.33086 SF 
8 21.97 263.13863 263.13902 L-phenylalanyl-
L-proline 
C14H18N2O3 √ 0.39222 SF/SL 
8 22.19 229.15415 229.15467 
229.15535 
/ 
Ile-Pro 
C11H20N2O3 
equivalent to SF 
√ 
√ 
0.51618 
1.2 
SF 
LSc 
9 31.79 200.97184 200.97130 / C4N4O4S √ 0.54000 SF 
9 31.83 182.96132 182.95690 / C7H2O2S2 √ 4.42038 SF 
 
 
Supplementary figure 36: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 3 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 36. 
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Supplementary table 36: Detected mass to charge ratios in sub-fraction 3 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 36. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 9.51 211.14306 211.14410 
211.14467 
/ 
Diketo-Pro-Ile 
C11H18N2O2 
equivalent to SF 
√ 
√ 
1.04280 
1.61 
SF 
LSc 
1 9.54 521.37963 521.37830 / C23H44N12O2 √ 1.33237 SF 
2 10.16 326.37732 326.37813 / C22H47N √ 0.80296 SF 
3 11.26 304.29895 304.29988 / C21H37N √ 0.92570 SF 
4 16.69 243.13297 243.13393 
243.1345 
/ 
Diketo-Glu-Ile 
C11H18N2O4 
equivalent to SF 
√ 
√ 
0.96772 
1.53 
SF 
LSc 
4 16.73 197.12723 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
1.22332 
1.79 
SF 
LSc 
5 17.49 340.18571 340.18670 / C16H25N3O5 √ 0.98997 SF 
5 17.49 362.16751 362.16836 
362.1677 
362.1677 
/ 
Gln-Gln-Ser 
Asn-Gln-Thr 
C14H19N9O3 
C13H23N5O7 
C13H23N5O7 
√ 
√ 
√ 
0.85513 
0.19 
0.19 
SF 
LSc 
LSc 
5 17.52 197.12747 197.12845 
197.12902 
/ 
Diketo-Pro-Val 
C10H16N2O2 
equivalent to SF 
√ 
√ 
0.98833 
1.55 
SF 
LSc 
6 17.73 132.10132 132.10191 / C6H13NO2 √ 0.58078 SF 
6 17.73 340.18581 340.18670 / C16H25N3O5 √ 0.88260 SF 
7 18.09 326.16995 326.16836 / C11H19N9O3 √ 1.58990 SF 
7 18.11 343.29432 343.29552 / C19H38N2O3 √ 1.19745 SF 
7 18.12 240.23096 240.23219 / C15H29NO √ 1.23473 SF 
8 18.95 390.16454 390.16346 
390.16262 
/ 
Gln-Glu-Asn 
C23H23N3OS 
C14H23N5O8 
√ 
√ 
1.08072 
1.92 
SF 
LSc 
8 18.96 182.08045 182.08117 
182.07725 
/ 
Tyrosine 
C9H11NO3 
equivalent to SF 
√ 
√ 
0.72298 
3.2 
SF 
LSc 
9 19.75 376.22161 376.22308 Leu-Pro-Phe C20H29N3O4 √ 1.47069 SF/SL 
9 19.88 342.23745 342.23873 Leu-Pro-Ile C17H31N3O4 √ 1.27770 SF/SL 
10 21.52 120.08031 120.08078 / C8H9N √ 0.46199 SF 
10 21.52 263.13828 263.13902 L-phenylalanyl-
L-proline 
C14H18N2O3 √ 0.74250 SF/SL 
11 31.26 182.96102 182.96027 / C4H6O2S3 √ 0.74985 SF 
11 31.27 200.97142 200.96958 / C5HN2O5P √ 1.83722 SF 
 
 
Supplementary figure 37: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 4 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 37. 
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Supplementary table 37: Detected mass to charge ratios in sub-fraction 4 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 37. Results highlighted in light 
green were also detected in the starting material. Results highlighted in light yellow were not detected in the 
sub-fractionated SEC-fraction but at least in one of the SEC-fractions. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 10.59 326.37774 326.37813 / C22H47N √ 0.38793 SF 
2 15.37 468.42005 468.41999 / C32H53NO √ 0.06142 SF 
2 16.09 304.29983 304.29988 / C21H37N √ 0.04263 SF 
3 17.45 374.17100 374.17105 / C19H23N3O5 √ 0.04506 SF 
4 17.60 340.18659 340.18803 / C17H21N7O √ 1.44000 SF 
5 17.80 166.08609 166.08626 
166.08233 
/ 
Phenylalanine 
C9H11NO2 
equivalent to SF 
√ 
√ 
0.16408 
3.76 
SF 
LSc 
5 17.80 209.09183 209.09207 / C10H12N2O3 √ 0.24319 SF 
5 17.80 374.17096 374.17238 / C20H19N7O √ 1.42207 SF 
6 18.23 240.23203 240.23219 / C15H29NO √ 0.15690 SF 
6 18.24 343.29599 343.29552 / C19H38N2O3 √ 0.47171 SF 
6 18.37 471.22424 471.22381 / C24H30N4O6 √ 0.43303 SF 
6 18.38 493.20577 493.20681 / C23H20N14 √ 1.04117 SF 
6 18.47 263.13898 263.13902 
263.1397 
/ 
Phe-Pro 
C14H18N2O3 
equivalent to SF 
√ 
√ 
0.03503 
0.72 
SF 
LSc 
7 31.56 200.97220 200.97130 / C4N4O4S √ 0.90322 SF 
7 31.58 156.98194 156.97976 / C4HN2O3P √ 2.18598 SF 
 
 
 
Supplementary figure 38: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 5 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 38. 
Supplementary table 38: Detected mass to charge ratios in sub-fraction 5 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 38. Results highlighted in light 
green were also detected in the starting material. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 10.63 326.37786 326.37813 / C22H47N √ 0.26875 SF 
2 11.81 304.29965 304.29988 / C21H37N √ 0.22565 SF 
3 18.27 240.23217 240.23219 / C15H29NO √ 0.01588 SF 
3 18.27 343.29546 343.29552 / C19H38N2O3 √ 0.05782 SF 
4 31.57 200.97201 200.97130 / C4N4O4S √ 0.70673 SF 
4 31.58 182.96151 182.95690 / C7H2O2S2 √ 4.59609 SF 
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Supplementary figure 39: Base Peak chromatogram (BPC) of the ESI positive MS/MS mode of the 
reconstituted sub-fraction 6 of SEC-A5 from sample 3. The numbering of the peaks correlates with the 
numbering in Supplementary table 39. 
 
Supplementary table 39: Detected mass to charge ratios in sub-fraction 6 of SEC-A5 sample 3. Indicated names 
of the substances were proposed by the operator (LSc) or calculated and identified by the spectral library (SL). 
Numbering in this table corresponds to the numbering in Supplementary figure 39. Results highlighted in light 
green were also detected in the starting material. 
 RT 
[min ] 
m/z meas.  m/z calc.  Name Molecular 
Formula 
MS/MS IΔm/zI 
[mDa] 
Annotations 
1 10.51 326.37777 326.37813 / C22H47N √ 0.35460 SF 
2 15.37 468.41969 468.41999 / C32H53NO √ 0.30243 SF 
3 16.20 304.29960 304.29988 / C21H37N √ 0.27441 SF 
4 18.39 343.29530 343.29552 / C19H38N2O3 √ 0.22200 SF 
4 18.41 240.23207 240.23219 / C15H29NO √ 0.12509 SF 
5 27.98 158.96409 158.96813 / C4H2N2OS √ 4.03651 SF 
5 27.98 226.95094 226.94673 / C8H2O4S2 √ 4.20961 SF 
6 31.87 182.96165 182.95690 / C7H2O2S2 √ 4.74804 SF 
7 31.88 200.97201 200.97130 / C4H4O4S √ 0.71101 SF 
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